MetLife Annual Report 2004

Plain-text annual report

Chairman’s Letter To MetLife’s Shareholders: MetLife is widely respected as a company that is financially strong and committed to meeting its long- term obligations: we deliver on the guarantees and promises we make. At the same time, our company has, for 137 years, demonstrated something equally important and compelling—that MetLife builds financial freedom for everyone. This commitment and the execution of our business plans in 2004 resulted in record results for MetLife’s shareholders—the owners of this great organization. For the third year in a row, MetLife delivered record net income. We did this by keeping a strong focus on effectively managing and further growing the businesses where we are a leader. Today, we’re leveraging the vast knowledge and thought leadership within MetLife to develop new and innovative solutions that will enhance and complement our current product portfolio. And with MetLife’s diverse offerings and strong financial ratings, our multiple distribution systems continue to successfully and effectively help our clients prepare for their financial future. Maintaining a focus on both product development and distribution is crucial because, even though we already serve tens of milli ons of customers, there are many more who can benefit from the financial solutions MetLife offers. In addition to a focus on business results, the entire management team at MetLife is committed to maintaining our high standards for corporate governance and strong ethics and compliance programs. Executive bonuses are tied directly to return on equity growth and we have stock ownership guidelines at every level of management from vice president and above to ensure that every officer has a stake in the future of MetLife. Growth and Record Results H In 2004, MetLife’s total revenues rose 10% to $39 billion. For the year, net income grew 24% to $2.76 billion; total premiums, fees and other revenues were up 8% to $26.4 billion; annuity deposits increased slightly; and assets under management grew 9%. In addition to maintaining a focus on financial performance, each of MetLife’s core businesses grew their top-line results. Institutional Business net income increased by 50% for the year, generated double-digit growth in the small, mid-sized and large group markets, achieved record structured settlement sales, launched a new annuity series in Retirement & Savings, and continued to introduce group product and service innovations. In addition, Institutional Business also launched a pilot program for MetLife’s new critical illness business. This new product initiative is a perfect example of our ability to leverage our expertise, market-leading position and strong ratings to develop a new offering in the marketplace. During the year, Individual Business net income increased by 45% over 2003 results. MetLife’s Individual Business organization is putting comprehensive plans in place to keep the company at the forefront of our industry by strengthening our retail distribution channels and by enhancing MetLife’s competitive portfolio of life and annuity products to meet our clients’ needs. In 2004, Individual Business launched a new guaranteed withdrawal benefit rider for all of the company’s individual variable annuities and grew the number of MetLife career agents for the first time since 1999. MetLife is committed to growing its career agency distribution channel by recruiting high quality, talented professionals. MetLife Auto & Home posted its third consecutive record year as net income for the segment grew 32% to $208 million. This was an impressive achievement considering that this earnings growth was attained in a year when the southeast U.S. experienced one of the worst hurricane seasons in history. MetLife Auto & Home has also significantly reduced its combined ratio. In addition to generating strong, top-line results during the year, MetLife International also grew its customer base by one million to nine million customers at December 31, 2004 as this segment continues to focus on growing and investing in key emerging markets outside of the United States. Since its launch in March 2004, Sino-U.S. MetLife Insurance Company has been focused on recruiting talented individuals to join our professional agency force in Beijing, China. In addition, in September 2004, MetLife purchased a 49.9% equity stake in BancoEstado Corredora de Seguros, a wholly-owned brokerage company of BancoEstado, one of the largest banks in Chile. Moving forward, International will continue to be a growth engine for MetLife. MetLife Bank more than doubled deposits during the year—growing from $1.3 billion at the end of 2003 to $2.7 billion at the end of 2004. Not only did MetLife Bank continue to bring in substantial deposit growth, it also achieved profitability one year ahead of plan. With the strong MetLife brand and competitive savings products, MetLife Bank continues to demonstrate its ability to compete in the aggressive retail banking marketplace. Delivering on Strategy H Though it was announced in January 2005, it is certainly important for me to highlight MetLife’s pending acquisition of the majority of The Travelers Insurance Company and substantially all of Citigroup Inc.’s international insurance businesses. This transaction will be a defining one for MetLife. Once completed, the acquisition will make MetLife the largest seller of individual life insurance in the United States, the second largest seller of annuities and will substantially increase MetLife’s international footprint. Equally important, it will expand the distribution reach of our organization through ten-year agreements we will sign with Citigroup. Not only is this transaction a strategic fit, it will also increase our customer base, bringing MetLife closer to achieving its goal of 100 million customers by 2010. In keeping with our core business strategy, in 2004 we made the decision to sell SSRM Holdings, Inc., the holding company of State Street Research & Management Company and SSR Realty Advisors, Inc., to BlackRock, Inc.—one of the largest publicly-traded investment management firms in the country. State Street Research clients, which include many MetLife Institutional customers, are now being well served by a successful, experienced investment management organization. We continued to build shareholder value during the year by effectively managing MetLife’s finances and appropriately diversifying the company’s investment portfolio, which grew to approximately $240 billion at the end of 2004. During the year, we repurchased approximately 26 million shares of common stock and doubled the shareholder dividend to $0.46 per share. At the same time, shareholders’ equity, excluding other comprehensive income, increased by 8% to $19.9 billion. A Strong Talent Base H While core business growth is a key priority, one of the attributes that has made MetLife a strong, well-diversified competitor in the marketplace has been our diverse and experienced talent pool. In 2004, we made several critical leadership changes. In June, C. Robert Henrikson was named MetLife, Inc.’s president and chief operating officer and now oversees all of the company’s revenue-generating businesses. Having all of MetLife’s business segments report to Rob will better position the company to leverage the common operating platform we’ve developed over the past several years and further improve results. Lisa M. Weber was named president of Individual Business and, effective January 1, 2005, also oversees the company’s Auto & Home segment. This moves all of MetLife’s retail insurance operations under one organization and better positions it to serve the needs of MetLife’s individual clients. Also on January 1, Catherine A. Rein, who oversaw six years of growth at MetLife Auto & Home, was named senior executive vice president and chief administrative officer. With all of MetLife’s support functions reporting to Cathy, including human resources, ethics and compliance, information technology and more, her organization is well structured to support the needs of each of MetLife’s business segments. Opportunities for Future Growth H Last year, I told you that it was an extremely exciting time to be at MetLife. Our momentum continues today as MetLife prepares, during 2005, to once again demonstrate our ability to deliver on our targets. As we continue to work hard to complete our acquisition of Travelers, we also remain keenly focused on our 2005 business plans. We are launching new products in the marketplace and identifying ways to grow our customer base. We know that people across the globe are under-insured, under-saved and, in the case of the baby boom generation, in need of retirement solutions that will guarantee income. MetLife is ready to meet these needs and more. Through our combined market leadership, financial strength and strong distribution systems, we are ready to meet those needs. I look forward to continuing to share our progress with you and I thank you for your continued confidence and support of MetLife. Sincerely, Robert H. Benmosche Chairman of the Board and Chief Executive Ofﬁcer MetLife, Inc. March 18, 2005 Note Regarding Forward-Looking Statements This Annual Report, including the Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in the operations and ﬁnancial results and the business and the products of the Registrant and its subsidiaries, as well as other statements including words such as ‘‘anticipate,’’ ‘‘believe,’’ ‘‘plan,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘intend’’ and other similar expressions. ‘‘MetLife’’ or the ‘‘Company’’ refers to MetLife, Inc., a Delaware corporation (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Such forward-looking statements are not guarantees of future performance. See ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations.’’ Selected Financial Data The following table sets forth selected consolidated ﬁnancial information for the Company. The selected consolidated ﬁnancial information for the years ended December 31, 2004, 2003, and 2002, and at December 31, 2004 and 2003 has been derived from the Company’s audited consolidated ﬁnancial statements included elsewhere herein. The selected consolidated ﬁnancial information for the years ended December 31, 2001 and 2000 and at December 31, 2002, 2001 and 2000 has been derived from the Company’s audited consolidated ﬁnancial statements not included elsewhere herein. The following information should be read in conjunction with and is qualiﬁed in its entirety by the information contained in ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations,’’ and the consolidated ﬁnancial statements appearing elsewhere herein. Some previously reported amounts have been reclassiﬁed to conform with the presentation at and for the year ended December 31, 2004. For the Years Ended December 31, 2004 2003 2002 2001 2000 (Dollars in millions) Statements of Income Data Revenues: Premiums ************************************************************* $22,316 Universal life and investment-type product policy fees ************************ 2,900 Net investment income(1) ************************************************ 12,418 Other revenues ******************************************************** 1,198 Net investment gains (losses)(1)(2)(3) ************************************** 182 Total revenues(4)(5)(6) ********************************************* 39,014 $20,673 2,496 11,539 1,199 (582) $19,077 2,147 11,183 1,166 (892) $17,212 1,889 11,101 1,340 (713) $16,317 1,820 10,886 2,070 (444) 35,325 32,681 30,829 30,649 Expenses: Policyholder beneﬁts and claims ****************************************** Interest credited to policyholder account balances *************************** Policyholder dividends *************************************************** Payments to former Canadian policyholders(7)******************************* Demutualization costs *************************************************** Other expenses(1) ****************************************************** Total expenses(4)(5)(6)(7)******************************************* Income from continuing operations before provision for income taxes ************* Provision for income taxes(1)(4)(8) ******************************************* Income from continuing operations ****************************************** Income from discontinued operations, net of income taxes(1)(4) ****************** Income before cumulative effect of a change in accounting********************** 2,844 Cumulative effect of a change in accounting, net of income taxes **************** (86) Net income************************************************************** $ 2,758 22,662 2,998 1,814 — — 7,761 3,779 1,071 2,708 136 35,235 Net income after April 7, 2000 (date of demutualization)************************* 20,665 3,035 1,975 — — 7,091 32,766 2,559 660 1,899 344 2,243 (26) 19,373 2,950 1,942 — — 6,813 31,078 1,603 490 1,113 492 1,605 — $ 2,217 $ 1,605 $ 18,295 3,084 2,086 — — 6,835 30,300 529 191 338 135 473 — 473 16,934 2,935 1,919 327 230 7,112 29,457 1,192 376 816 137 953 — 953 $ $ 1,173 MetLife, Inc. 1 2004 2003 2002 2001 2000 (Dollars in millions) At December 31, Balance Sheet Data Assets: General account assets ******************************************** $270,039 Separate account assets******************************************* 86,769 Total assets(4) ************************************************** $356,808 $251,085 75,756 $217,733 59,693 $194,256 62,714 $183,912 70,250 $326,841 $277,426 $256,970 $254,162 Liabilities: Life and health policyholder liabilities(9) ******************************* $190,847 Property and casualty policyholder liabilities**************************** 3,180 Short-term debt ************************************************** 1,445 Long-term debt *************************************************** 7,412 Other liabilities **************************************************** 44,331 Separate account liabilities ***************************************** 86,769 Total liabilities(4)************************************************* Company-obligated mandatorily redeemable securities of subsidiary trusts** 333,984 — $176,628 2,943 3,642 5,703 41,020 75,756 $162,569 2,673 1,161 4,411 28,269 59,693 $148,395 2,610 355 3,614 21,964 62,714 $140,040 2,559 1,085 2,353 20,396 70,250 305,692 258,776 239,652 236,683 — 1,265 1,256 1,090 Stockholders’ Equity: Common stock, at par value(10) ************************************ Additional paid-in capital(10) **************************************** Retained earnings(10)********************************************** Treasury stock, at cost(10) ***************************************** Accumulated other comprehensive income (loss)(10) ******************* Total stockholders’ equity***************************************** 22,824 Total liabilities and stockholders’ equity ***************************** $356,808 8 15,037 6,608 (1,785) 2,956 8 14,991 4,193 (835) 2,792 21,149 8 14,968 2,807 (2,405) 2,007 17,385 8 14,966 1,349 (1,934) 1,673 16,062 8 14,926 1,021 (613) 1,047 16,389 $326,841 $277,426 $256,970 $254,162 At or for the Years Ended December 31, 2004 2003 2002 2001 2000 (Dollars in millions) Other Data Net income ****************************************************** $ Return on equity(11) *********************************************** Return on equity, excluding accumulated other comprehensive income **** Total assets under management(12)********************************** $386,951 2,758 12.5% 14.4% Income from Continuing Operations Available to Common Shareholders Per Share(13) Basic *********************************************************** $ Diluted ********************************************************** $ Income from Discontinued Operations Per Share(13) Basic *********************************************************** $ Diluted ********************************************************** $ 3.61 3.59 0.18 0.18 Cumulative Effect of a Change in Accounting Per Share(13) Basic *********************************************************** $ Diluted ********************************************************** $ (0.11) (0.11) Net Income Available to Common Shareholders Per Share(13) Basic *********************************************************** $ Diluted ********************************************************** $ Dividends Declared Per Share ************************************* $ 3.68 3.65 0.46 $ 2,217 $ 1,605 $ 11.5% 13.1% 9.6% 10.8% $ 473 2.9% 3.2% 953 6.3% 12.1% $350,235 $299,187 $282,486 $301,325 $ $ $ $ $ $ $ $ $ 2.55 2.51 0.47 0.46 (0.04) (0.03) 2.98 2.94 0.23 $ $ $ $ $ $ $ $ $ 1.58 1.53 0.70 0.67 — — 2.28 2.20 0.21 $ $ $ $ $ $ $ $ $ 0.46 0.45 0.18 0.18 — — 0.64 0.62 0.20 $ $ $ $ $ $ $ $ $ 1.41 1.39 0.11 0.11 — — 1.52 1.49 0.20 (1) In accordance with Statement of Financial Accounting Standards (‘‘SFAS’’) No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (‘‘SFAS 144’’), income related to real estate sold or classiﬁed as held-for-sale for transactions initiated on or after January 1, 2002 is presented as discontinued operations. The following table presents the components of income from discontinued real estate operations (see footnote 4): For the Years Ended December 31, 2004 2003 2002 2001 2000 (Dollars in millions) Investment income ************************************************ $136 Investment expense *********************************************** (82) Net investment gains (losses) *************************************** 139 Total revenues ************************************************** Interest expense ************************************************** Provision for income taxes****************************************** 193 13 63 Income from discontinued operations, net of income taxes************* $117 $ 231 (138) 420 513 4 186 $ 530 (351) 582 761 1 276 $ 525 (339) — 186 — 68 $177 — — 177 — 65 $ 323 $ 484 $ 118 $112 (2) Net investment gains (losses) exclude amounts related to real estate operations reported as discontinued operations in accordance with SFAS 144. 2 MetLife, Inc. (3) Net investment gains (losses) presented include scheduled periodic settlement payments on derivative instruments that do not qualify for hedge accounting under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended, of $51 million, $84 million, $32 million and $24 million for the years ended December 31, 2004, 2003, 2002 and 2001, respectively. (4) During the third quarter of 2004, the Company entered into an agreement to sell its wholly-owned subsidiary, SSRM Holdings, Inc. (‘‘SSRM’’), to a third party, which was sold on January 31, 2005. In accordance with SFAS 144, the assets, liabilities and operations of SSRM have been reclassiﬁed into discontinued operations for all periods presented. The following tables present the operations of SSRM: For the Years Ended December 31, 2004 2003 2002 2001 2000 (Dollars in millions) Revenues from discontinued operations ************************************ $328 $231 $239 $254 $258 Income from discontinued operations, before provision for income taxes********* $ 32 Provision for income taxes *********************************************** 13 Income from discontinued operations, net of income taxes ****************** $ 19 $ 34 13 $ 21 $ 14 6 $ 8 $ 24 7 $ 17 $ 47 22 $ 25 General account assets ************************************************* $379 Total assets ********************************************************* $379 $183 $183 $198 $198 $203 $203 $228 $228 For the Years Ended December 31, 2004 2003 2002 2001 2000 (Dollars in millions) Short-term debt ******************************************************** $ 19 Long-term debt ******************************************************** — Other liabilities ********************************************************* 221 Total liabilities ******************************************************** $240 $ — $ — $ — $ — 47 95 14 80 14 78 — 70 $ 70 $ 92 $ 94 $142 (5) Includes the following combined ﬁnancial statement data of Conning Corporation (‘‘Conning’’), which was sold in 2001, and MetLife’s interest in Nvest Companies, L.P. (‘‘Nvest’’) and its afﬁliates, which was sold in 2000: For the Years Ended December 31, 2001 2000 (Dollars in millions) Total revenues********************************************************************************* $32 Total expenses ******************************************************************************** $33 $605 $580 (6) (7) As a result of these sales, investment gains of $25 million and $663 million were recorded for the years ended December 31, 2001 and 2000, respectively. Included in total revenues and total expenses for the year ended December 31, 2002 are $421 million and $358 million, respectively, related to Aseguradora Hidalgo S.A., which was acquired in June 2002. In July 1998, Metropolitan Life sold a substantial portion of its Canadian operations to Clarica Life Insurance Company (‘‘Clarica Life’’). As part of that sale, a large block of policies in effect with Metropolitan Life in Canada was transferred to Clarica Life, and the holders of the transferred Canadian policies became policyholders of Clarica Life. Those transferred policyholders are no longer policyholders of Metropolitan Life and, therefore, were not entitled to compensation under the plan of reorganization. However, as a result of a commitment made in connection with obtaining Canadian regulatory approval of that sale and in connection with the demutualization, Metropolitan Life’s Canadian branch made cash payments to those who were, or were deemed to be, holders of these transferred Canadian policies. The payments were determined in a manner that is consistent with the treatment of, and fair and equitable to, eligible policyholders of Metropolitan Life. (8) Provision for income taxes includes a credit of $145 million for surplus taxes for the year ended December 31, 2000. Prior to its demutualization, Metropolitan Life was subject to surplus tax imposed on mutual life insurance companies under Section 809 of the Internal Revenue Code. (9) Policyholder liabilities include future policy beneﬁts and other policyholder funds. Life and health policyholder liabilities also include policyholder account balances, policyholder dividends payable and the policyholder dividend obligation. (10) For additional information regarding these items, see Notes 1 and 12 to the Consolidated Financial Statements. (11) Return on equity is deﬁned as net income divided by average total equity. (12) Includes MetLife’s general account and separate account assets and assets managed on behalf of third parties. Includes $21 billion of assets under management managed by Conning at December 31, 2000, which was sold in 2001. Includes assets managed on behalf of third parties related to SSRM, which was sold on January 31, 2005, of $30 billion, $23 billion, $22 billion, $26 billion and $26 billion at December 31, 2004, 2003, 2002, 2001 and 2000, respectively. (13) Based on earnings subsequent to the date of demutualization. For additional information regarding net income per share data, see Note 14 to the Consolidated Financial Statements. MetLife, Inc. 3 Management’s Discussion and Analysis of Financial Condition and Results of Operations For purposes of this discussion, the terms ‘‘MetLife’’ or the ‘‘Company’’ refers to MetLife, Inc., a Delaware corporation (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). Following this summary is a discussion addressing the consolidated results of operations and ﬁnancial condition of the Company for the periods indicated. This discussion should be read in conjunction with the Company’s consolidated ﬁnancial statements included elsewhere herein. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in the operations and ﬁnancial results and the business and the products of the Registrant and its subsidiaries, as well as other statements including words such as ‘‘anticipate,’’ ‘‘believe,’’ ‘‘plan,’’ ‘‘estimate,’’ ‘‘expect,’’ ‘‘intend’’ and other similar expressions. Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Such forward-looking statements are not guarantees of future performance. Actual results may differ materially from those included in the forward-looking statements as a result of risks and uncertainties including, but not limited to, the following: (i) changes in general economic conditions, including the performance of ﬁnancial markets and interest rates; (ii) heightened competition, including with respect to pricing, entry of new competitors and the development of new products by new and existing competitors; (iii) unanticipated changes in industry trends; (iv) MetLife, Inc.’s primary reliance, as a holding company, on dividends from its subsidiaries to meet debt payment obligations and the applicable regulatory restrictions on the ability of the subsidiaries to pay such dividends; (v) deterioration in the experience of the ‘‘closed block’’ established in connection with the reorganization of Metropolitan Life; (vi) catastrophe losses; (vii) adverse results or other consequences from litigation, arbitration or regulatory investigations; (viii) regulatory, accounting or tax changes that may affect the cost of, or demand for, the Company’s products or services; (ix) downgrades in the Company’s and its afﬁliates’ claims paying ability, ﬁnancial strength or credit ratings; (x) changes in rating agency policies or practices; (xi) discrepancies between actual claims experience and assumptions used in setting prices for the Company’s products and establishing the liabilities for the Company’s obligations for future policy beneﬁts and claims; (xii) discrepancies between actual experience and assumptions used in establishing liabilities related to other contingencies or obligations; (xiii) the effects of business disruption or economic contraction due to terrorism or other hostilities; (xiv) the Company’s ability to identify and consummate on successful terms any future acquisitions, and to successfully integrate acquired businesses with minimal disruption; and (xv) other risks and uncertainties described from time to time in MetLife, Inc.’s ﬁlings with the United States Securities and Exchange Commission (‘‘SEC’’), including its S-1 and S-3 registration statements. The Company speciﬁcally disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Economic Capital Beginning in 2003, the Company changed its methodology of allocating capital to its business segments from Risk-Based Capital (‘‘RBC’’) to Economic Capital. Prior to 2003, the Company’s business segments’ allocated equity was primarily based on RBC, an internally developed formula based on applying a multiple to the National Association of Insurance Commissioners (‘‘NAIC’’) Statutory Risk-Based Capital and included certain adjustments in accordance with accounting principles generally accepted in the United States of America (‘‘GAAP’’). Economic Capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The Economic Capital model accounts for the unique and speciﬁc nature of the risks inherent in MetLife’s businesses. This is in contrast to the standardized regulatory RBC formula, which is not as reﬁned in its risk calculations with respect to the nuances of the Company’s businesses. The change in methodology is being applied prospectively. This change has and will continue to impact the level of net investment income and net income of each of the Company’s business segments. A portion of net investment income is credited to the segments based on the level of allocated equity. This change in methodology of allocating equity does not impact the Company’s consolidated net investment income or net income. The following table presents actual and pro forma net investment income with respect to the Company’s segments for the year ended Decem- ber 31, 2002. The amounts shown as pro forma reﬂect net investment income that would have been reported in 2002 had the Company allocated capital based on Economic Capital rather than on the basis of RBC. Net Investment Income For the Year Ended December 31, 2002 Actual Pro forma (Dollars in millions) Institutional ********************************************************************************* $ 3,909 Individual*********************************************************************************** 6,237 Auto & Home******************************************************************************* 177 International ******************************************************************************** 461 Reinsurance ******************************************************************************** 421 Corporate & Other*************************************************************************** (22) Total ********************************************************************************** $11,183 $ 3,971 6,148 160 424 382 98 $11,183 Acquisitions and Dispositions On January 31, 2005, the Holding Company completed the sale of SSRM Holdings, Inc. (‘‘SSRM’’) to a third party for $328 million of cash and stock. As a result of the sale of SSRM, the Company recognized income from discontinued operations of approximately $150 million, net of income taxes, comprised of a realized gain of $166 million, net of income taxes, and an operating expense related to a lease abandonment of $16 million, net of income taxes. Under the terms of the agreement, MetLife will have an opportunity to receive, prior to the end of 2006, additional payments aggregating up to approximately 25% of the base purchase price, based on, among other things, certain revenue retention and growth measures. The purchase price is also subject to reduction over ﬁve years, depending on retention of certain MetLife-related business. The Company has reclassiﬁed the assets, liabilities and operations of SSRM into discontinued operations for all periods presented in the consolidated ﬁnancial statements. Additionally, the sale of SSRM resulted in the elimination of the Company’s Asset Management segment. The remaining asset management business, which is insigniﬁcant, has been reclassiﬁed into Corporate & Other. The Company’s discontinued operations for the year ended December 31, 2004 also includes expenses of approximately $20 million, net of income taxes, related to the sale of SSRM. 4 MetLife, Inc. In 2003, a subsidiary of the Company, Reinsurance Group of America, Incorporated (‘‘RGA’’), entered into a coinsurance agreement under which it assumed the traditional U.S. life reinsurance business of Allianz Life Insurance Company of North America (‘‘Allianz Life’’). The transaction added approximately $278 billion of life reinsurance in-force, $246 million of premium and $11 million of income before income tax expense, excluding minority interest expense, in 2003. The effects of such transaction are included within the Reinsurance segment. In 2002, the Company acquired Aseguradora Hidalgo S.A. (‘‘Hidalgo’’), an insurance company based in Mexico with approximately $2.5 billion in assets as of the date of acquisition (June 20, 2002). During the second quarter of 2003, as a part of its acquisition and integration strategy, the International segment completed the legal merger of Hidalgo into its original Mexican subsidiary, Seguro Genesis, S.A., forming MetLife Mexico, S.A. As a result of the merger of these companies, the Company recorded $62 million of earnings, net of income taxes, from the merger and a reduction in policyholder liabilities resulting from a change in reserve methodology. Such beneﬁt was recorded in the second quarter of 2003 in the International segment. See ‘‘— Subsequent Events’’ below. Summary of Critical Accounting Estimates The preparation of ﬁnancial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated ﬁnancial statements. The most critical estimates include those used in determining: (i) investment impairments; (ii) the fair value of investments in the absence of quoted market values; (iii) application of the consolidation rules to certain investments; (iv) the fair value of and accounting for derivatives; (v) the capitalization and amortization of deferred policy acquisition costs (‘‘DAC’’), including value of business acquired (‘‘VOBA’’); (vi) the liability for future policyholder beneﬁts; (vii) the liability for litigation and regulatory matters; and (viii) accounting for reinsurance transactions and employee beneﬁt plans. In applying these policies, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and ﬁnancial services industries; others are speciﬁc to the Company’s businesses and operations. Actual results could differ from those estimates. Investments The Company’s principal investments are in ﬁxed maturities, mortgage and other loans and real estate, all of which are exposed to three primary sources of investment risk: credit, interest rate and market valuation. The ﬁnancial statement risks are those associated with the recognition of impairments and income, as well as the determination of fair values. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used by the Company in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the market value has been below cost or amortized cost; (ii) the potential for impairments of securities when the issuer is experiencing signiﬁcant ﬁnancial difﬁculties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources; (vi) the Company’s ability and intent to hold the security for a period of time sufﬁcient to allow for the recovery of its value to an amount equal to or greater than cost or amortized cost; (vii) unfavorable changes in forecasted cash ﬂows on asset-backed securities; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. In addition, the earnings on certain investments are dependent upon market conditions, which could result in prepayments and changes in amounts to be earned due to changing interest rates or equity markets. The determination of fair values in the absence of quoted market values is based on: (i) valuation methodologies; (ii) securities the Company deems to be comparable; and (iii) assumptions deemed appropriate given the circumstances. The use of different methodologies and assumptions may have a material effect on the estimated fair value amounts. In addition, the Company enters into certain structured investment transactions, real estate joint ventures and limited partnerships for which the Company may be deemed to be the primary beneﬁciary and, therefore, may be required to consolidate such investments. The accounting rules for the determination of the primary beneﬁciary are complex and require evaluation of the contractual rights and obligations associated with each party involved in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party. Derivatives The Company enters into freestanding derivative transactions primarily to manage the risk associated with variability in cash ﬂows or changes in fair values related to the Company’s ﬁnancial assets and liabilities. The Company also uses derivative instruments to hedge its currency exposure associated with net investments in certain foreign operations. The Company also purchases investment securities, issues certain insurance policies and engages in certain reinsurance contracts that have embedded derivatives. The associated ﬁnancial statement risk is the volatility in net income which can result from (i) changes in fair value of derivatives not qualifying as accounting hedges; (ii) ineffectiveness of designated hedges; and (iii) counterparty default. In addition, there is a risk that embedded derivatives requiring bifurcation are not identiﬁed and reported at fair value in the consolidated ﬁnancial statements. Accounting for derivatives is complex, as evidenced by signiﬁcant authoritative interpretations of the primary accounting standards which continue to evolve, as well as the signiﬁcant judgments and estimates involved in determining fair value in the absence of quoted market values. These estimates are based on valuation methodologies and assumptions deemed appropriate in the circumstances. Such assumptions include estimated volatility and interest rates used in the determination of fair value where quoted market values are not available. The use of different assumptions may have a material effect on the estimated fair value amounts. Deferred Policy Acquisition Costs The Company incurs signiﬁcant costs in connection with acquiring new and renewal insurance business. These costs, which vary with and are primarily related to the production of that business, are deferred. The recovery of such costs is dependent upon the future proﬁtability of the related business. The amount of future proﬁt is dependent principally on investment returns in excess of the amounts credited to policyholders, mortality, morbidity, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inﬂation. Of these factors, the Company anticipates that investment returns are most likely to impact the rate of amortization of such costs. The aforementioned factors enter into management’s estimates of gross margins and proﬁts, which generally are used to amortize such costs. Revisions to estimates result in changes to the amounts expensed in the reporting period in which the revisions are made and could result in the impairment of the asset and a charge to income if estimated future gross margins and proﬁts are less than amounts deferred. In addition, the Company utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC, including VOBA. This practice MetLife, Inc. 5 assumes that the expectation for long-term appreciation in equity markets is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Liability for Future Policy Beneﬁts and Unpaid Claims and Claim Expenses The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities and non- medical health insurance. Generally, amounts are payable over an extended period of time and liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy beneﬁts are mortality, morbidity, expenses, persistency, investment returns and inﬂation. The Company also establishes liabilities for unpaid claims and claim expenses for property and casualty claim insurance which represent the amount estimated for claims that have been reported but not settled and claims incurred but not reported. Liabilities for unpaid claims are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation. Differences between actual experience and the assumptions used in pricing these policies and in the establishment of liabilities result in variances in proﬁt and could result in losses. The effects of changes in such estimated reserves are included in the results of operations in the period in which the changes occur. Reinsurance The Company enters into reinsurance transactions as both a provider and a purchaser of reinsurance. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the ﬁnancial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Additionally, for each of its reinsurance contracts, the Company must determine if the contract provides indemniﬁcation against loss or liability relating to insurance risk, in accordance with applicable accounting standards. The Company must review all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. If the Company determines that a reinsurance contract does not expose the reinsurer to a reasonable possibility of a signiﬁcant loss from insurance risk, the Company records the contract using the deposit method of accounting. Litigation The Company is a party to a number of legal actions and regulatory investigations. Given the inherent unpredictability of these matters, it is difﬁcult to estimate the impact on the Company’s consolidated ﬁnancial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities related to certain lawsuits, including the Company’s asbestos-related liability, are especially difﬁcult to estimate due to the limitation of available data and uncertainty regarding numerous variables used to determine amounts recorded. The data and variables that impact the assumptions used to estimate the Company’s asbestos-related liability include the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. On a quarterly and annual basis the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. It is possible that an adverse outcome in certain of the Company’s litigation and regulatory investigations, including asbestos- related cases, or the use of different assumptions in the determination of amounts recorded could have a material effect upon the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Employee Beneﬁt Plans The Company sponsors pension and other retirement plans in various forms covering employees who meet speciﬁed eligibility requirements. The reported expense and liability associated with these plans requires an extensive use of assumptions which include the discount rate, expected return on plan assets and rate of future compensation increases as determined by the Company. Management determines these assumptions based upon currently available market and industry data, historical performance of the plan and its assets, and consultation with an independent consulting actuarial ﬁrm. These assumptions used by the Company may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of the participants. These differences may have a signiﬁcant effect on the Company’s consolidated ﬁnancial statements and liquidity. Results of Operations Executive Summary MetLife, Inc., through its subsidiaries and afﬁliates, is a leading provider of insurance and other ﬁnancial services to individual and institutional customers. The Company offers life insurance, annuities, automobile and homeowner’s insurance and retail banking services to individuals, as well as group insurance, reinsurance, and retirement & savings products and services to corporations and other institutions. The MetLife companies serve individuals in approximately 13 million households in the United States and provide beneﬁts to 37 million employees and family members through their plan sponsors including 88 of the top one hundred FORTUNE˛ 500 companies. Outside the United States, the MetLife companies serve approximately 9 million customers through direct insurance operations in Argentina, Brazil, Chile, China, Hong Kong, India, Indonesia, Mexico, South Korea, Taiwan and Uruguay. MetLife is organized into ﬁve operating segments: Institutional, Individual, Auto & Home, International and Reinsurance, as well as Corporate & Other. Year ended December 31, 2004 compared with the year ended December 31, 2003 The Company reported $2,758 million in net income and diluted earnings per share of $3.65 for the year ended December 31, 2004 compared to $2,217 million in net income and diluted earnings per share of $2.94 for the year ended December 31, 2003. Continued top-line revenue growth across all of the Company’s business segments, strong interest rate spreads and an improvement in net investment gains (losses) are the leading contributors to the 24% increase in net income for the year ended December 31, 2004 over the comparable 2003 period. Total premiums, fees and other revenues increased to $26.4 billion, up 8%, from the year ended December 31, 2003, primarily from continued sales growth across most of the Company’s business segments, as well as the positive impact of the U.S. ﬁnancial markets on policy fees. Policy fees from variable life and annuity and investment- type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. Continued strong investment spreads are largely due to higher than expected net investment income from corporate joint venture income and bond and commercial mortgage prepayment fees. In addition, an improvement in net investment gains (losses), net of income taxes, of 6 MetLife, Inc. $485 million is primarily due to the more favorable economic environment in 2004. These increases are partially offset by an $86 million, net of income taxes, cumulative effect of a change in accounting principle in 2004 recorded in accordance with Statement of Position 03-1, Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts (‘‘SOP 03-1’’). In comparison, in the 2003 period the Company recorded a $26 million charge for a cumulative effect of a change in accounting in accordance with FASB Statement 133 Implementation Issue B36 (‘‘Issue B36’’). Year ended December 31, 2003 compared with the year ended December 31, 2002 The marketplace for ﬁnancial services is extremely competitive. MetLife reported $2,217 million in net income and diluted earnings per share of $2.94 for the year ended December 31, 2003. In 2003, after a three-year economic slowdown, there were improvements in both the credit and equity markets. At the same time, interest rates remained at historic lows and the S&P 500 Index was up 26% for the year. Total premiums and fees increased to $23.2 billion, up 9% over the prior year, which primarily stems from continued sales growth across most of the Company’s segments, as well as the positive impact of the U.S. ﬁnancial markets on policy fees. Assets under management grew to $350.2 billion, up 17% over the prior year, and Individual annuity deposits grew to $11.2 billion, up 42% over the prior year. MetLife generated over $11 billion of net investment income while adhering to rigorous asset-liability management principles and portfolio diversiﬁcation. An increase in expenses year over year is primarily attributable to employee-related expenses, including pension and postretirement beneﬁt expense and severance, expenses associated with strengthening the Company’s distribution systems and taking action in consolidating ofﬁce space and reducing redundancies, while continuing to invest heavily in infrastructure. In addition, regulatory capital increased and the Company repurchased stock through its buyback program. Industry Trends The Company’s segments continue to be inﬂuenced by a variety of industry trends and the Company believes that each of its businesses is well positioned to capitalize on those trends. In general, the Company sees more employers, both large and small, outsourcing their beneﬁts functions. Further, companies are offering broader arrays of voluntary beneﬁts to help retain employees while adding little to their overall beneﬁts costs. The Company believes that these trends will likely continue and in fact expand across companies of all sizes. Employers are also demanding substantial online access for their employees for various self-service functions. This functionality requires substantial information technology investment that smaller companies will ﬁnd difﬁcult to absorb. This will put pressure on those smaller and mid-size companies to gain scale quickly or exit the business. Additionally, the Company is seeing a continuing trend of employers moving to deﬁned contribution plans over deﬁned beneﬁt plans. In addition, alternative beneﬁt structures, such as simple ﬁxed beneﬁt products, are becoming more popular as the cost of traditional medical indemnity products has continued to increase rapidly. These low cost ﬁxed beneﬁt products can provide effective catastrophic protection for high cost illnesses to supplement the basic health coverage provided by medical indemnity insurance. From a demographics standpoint, the bulk of the United States population is moving from an asset accumulation phase to an asset distribution phase. People within ten years of retirement hold signiﬁcant assets. With continually lengthening lifespans and unstructured asset distribution, the Company believes many of these people may outlive their retirement savings and/or require long-term care. As a result, the Company expects that the demand for retirement payout solutions with guarantees will increase dramatically over the next decade. In each of these demographic scenarios, the quality of the guarantee will be a key driver of growth. The Company believes that these guarantees will be evaluated through balance sheet strength, the claims paying ability and ﬁnancial strength ratings of the guarantor, as well as the reputation of the Company. The Company believes that in each of these comparisons, it will be at a distinct advantage versus the industry on average. The Company expects that these trends will continue to favor those with scale, breadth of distribution and product, ability to provide advice and ﬁnancial strength to support long-term guarantees. Discussion of Results Revenues Premiums*********************************************************************** Universal life and investment-type product policy fees ********************************** Net investment income *********************************************************** Other revenues ****************************************************************** Net investment gains (losses) ****************************************************** Total revenues *************************************************************** Expenses Policyholder beneﬁts and claims **************************************************** Interest credited to policyholder account balances ************************************* Policyholder dividends ************************************************************ Other expenses ***************************************************************** Total expenses ************************************************************** Income from continuing operations before provision for income taxes ********************* Provision for income taxes********************************************************* Income from continuing operations************************************************** Income from discontinued operations, net of income taxes****************************** Income before cumulative effect of a change in accounting ***************************** Cumulative effect of a change in accounting, net of income taxes *********************** Net income ********************************************************************* Year Ended December 31, 2004 2003 2002 (Dollars in millions) $22,316 2,900 12,418 1,198 182 $20,673 2,496 11,539 1,199 (582) $19,077 2,147 11,183 1,166 (892) 39,014 35,325 32,681 22,662 2,998 1,814 7,761 35,235 3,779 1,071 2,708 136 2,844 (86) 20,665 3,035 1,975 7,091 32,766 2,559 660 1,899 344 2,243 (26) 19,373 2,950 1,942 6,813 31,078 1,603 490 1,113 492 1,605 — $ 2,758 $ 2,217 $ 1,605 MetLife, Inc. 7 Year ended December 31, 2004 compared with the year ended December 31, 2003 — The Company Income from continuing operations increased by $809 million, or 43%, to $2,708 million for the year ended December 31, 2004 from $1,899 million in the comparable 2003 period. Income from continuing operations for the years ended December 31, 2004 and 2003 includes the impact of certain transactions or events, the timing, nature and amount of which are generally unpredictable. These transactions are described in each applicable segment’s discussion below. These items contributed a beneﬁt of $113 million, net of income taxes, to the year ended December 31, 2004 and a beneﬁt of $159 million, net of income taxes, to the comparable 2003 period. Excluding the impact of these items, income from continuing operations increased by $855 million for the year ended December 31, 2004 compared to the prior 2003 period. This increase is primarily the result of an improvement in net investment gains (losses), net of income taxes, of $485 million. Also contributing to the increase is higher earnings from interest rate spreads of approximately $302 million, net of income taxes, in the Institutional and Individual segments. Additionally, the Individual segment contributed $154 million, net of income taxes, as a result of increased income from policy fees on investment-type products partially offset by higher amortization associated with DAC of $74 million, net of income taxes, and a reduction in earnings of $78 million, net of income taxes, resulting from an increase in the closed block policyholder dividend obligation. In addition, the Auto & Home segment’s earnings increased primarily due to an improved non-catastrophe combined ratio and favorable claim development related to prior accident years of $113 million, net of income taxes. This increase was partially offset by higher catastrophe losses of $73 million, net of income taxes. Premiums, fees and other revenues increased by $2,046 million, or 8%, to $26,414 million for the year ended December 31, 2004 from $24,368 million from the comparable 2003 period. The Institutional segment contributed 55% to the year over year increase. This increase stems largely from sales growth and the acquisitions of new businesses in the group life and the non-medical health & other businesses, as well as an increase in structured settlements sales and pension close outs. The Reinsurance segment contributed approximately 35% to the Company’s year over year increase in premium, fees and other revenues. This growth is primarily attributable to this segment’s coinsurance agreement with Allianz Life and continued growth in its traditional life reinsurance operations. The Individual segment contributed 5% to the year over year increase primarily due to higher fee income, partially offset by a reduction in the Company’s closed block premiums as the business continues to run-off. Interest rate spreads, which generally represent the margin between net investment income and interest credited to policyholder account balances, increased across the Institutional and Individual segments during the year ended December 31, 2004 compared to the prior year period. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment- related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees for which the timing and amount are generally unpredictable, and, as a result, can ﬂuctuate from period to period. If interest rates remain low, it could result in compression of the Company’s interest rate spreads on several of its products, which provide guaranteed minimum rates of return to policyholders. This compression could adversely impact the Company’s future ﬁnancial results. Underwriting results in the Institutional and Individual segments in the year ended December 31, 2004 were less favorable compared to the 2003 period. Underwriting results are signiﬁcantly inﬂuenced by mortality and morbidity trends, claim experience and the reinsurance activity related to certain blocks of business, and, as a result, can ﬂuctuate from period to period. Underwriting results in the Auto & Home segment were favorable in 2004 as the combined ratio declined to 90.4%, excluding catastrophes, from 97.1% in the prior year period. This result is largely due to continued improvement in both auto and homeowner claim frequencies, lower auto severities and an increase in average earned premiums. Other expenses increased by $670 million, or 9%, to $7,761 million for the year ended December 31, 2004 from $7,091 million for the comparable 2003 period. The 2004 period reﬂects a $49 million reduction of a premium tax liability and a $22 million reduction of a liability for interest associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. These decreases were partially offset by a $50 million contribution of appreciated stock to the MetLife Foundation. The 2003 period includes the impact of a $144 million reduction of a previously established liability related to the Company’s race-conscious underwriting settlement. In addition, the 2003 period includes a $48 million charge related to certain improperly deferred expenses at New England Financial and a $45 million charge related to VOBA associated with a change in reserve methodology in the Company’s International segment. Excluding the impact of these transactions, other expenses increased by $640 million, or 9%, from the comparable 2003 period. The Reinsurance segment contributed 35% to this year over year variance primarily due to the growth in expenses with Allianz Life and continued revenue growth, as mentioned above. In addition, 27% of this variance is primarily attributable to increases in direct business support expenses and non-deferrable commission expenses associated with general business growth, as well as infrastructure improvements, partially offset by costs in 2003 associated with ofﬁce consolidations and an impairment of assets in the Institutional segment. The Individual segment contributed 22% to this increase primarily due to accelerated DAC amortization, as well as an increase in expenses associated with general business growth. The remainder of the increase is the result of general business growth across the remaining segments and Corporate & Other. Net investment gains (losses) increased by $764 million, or 131%, to a net investment gain of $182 million for the year ended December 31, 2004 from a net investment loss of ($582) million for the comparable 2003 period. This increase is primarily due to the more favorable economic environment in 2004. Income tax expense for the year ended December 31, 2004 was $1,071 million, or 28% of income from continuing operations before provision for income taxes, compared with $660 million, or 26%, for the comparable 2003 period. The 2004 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, a decrease in the deferred tax valuation allowance to recognize the effect of certain foreign net operating loss carryforwards in South Korea, and the contribution of appreciated stock to the MetLife Foundation. In addition, the 2004 effective tax rate reﬂects an adjustment of $91 million for the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Also, the 2004 effective tax rate reﬂects an adjustment of $9 million consisting primarily of a revision in the estimate of income taxes for 2003. The 2003 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, and tax beneﬁts related to the sale of foreign subsidiaries. In addition, the 2003 effective tax rate reﬂects an adjustment of $36 million consisting primarily of a revision in the estimate of income taxes for 2002. The income from discontinued operations is comprised of the operations of SSRM and net investment income and net investment gains related to real estate properties that the Company has classiﬁed as available-for-sale. The Company entered into an agreement to sell SSRM during the third quarter of 2004. As previously discussed, SSRM was sold effective January 31, 2005. Income from discontinued operations, net of income taxes, decreased $208 million, or 60%, to $136 million for the year ended December 31, 2004 from $344 million for the comparable 2003 period. The decrease is primarily due to lower recognized net investment gains from real estate properties 8 MetLife, Inc. sold in 2004 as compared to the prior year. For the years ended December 31, 2004 and 2003, the Company recognized $139 million and $420 million of net investment gains, respectively, from discontinued operations related to real estate properties sold or held-for-sale. During the year ended December 31, 2004, the Company recorded an $86 million charge, net of income taxes, for a cumulative effect of a change in accounting in accordance with SOP 03-1, which provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. This charge is primarily related to those long-duration contract liabilities where the amount of the liability is indexed to the performance of a target portfolio of investment securities. During the year ended December 31, 2003, the Company recorded a $26 million charge, net of income taxes, for a cumulative effect of a change in accounting in accordance with Issue B36. Year ended December 31, 2003 compared with the year ended December 31, 2002 — The Company Income from continuing operations increased by $786 million, or 71%, to $1,899 million for the year ended December 31, 2003 from $1,113 million in the comparable 2002 period. Income from continuing operations for the years 2003 and 2002 includes the impact of certain transactions or events that result in net income not being indicative of future earnings, which are described in the applicable segment’s results of operations discussions. These items contributed a beneﬁt of $159 million, net of income taxes, in 2003 and a charge of $150 million, net of income taxes, in 2002. Excluding the impact of these items, income from continuing operations increased by $477 million in 2003 compared to the prior year. Declines in net investment losses account for $197 million, net of income taxes, of this increase with the balance being contributed by the Company’s operations. The decline in net investment losses is largely attributable to less credit-related losses, which is consistent with the U.S. ﬁnancial market environment. Premiums, fees and other revenues increased 9% over the prior year primarily as a result of growth in the annuities, retirement & savings and variable and universal life product lines. This increase stems in part from policy fee income earned on annuity deposits, which were $11.2 billion in 2003, increasing 42% from the prior year. In addition, the annuity separate account balance was $28.7 billion at December 31, 2003, up 57% versus the prior year end. Growth in retirement & savings is primarily attributable to higher sales in structured settlement products. Fee income from variable and universal life products increased 12% over the prior year primarily as a result of a 25% growth in separate account balances. In addition, the coinsurance agreement with Allianz Life in the Reinsurance segment contributed approximately 1% to the year over year increase. Partially offsetting these increases is a decline in traditional life premiums, which is largely attributable to run off in the Company’s closed block of business. Investment margins, which represent the spread between net investment income and interest credited to policyholder account balances, remained favorable in 2003 as the Company took appropriate crediting rate reductions in most products in an effort to keep pace with the market environment. In several product lines, where investment margins are a substantial part of earnings, the Company still has a reasonable amount of ﬂexibility to reduce crediting rates further if portfolio yields were to decline from year-end 2003 levels. Investment margins in 2003 did beneﬁt from higher than expected levels of prepayments. Underwriting results varied in 2003. The group life mortality ratio continues to be favorable at 92%. The Individual life mortality ratio was also solid at 88%, which includes the impact of several large claims in the variable and universal product line, some of which had lower levels of reinsurance. Group disability’s morbidity ratio increased to 98.5%, from 97.9% in the prior year but is still within management’s expected range. The Auto & Home combined ratio, which is a measure of both the loss and loss adjustment expense ratio, as well as the expense ratio, remained favorable at 97.1% excluding catastrophes. The Company’s International segment increased its loss recognition reserve in Taiwan as a result of low interest rates relative to product guarantees. This action resulted in a $19 million charge, net of income taxes. Other expenses increased 4% over the prior year period primarily as a result of an increase of $133 million in pension and postretirement expenses. As a result of contributions made to the pension plan in late 2003 and early 2004, which totaled approximately $750 million, and the stronger performance of the pension plan assets in 2003, the Company anticipates the pension and postretirement expenses to moderate in 2004. Other expenses in 2003 also include the impact of several actions taken by management in the fourth quarter, including lease terminations, ofﬁce consolida- tions and closures, and asset impairments. In addition, severance costs and expenses associated with strategic initiatives at New England Financial contributed to the increase in expenses year over year. Also, there was an increase in many of the product lines’ volume-related expenses, which are in line with 2003 business growth. Net investment losses decreased by $310 million, or 35%, to $582 million for the year ended December 31, 2003 from $892 million for the comparable 2002 period. This improvement is primarily due to lower credit-related losses. Income tax expense for the year ended December 31, 2003 was $660 million, or 26% of income from continuing operations before provision for income taxes and cumulative effect of change in accounting, compared with $490 million, or 31%, for the comparable 2002 period. The 2003 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, tax credits for investments in low income housing, a recovery of prior year tax overpayments on tax-exempt bonds, and an adjustment consisting primarily of a revision in the estimate of income taxes for 2002. In addition, the 2003 effective tax rate includes a reduction of the deferred tax valuation allowance related to certain foreign net operating loss carryforwards, and tax beneﬁts related to the sale and merger of foreign subsidiaries reﬂected in the International segment. The 2002 effective tax rate differs from the corporate tax rate of 35% primarily due to the impact of non-taxable investment income, partially offset by the inability to utilize tax beneﬁts on certain foreign capital losses. The income from discontinued operations is comprised of the operations of SSRM and net investment income and net investment gains related to real estate properties that the Company has classiﬁed as available-for-sale. The Company sold SSRM on January 31, 2005. Income from discontinued operations declined $148 million, or 30%, to $344 million for the year ended December 31, 2003 from $492 million in the comparable prior year period. The decrease is primarily due to lower recognized net investment gains from real estate properties sold in 2003 as compared to the prior year. For the years ended December 31, 2003 and 2002, the Company recognized $420 million and $582 million of net investment gains, respectively, from discontinued operations related to real estate properties sold or held-for-sale. The Company changed its method of accounting for embedded derivatives in certain insurance products as required by new accounting guidance which became effective on October 1, 2003, and recorded the impact as a cumulative effect of a change in accounting principle. MetLife, Inc. 9 Institutional The following table presents consolidated ﬁnancial information for the Institutional segment for the years indicated: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Revenues Premiums************************************************************************ $10,103 Universal life and investment-type product policy fees *********************************** 717 Net investment income ************************************************************ 4,472 Other revenues ******************************************************************* 632 Net investment gains (losses) ******************************************************* 186 Total revenues ****************************************************************** 16,110 Expenses Policyholder beneﬁts and claims ***************************************************** Interest credited to policyholder account balances ************************************** Policyholder dividends ************************************************************* Other expenses ****************************************************************** Total expenses ***************************************************************** Income from continuing operations before provision for income taxes ********************** Provision for income taxes********************************************************** Income from continuing operations*************************************************** Income from discontinued operations, net of income taxes******************************* Income before cumulative effect of a change in accounting ****************************** 1,331 Cumulative effect of a change in accounting, net of income taxes ************************ (60) Net income ********************************************************************** $ 1,271 11,134 960 107 1,907 1,321 10 2,002 681 14,108 $ 9,093 635 4,028 592 (293) $ 8,245 624 3,909 609 (488) 14,055 12,899 9,843 915 198 1,784 9,345 932 115 1,531 12,740 11,923 1,315 477 838 37 875 (26) $ 849 $ 976 344 632 127 759 — 759 Year ended December 31, 2004 compared with the year ended December 31, 2003 — Institutional Income from continuing operations increased by $483 million, or 58%, to $1,321 million for the year ended December 31, 2004 from $838 million for the comparable 2003 period. An improvement of $241 million, net of income taxes, in net investment gains (losses), net of adjustments of $63 million to policyholder beneﬁt and claims related to net investment gains (losses), is a signiﬁcant component of the increase. In addition, favorable interest rate spreads contributed $225 million, net of income taxes, to the increase compared to the prior year period, with the retirement & savings products generating $183 million, net of income taxes, of this increase. Higher investment yields, growth in the asset base and lower average crediting rates are the primary drivers of the year over year increase in interest rate spreads. These spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads for the year ended December 31, 2004 increased to 2.06%, 1.66% and 1.88% for group life, retirement & savings and the non-medical health & other businesses, respectively, from 2.04%, 1.40% and 1.51% for the group life, retirement & savings, and the non-medical health & other businesses, respectively, in the comparable prior year period. Management generally expects these spreads to be in the range of 1.60% to 1.80%, 1.30% to 1.45%, and 1.30% to 1.50% for the group life, retirement & savings, and the non-medical health & other businesses, respectively. Earnings from interest rate spreads are inﬂuenced by several factors, including business growth, movement in interest rates, and certain investment and investment-related transactions, such as corporate joint venture income and bond and commercial mortgage prepayment fees for which the timing and amount are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from period to period. Also contributing to the increase in income from continuing operations is a reduction in a premium tax liability of $31 million in the second quarter of 2004, net of income taxes. These increases in income from continuing operations are partially offset by less favorable underwriting results, which are estimated to have declined $30 million, net of income taxes, compared to the prior year period. Management attributes approximately $20 million, net of income taxes, of this decrease to mixed claim experience in the non-medical health & other business. Underwriting results are signiﬁcantly inﬂuenced by mortality and morbidity trends, as well as claim experience and, as a result, can ﬂuctuate from year to year. Total revenues, excluding net investment gains (losses), increased by $1,576 million, or 11%, to $15,924 million for the year ended December 31, 2004 from $14,348 million for the comparable 2003 period. Growth of $1,132 million in premiums, fees, and other revenues contributed to the revenue increase. A $480 million increase in premiums, fees and other revenues in the non-medical health & other business compared to the prior year is partly due to the continued growth in long-term care of $148 million, of which $41 million is related to the 2004 acquisition of TIAA/CREF’s long-term care business. Growth in the small market products, disability business, and dental business contributed $305 million to the year over year increase. Group life insurance premiums, fees and other revenues increased by $461 million, which management primarily attributes to improved sales and favorable persistency, as well as the acquisition of the John Hancock group life insurance business in late 2003, which contributed $20 million to the increase. Retirement & savings’ premiums, fees and other revenues increased by $191 million, which is largely due to a growth in premiums of $172 million, resulting primarily from an increase in structured settlement sales and pension close-outs. Premiums, fees and other revenues from retirement & savings products are signiﬁcantly inﬂuenced by large transactions, and as a result, can ﬂuctuate from year to year. In addition, an increase of $444 million in net investment income, which is primarily due to higher income from growth in the asset base, earnings on corporate joint venture income and bond and commercial mortgage prepayment fees contributed to the overall increase in revenues. This increase is a component of the favorable interest rate spreads discussed above. Total expenses increased by $1,368 million, or 11%, to $14,108 million for the year ended December 31, 2004 from $12,740 million for the comparable 2003 period. Policyholder beneﬁts and claims combined with policyholder dividends increased by $1,200 million to $11,241 million for the year ended December 31, 2004 from $10,041 million for the comparable prior year period. This increase is primarily attributable to a $459 million, $461 million, and $280 million increase in the group life, non-medical health & other and retirement & savings businesses, respectively. These increases 10 MetLife, Inc. are predominately attributable to the business growth discussed in the revenue discussion above. The increases in group life and the non-medical health & other businesses include the impact of the acquisition of certain businesses from John Hancock and TIAA/CREF of $11 million and $39 million, respectively. Also included in the increase is the impact of less favorable claim experience, primarily in the non-medical health & other business. Interest credited to policyholder account balances increased by $45 million over the prior year period primarily as a result of the impact of growth in guaranteed interest contracts within the retirement & savings business. Other operating expenses increased $123 million. The largest component of this expense growth is an increase of $97 million related to increases in direct business support expenses. In addition, non-deferrable commissions and premium taxes increased by $25 million. This is net of a $49 million reduction in a premium tax liability in the second quarter of 2004. Excluding this item, non-deferrable commissions and premium taxes increased by $74 million, which is commensurate with the aforementioned revenue growth. In addition, the Company incurred infrastructure improvement costs of $34 million and expenses of $12 million related to the closing of one of the Company’s disability claims centers which were partially offset by a decline of $45 million primarily relating to expenses incurred in the prior year for ofﬁce closures and consolidations and an impairment of related assets. Year ended December 31, 2003 compared with the year ended December 31, 2002 — Institutional Income from continuing operations increased by $206 million, or 33%, to $838 million for the year ended December 31, 2003 from $632 million for the comparable 2002 period. Revenue growth combined with favorable underwriting results and interest margins contributed to the year over year increase. Lower net investment losses in 2003 versus 2002 contributed $124 million, net of income taxes, to the year over year increase. Favorable underwriting experience was partially offset by an increase in expenses associated with ofﬁce closures and other consolidations, as well as an increase in pension and postretirement beneﬁt costs. In addition, the prior year period includes a $20 million, net of income taxes, beneﬁt from the reduction of a previously established liability for the Company’s 2001 business realignment initiatives and a $17 million, net of income taxes, beneﬁt from the reduction of a previously established liability for disability insurance-related losses from the September 11, 2001 tragedies. Total revenues, excluding net investment gains and losses, increased by $961 million, or 7%, to $14,348 million for the year ended December 31, 2003 from $13,387 million for the comparable 2002 period. The increase is attributable to both the group insurance and the retirement & savings product lines. Within group insurance, life insurance premiums and fees increased by $248 million, or 5%, which is in line with management’s expectations. This increase is attributable primarily to higher sales and favorable persistency. The late 2003 acquisition of the John Hancock block of group life business contributed $72 million to this increase. In addition, the long-term care, dental, and disability products experienced continued growth at a combined rate of approximately 14%, which is in line with management’s expectations. Retirement & savings revenues increased approximately 12% primarily due to higher sales in the structured settlement products partially offset by the impact of a sale of a signiﬁcant, single premium contract in the second quarter of 2002. Premiums and fees from retirement and saving products are signiﬁcantly inﬂuenced by large transactions and, as a result, can ﬂuctuate from year to year. These increases were partially offset by a decrease in revenues primarily due to a decline in retirement & savings administrative fees from the Company’s 401(k) business. This decline resulted from the exit from the large market 401(k) business in late 2001. Consequently, revenue decreased as business was transferred to other carriers throughout 2002. Total expenses increased by $817 million, or 7%, to $12,740 million for the year ended December 31, 2003 from $11,923 million for the comparable 2002 period. Policyholder-related expenses increased $564 million primarily as a function of the growth in business. The increase in expenses is offset by favorable underwriting results in the term life insurance, dental, long-term care, and retirement & savings products. The term life mortality incurred loss ratio, which represents actual life claims as a percentage of assumed claims incurred used in the determination of future policy beneﬁts, was 92% for 2003 as compared to 93.6% in 2002. Underwriting results declined in disability as the morbidity incurred loss ratio, which represents actual disability claims as a percentage of assumed claims incurred used in the determination of future policy beneﬁts, increased to 98.5% in 2003 from 97.9% in the prior year. The 2003 ratio was within management’s expected range. In addition, the 2002 period includes a $28 million release of a previously established liability for disability insurance-related losses from the September 11, 2001 tragedies. Other expenses increased by $253 million over the prior year period. Group insurance and retirement & savings expenses increased $115 million primarily due to an increase in non- deferrable expenses associated with the aforementioned revenue growth, $77 million from an increase in pension and postretirement beneﬁt expense, and a $33 million increase in expenses associated with ofﬁce closures and other consolidations. In addition, the prior year period includes a $30 million reduction of a previously established liability for the Company’s 2001 business realignment initiatives. MetLife, Inc. 11 Individual The following table presents consolidated ﬁnancial information for the Individual segment for the years indicated: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Revenues Premiums************************************************************************ $ 4,172 Universal life and investment-type product policy fees *********************************** 1,831 Net investment income ************************************************************ 6,130 Other revenues ******************************************************************* 444 Net investment gains (losses) ******************************************************* 74 Total revenues **************************************************************** 12,651 Expenses Policyholder beneﬁts and claims ***************************************************** Interest credited to policyholder account balances ************************************** Policyholder dividends ************************************************************* Other expenses ****************************************************************** Total expenses *************************************************************** Income from continuing operations before provision for income taxes ********************** Provision for income taxes********************************************************** Income from continuing operations*************************************************** Income from discontinued operations, net of income taxes******************************* Net income ********************************************************************** $ 5,102 1,674 1,638 2,939 11,353 $ 4,344 1,589 6,194 407 (307) $ 4,507 1,379 6,237 418 (290) 12,227 12,251 5,039 1,793 1,700 2,847 5,064 1,793 1,770 2,639 11,379 11,266 1,298 431 867 3 870 848 281 567 34 601 $ 985 363 622 204 826 $ Year ended December 31, 2004 compared with the year ended December 31, 2003 — Individual Income from continuing operations increased by $300 million, or 53%, to $867 million for the year ended December 31, 2004 from $567 million for the comparable 2003 period. Included in this increase is an improvement in net investment gains (losses) of $242 million, net of income taxes. This increase includes additional fee income of $154 million, net of income taxes, primarily related to separate account products. In addition, improvement in interest rate spreads contributed $77 million, net of income taxes, to the year over year increase. These spreads are generally the percentage point difference between the yield earned on invested assets and the interest rate the Company uses to credit on certain liabilities. Therefore, given a constant value of assets and liabilities, an increase in interest rate spreads would result in higher income to the Company. Interest rate spreads include income from certain investment transactions, including corporate joint venture income and bond and commercial mortgage prepayment fees, the timing and amount of which are generally unpredictable. As a result, income from these investment transactions may ﬂuctuate from year to year. These types of investment transactions contributed $38 million, net of income taxes, to the improvement in interest rate spreads. Additionally, the charge of $31 million, net of income taxes, in 2003 related to certain improperly deferred expenses at New England Financial, and a reduction in policyholder dividends of $39 million, net of income taxes, in 2004 contributed to the increase in income from continuing operations. These increases in income from continuing operations are partially offset by a reduction in earnings of $78 million, net of income taxes, resulting from an increase in the closed block-related policyholder dividend obligation, associated primarily with an improvement in net investment gains (losses). Higher DAC amortization of $74 million, net of income taxes, also increased expenses for the year ended December 31, 2004. Additionally, offsetting these increases are lower net investment income on traditional life and income annuity products of $43 million, net of income taxes. The application of SOP 03-1 and the corresponding cost of hedging guaranteed annuity beneﬁt riders reduced earnings by $30 million, net of income taxes. In addition, less favorable underwriting results in the traditional and universal life products of $20 million, net of income taxes, and higher general spending of $15 million, net of income taxes, added to this offset. These underwriting results are signiﬁcantly inﬂuenced by mortality experience and the reinsurance activity related to certain blocks of business, and as a result can ﬂuctuate from year to year. Total revenues, excluding net investment gains (losses), increased by $43 million, or less than 1%, to $12,577 million for the year ended December 31, 2004 from $12,534 million for the comparable 2003 period. This increase includes higher fee income primarily from separate account products of $252 million resulting from a combination of growth in the business and improved overall market performance. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of the average assets in policyholder accounts. The value of these assets can ﬂuctuate depending on equity performance. In addition, management attributes higher premiums of $37 million in 2004 to the active marketing of income annuity products. The increased volume of sales in 2004 also resulted in higher broker/dealer and other subsidiaries revenues of $27 million. Partially offsetting the increases in total revenues for the year ended December 31, 2004 are lower premiums related to the Company’s closed block of business of $209 million, which continues to run off at management’s expected range of 3% to 6% per year. In addition, lower net investment income of $64 million resulting from lower investment yields offset other increases in revenues. Total expenses decreased by $26 million, or less than 1%, to $11,353 million for the year ended December 31, 2004 from $11,379 million for the comparable 2003 period. Lower expenses are primarily the result of a $181 million decrease in the closed block policyholder beneﬁts partially attributable to lower activity associated with the run off of this business and a $119 million decline in interest credited to policyholder account balances due to lower crediting rates. Also included in the decrease in expenses are lower policyholder dividends of $62 million resulting from reductions in the dividend scale in late 2003 and a charge in 2003 related to certain improperly deferred expenses at New England Financial of $48 million. Partially offsetting these decreases in expenses is a $123 million increase in the closed block-related policyholder dividend obligation based on positive performance of the closed block and higher DAC amortization of $116 million. The increase in DAC amortization is a result of accelerated amortization resulting from improvement in net investment gains (losses) and the update of management’s assumptions used to determine estimated gross margins. Additionally, offsetting the decrease to expenses is a $46 million increase from the application of SOP 03-1 and the corresponding cost of hedging guaranteed annuity beneﬁt riders and a $35 million increase in future policy beneﬁts commensurate with the increase in income annuity premiums. Further, the 12 MetLife, Inc. decrease in expenses was offset by less favorable underwriting results in the traditional and universal life products of $32 million, higher general spending of $23 million and a $10 million increase in broker/dealer and other subsidiaries related expenses. Year ended December 31, 2003 compared with the year ended December 31, 2002 — Individual Income from continuing operations decreased by $55 million, or 9%, to $567 million for the year ended December 31, 2003 from $622 million for the comparable 2002 period. The decrease year over year is primarily driven by an increase in expenses of $113 million, or 1%, which is largely attributable to an increase in expenses associated with ofﬁce closures and other consolidations, pension and postretirement beneﬁt costs, an increase in legal-related costs and an adjustment related to certain improperly deferred expenses at New England Financial. Although revenues are essentially ﬂat year over year, policy fees from variable life and annuity and investment-type products grew 15% year over year. In addition, there is a slight increase in premiums related to other traditional life products. These increases are offset by a 5% decline in premiums from the Company’s closed block business, which consists of participating policies issued prior to the Company’s demutualization. Premiums on the closed block represent approximately 80% of this segment’s premiums for the year ended December 31, 2003. Total revenues, excluding net investment gains and losses, decreased by $7 million, or less than 1%, to $12,534 million for the year ended December 31, 2003 from $12,541 million for the comparable 2002 period. Policy fees from variable life and annuity and investment-type products grew by 15% over the prior year period. This growth is primarily a result of an 18% increase in the average separate account balances, which is largely attributable to improvements in the U.S. ﬁnancial markets. Additionally, this increase is associated with the aging of the in-force policies, as well as an increase in the sales of the enterprise variable annuity product through non-traditional distribution channels. Policy fees from variable life and annuity and investment-type products are typically calculated as a percentage of average assets. The value of these assets can ﬂuctuate depending on equity market performance. This increase in policy fee income was almost entirely offset by declines in premiums and net investment income. Premiums associated with the Company’s closed block of business declined by $186 million, or 5%, which is in line with management’s expectations, as this business continues to run-off. Partially offsetting this decline is a slight increase in the other traditional life products. The decline in net investment income is mainly due to the change in capital allocation methodology and lower investment yields year over year. Total expenses increased by $113 million, or 1%, to $11,379 million for the year ended December 31, 2003 from $11,266 million for the comparable 2002 period. Other expenses increased by $208 million over the prior year period primarily as a result of expenses associated with certain efﬁciency initiatives and events. The most signiﬁcant items include an increase of $67 million from pension and postretirement beneﬁt expense, a $48 million expense recorded in the second quarter of 2003 for an adjustment related to certain improperly deferred expenses at New England Financial, $42 million in expenses associated with ofﬁce closures and other consolidations, $42 million increase in legal-related costs, and other expenses associated with strategic initiatives at New England Financial. Offsetting these expense increases are a decline in policyholder beneﬁts consistent with the aforementioned decline in the closed block and a decrease in dividends due to the reduction of the dividend scale in the fourth quarter of 2002, reﬂecting the impact of the low U.S. interest rate environment on the asset portfolios supporting these policies. Auto & Home The following table presents consolidated ﬁnancial information for the Auto & Home segment for the years indicated: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Revenues Premiums *************************************************************************** $2,948 Net investment income **************************************************************** 171 Other revenues ********************************************************************** 35 Net investment gains (losses) ********************************************************** (9) Total revenues ******************************************************************* 3,145 Expenses Policyholder beneﬁts and claims ******************************************************** Policyholder dividends***************************************************************** Other expenses ********************************************************************** Total expenses******************************************************************* Income before provision (beneﬁt) for income taxes ***************************************** 269 Provision (beneﬁt) for income taxes ****************************************************** 61 Net income ************************************************************************* $ 208 2,079 2 795 2,876 $2,908 158 32 (15) $2,828 177 26 (46) 3,083 2,985 2,139 1 756 2,896 187 30 2,019 — 793 2,812 173 41 $ 157 $ 132 Year ended December 31, 2004 compared with the year ended December 31, 2003 — Auto & Home Net income increased by $51 million, or 32%, to $208 million for the year ended December 31, 2004 from $157 million for the comparable 2003 period. This increase is primarily attributable to an improved non-catastrophe combined ratio, which resulted in a beneﬁt of $52 million, net of income taxes, improved claim development related to prior accident years of $61 million, net of income taxes, and an increase in net investment income of $13 million, net of income taxes. Partially offsetting these favorable variances are increased catastrophe losses of $73 million, net of income taxes. This increase resulted from the four hurricanes that struck the Southeastern United States in August and September of 2004. Total revenues, excluding net investment gains (losses), increased by $56 million, or 2%, to $3,154 million for the year ended December 31, 2004 from $3,098 million for the comparable 2003 period. This increase is primarily attributable to a $40 million increase in premiums, which is largely the result of an increase in the average earned premium resulting from continued rate increases. In addition, a $13 million increase in net investment income is largely attributable to growth in the underlying asset base, an increase in the investment yield and higher income related to tax advantaged municipal bonds. Total expenses decreased by $20 million, or 1%, to $2,876 for the year ended December 31, 2004 from $2,896 million for the comparable 2003 period. This decrease is the result of an improvement in policyholder beneﬁts and claims due to a favorable change of $94 million in prior year claim development, as well as a decrease in expenses of $80 million resulting from an improved non-catastrophe combined ratio primarily attributable to lower MetLife, Inc. 13 automobile and homeowner’s claim frequencies. These favorable changes in expenses are partially offset by an increase in losses from catastrophes of $112 million and a $39 million increase in expenses primarily due to inﬂation and employee and other related labor costs. The combined ratio excluding catastrophes declined to 90.4% for the year ended December 31, 2004 from 97.1% for the comparable 2003 period. Year ended December 31, 2003 compared with the year ended December 31, 2002 — Auto & Home Net income increased by $25 million, or 19%, to $157 million for the year ended December 31, 2003 from $132 million for the comparable 2002 period. The increase in earnings year over year is mainly due to premium growth, lower investment losses and a reduction in expenses, partially offset by adverse claims development. Total revenues, excluding net investment gains and losses, increased by $67 million, or 2%, to $3,098 million for the year ended December 31, 2003 from $3,031 million for the comparable 2002 period. This variance is mainly due to increases in the average earned premium due to rate increases, partially offset by lower investment income primarily resulting from the change in capital allocation methodology. Total expenses increased by $84 million, or 3%, to $2,896 million for the year ended December 31, 2003 from $2,812 million for the comparable 2002 period. Adverse claims development related to prior accident years, resulting mostly from bodily injury and uninsured motorists claims, accounted for $46 million of the increase in policyholder beneﬁts. Also contributing to this increase are higher catastrophe losses of $22 million. Partially offsetting these increases are improved non-catastrophe homeowner’s claims frequencies, a reduction in the number of auto and homeowner’s policies in-force, and underwriting and agency management actions. In addition, there was a $23 million reduction in expenses resulting from the completion of the St. Paul integration and a $35 million reduction in the cost associated with the New York assigned risk plan. The combined ratio, excluding catastrophes, which represents losses and total expenses including claims as a percentage of premiums, declined to 97.1% for the year ended December 31, 2003 versus 97.4% for the comparable 2002 period. International The following table presents consolidated ﬁnancial information for the International segment for the years indicated: Revenues Premiums *************************************************************************** $1,735 Universal life and investment-type product policy fees ************************************** 350 Net investment income **************************************************************** 585 Other revenues ********************************************************************** 23 Net investment gains (losses) ********************************************************** 23 Total revenues ******************************************************************* 2,716 $1,678 272 502 80 8 $1,511 144 461 14 (9) 2,540 2,121 Year Ended December 31, 2004 2003 2002 (Dollars in millions) Expenses Policyholder beneﬁts and claims ******************************************************** Interest credited to policyholder account balances ***************************************** Policyholder dividends***************************************************************** Other expenses ********************************************************************** Total expenses******************************************************************* Income from continuing operations before provision for income taxes ************************* Provision for income taxes ************************************************************* Income from continuing operations before cumulative effect of a change in accounting ********** 193 Cumulative effect of a change in accounting, net of income taxes **************************** (30) Net income ************************************************************************* $ 163 1,614 152 47 624 279 86 2,437 1,457 143 55 660 2,315 225 17 208 — $ 208 $ 1,388 79 35 507 2,009 112 28 84 — 84 Year ended December 31, 2004 compared with the year ended December 31, 2003 — International Income from continuing operations decreased by $15 million, or 7%, to $193 million for the year ended December 31, 2004 from $208 million for the comparable 2003 period. The prior year includes a $62 million beneﬁt, net of income taxes, from the merger of the Mexican operations and a reduction in policyholder liabilities resulting from a change in reserve methodology, a $12 million tax beneﬁt in Chile related to the merger of two subsidiaries and an $8 million beneﬁt, net of income taxes, related to reinsurance treaties. These increases are partially offset by a $19 million charge, net of income taxes, in Taiwan related to an increased loss recognition reserve due to low interest rates relative to product guarantees. The prior year also includes a $4 million beneﬁt, net of income taxes, related to the Spanish operations, which were sold in 2003. Excluding these items, income from continuing operations increased by $52 million or 37%. A signiﬁcant component of this increase is attributable to the application of SOP 03-1 in the current year, which resulted in a $21 million decrease, net of income taxes, in policyholder liabilities in Mexico. The primary driver of the current year impact is a decline in the fair value of the underlying assets associated with these contracts. Additionally, a $10 million, net of income taxes, increase in net investment gains is primarily due to the gain from the sale of the Spanish operations. In addition, 2004 includes $8 million of certain tax-related beneﬁts in South Korea. The remainder of the increase can be attributed to business growth in other countries. Total revenues, excluding net investment gains (losses), increased by $161 million, or 6%, to $2,693 million for the year ended December 31, 2004 from $2,532 million for the comparable 2003 period. The prior year period includes $230 million of revenues related to the Spanish operations, which were sold in 2003. Excluding the sale of these operations, revenues increased by $391 million, or 17%. The Company’s Mexican and Chilean operations increased revenues by $144 million and $58 million, respectively, primarily due to growth in the business, as well as improved investment earnings. The Company’s operations in South Korea and Taiwan also have increased revenues by $121 million and $34 million, respectively, primarily due to increased new sales and renewal business. Changes in foreign currency exchange rates contributed $14 million to the year over year increase in revenues. The remainder of the increase can be attributed to business growth in other countries. Total expenses increased by $122 million, or 5%, to $2,437 million for the year ended December 31, 2004 from $2,315 million for the comparable 2003 period. The prior year includes expenses of $223 million related to the Spanish operations, which were sold in 2003. The prior year also includes a 14 MetLife, Inc. $79 million beneﬁt related to a reduction in the Mexican operation’s policyholder liabilities resulting from a change in reserve methodology, partially offset by a related increase of $45 million in amortization of VOBA. Additionally, Taiwan’s 2003 expenses include a $30 million pre-tax charge due to an increased loss recognition reserve as a result of low interest rates relative to product guarantees. Excluding these items, expenses increased $341 million, or 16%, over the prior year. Expenses grew by $71 million, $98 million, $58 million and $36 million for the operations in Mexico, South Korea, Chile and Taiwan, respectively, which is commensurate with the revenue growth discussed above. In addition, 2004 includes a $33 million decrease in Mexico’s policyholder liabilities resulting from the application of SOP 03-1. Canada’s expenses increased by $13 million due primarily to the strengthening of the liability on its pension business related to changes in mortality assumptions in the fourth quarter of 2004. Changes in foreign currency exchange rates contributed $18 million to the year over year increase in expenses. The remainder of the increase in total expenses is primarily related to the ongoing investment in infrastructure. Year ended December 31, 2003 compared with the year ended December 31, 2002 — International Net income increased by $124 million, or 148%, to $208 million for the year ended December 31, 2003 from $84 million for the comparable 2002 period. The acquisition of Hidalgo accounted for $48 million of this increase. Also contributing to the increase in earnings during 2003 is a $62 million beneﬁt, net of income taxes, from the merger of the Mexican operations and a reduction in policyholder liabilities resulting from a change in reserve methodology, a $12 million tax beneﬁt in Chile and an $8 million beneﬁt, net of income taxes, related to reinsurance treaties. These increases are partially offset by a $19 million charge, net of income taxes, in Taiwan related to an increased loss recognition reserve due to low interest rates relative to product guarantees. Total revenues, excluding net investment gains and losses, increased by $402 million, or 19%, to $2,532 million for the year ended December 31, 2003 from $2,130 million for the comparable 2002 period. This increase is primarily due to the acquisition of Hidalgo, which accounted for $469 million of the variance, partially offset by decreases in Canada of $106 million attributable to a non-recurring sale of an annuity contract and $28 million relating to the restructuring of a pension contract from an investment-type product to a long-term annuity, both of which occurred in 2002. In addition, South Korea’s, Chile’s and Taiwan’s revenues increased by $102 million, $60 million and $36 million, respectively, primarily due to business growth. These increases are partially offset by a $161 million decrease in Mexico, excluding Hidalgo. Anticipated actions taken by the Mexican government adversely impacted the insurance and annuities market and resulted in a decline in premiums in Mexico’s group and individual life businesses. In addition, the cancellation of a large broker-sponsored case at the end of 2002 and the weakening of the peso also contributed to the 2003 decline in Mexico. Total expenses increased by $306 million, or 15%, to $2,315 million for the year ended December 31, 2003 from $2,009 million for the comparable 2002 period. The acquisition of Hidalgo contributed $394 million to this increase. Partially offsetting this is a decrease of $106 million for the aforementioned non-recurring sale of an annuity contract and a decrease of $28 million for the restructuring of a pension contract, both of which occurred in 2002. In addition, South Korea’s, Chile’s and Taiwan’s expenses increased by $95 million, $65 million and $64 million, respectively, commensurate with the revenue increases in each country. Additionally, Taiwan’s expenses include a $30 million pre-tax charge due to an increased loss recognition reserve as a result of low interest rates relative to product guarantees. These increases are partially offset by a $251 million decrease in Mexico, other than Hidalgo, primarily as a result of the impact on expenses from the aforementioned revenue decline in Mexico and a reduction in policyholder liabilities related to a change in reserve methodology. Reinsurance The following table presents consolidated ﬁnancial information for the Reinsurance segment for the years indicated: Revenues Premiums ************************************************************************** Net investment income *************************************************************** Other revenues ********************************************************************* Net investment gains (losses) ********************************************************* Total revenues ****************************************************************** Expenses Policyholder beneﬁts and claims ******************************************************* Interest credited to policyholder account balances **************************************** Policyholder dividends**************************************************************** Other expenses ********************************************************************* Total expenses****************************************************************** Income before provision for income taxes *********************************************** Provision for income taxes ************************************************************ Income from continuing operations before cumulative effect of a change in accounting ********* Cumulative effect of a change in accounting, net of income taxes *************************** Net income ************************************************************************ Year Ended December 31, 2004 2003 2002 (Dollars in millions) $3,367 588 57 60 $2,668 473 49 31 $2,005 421 43 (3) 4,072 3,221 2,466 2,725 212 20 964 3,921 151 51 100 5 $ 105 $ 2,136 184 21 740 3,081 140 48 92 — 92 1,554 146 22 617 2,339 127 43 84 — 84 $ Year ended December 31, 2004 compared with the year ended December 31, 2003 — Reinsurance Income from continuing operations increased $8 million, or 9%, to $100 million for the year ended December 31, 2004 from $92 million for the comparable 2003 period. This increase is attributable to a 26% increase in revenues, primarily due to strong premium growth across all of RGA’s geographical segments, which includes the effect of the Allianz Life transaction. The growth in income from continuing operations is partially offset by higher minority interest expense as MetLife’s ownership in RGA decreased from 59% to 52% in the comparable periods and a negotiated claim settlement in RGA’s accident and health business, which is currently in run-off, of $8 million for the third quarter of 2004, net of income taxes and minority interest. MetLife, Inc. 15 Total revenues, excluding net investment gains (losses), increased by $822 million, or 26%, to $4,012 million for the year ended December 31, 2004 from $3,190 million for the comparable 2003 period due primarily to a $699 million increase in premiums. The premium increase during the year ended December 31, 2004 is partially the result of RGA’s coinsurance agreement with Allianz Life under which RGA assumed 100% of Allianz Life’s United States traditional life reinsurance business. This transaction closed during 2003, with six months of reinsurance activity recorded in 2003, as compared to twelve months in 2004. New premiums from facultative and automatic treaties and renewal premiums on existing blocks of business in the United States and certain international operations also contributed to the premium growth. Premium levels are signiﬁcantly inﬂuenced by large transactions, such as the Allianz Life transaction, and reporting practices of ceding companies, and as a result, can ﬂuctuate from period to period. Net investment income also contributed to revenue growth, increasing $115 million, or 24%, to $588 million in 2004 from $473 million in 2003. The growth in net investment income is the result of the growth in RGA’s operations and asset base, as well as the conversion of a large reinsurance treaty from a funds withheld to coinsurance basis which resulted in an increase of $12 million in net investment income. Total expenses increased by $840 million, or 27%, to $3,921 million for the year ended December 31, 2004 from $3,081 million for the comparable 2003 period. This increase is commensurate with the growth in revenues and is primarily attributable to an increase of $617 million in policyholder beneﬁts and claims and interest credited to policyholder account balances, primarily associated with RGA’s growth in insurance in force of approximately $200 billion, a negotiated claim settlement in RGA’s accident and health business of $24 million, and the inclusion of only six months of results from the Allianz Life transaction in the prior year. Also, during the fourth quarter of 2004, RGA recorded approximately $18 million in policy beneﬁts and claims as a result of the Indian Ocean tsunami on December 26, 2004 and claims development associated with its reinsurance of Argentine pension business. Other expenses increased primarily due to an increase of $106 million in allowances and related expenses on assumed reinsurance associated with RGA’s growth in premiums and insurance in force and $15 million in additional amortization of DAC from the conversion of a large reinsurance treaty from a funds withheld to coinsurance basis. The balance of the growth in other expenses is primarily due to the aforementioned increase in minority interest expense from $114 million in 2003 to $161 million in 2004. Year ended December 31, 2003 compared with the year ended December 31, 2002 — Reinsurance Net income increased by $8 million, or 10%, to $92 million for the year ended December 31, 2003 from $84 million for the comparable 2002 period. The increase in earnings year over year is primarily attributable to new business growth, additional renewal premiums, as well as a large coinsurance agreement with Allianz Life under which RGA assumed 100% of Allianz Life’s U.S. traditional life reinsurance business. Total revenues, excluding net investment gains and losses, increased by $721 million, or 29%, to $3,190 million for the year ended December 31, 2003 from $2,469 million for the comparable 2002 period. This increase is primarily due to new premiums from facultative and automatic treaties and renewal premiums on existing blocks of business, particularly in the United States and United Kingdom reinsurance operations. In addition, there was a $252 million increase in revenues due to the transaction with Allianz Life in late 2003. Total expenses increased by $742 million, or 32%, to $3,081 million for the year ended December 31, 2003 from $2,339 million for the comparable 2002 period. This increase is consistent with the growth in revenues and is primarily attributable to policyholder beneﬁts and claims and allowances paid on assumed reinsurance, particularly on certain higher commission business in the United Kingdom. The aforementioned transaction with Allianz Life contributed $242 million to this increase. Corporate & Other The following table presents consolidated ﬁnancial information for the Corporate & Other for the years indicated: Revenues Premiums ***************************************************************************** Universal life and investment-type product policy fees***************************************** Net investment income ****************************************************************** Other revenues ************************************************************************* Net investment gains (losses) ************************************************************* Total revenues********************************************************************** Expenses Policyholder beneﬁts and claims *********************************************************** Other expenses ************************************************************************ Total expenses ********************************************************************* Income (Loss) from continuing operations before income tax beneﬁt ***************************** Income tax beneﬁt ********************************************************************** Income (Loss) from continuing operations *************************************************** Income from discontinued operations, net of income taxes ************************************ Income (Loss) before cumulative effect of a change in accounting ****************************** Cumulative effect of a change in accounting, net of income taxes ****************************** Net income (loss) *********************************************************************** Year Ended December 31, 2004 2003 2002 (Dollars in millions) $ (9) 2 472 7 (152) 320 $ (18) — 184 39 (6) $ (19) — (22) 56 (56) 199 (41) 8 532 540 (220) (239) 19 123 142 (1) 51 304 355 (156) (193) 37 273 310 — 3 726 729 (770) (329) (441) 161 (280) — $ 141 $ 310 $(280) Year ended December 31, 2004 compared with the year ended December 31, 2003 — Corporate & Other Income (Loss) from continuing operations decreased by $18 million, or 49%, to $19 million for the year ended December 31, 2004 from $37 million for the comparable 2003 period. The 2004 period includes a $105 million beneﬁt associated with the resolution of issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. Also included in the 2004 year is an expense related to a $32 million contribution, net of income taxes, to the MetLife Foundation and a $9 million beneﬁt from a revision of the estimate of income taxes for 2003. The year ended December 31, 2003 includes a $92 million beneﬁt, net of income taxes, from the reduction of a previously established liability related to the Company’s race-conscious underwriting settlement, as well as a $36 million beneﬁt from a revision of the estimate of income taxes for 2002. 16 MetLife, Inc. Excluding the impact of these items, income from continuing operations increased by $28 million in the year ended December 31, 2004 from the comparable 2003 period. The increase in earnings in 2004 over the prior year period is primarily attributable to an increase in net investment income of $183 million and a decrease in policyholder beneﬁts and claims of $27 million, both of which are net of income taxes. This is partially offset by an increase in net investment losses of $93 million and an increase in interest on bank holder deposits of $14 million, a charge related to unoccupied space of $10 million, as well as expenses associated with the piloting of a new product of $7 million, all net of income taxes. In addition, the tax beneﬁt increased by $41 million as a result of a change in the Company’s allocation of tax expense among segments. Total revenues, excluding net investment gains (losses), increased by $267 million, or 130%, to $472 million for the year ended December 31, 2004 from $205 million for the comparable 2003 period. The increase in revenue is primarily attributable to increases in income on ﬁxed maturity securities, corporate joint venture income, mortgage loans on real estate and equity securities due to increased invested assets and higher yields. Total expenses increased by $185 million, or 52%, to $540 million for the year ended December 31, 2004 from $355 million for the comparable 2003 period. The year ended December 31, 2004 includes a $50 million contribution to the MetLife Foundation, partially offset by a $22 million reduction of interest expense associated with the resolution of all issues relating to the Internal Revenue Service’s audit of Metropolitan Life’s and its subsidiaries’ tax returns for the years 1997-1999. The year ended December 31, 2003 includes a $144 million beneﬁt from a reduction of a previously established liability associated with the Company’s race-conscious underwriting settlement. Excluding these items, other expenses increased by $13 million for the year ended December 31, 2004. This increase is attributable to higher interest expense of $61 million as a result of the issuance of senior notes at the end of 2003 and during 2004, as well as higher interest credited to bank holder deposits of $22 million as a result of growth in MetLife Bank, N.A., (‘‘MetLife Bank’’), a national bank’s, business. This increase is partially offset by a decrease of $54 million from lower interest expense on surplus notes, as well as lower expenses from policyholder beneﬁts and claims of $43 million, a charge related to unoccupied space of $15 million, as well as expenses associated with the piloting of a new product of $11 million. Year ended December 31, 2003 compared with the year ended December 31, 2002 — Corporate & Other Income (Loss) from continuing operations increased by $478 million, or 108%, to $37 million for the year ended December 31, 2003 from ($441) million for the comparable 2002 period. The 2003 period includes a $92 million beneﬁt, net of income taxes, from a reduction of a previously established liability related to the Company’s race conscious underwriting settlement and a $36 million beneﬁt from a revision of the estimate of income tax for 2002. The 2002 period includes a $169 million charge, net of income taxes, to cover costs associated with asbestos-related claims, a $48 million charge, net of income taxes, to cover costs associated with the resolution of a federal government investigation of General American Life Insurance Company’s (‘‘General American’’) former Medicare business, and a $30 million reduction, net of income taxes, of a previously established liability related to the Company’s sales practice class action settlement in 1999. Excluding the impact of these items, the increase in earnings year over year is mainly due to higher investment income. Total revenues, excluding net investment gains and losses, increased by $190 million, or 1,267%, to $205 million for the year ended December 31, 2003 from $15 million for the comparable 2002 period. This variance is mainly due to higher investment income resulting from the change in capital allocation methodology, as well as increases in income from corporate joint ventures, equity-linked notes and securities lending. Total expenses decreased by $374 million, or 51%, to $355 million for the year ended December 31, 2003 from $729 million for the comparable 2002 period. The 2003 period includes a $144 million reduction of a previously established liability related to the Company’s race-conscious underwriting settlement. The 2002 period includes a $266 million charge to increase the Company’s asbestos-related liability and expenses to cover costs associated with the resolution of federal government investigations of General American’s former Medicare business. MetLife Capital Trust I In connection with MetLife, Inc.’s, initial public offering in April 2000, the Holding Company and MetLife Capital Trust I (the ‘‘Trust’’) issued equity security units (the ‘‘units’’). Each unit originally consisted of (i) a contract to purchase, for $50, shares of the Holding Company’s common stock (the ‘‘purchase contracts’’) on May 15, 2003; and (ii) a capital security of the Trust, with a stated liquidation amount of $50. In accordance with the terms of the units, the Trust was dissolved on February 5, 2003, and $1,006 million aggregate principal amount of 8.00% debentures of the Holding Company (the ‘‘MetLife debentures’’), the sole assets of the Trust, were distributed to the owners of the Trust’s capital securities in exchange for their capital securities. The MetLife debentures were remarketed on behalf of the debenture owners on February 12, 2003 and the interest rate on the MetLife debentures was reset as of February 15, 2003 to 3.911% per annum for a yield to maturity of 2.876%. As a result of the remarketing, the debenture owners received $21 million ($0.03 per diluted common share) in excess of the carrying value of the capital securities. This excess was recorded by the Company as a charge to additional paid-in capital and, for the purpose of calculating earnings per share, is subtracted from net income to arrive at net income available to common shareholders. On May 15, 2003, the purchase contracts associated with the units were settled. In exchange for $1,006 million, the Company issued 2.97 shares of MetLife, Inc. common stock per purchase contract, or 59.8 million shares of treasury stock. The excess of the Company’s cost of the treasury stock ($1,662 million) over the contract price of the stock issued to the purchase contract holders ($1,006 million) was $656 million, which was recorded as a direct reduction to retained earnings. Due to the dissolution of the Trust in 2003, there was no interest expense on capital securities for the year ended December 31, 2004. Interest expense on the capital securities is included in other expenses and was $10 million and $81 million for the years ended December 31, 2003 and 2002, respectively. Subsequent Events On January 31, 2005, the Holding Company entered into an agreement to acquire all of the outstanding shares of capital stock of certain indirect subsidiaries of Citigroup Inc., including the majority of The Travelers Insurance Company (‘‘Travelers’’), and substantially all of Citigroup Inc.’s international insurance businesses for a purchase price of $11.5 billion, subject to adjustment as described in the acquisition agreement. As a condition to closing, Citigroup Inc. and the Holding Company will enter into ten-year agreements under which the Company will expand its distribution by making products available through certain Citigroup distribution channels, subject to appropriate suitability and other standards. The transaction is expected to close in the summer of 2005. Approximately $1 billion to $3 billion of the purchase price will be paid in MetLife stock with the remainder paid in cash which will be ﬁnanced through a combination of cash on hand, debt, mandatorily convertible securities and selected asset sales depending on market conditions, timing, valuation considerations and the relative attractiveness of funding alternatives. The Company has entered into brokerage agreements relating to the possible sale of two of its real estate investments, 200 Park Avenue and One Madison Avenue in New York City. The Company is also contemplating other asset sales, including selling some or all of its beneﬁcially owned shares in RGA. MetLife, Inc. 17 On January 31, 2005, the Holding Company completed the sale of SSRM to a third party for $328 million of cash and stock. As a result of the sale of SSRM, the Company recognized income from discontinued operations of approximately $150 million, net of income taxes, comprised of a realized gain of $166 million, net of income taxes, and an operating expense related to a lease abandonment of $16 million, net of income taxes. Under the terms of the agreement, MetLife will have an opportunity to receive, prior to the end of 2006, additional payments aggregating up to approximately 25% of the base purchase price, based on, among other things, certain revenue retention and growth measures. The purchase price is also subject to reduction over ﬁve years, depending on retention of certain MetLife-related business. The Company has reclassiﬁed the assets, liabilities and operations of SSRM into discontinued operations for all periods presented in the consolidated ﬁnancial statements. Additionally, the sale of SSRM resulted in the elimination of the Company’s Asset Management segment. The remaining asset management business, which is insigniﬁcant, has been reclassiﬁed into Corporate & Other. The Company’s discontinued operations for the year ended December 31, 2004 also includes expenses of approximately $20 million, net of income taxes, related to the sale of SSRM. Liquidity and Capital Resources For purposes of this discussion, the terms ‘‘MetLife’’ or the ‘‘Company’’ refer to MetLife, Inc., a Delaware corporation (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). The Company Capital RBC. Section 1322 of the New York Insurance Law requires that New York domestic life insurers report their RBC based on a formula calculated by applying factors to various asset, premium and statutory reserve items. Similar rules apply to each of the Company’s domestic insurance subsidiaries. The formula takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk and business risk. Section 1322 gives the New York Superintendent of Insurance (the ‘‘Superintendent’’) explicit regulatory authority to require various actions by, or to take various actions against, insurers whose total adjusted capital does not exceed certain RBC levels. At December 31, 2004, Metropolitan Life’s and each of the Holding Company’s domestic insurance subsidiaries’ total adjusted capital was in excess of each of the RBC levels required by each state of domicile. The NAIC adopted the Codiﬁcation of Statutory Accounting Principles (‘‘Codiﬁcation’’) in 2001. Codiﬁcation was intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. The New York State Department of Insurance (the ‘‘Department’’) has adopted Codiﬁcation with certain modiﬁcations for the preparation of statutory ﬁnancial statements of insurance companies domiciled in New York. Modiﬁcations by the various state insurance departments may impact the effect of Codiﬁcation on the statutory capital and surplus of Metropolitan Life and the Holding Company’s other insurance subsidiaries. Asset/Liability Management The Company actively manages its assets using an approach that balances quality, diversiﬁcation, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that the assets and liabilities are managed on a cash ﬂow and duration basis. The asset/liability management process is the shared responsibility of the Portfolio Management Unit, the Business Finance Asset/Liability Management Unit, and the operating business segments under the supervision of the various product line speciﬁc Asset/Liability Management Committees (‘‘A/LM Committees’’). The A/LM Committees’ duties include reviewing and approving target portfolios on a periodic basis, establishing investment guidelines and limits and providing oversight of the asset/liability management process. The portfolio managers and asset sector specialists, who have responsibility on a day-to-day basis for risk management of their respective investing activities, implement the goals and objectives established by the A/LM Committees. The Company establishes target asset portfolios for each major insurance product, which represent the investment strategies used to proﬁtably fund its liabilities within acceptable levels of risk. These strategies include objectives for effective duration, yield curve sensitivity, convexity, liquidity, asset sector concentration and credit quality. In executing these asset/liability-matching strategies, management regularly re-evaluates the estimates used in determining the approximate amounts and timing of payments to or on behalf of policyholders for insurance liabilities. Many of these estimates are inherently subjective and could impact the Company’s ability to achieve its asset/liability management goals and objectives. Liquidity Liquidity refers to a company’s ability to generate adequate amounts of cash to meet its needs. The Company’s liquidity position (cash and cash equivalents and short-term investments, excluding securities lending) was $5.5 billion and $4.5 billion at December 31, 2004 and 2003, respectively. Liquidity needs are determined from a rolling 12-month forecast by portfolio and are monitored daily. Asset mix and maturities are adjusted based on forecast. Cash ﬂow testing and stress testing provide additional perspectives on liquidity. The Company believes that it has sufﬁcient liquidity to fund its cash needs under various scenarios that include the potential risk of early contractholder and policyholder withdrawal. The Company includes provisions limiting withdrawal rights on many of its products, including general account institutional pension products (generally group annuities, including guaranteed investment contracts (‘‘GICs’’), and certain deposit funds liabilities) sold to employee beneﬁt plan sponsors. Certain of these provisions prevent the customer from making withdrawals prior to the maturity date of the product. In the event of signiﬁcant unanticipated cash requirements beyond normal liquidity, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These options include cash ﬂow from operations (insurance premiums, annuity considerations and deposit funds), borrowings under committed credit facilities, secured borrowings, the ability to issue commercial paper, long-term debt, capital securities, common equity and, if necessary, the sale of liquid long-term assets. The Company’s ability to sell investment assets could be limited by accounting rules including rules relating to the intent and ability to hold impaired securities until the market value of those securities recovers. In extreme circumstances, all general account assets within a statutory legal entity are available to fund any obligation of the general account within that legal entity. Liquidity Sources Cash Flow from Operations. The Company’s principal cash inﬂows from its insurance activities come from insurance premiums, annuity considera- tions and deposit funds. A primary liquidity concern with respect to these cash inﬂows is the risk of early contractholder and policyholder withdrawal. The Company includes provisions limiting withdrawal rights on many of its products, including general account institutional pension products (generally group annuities, including GICs and certain deposit fund liabilities) sold to employee beneﬁt plan sponsors. 18 MetLife, Inc. The Company’s principal cash inﬂows from its investment activities come from repayments of principal, proceeds from maturities and sales of invested assets and investment income. The primary liquidity concerns with respect to these cash inﬂows are the risk of default by debtors and market volatilities. The Company closely monitors and manages these risks through its credit risk management process. Liquid Assets. An integral part of the Company’s liquidity management is the amount of liquid assets it holds. Liquid assets include cash, cash equivalents, short-term investments, marketable ﬁxed maturity and equity securities. Liquid assets exclude assets relating to securities lending and dollar roll activities. At December 31, 2004 and 2003, the Company had $136 billion and $125 billion in liquid assets, respectively. Global Funding Sources. Liquidity is also provided by a variety of both short- and long-term instruments, including repurchase agreements, commercial paper, medium- and long-term debt, capital securities and stockholders’ equity. The diversiﬁcation of the Company’s funding sources enhances funding ﬂexibility, limits dependence on any one source of funds and generally lowers the cost of funds. At December 31, 2004 and 2003, the Company had $1.4 billion and $3.6 billion in short-term debt outstanding, and $7.4 billion and $5.7 billion in long-term debt outstanding, respectively. MetLife Funding, Inc. (‘‘MetLife Funding’’), a subsidiary of Metropolitan Life, serves as a centralized ﬁnance unit for the Company. Pursuant to a support agreement, the Company has agreed to cause MetLife Funding to have a tangible net worth of at least one dollar. At December 31, 2004 and 2003, MetLife Funding had a tangible net worth of $10.9 million and $10.8 million, respectively. MetLife Funding raises funds from various funding sources and uses the proceeds to extend loans, through MetLife Credit Corp., another subsidiary of Metropolitan Life, to the Holding Company, Metropolitan Life and other afﬁliates. MetLife Funding manages its funding sources to enhance the ﬁnancial ﬂexibility and liquidity of Metropolitan Life and other afﬁliated companies. At December 31, 2004 and 2003, MetLife Funding had total outstanding liabilities, including accrued interest payable, of $1,448 million and $1,042 million, respectively, consisting primarily of commercial paper. Credit Facilities. The Company maintains committed and unsecured credit facilities aggregating $2.8 billion ($1.1 billion expiring in 2005, $175 million expiring in 2006 and $1.5 billion expiring in 2009). If these facilities were drawn upon, they would bear interest at varying rates in accordance with the respective agreements. The facilities can be used for general corporate purposes and $2.5 billion of the facilities also serve as back-up lines of credit for the Company’s commercial paper programs. At December 31, 2004, the Company had drawn approximately $56 million under the facilities expiring in 2005 at interest rates ranging from 5.44% to 6.38% and approximately $50 million under a facility expiring in 2006 at an interest rate of 2.99%. Liquidity Uses Insurance Liabilities. The Company’s principal cash outﬂows primarily relate to the liabilities associated with its various life insurance, property and casualty, annuity and group pension products, operating expenses and income taxes, as well as principal and interest on its outstanding debt obligations. Liabilities arising from its insurance activities primarily relate to beneﬁt payments under the aforementioned products, as well as payments for policy surrenders, withdrawals and loans. Investment and Other. Additional cash outﬂows include those related to obligations of securities lending and dollar roll activities, investments in real estate, limited partnerships and joint ventures, as well as litigation-related liabilities. The following table summarizes the Company’s major contractual obligations as of December 31, 2004: Contractual Obligations Payments Due By Period Total Less Than Three Years Three to Five Years More than Five Years (Dollars in millions) Other long-term liabilities(1)(2) *************************************************** $80,167 Long-term debt(3) ************************************************************ 7,368 Partnership investments(4) ***************************************************** 1,324 Operating leases(5) *********************************************************** 1,084 Mortgage commitments******************************************************** 1,189 Shares subject to mandatory redemption(3) *************************************** 350 Capital leases **************************************************************** 66 Total ************************************************************************ $91,548 $ 9,408 2,110 1,324 347 1,189 — 18 $14,396 $8,901 104 — 317 — — 35 $9,357 $61,858 5,154 — 420 — 350 13 $67,795 (1) Other long-term liabilities include various investment-type products with contractually scheduled maturities, including guaranteed interest contracts, structured settlements, pension closeouts, certain annuity policies and certain indemnities. (2) Other long-term liabilities include beneﬁt and claim liabilities for which the Company believes the amount and timing of the payment is essentially ﬁxed and determinable. Such amounts generally relate to (i) policies or contracts where the Company is currently making payments and will continue to do so until the occurrence of a speciﬁc event, such as death and (ii) life insurance and property and casualty incurred and reported claims. Liabilities for future policy beneﬁts of approximately $71.5 billion and policyholder account balances of approximately $77.8 billion at December 31, 2004, have been excluded from this table. Amounts excluded from the table are generally comprised of policies or contracts where (i) the Company is not currently making payments and will not make payments in the future until the occurrence of an insurable event, such as death or disability or (ii) the occurrence of a payment triggering event, such as a surrender of a policy or contract, is outside of the control of the Company. The determination of these liability amounts and the timing of payment are not reasonably ﬁxed and determinable since the insurable event or payment triggering event has not yet occurred. Such excluded liabilities primarily represent future policy beneﬁts of approximately $60.3 billion relating to traditional life, health and disability insurance products and policyholder account balances of approximately $29.3 billion relating to deferred annuities, approximately $21.8 bil- lion for group and universal life products and approximately $13.8 billion for funding agreements without ﬁxed maturity dates. Signiﬁcant uncertainties relating to these liabilities include mortality, morbidity, expenses, persistency, investment returns, inﬂation and the timing of payments. See ‘‘— The Company — Asset/Liability Management.’’ Amounts included in other long-term liabilities reﬂect estimated cash payments to be made to policyholders. Such cash outﬂows reﬂect adjustments for the estimated timing of mortality, retirement, and other appropriate factors, but are undiscounted with respect to interest. The amount shown in the MetLife, Inc. 19 more than ﬁve years column represents the sum of cash ﬂows, also adjusted for the estimated timing of mortality, retirement and other appropriate factors and undiscounted with respect to interest, extending for more than 100 years from the present date. As a result, the sum of the cash outﬂows shown for all years in the table of $80.2 billion exceeds the corresponding liability amounts of $36.2 billion included in the consolidated ﬁnancial statements at December 31, 2004. The liability amount in the consolidated ﬁnancial statements reﬂects the discounting for interest, as well as adjustments for the timing of other factors as described above. (3) Amounts differ from the balances presented on the consolidated balance sheets. The amounts above do not include related premiums and discounts or capital leases which are presented separately. (4) The Company anticipates that these amounts could be invested in these partnerships any time over the next ﬁve years, but are presented in the current period, as the timing of the fulﬁllment of the obligation cannot be predicted. (5) Excluded from operating leases in the above contractual obligations table is $117 million, $26 million, $38 million, and $53 million for total, less than three years, three to ﬁve years, and more than ﬁve years, respectively, related to discontinued operations pertaining to SSRM. As of December 31, 2004, and relative to its liquidity program, the Company had no material (individually or in the aggregate) purchase obligations or material (individually or in the aggregate) unfunded pension or other postretirement beneﬁt obligations due within one year. On April 11, 2003, an afﬁliate of the Company elected not to make future payments required by the terms of a non-recourse loan obligation. The book value of this loan was approximately $17 million at December 31, 2004. The Company’s exposure under the terms of the applicable loan agreement is limited solely to its investment in certain securities held by an afﬁliate. Subsequent to December 31, 2004, in connection with the sale of the related equity investment, the loan was forgiven and the afﬁliate was discharged and released from its obligations thereunder. Letters of Credit. At December 31, 2004 and 2003, the Company had outstanding $961 million and $828 million, respectively, in letters of credit from various banks, all of which expire within one year. Since commitments associated with letters of credit and ﬁnancing arrangements may expire unused, these amounts do not necessarily reﬂect the actual future cash funding requirements. Support Agreements. Metropolitan Life entered into a net worth maintenance agreement with New England Life Insurance Company (‘‘NELICO’’) at the time Metropolitan Life merged with New England Mutual Life Insurance Company. Under the agreement, Metropolitan Life agreed, without limitation as to the amount, to cause NELICO to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than the company action level RBC, as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. At December 31, 2004, the capital and surplus of NELICO was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2004. In connection with the Company’s acquisition of GenAmerica Financial Corporation (‘‘GenAmerica’’), Metropolitan Life entered into a net worth maintenance agreement with General American. Under the agreement, Metropolitan Life agreed, without limitation as to amount, to cause General American to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than 180% of the company action level RBC, as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. The agreement was subsequently amended to provide that, for the ﬁve year period from 2003 through 2007, total adjusted capital must be maintained at a level not less than 200% of the company action level RBC, as deﬁned by state insurance statutes. At December 31, 2004, the capital and surplus of General American was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2004. Metropolitan Life has also entered into arrangements for the beneﬁt of some of its other subsidiaries and afﬁliates to assist such subsidiaries and afﬁliates in meeting various jurisdictions’ regulatory requirements regarding capital and surplus and security deposits. In addition, Metropolitan Life has entered into a support arrangement with respect to a subsidiary under which Metropolitan Life may become responsible, in the event that the subsidiary becomes the subject of insolvency proceedings, for the payment of certain reinsurance recoverables due from the subsidiary to one or more of its cedents in accordance with the terms and conditions of the applicable reinsurance agreements. General American has agreed to guarantee the contractual obligations of its subsidiary, Paragon Life Insurance Company, and certain contractual obligations of its former subsidiaries, MetLife Investors Insurance Company (‘‘MetLife Investors’’), First MetLife Investors Insurance Company and MetLife Investors Insurance Company of California. In addition, General American has entered into a contingent reinsurance agreement with MetLife Investors. Under this agreement, in the event that MetLife Investors’ statutory capital and surplus is less than $10 million or total adjusted capital falls below 150% of the company action level RBC, as deﬁned by state insurance statutes, General American would assume as assumption reinsurance, subject to regulatory approvals and required consents, all of MetLife Investors’ life insurance policies and annuity contract liabilities. At December 31, 2004, the capital and surplus of MetLife Investors was in excess of the minimum capital and surplus amount referenced above, and its total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2004. Management does not anticipate that these arrangements will place any signiﬁcant demands upon the Company’s liquidity resources. Litigation. Various litigation, claims and assessments against the Company in addition to those discussed elsewhere herein and those otherwise provided for in the Company’s consolidated ﬁnancial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. It is not feasible to predict or determine the ultimate outcome of all pending investigations and legal proceedings or provide reasonable ranges of potential losses except as noted elsewhere herein in connection with speciﬁc matters. In some of the matters referred to herein, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations, it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s consolidated ﬁnancial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. 20 MetLife, Inc. Other. Based on management’s analysis of its expected cash inﬂows from operating activities, the dividends it receives from subsidiaries, including Metropolitan Life, that are permitted to be paid without prior insurance regulatory approval and its portfolio of liquid assets and other anticipated cash ﬂows, management believes there will be sufﬁcient liquidity to enable the Company to make payments on debt, make cash dividend payments on its common stock, pay all operating expenses, and meet its cash needs. The nature of the Company’s diverse product portfolio and customer base lessens the likelihood that normal operations will result in any signiﬁcant strain on liquidity. Subsequent Events. See ‘‘—The Holding Company — Liquidity Uses — Subsequent Events.’’ Consolidated cash ﬂows. Net cash provided by operating activities was $8,066 million and $7,030 million for the years ended December 31, 2004 and 2003, respectively. The $1,036 million increase in operating cash ﬂows in 2004 over the comparable 2003 period is primarily attributable to continued growth in the group life, long-term care, dental and disability businesses, as well as an increase in retirement & savings’ structured settlements due to a large multi-contract sale in 2004. Also, the late 2003 acquisition of John Hancock’s group life business and the acquisition of TIAA-CREF’s long- term care business contributed to growth in the 2004 period. In addition, an increase in MetLife Bank’s customer deposits, particularly in the personal and business savings accounts, contributed to the increase in operating cash ﬂows. Net cash provided by operating activities was $7,030 million and $4,180 million for the years ended December 31, 2003 and 2002, respectively. The $2,850 million increase in operating cash ﬂow in 2003 over the comparable 2002 period is primarily attributable to sales growth in the group life, dental, disability and long-term care businesses, as well as higher sales in retirement & savings’ structured settlement products. The acquisition of John Hancock’s group business also contributed to sales growth in the 2003 period. In addition, growth in MetLife Bank’s customer deposits, accelerated prepayments of mortgage-backed securities that have been previously purchased at a premium, and an increase in funds withheld related to reinsurance activity contributed to the increase in operating cash ﬂows. These items were partially offset by the Company’s contribution to its qualiﬁed deﬁned beneﬁt plans in December 2003. Net cash used in investing activities was $13,015 million and $17,688 million for the years ended December 31, 2004 and 2003, respectively. The $4,673 million decrease in net cash used in investing activities in 2004 over the comparable 2003 period is primarily due to less cash provided by ﬁnancing activities, partially offset by an increase in cash generated from operations. This decrease in available cash resulted in reduced investments in ﬁxed maturities for the current year versus the prior year. Additionally, there was a decrease in securities lending cash collateral invested in 2004 as compared to 2003. These items are partially offset by an increase in mortgage and other loan origination as the Company continues to take advantage of favorable market conditions in this sector as well as an increase in cash used for equity securities and short-term investments for the comparable periods. Net cash used in investing activities was $17,688 million and $16,213 million for the years ended December 31, 2003 and 2002, respectively. The $1,475 million increase in net cash used in investing activities in 2003 over the comparable 2002 period is primarily attributable to an increase in the purchase of ﬁxed maturities and commercial mortgage loan origination, as well as an increase in the amount of securities lending cash collateral invested, which resulted from an expansion of the program. In addition, the Company invested income generated from operations and cash raised through the issuance of GICs. These items were partially offset by lower income resulting from lower market rates and the June 2002 acquisition of Hidalgo. In addition, the 2003 period had less proceeds from sales of equity securities and real estate to use in investing activities. The 2002 period included proceeds from a signiﬁcant sale of equity securities and cash generated by the Company’s real estate sales program. Net cash provided by ﬁnancing activities was $5,322 million and $12,068 million for the years ended December 31, 2004 and 2003, respectively. The $6,746 million decrease in net cash provided by ﬁnancing activities in 2004 over the comparable 2003 period is primarily due to repayments of short-term debt associated with dollar roll activity, and an increase in cash used in the Company’s stock repurchase program. In addition, net cash provided by policyholder account balances decreased for the comparable 2003 period mainly as a result of a decrease in GICs sold in 2004 as compared to 2003. The 2003 period included payments of $1,006 million received on the settlement of common stock purchase contracts (see ‘‘— The Holding Company — Liquidity Sources — Global Funding Sources’’), and $317 million net cash proceeds associated with RGA’s issuance of common stock. The Company also doubled its annual dividend per share in 2004. These items were partially offset by additional proceeds from the issuance of senior notes by the Holding Company and a decrease in repayments of long-term debt for the comparable periods. Net cash provided by ﬁnancing activities was $12,068 million and $6,883 million for the years ended December 31, 2003 and 2002, respectively. The $5,185 million increase in net cash provided by ﬁnancing activities in 2003 over the comparable 2002 period is due to an increase in policyholder account balances primarily from sales of annuity products, as well as additional short-term debt issued related to dollar roll activity. In 2003, the Company received $1,006 million on the settlement of common stock purchase contracts (see ‘‘— The Holding Company — Liquidity Sources — Global Funding Sources’’), issued $700 million of senior notes and had a decrease in cash used in the stock repurchase program as compared to 2002. The 2003 period also includes $317 million net cash proceeds associated with RGA’s issuance of common stock. These cash ﬂows were partially offset by additional repayments of long-term debt and a 10% increase in cash dividends per share in 2003 as compared to 2002. The Holding Company Capital Restrictions and Limitations on Bank Holding Companies and Financial Holding Companies — Capital. MetLife, Inc. and its insured depository institution subsidiary, MetLife Bank, are subject to risk-based and leverage capital guidelines issued by the federal banking regulatory agencies for banks and ﬁnancial holding companies. The federal banking regulatory agencies are required by law to take speciﬁc prompt corrective actions with respect to institutions that do not meet minimum capital standards. At December 31, 2004, MetLife, Inc. and MetLife Bank were in compliance with the aforementioned guidelines. MetLife, Inc. 21 The following table contains the RBC ratios as of December 31, 2004 and 2003 and the regulatory requirements for MetLife Inc., as a bank holding company, and MetLife Bank: MetLife, Inc. RBC Ratios — Bank Holding Company Total RBC Ratio ************************************************ Tier 1 RBC Ratio *********************************************** Tier 1 Leverage Ratio ******************************************* 10.20% 11.19% 9.19% 6.12% 9.73% 6.06% 8.00% 4.00% 3.00% 10.00% 6.00% 5.00% As of December 31, 2004 2003 Regulatory Requirements Minimum Regulatory Requirements ‘‘Well Capitalized’’ MetLife Bank RBC Ratios — Bank As of December 31, 2004 2003 Regulatory Requirements Minimum Regulatory Requirements ‘‘Well Capitalized’’ Total RBC Ratio ************************************************* 17.09% 13.12% Tier 1 RBC Ratio ************************************************ 16.38% 12.50% Tier 1 Leverage Ratio ******************************************** 10.84% 8.81% 8.00% 4.00% 3.00% 10.00% 6.00% 5.00% Liquidity Liquidity is managed to preserve stable, reliable and cost-effective sources of cash to meet all current and future ﬁnancial obligations and is provided by a variety of sources, including a portfolio of liquid assets, a diversiﬁed mix of short- and long-term funding sources from the wholesale ﬁnancial markets and the ability to borrow through committed credit facilities. The Holding Company is an active participant in the global ﬁnancial markets through which it obtains a signiﬁcant amount of funding. These markets, which serve as cost-effective sources of funds, are critical components of the Holding Company’s liquidity management. Decisions to access these markets are based upon relative costs, prospective views of balance sheet growth and a targeted liquidity proﬁle. A disruption in the ﬁnancial markets could limit the Holding Company’s access to liquidity. The Holding Company’s ability to maintain regular access to competitively priced wholesale funds is fostered by its current credit ratings from the major credit rating agencies. Management views its capital ratios, credit quality, stable and diverse earnings streams, diversity of liquidity sources and its liquidity monitoring procedures as critical to retaining high credit ratings. Liquidity is monitored through the use of internal liquidity risk metrics, including the composition and level of the liquid asset portfolio, timing differences in short-term cash ﬂow obligations, access to the ﬁnancial markets for capital and debt transactions and exposure to contingent draws on the Holding Company’s liquidity. Liquidity Sources Dividends. The primary source of the Holding Company’s liquidity is dividends it receives from Metropolitan Life. Under New York State Insurance Law, Metropolitan Life is permitted, without prior insurance regulatory clearance, to pay a dividend to the Holding Company as long as the aggregate amount of all such dividends in any calendar year does not exceed the lesser of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year; and (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). Metropolitan Life will be permitted to pay a dividend to the Holding Company in excess of the lesser of such two amounts only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the Superintendent and the Superintendent does not disapprove the distribution. Under New York State Insurance Law, the Superintendent has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its stockholders. The New York State Department of Insurance has established informal guidelines for such determinations. The guidelines, among other things, focus on the insurer’s overall ﬁnancial condition and proﬁtability under statutory accounting practices. Management of the Holding Company cannot provide assurance that Metropolitan Life will have statutory earnings to support payment of dividends to the Holding Company in an amount sufﬁcient to fund its cash requirements and pay cash dividends or that the Superintendent will not disapprove any dividends that Metropolitan Life must submit for the Superintendent’s consideration. In addition, the Holding Company receives dividends from its other subsidiaries. The Holding Company’s other insurance subsidiaries are also subject to similar restrictions on the payment of dividends to their respective parent companies. The dividend limitation is based on statutory ﬁnancial results. Statutory accounting practices, as prescribed by insurance regulators of various states in which the Company conducts business, differ in certain respects from accounting principles used in ﬁnancial statements prepared in conformity with GAAP. The signiﬁcant differences relate to the treatment of DAC, certain deferred income taxes, required investment reserves, reserve calculation assumptions, goodwill and surplus notes. As of December 31, 2004, the maximum amount of the dividend which may be paid to the Holding Company by Metropolitan Life, Metropolitan Property and Casualty Insurance Company and Metropolitan Tower Life Insurance Company in 2005, without prior regulatory approval, is $880 million, $187 million and $119 million, respectively. Liquid Assets. An integral part of the Holding Company’s liquidity management is the amount of liquid assets that it holds. Liquid assets include cash, cash equivalents, short-term investments, marketable ﬁxed maturity and equity securities. Liquid assets exclude assets relating to securities lending and dollar roll activities. At December 31, 2004 and 2003, the Holding Company had $2,090 million and $1,302 million in liquid assets, respectively. Global Funding Sources. Liquidity is also provided by a variety of both short and long-term instruments, including repurchase agreements, commercial paper, medium and long-term debt, capital securities and stockholders’ equity. The diversiﬁcation of the Holding Company’s funding sources enhances funding ﬂexibility and limits dependence on any one source of funds, and generally lowers the cost of funds. At December 31, 2004, the Holding Company had no short-term debt outstanding as compared to $106 million at December 31, 2003. At December 31, 2004 and 2003, the Holding Company had $5.7 billion and $4.0 billion in long-term debt outstanding, respectively. 22 MetLife, Inc. As of December 31, 2004, the Holding Company has issued an aggregate principal amount of senior debt of $1.2 billion under the $5.0 billion shelf registration statement ﬁled with the SEC during the ﬁrst quarter of 2004. The shelf registration will permit the registration and issuance of a wide range of debt and equity securities. Approximately $44 million of registered but unissued securities remaining from the Company’s 2001 $4.0 billion shelf registration statement was carried over to this shelf registration. The Holding Company issued senior debt in the aggregate principal amount of $2.95 billion under the 2001 $4.0 billion shelf registration statement from November 2001 through November 2003. In addition, under this shelf registration statement, in February 2003, the Holding Company remarketed debentures in the aggregate principal amount of $1.01 billion in accordance with the terms of the then-outstanding equity security units. On December 9, 2004, the Holding Company issued 350 million pounds sterling aggregate principal amount of 5.375% senior notes due December 9, 2024. The senior notes were initially offered and sold outside the United States in reliance upon Regulation S under the Securities Act of 1933, as amended. Up to 35 million pounds sterling, or $66.8 million (translated from pounds sterling to U.S. dollars using the noon buying rate for pound sterling on November 30, 2004 as announced by the U.S. Federal Reserve Bank of New York) of the senior notes initially offered and sold outside the United States may be resold in the United States pursuant to the Company’s shelf registration statement. The following table summarizes the Holding Company’s senior debt issuances: Issue Date Principal (Dollars in millions) Interest Rate Maturity December 2004(1) *********************************************************** June 2004(2) **************************************************************** June 2004(2) **************************************************************** November 2003************************************************************** November 2003************************************************************** December 2002 ************************************************************* December 2002 ************************************************************* November 2001************************************************************** November 2001************************************************************** $671 $350 $750 $500 $200 $400 $600 $500 $750 5.38% 2024 5.50% 2014 6.38% 2034 5.00% 2013 5.88% 2033 5.38% 2012 6.50% 2032 5.25% 2006 6.13% 2011 (1) This amount represents the translation of 350 million pounds sterling into U.S. Dollars using the noon buying rate on December 31, 2004 of 1.916 as announced by the U.S. Federal Reserve Bank of New York. (2) On July 23, 2004, the Holding Company reopened its June 3, 2004 senior notes offering and increased the principal outstanding on the 5.50% notes due June 2014, from $200 million to $350 million and on the 6.38% notes due June 2034, from $400 million to $750 million. (3) This table excludes the remarketed debentures of $1.01 billion and any premium or discount on the senior debt issuances. Other sources of the Holding Company’s liquidity include programs for short- and long-term borrowing, as needed, arranged through Metropolitan Life. Credit Facilities. The Holding Company maintains committed and unsecured credit facilities aggregating $2.5 billion ($1 billion expiring in 2005 and $1.5 billion expiring in 2009) which it shares with Metropolitan Life and MetLife Funding. Borrowings under these facilities bear interest at varying rates stated in the agreements. These facilities are primarily used for general corporate purposes and as back-up lines of credit for the borrowers’ commercial paper programs. At December 31, 2004, none of the Holding Company, Metropolitan Life or MetLife Funding had borrowed against these credit facilities. Liquidity Uses The primary uses of liquidity of the Holding Company include service on debt, cash dividends on common stock, capital contributions to subsidiaries, payment of general operating expenses and the repurchase of the Holding Company’s common stock. Dividends. On September 28, 2004, the Holding Company’s Board of Directors approved an annual dividend for 2004 of $0.46 per share payable on December 13, 2004 to shareholders of record on November 5, 2004. The 2004 dividend represents a 100% increase from the 2003 annual dividend of $0.23 per share. Future dividend decisions will be determined by the Holding Company’s Board of Directors after taking into consideration factors such as the Holding Company’s current earnings, expected medium- and long-term earnings, ﬁnancial condition, regulatory capital position, and applicable governmental regulations and policies. Capital Contributions to Subsidiaries. During the years ended December 31, 2004 and 2003, the Holding Company contributed an aggregate of $761 million and $239 million to various subsidiaries, respectively. Share Repurchase. On October 26, 2004, the Holding Company’s Board of Directors authorized a $1 billion common stock repurchase program. This program began after the completion of the February 19, 2002 and March 28, 2001 repurchase programs, each of which authorized the repurchase of $1 billion of common stock. Under these authorizations, the Holding Company may purchase its common stock from the MetLife Policyholder Trust, in the open market and in privately negotiated transactions. On December 16, 2004, the Holding Company repurchased 7,281,553 shares of its outstanding common stock at an aggregate cost of approximately $300 million under an accelerated share repurchase agreement with a major bank. The bank borrowed the stock sold to the Holding Company from third parties and is purchasing the shares in the open market over the next few months to return to the lenders. The Holding Company will either pay or receive an amount based on the actual amount paid by the bank to purchase the shares. The ﬁnal purchase price is expected to be determined in April 2005 and will be settled in either cash or Holding Company stock at the Holding Company’s option. The Holding Company recorded the initial repurchase of shares as treasury stock and will record any amount paid or received as an adjustment to the cost of the treasury stock. MetLife, Inc. 23 The following table summarizes the 2004, 2003 and 2002 repurchase activity, which includes the accelerated share repurchase activity in the fourth quarter of 2004: December 31, 2004 2003 2002 (Dollars in millions) Shares Repurchased*************************************************** Cost **************************************************************** 26,373,952 1,000 $ 2,997,200 97 $ 15,244,492 471 $ At December 31, 2004, the Holding Company had approximately $710 million remaining on its existing share repurchase program. As a result of the Holding Company’s agreement to acquire Travelers from Citigroup, the Holding Company has suspended its share repurchase activity. In the fourth quarter of 2003, RGA offered to the public 12,075,000 shares of its common stock at $36.65 per share. MetLife and its afﬁliates purchased 3,000,000 shares of the common stock offered by RGA. As a result of this offering, MetLife’s ownership percentage of outstanding shares of RGA common stock was reduced from approximately 59% at December 31, 2002 to approximately 52% at December 31, 2003. MetLife’s ownership percentage of the outstanding shares of RGA common stock remains approximately 52% at December 31, 2004. Letters of Credit. At December 31, 2004 and 2003, the Holding Company had outstanding $369 million and $206 million, respectively, in the letters of credit from various banks, all of which expire within one year. Since commitments associated with letters of credit and ﬁnancing arrangements may expire unused, these amounts do not necessarily reﬂect the actual future cash funding requirements. Support Agreements. In 2002, the Holding Company entered into a net worth maintenance agreement with three of its insurance subsidiaries, MetLife Investors Insurance Company, First MetLife Investors Insurance Company and MetLife Investors Insurance Company of California. Under the agreements, as subsequently amended, the Holding Company agreed, without limitation as to the amount, to cause each of these subsidiaries to have a minimum capital and surplus of $10 million, total adjusted capital at a level not less than 150% of the company action level RBC, as deﬁned by state insurance statutes, and liquidity necessary to enable it to meet its current obligations on a timely basis. At December 31, 2004, the capital and surplus of each of these subsidiaries is in excess of the minimum capital and surplus amounts referenced above, and their total adjusted capital was in excess of the most recent referenced RBC-based amount calculated at December 31, 2004. Based on management’s analysis and comparison of its current and future cash inﬂows from the dividends it receives from subsidiaries, including Metropolitan Life, that are permitted to be paid without prior insurance regulatory approval and its portfolio of liquid assets and other anticipated cash ﬂows, management believes there will be sufﬁcient liquidity to enable the Holding Company to make payments on debt, make cash dividend payments on its common stock, contribute capital to its subsidiaries, pay all operating expenses, and meet its cash needs. Subsequent Events. On January 31, 2005, the Holding Company entered into an agreement to acquire all of the outstanding shares of capital stock of certain indirect subsidiaries of Citigroup Inc., including the majority of Travelers, and substantially all of Citigroup Inc.’s international insurance businesses for a purchase price of $11.5 billion, subject to adjustment as described in the acquisition agreement. As a condition to closing, Citigroup Inc. and the Holding Company will enter into ten-year agreements under which the Company will expand its distribution by making products available through certain Citigroup distribution channels, subject to appropriate suitability and other standards. The transaction is expected to close in the summer of 2005. Approximately $1 billion to $3 billion of the purchase price will be paid in MetLife stock with the remainder paid in cash which will be ﬁnanced through a combination of cash on hand, debt, mandatorily convertible securities and selected asset sales depending on market conditions, timing, valuation considerations and the relative attractiveness of funding alternatives. The Company has entered into brokerage agreements relating to the possible sale of two of its real estate investments, 200 Park Avenue and One Madison Avenue in New York City. The Company is also contemplating other asset sales, including selling some or all of its beneﬁcially owned shares in RGA. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require life insurers doing business within the jurisdiction to participate in guaranty associations, which are organized to pay contractual beneﬁts owed pursuant to insurance policies issued by impaired, insolvent or failed life insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. Assessments levied against the Company from January 1, 2001 through December 31, 2004 aggregated $20 million. The Company maintained a liability of $73 million at December 31, 2004 for future assessments in respect of currently impaired, insolvent or failed insurers. In the past ﬁve years, none of the aggregate assessments levied against MetLife’s insurance subsidiaries has been material. The Company has established liabilities for guaranty fund assessments that it considers adequate for assessments with respect to insurers that are currently subject to insolvency proceedings. Effects of Inﬂation The Company does not believe that inﬂation has had a material effect on its consolidated results of operations, except insofar as inﬂation may affect interest rates. Application of Recent Accounting Pronouncements In December 2004, the Financial Accounting Standards Board (‘‘FASB’’) issued Staff Position Paper (‘‘FSP’’) 109-2, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004 (‘‘AJCA’’). The AJCA introduced a one-time dividend received deduction on the repatriation of certain earnings to a U.S. taxpayer. FSP 109-2 provides companies additional time beyond the ﬁnancial reporting period of enactment to evaluate the effects of the AJCA on their plans to repatriate foreign earnings for purposes of applying SFAS 109, Accounting for Income Taxes. The Company is currently evaluating the repatriation provision of the AJCA. If the repatriation provision is implemented by the Company, the impact on the Company’s income tax expense and deferred income tax assets and liabilities would be immaterial. In December 2004, the FASB issued SFAS No. 153 Exchange of Nonmonetary Assets, an amendment of Accounting Principles Board (‘‘APB’’) Opinion No. 29 (‘‘SFAS 153’’). SFAS 153 amends prior guidance to eliminate the exception for nonmonetary exchanges of similar productive assets and 24 MetLife, Inc. replaces it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial substance if the future cash ﬂows of the entity are expected to change signiﬁcantly as a result of the exchange. The provisions of SFAS 153 are effective for nonmonetary asset exchanges occurring in ﬁscal periods beginning after June 15, 2005 and shall be applied prospectively. SFAS 153 is not expected to have a material impact on the Company’s consolidated ﬁnancial statements at the date of adoption. In December 2004, FASB revised SFAS No. 123 Accounting for Stock-Based Compensation (‘‘SFAS 123’’) to Share-Based Payment (‘‘SFAS 123(r)’’). SFAS 123(r) provides additional guidance on determining whether certain ﬁnancial instruments awarded in share-based payment transactions are liabilities. SFAS 123(r) also requires that the cost of all share-based transactions be recorded in the ﬁnancial statements. The revised pronouncement must be adopted by the Company by July 1, 2005. As all stock options currently accounted for under APB Opinion No. 25, Accounting for Stock Issued to Employees (‘‘APB 25’’) will vest prior to the effective date, implementation of SFAS 123(r) will not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS No. 148, Accounting for Stock-Based Compensation — Transition and Disclosure (‘‘SFAS 148’’), which provides guidance on how to apply the fair value method of accounting for share-based payments. As permitted under SFAS 148, the Company elected to use the prospective method of accounting for stock options granted subsequent to December 31, 2002. Options granted prior to January 1, 2003 will continue to be accounted for under the intrinsic value method until the adoption of SFAS 123(r), and the pro forma impact of accounting for these options at fair value will continue to be disclosed in the consolidated ﬁnancial statements until the last of those options vest in 2005. In March 2004, the Emerging Issues Task Force (‘‘EITF’’) reached further consensus on Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments (‘‘EITF 03-1’’). EITF 03-1 provides accounting guidance regarding the determination of when an impairment of debt and marketable equity securities and investments accounted for under the cost method should be considered other-than-temporary and recognized in income. An EITF 03-1 consensus reached in November 2003 also requires certain quantitative and qualitative disclosures for debt and marketable equity securities classiﬁed as available-for-sale or held-to-maturity under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities, that are impaired at the balance sheet date but for which an other-than-temporary impairment has not been recognized. The Company has complied with the disclosure requirements of EITF 03-1 which were effective December 31, 2003. The accounting guidance of EITF 03-1 relating to the recognition of investment impairment which was to be effective in the third quarter of 2004 has been delayed pending the development of additional guidance. The Company is actively monitoring the deliberations relating to this issue at the FASB and currently is unable to determine the ultimate impact EITF 03-1 will have on its consolidated ﬁnancial statements. In March 2004, the EITF reached consensus on Issue No. 03-6, Participating Securities and the Two — Class Method under FASB Statement No. 128 (‘‘EITF 03-6’’). EITF 03-6 provides guidance in determining whether a security should be considered a participating security for purposes of computing earnings per share and how earnings should be allocated to the participating security. EITF 03-6 did not have an impact on the Company’s earnings per share calculations or amounts. In March 2004, the EITF reached consensus on Issue No. 03-16, Accounting for Investments in Limited Liability Companies (‘‘EITF 03-16’’). EITF 03-16 provides guidance regarding whether a limited liability company should be viewed as similar to a corporation or similar to a partnership for purposes of determining whether a noncontrolling investment should be accounted for using the cost method or the equity method of accounting. EITF 03-16 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2004, the Company adopted SOP 03-1, as interpreted by Technical Practices Aids issued by the American Institute of Certiﬁed Public Accountants. SOP 03-1 provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. In June 2004, the FASB released FSP No. 97-1, Situations in Which Paragraphs 17(b) and 20 of FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments, Permit or Require Accrual of an Unearned Revenue Liability (‘‘FSP 97-1’’) which included clariﬁcation that unearned revenue liabilities should be considered in determining the necessary insurance beneﬁt liability required under SOP 03-1. Since the Company had considered unearned revenue in determining its SOP 03-1 beneﬁt liabilities, FSP 97-1 did not impact its consolidated ﬁnancial statements. As a result of the adoption of SOP 03-1, effective January 1, 2004, the Company decreased the liability for future policyholder beneﬁts for changes in the methodology relating to various guaranteed death and annuitization beneﬁts and for determining liabilities for certain universal life insurance contracts by $4 million, which has been reported as a cumulative effect of a change in accounting. This amount is net of corresponding changes in DAC, including VOBA and unearned revenue liability (‘‘offsets’’) under certain variable annuity and life contracts and income taxes. Certain other contracts sold by the Company provide for a return through periodic crediting rates, surrender adjustments or termination adjustments based on the total return of a contractually referenced pool of assets owned by the Company. To the extent that such contracts are not accounted for as derivatives under the provisions of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities (‘‘SFAS 133’’) and not already credited to the contract account balance, under SOP 03-1 the change relating to the fair value of the referenced pool of assets is recorded as a liability with the change in the liability recorded as policyholder beneﬁts and claims. Prior to the adoption of SOP 03-1, the Company recorded the change in such liability as other comprehensive income. At adoption, this change decreased net income and increased other comprehensive income by $63 million, net of income taxes, which were recorded as cumulative effects of changes in accounting. Effective with the adoption of SOP 03-1, costs associated with enhanced or bonus crediting rates to contractholders must be deferred and amortized over the life of the related contract using assumptions consistent with the amortization of DAC. Since the Company followed a similar approach prior to adoption of SOP 03-1, the provisions of SOP 03-1 relating to sales inducements had no signiﬁcant impact on the Company’s consolidated ﬁnancial statements. At adoption, the Company reclassiﬁed $155 million of ownership in its own separate accounts from other assets to ﬁxed maturities, equity securities and cash and cash equivalents. This reclassiﬁcation had no signiﬁcant impact on net income or other comprehensive income at adoption. In accordance with SOP 03-1’s guidance for the reporting of certain separate accounts, at adoption, the Company also reclassiﬁed $1.7 billion of separate account assets to general account investments and $1.7 billion of separate account liabilities to future policy beneﬁts and policyholder account balances. This reclassiﬁcation decreased net income and increased other comprehensive income by $27 million, net of income taxes, which were reported as cumulative effects of changes in accounting. The application of SOP 03-1 decreased the Company’s 2004 net income by $67 million, including the cumulative effect of adoption of a decrease in net income of $86 million as described above. In December 2003, FASB revised SFAS No. 132, Employers’ Disclosures about Pensions and Other Postretirement Beneﬁts — an Amendment of FASB Statements No. 87, 88 and 106 (‘‘SFAS 132(r)’’). SFAS 132(r) retains most of the disclosure requirements of SFAS 132 and requires additional disclosure about assets, obligations, cash ﬂows and net periodic beneﬁt cost of deﬁned beneﬁt pension plans and other postretirement plans. SFAS 132(r) was primarily effective for ﬁscal years ending after December 15, 2003; however, certain disclosures about foreign plans and estimated MetLife, Inc. 25 future beneﬁt payments were effective for ﬁscal years ending after June 15, 2004. The Company’s adoption of SFAS 132(r) on December 31, 2003 did not have a signiﬁcant impact on its consolidated ﬁnancial statements since it only revised disclosure requirements. In May 2004, the FASB issued FASB Staff Position (‘‘FSP’’) No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (‘‘FSP 106-2’’), which provides accounting guidance to a sponsor of a postretirement health care plan that provides prescription drug beneﬁts. The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 based on the Company’s determination that the prescription drug beneﬁts offered under certain postretirement plans are actuarially equivalent to the beneﬁts offered under Medicare Part D. FSP 106-2 was effective for interim periods beginning after June 15, 2004 and provides for either retroactive application to the date of enactment of the legislation or prospective application from the date of adoption of FSP 106-2. Effective July 1, 2004, the Company adopted FSP 106-2 prospectively and the postretirement beneﬁt plan assets and accumulated beneﬁt obligation were remeasured to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation and net periodic postretirement beneﬁt cost was reduced by $213 million and $17 million, for 2004, respectively. Effective October 1, 2003, the Company adopted Statement 133 Implementation Issue No. B36, Embedded Derivatives: Modiﬁed Coinsurance Arrangements and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to the Creditworthiness of the Obligor under Those Instruments (‘‘Issue B36’’). Issue B36 concluded that (i) a company’s funds withheld payable and/or receivable under certain reinsurance arrangements, and (ii) a debt instrument that incorporates credit risk exposures that are unrelated or only partially related to the creditworthi- ness of the obligor include an embedded derivative feature that is not clearly and closely related to the host contract. Therefore, the embedded derivative feature is measured at fair value on the balance sheet and changes in fair value are reported in income. The Company’s application of Issue B36 increased (decreased) net income by $4 million and ($12) million, net of amortization of DAC and income taxes, for 2004 and 2003, respectively. The 2003 impact includes a decrease in net income of $26 million relating to the cumulative effect of a change in accounting from the adoption of the new guidance. Effective July 1, 2003, the Company adopted SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities (‘‘SFAS 149’’). SFAS 149 amended and clariﬁed the accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Except for certain previously issued and effective guidance, SFAS 149 was effective for contracts entered into or modiﬁed after June 30, 2003. The Company’s adoption of SFAS 149 did not have a signiﬁcant impact on its consolidated ﬁnancial statements. During 2003, the Company adopted FASB (‘‘FIN’’) Interpretation No. 46, Consolidation of Variable Interest Entities — An Interpretation of ARB No. 51 (‘‘FIN 46’’), and its December 2003 revision (‘‘FIN 46(r)’’). Certain of the Company’s investments in real estate joint ventures and other limited partnership interests meet the deﬁnition of a variable interest entity (‘‘VIE’’) and have been consolidated, in accordance with the transition rules and effective dates, because the Company is deemed to be the primary beneﬁciary. A VIE is deﬁned as (i) any entity in which the equity investments at risk in such entity do not have the characteristics of a controlling ﬁnancial interest, or (ii) any entity that does not have sufﬁcient equity at risk to ﬁnance its activities without additional subordinated support from other parties. Effective February 1, 2003, the Company adopted FIN 46 for VIEs created or acquired on or after February 1, 2003 and, effective December 31, 2003, the Company adopted FIN 46(r) with respect to interests in entities formerly considered special purpose entities (‘‘SPEs’’), including interests in asset-backed securities and collateralized debt obligations. The adoption of FIN 46 as of February 1, 2003 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. The adoption of the provisions of FIN 46(r) at December 31, 2003 did not require the Company to consolidate any additional VIEs that were not previously consolidated. In accordance with the provisions of FIN 46(r), the Company elected to defer until March 31, 2004 the consolidation of interests in VIEs for non-SPEs acquired prior to February 1, 2003 for which it is the primary beneﬁciary. As of March 31, 2004, the Company consolidated assets and liabilities relating to real estate joint ventures of $78 million and $11 million, respectively, and assets and liabilities relating to other limited partnerships of $29 million and less than $1 million, respectively, for VIEs for which the Company was deemed to be the primary beneﬁciary. There was no impact to net income from the adoption of FIN 46. Effective January 1, 2003, the Company adopted FIN No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (‘‘FIN 45’’). FIN 45 requires entities to establish liabilities for certain types of guarantees and expands ﬁnancial statement disclosures for others. The initial recognition and initial measurement provisions of FIN 45 were applicable on a prospective basis to guarantees issued or modiﬁed after December 31, 2002. The adoption of FIN 45 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (‘‘SFAS 146’’). SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recorded and measured initially at fair value only when the liability is incurred rather than at the date of an entity’s commitment to an exit plan as required by EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Beneﬁts and Other Costs to Exit an Activity Including Certain Costs Incurred in a Restructuring (‘‘EITF 94-3’’). The Company’s activities subject to this guidance in 2004 and 2003 were not signiﬁcant. Effective January 1, 2003, the Company adopted SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections (‘‘SFAS 145’’). In addition to amending or rescinding other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions, SFAS 145 generally precludes companies from recording gains and losses from the extinguishment of debt as an extraordinary item. SFAS 145 also requires sale-leaseback treatment for certain modiﬁcations of a capital lease that result in the lease being classiﬁed as an operating lease. The adoption of SFAS 145 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2002, the Company adopted SFAS No. 144. SFAS 144 provides a single model for accounting for long-lived assets to be disposed of by superseding SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of (‘‘SFAS 121’’), and the accounting and reporting provisions of APB Opinion No. 30, Reporting the Results of Operations — Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions (‘‘APB 30’’). Under SFAS 144, discontinued operations are measured at the lower of carrying value or fair value less costs to sell, rather than on a net realizable value basis. Future operating losses relating to discontinued operations also are no longer recognized before they occur. SFAS 144: (i) broadens the deﬁnition of a discontinued operation to include a component of an entity (rather than a segment of a business); (ii) requires long-lived assets to be disposed of other than by sale to be considered held and used until disposed; and (iii) retains the basic provisions of (a) APB 30 regarding the presentation of discontinued operations in the statements of income, (b) SFAS 121 relating to recognition and measurement of impaired long-lived assets (other than goodwill), and (c) SFAS 121 relating to the measurement of long-lived assets classiﬁed as held-for-sale. Adoption of SFAS 144 did not have a material impact on the 26 MetLife, Inc. Company’s consolidated ﬁnancial statements other than the presentation as discontinued operations of net investment income and net investment gains related to operations of real estate on which the Company initiated disposition activities subsequent to January 1, 2002 and the classiﬁcation of such real estate as held-for-sale on the consolidated balance sheets. Effective January 1, 2002, the Company adopted SFAS No. 142, Goodwill and Other Intangible Assets, (‘‘SFAS 142’’). SFAS 142 eliminates the systematic amortization and establishes criteria for measuring the impairment of goodwill and certain other intangible assets by reporting unit. There was no impairment of identiﬁed intangibles or signiﬁcant reclassiﬁcations between goodwill and other intangible assets at January 1, 2002. Amortization of other intangible assets was not material for the years ended December 31, 2004, 2003 and 2002. Investments The Company’s primary investment objective is to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that assets and liabilities are managed on a cash ﬂow and duration basis. The Company is exposed to three primary sources of investment risk: ) Credit risk, relating to the uncertainty associated with the continued ability of a given obligor to make timely payments of principal and interest; ) Interest rate risk, relating to the market price and cash ﬂow variability associated with changes in market interest rates; and ) Market valuation risk. The Company manages risk through in-house fundamental analysis of the underlying obligors, issuers, transaction structures and real estate properties. The Company also manages credit risk and market valuation risk through industry and issuer diversiﬁcation and asset allocation. For real estate and agricultural assets, the Company manages credit risk and valuation risk through geographic, property type and product type diversiﬁcation and asset allocation. The Company manages interest rate risk as part of its asset and liability management strategies, product design, such as the use of market value adjustment features and surrender charges, and proactive monitoring and management of certain non-guaranteed elements of its products, such as the resetting of credited interest and dividend rates for policies that permit such adjustments. MetLife, Inc. 27 Composition of Portfolio and Investment Results The following table illustrates the net investment income and annualized yields on average assets for each of the components of the Company’s investment portfolio for the years ended December 31, 2004, 2003 and 2002. The decline in annualized yields is due primarily to the decline in interest rates during these periods. December 31, 2004 2003 2002 (Dollars in millions) 6.55% 6.86% 11.64% 516 162 4,329 Fixed Maturities Yield(2) ****************************************************************************** Investment income********************************************************************* $ 9,042 Net investment gains (losses) ************************************************************ $ 71 Ending assets************************************************************************* $176,763 Mortgage and Other Loans Yield(2) ****************************************************************************** Investment income(3)******************************************************************* $ 1,961 Net investment gains (losses) ************************************************************ $ (47) Ending assets************************************************************************* $ 32,406 Real Estate and Real Estate Joint Ventures(4) Yield(2) ****************************************************************************** Investment income(5)******************************************************************* $ Net investment gains (losses) ************************************************************ $ Ending assets(6)*********************************************************************** $ Policy Loans Yield(2) ****************************************************************************** Investment income********************************************************************* $ Ending assets************************************************************************* $ Equity Securities and Other Limited Partnership Interests Yield(2) ****************************************************************************** Investment income(5)******************************************************************* $ Net investment gains (losses) ************************************************************ $ Ending assets(6)*********************************************************************** $ Cash and Short-Term Investments Yield(2) ****************************************************************************** Investment income(5)******************************************************************* $ Net investment gains (losses) ************************************************************ $ Ending assets(6)*********************************************************************** $ Other Invested Assets(7) Yield(2) ****************************************************************************** Investment income(5)******************************************************************* $ Net investment gains (losses)(8)(9) ******************************************************** $ Ending assets(6)*********************************************************************** $ Total Investments Gross investment income yield(2) ******************************************************** Investment fees and expenses yield ****************************************************** Net investment income yield************************************************************* Gross investment income *************************************************************** $ 12,876 Investment fees and expenses*********************************************************** (262) Net investment income(1)(4)(5)(7)(9) ******************************************************* $ 12,614 Ending assets(1)*********************************************************************** $239,289 Net investment gains (losses)(1)(4)(7)(8)(9) ************************************************* $ 244 6.15% 541 8,899 9.90% 404 208 5,144 2.99% 153 (1) 6,802 6.38% 259 (149) 4,946 6.67% (0.14)% 6.53% 6.89% 7.46% 8,502 $ $ (398) $167,752 8,076 $ $ (917) $140,288 7.48% 7.84% 1,903 $ $ (56) $ 26,249 1,883 $ $ (22) $ 25,086 10.90% 513 440 4,680 6.40% 554 8,749 3.02% 111 (43) 4,198 2.73% 165 1 5,559 8.53% 290 (180) 4,645 $ $ $ $ $ $ $ $ $ $ $ $ $ $ 11.48% 637 576 4,637 6.49% 543 8,580 2.66% 99 222 4,096 4.17% 232 — 4,244 8.82% 218 (206) 3,727 $ $ $ $ $ $ $ $ $ $ $ $ $ $ 6.86% (0.15)% 6.71% 7.40% (0.15)% 7.25% $ 12,038 (266) $ 11,688 (235) $ 11,772 $ 11,453 $221,832 $190,658 $ (236) $ (347) (1) Included in ending assets, investment income and investment gains (losses) is $2,139 million, $86 million and $25 million, respectively, related to the consolidation of separate accounts under SOP 03-1 for the year ended December 31, 2004. (2) Yields are based on quarterly average asset carrying values, excluding recognized and unrealized investment gains (losses), and for yield calculation (5) purposes, average assets exclude collateral associated with the Company’s securities lending program. Investment income from mortgage and other loans includes prepayment fees. (3) (4) Real estate and real estate joint venture income includes amounts classified as discontinued operations of $54 million, $93 million and $180 million for the years ended December 31, 2004, 2003 and 2002, respectively. Net investment gains (losses) include $139 million, $420 million and $582 million of gains classified as discontinued operations for the years ended December 31, 2004, 2003 and 2002, respectively. Included in investment income from real estate and real estate joint ventures, equity securities and other limited partnership interests, cash and short- term investments, other invested assets, and investment expenses and fees is a total of $65 million, $56 million and $59 million for the years ended December 31, 2004, 2003 and 2002, respectively, related to discontinued operations pertaining to SSRM. Included in ending assets for real estate and real estate joint ventures, equity securities and other limited partnership interests, cash and short-term investments and other invested assets is a total of $96 million, $49 million, $88 million and $20 million, respectively, pertaining to SSRM at December 31, 2004. Included in ending assets for real estate and real estate joint ventures, equity securities and other limited partnership interests, cash and short-term investments, and other invested assets is a total of $3 million, $14 million, $67 million and $8 million, respectively, pertaining to SSRM at December 31, 2003. Included in ending assets for real estate and real estate joint ventures, equity securities and other limited partnership interests, cash and short-term investments, and other invested assets is a total of $19 million, $7 million, $54 million and $5 million, respectively, pertaining to SSRM at December 31, 2002. (6) 28 MetLife, Inc. (7) (8) (9) Investment income from other invested assets includes scheduled periodic settlement payments on derivative instruments that do not qualify for hedge accounting under SFAS 133 of $51 million, $84 million and $32 million for the years ended December 31, 2004, 2003 and 2002, respectively. These amounts are excluded from net investment gains (losses). Included in net investment gains (losses) from other invested assets is $0 million, $10 million and $(4) million for the years ended December 31, 2004, 2003 and 2002, respectively, related to discontinued operations pertaining to SSRM. Included in net investment gains (losses) from other invested assets for the year ended December 31, 2004, is a charge of $26 million related to a funds withheld reinsurance treaty that was converted to a coinsurance agreement. This amount is classiﬁed in net investment income in the consolidated statements of income. Fixed Maturities and Equity Securities Fixed maturities consist principally of publicly traded and privately placed debt securities, and represented 73.9% and 75.7% of total cash and invested assets at December 31, 2004 and 2003, respectively. Based on estimated fair value, public ﬁxed maturities represented $154,456 million, or 87.4%, and $147,489 million, or 87.9%, of total ﬁxed maturities at December 31, 2004 and 2003, respectively. Based on estimated fair value, private ﬁxed maturities represented $22,307 million, or 12.6%, and $20,263 million, or 12.1%, of total ﬁxed maturities at December 31, 2004 and 2003, respectively. In cases where quoted market prices are not available, fair values are estimated using present value or valuation techniques. The fair value estimates are made at a speciﬁc point in time, based on available market information and judgments about the ﬁnancial instruments, including estimates of the timing and amounts of expected future cash ﬂows and the credit standing of the issuer or counterparty. Factors considered in estimating fair value include: coupon rate, maturity, estimated duration, call provisions, sinking fund requirements, credit rating, industry sector of the issuer and quoted market prices of comparable securities. The Securities Valuation Ofﬁce of the NAIC evaluates the ﬁxed maturity investments of insurers for regulatory reporting purposes and assigns securities to one of six investment categories called ‘‘NAIC designations.’’ The NAIC ratings are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC ratings 1 and 2 include bonds generally considered investment grade (rated ‘‘Baa3’’ or higher by Moody’s Investors Services (‘‘Moody’s’’), or rated ‘‘BBB–’’ or higher by Standard & Poor’s (‘‘S&P’’) by such rating organizations. NAIC ratings 3 through 6 include bonds generally considered below investment grade (rated ‘‘Ba1’’ or lower by Moody’s, or rated ‘‘BB+’’ or lower by S&P). The following table presents the Company’s total ﬁxed maturities by Nationally Recognized Statistical Rating Organizations designation and the equivalent ratings of the NAIC, as well as the percentage, based on estimated fair value, that each designation is comprised of at: NAIC Rating Rating Agency Designation(1) 1 2 3 4 5 6 Aaa/Aa/A******************************************* Baa *********************************************** Ba ************************************************ B ************************************************* Caa and lower ************************************** In or near default ************************************ Subtotal******************************************** Redeemable preferred stock*************************** Total ﬁxed maturities********************************** December 31, 2004 December 31, 2003 Cost or Amortized Cost $113,071 42,165 6,907 4,097 329 101 166,670 326 Estimated Fair Value % of Total Cost or Amortized Cost Estimated Fair Value % of Total $118,779 45,311 7,500 4,414 366 90 176,460 303 (Dollars in millions) 67.2% $106,779 39,006 25.6 7,388 4.2 3,578 2.5 630 0.2 341 0.1 99.8 0.2 157,722 611 $112,333 42,057 8,011 3,814 629 371 167,215 537 67.0% 25.0 4.8 2.3 0.4 0.2 99.7 0.3 $166,996 $176,763 100.0% $158,333 $167,752 100.0% (1) Amounts presented are based on rating agency designations. Comparisons between NAIC ratings and rating agency designations are published by the NAIC. The rating agency designations are based on availability and the lower of the applicable ratings between Moody’s and S&P. The current period ratings are presented so that the consolidated rating is equal to the Moody’s or S&P rating, whichever is more conservative. If no rating is available from a rating agency, then the MetLife rating will be used. The following table shows the amortized cost and estimated fair value of ﬁxed maturities, by contractual maturity dates (excluding scheduled sinking funds) at: December 31, 2004 December 31, 2003 Cost or Amortized Cost Estimated Fair Value Cost or Amortized Cost Estimated Fair Value Due in one year or less ***************************************************** $ Due after one year through ﬁve years ****************************************** Due after ﬁve years through ten years ***************************************** Due after ten years ********************************************************* Subtotal ************************************************************** Mortgage-backed, commercial mortgage-backed and other asset-backed securities ** Subtotal ************************************************************** Redeemable preferred stock ************************************************* 166,670 326 Total ﬁxed maturities **************************************************** $166,996 6,751 29,850 33,543 41,960 112,104 54,566 (Dollars in millions) $ 6,845 31,168 36,008 46,832 120,853 55,607 176,460 303 $ 5,381 30,893 29,342 39,011 104,627 53,095 157,722 611 $ 5,542 32,431 31,830 43,064 112,867 54,348 167,215 537 $176,763 $158,333 $167,752 Bonds not due at a single maturity date have been included in the above table in the year of ﬁnal contractual maturity. Actual maturities may differ from contractual maturities due to the exercise of prepayment options. MetLife, Inc. 29 The following tables set forth the cost or amortized cost, gross unrealized gain and loss, and estimated fair value of the Company’s ﬁxed maturities by sector and equity securities, as well as the percentage of the total ﬁxed maturities holdings that each sector represents and the percentage of the total equity securities at: December 31, 2004 Cost or Amortized Cost Gross Unrealized Gain Loss Estimated Fair Value % of Total (Dollars in millions) U.S. treasury/agency securities ******************************************** $ 16,534 State and political subdivision securities ************************************* 3,683 U.S. corporate securities ************************************************* 58,022 Foreign government securities ********************************************* 7,637 Foreign corporate securities *********************************************** 25,341 Residential mortgage-backed securities ************************************* 31,683 Commercial mortgage-backed securities ************************************ 12,099 Asset-backed securities ************************************************** 10,784 Other ﬁxed maturity securities ********************************************* 887 Total bonds ******************************************************** Redeemable preferred stocks ********************************************* 166,670 326 Total ﬁxed maturities ************************************************* $166,996 $ 1,314 220 3,870 974 2,582 612 440 125 131 10,268 — $ 22 4 172 26 85 65 38 33 33 478 23 $ 17,826 3,899 61,720 8,585 27,838 32,230 12,501 10,876 985 176,460 303 10.1% 2.2 34.9 4.9 15.7 18.2 7.1 6.1 0.6 99.8 0.2 $10,268 $501 $176,763 100.0% Common stocks ******************************************************** $ Nonredeemable preferred stocks ****************************************** Total equity securities(1) ********************************************** $ 1,412 501 1,913 $ $ 244 39 283 $ 5 3 $ 8 $ $ 1,651 537 75.5% 24.5 2,188 100.0% December 31, 2003 Cost or Amortized Cost Gross Unrealized Gain Loss Estimated Fair Value % of Total (Dollars in millions) U.S. treasury/agency securities ******************************************** $ 14,707 State and political subdivision securities ************************************* 3,155 U.S. corporate securities ************************************************* 56,757 Foreign government securities ********************************************* 7,789 Foreign corporate securities *********************************************** 21,727 Residential mortgage-backed securities ************************************* 30,836 Commercial mortgage-backed securities ************************************ 10,523 Asset-backed securities ************************************************** 11,736 Other ﬁxed maturity securities ********************************************* 492 Total bonds ******************************************************** Redeemable preferred stocks ********************************************* 157,722 611 Total ﬁxed maturities ************************************************* $158,333 Common stocks ******************************************************** $ Nonredeemable preferred stocks ****************************************** 613 602 Total equity securities(1) ********************************************** $ 1,215 $ 1,264 209 3,886 1,003 2,194 720 530 187 167 10,160 2 $ 26 15 252 28 79 102 22 60 83 667 76 $ 15,945 3,349 60,391 8,764 23,842 31,454 11,031 11,863 576 167,215 537 9.5% 2.0 36.0 5.2 14.2 18.8 6.6 7.1 0.3 99.7 0.3 $10,162 $743 $167,752 100.0% $ $ 327 48 375 $ 2 4 $ 6 $ $ 938 646 59.2% 40.8 1,584 100.0% (1) Equity securities primarily consist of investments in common and preferred stocks and mutual fund interests. Such securities include private equity securities with an estimated fair value of $332 million and $432 million at December 31, 2004 and 2003, respectively. Fixed Maturity and Equity Security Impairment. The Company classiﬁes all of its ﬁxed maturities and equity securities as available-for-sale and marks them to market through other comprehensive income, except for non-marketable private equities, which are generally carried at cost. All securities with gross unrealized losses at the consolidated balance sheet date are subjected to the Company’s process for identifying other-than-temporary impairments. The Company writes down to fair value securities that it deems to be other-than-temporarily impaired in the period the securities are deemed to be so impaired. The assessment of whether such impairment has occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors, as described in ‘‘Summary of Critical Accounting Estimates — Investments,’’ about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. The Company’s review of its ﬁxed maturities and equity securities for impairments includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for six months or greater. While all of these securities are monitored for potential impairment, the Company’s experience indicates that the ﬁrst two categories do not present as great a risk of impairment, and often, fair values recover over time as the factors that caused the declines improve. The Company records impairments as investment losses and adjusts the cost basis of the ﬁxed maturities and equity securities accordingly. The Company does not change the revised cost basis for subsequent recoveries in value. Impairments of ﬁxed maturities and equity securities were 30 MetLife, Inc. $102 million, $355 million and $1,375 million for the years ended December 31, 2004, 2003 and 2002, respectively. The Company’s three largest impairments totaled $53 million, $125 million and $352 million for the years ended December 31, 2004, 2003 and 2002, respectively. The circum- stances that gave rise to these impairments were either ﬁnancial restructurings or bankruptcy ﬁlings. During the years ended December 31, 2004, 2003 and 2002, the Company sold or disposed of ﬁxed maturities and equity securities at a loss that had a fair value of $29,939 million, $21,984 million and $10,128 million, respectively. Gross losses excluding impairments for ﬁxed maturities and equity securities were $516 million, $500 million and $979 million for the years ended December 31, 2004, 2003 and 2002, respectively. The following table presents the cost or amortized cost, gross unrealized losses and number of securities for ﬁxed maturities and equity securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%, or 20% or more for: Cost or Amortized Cost December 31, 2004 Gross Unrealized Losses Number of Securities Less than 20% 20% or more Less than 20% 20% or more Less than 20% 20% or more (Dollars in millions) Less than six months********************************************** $27,178 Six months or greater but less than nine months*********************** 8,477 Nine months or greater but less than twelve months******************** 1,595 Twelve months or greater ****************************************** 2,798 Total ******************************************************** $40,048 $ 79 9 19 19 $126 $246 111 33 80 $470 $18 2 4 15 $39 3,188 687 206 395 4,476 117 5 5 7 134 The gross unrealized loss related to the Company’s ﬁxed maturities and equity securities at December 31, 2004 was $509 million. These securities are concentrated by sector in United States corporates (34%); foreign corporates (17%); and residential mortgage-backed (13%); and are concentrated by industry in mortgage-backed (20%); ﬁnance (10%); and services (10%) (calculated as a percentage of gross unrealized loss). Non-investment grade securities represent 4% of the $39,665 million fair value and 12% of the $509 million gross unrealized loss. The Company did not hold any single ﬁxed maturity or equity security with a gross unrealized loss at December 31, 2004 greater than $10 million. Corporate Fixed Maturities. The table below shows the major industry types that comprise the corporate ﬁxed maturity holdings at: December 31, 2004 December 31, 2003 Estimated Fair Value % of Total Estimated Fair Value % of Total Industrial *************************************************************************** $35,785 Utility ****************************************************************************** 10,800 Finance**************************************************************************** 14,481 Foreign(1) ************************************************************************** 27,838 Other ***************************************************************************** 654 Total ************************************************************************** $89,558 (Dollars in millions) 39.9% $34,474 9,955 12.1 14,287 16.2 23,842 31.1 1,675 0.7 40.9% 11.8 17.0 28.3 2.0 100.0% $84,233 100.0% (1) Includes U.S. dollar-denominated debt obligations of foreign obligors, and other foreign investments. The Company maintains a diversiﬁed corporate ﬁxed maturity portfolio across industries and issuers. The portfolio does not have exposure to any single issuer in excess of 1% of the total invested assets of the portfolio. At December 31, 2004 and 2003, the Company’s combined holdings in the ten issuers to which it had the greatest exposure totaled $4,967 million and $4,683 million, respectively, both of which was less than 3% of the Company’s total invested assets at such date. The exposure to the largest single issuer of corporate ﬁxed maturities held at December 31, 2004 and 2003 was $631 million and $618 million, respectively. The Company has hedged all of its material exposure to foreign currency risk in its invested assets. In the Company’s international insurance operations, both its assets and liabilities are generally denominated in local currencies. Structured Securities. The following table shows the types of structured securities the Company held at: December 31, 2004 December 31, 2003 Estimated Fair Value % of Total Estimated Fair Value % of Total (Dollars in millions) Residential mortgage-backed securities: Pass-through securities ************************************************************ $12,478 Collateralized mortgage obligations *************************************************** 19,752 Total residential mortgage-backed securities ************************************* Commercial mortgage-backed securities ************************************************ Asset-backed securities ************************************************************** 32,230 12,501 10,876 Total ********************************************************************** $55,607 22.4% $15,427 16,027 35.5 57.9 22.5 19.6 31,454 11,031 11,863 28.4% 29.5 57.9 20.3 21.8 100.0% $54,348 100.0% The majority of the residential mortgage-backed securities are guaranteed or otherwise supported by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation or the Government National Mortgage Association. At December 31, 2004 and 2003, $31,768 million and $31,210 million, respectively, or 98.6% and 99.2%, respectively, of the residential mortgage-backed securities were rated Aaa/AAA by Moody’s or S&P. At December 31, 2004 and 2003, $8,750 million and $6,992 million, respectively, or 70.0% and 63.4%, respectively, of the commercial mortgage- backed securities were rated Aaa/AAA by Moody’s or S&P. The Company’s asset-backed securities are diversiﬁed both by sector and by issuer. Credit card and home equity loan securitizations, accounting for about 26% and 32% of the total holdings, respectively, constitute the largest exposures in the Company’s asset-backed securities portfolio. MetLife, Inc. 31 Approximately $6,775 million and $7,528 million, or 62.3% and 63.5%, of total asset-backed securities were rated Aaa/AAA by Moody’s or S&P at December 31, 2004 and 2003, respectively. Structured Investment Transactions. The Company participates in structured investment transactions, primarily asset securitizations and structured notes. These transactions enhance the Company’s total return of the investment portfolio principally by generating management fee income on asset securitizations and by providing equity-based returns on debt securities through structured notes and similar instruments. The Company sponsors ﬁnancial asset securitizations of high yield debt securities, investment grade bonds and structured ﬁnance securities and also is the collateral manager and a beneﬁcial interest holder in such transactions. As the collateral manager, the Company earns management fees on the outstanding securitized asset balance, which are recorded in income as earned. When the Company transfers assets to a bankruptcy-remote SPE and surrenders control over the transferred assets, the transaction is accounted for as a sale. Gains or losses on securitizations are determined with reference to the carrying amount of the ﬁnancial assets transferred, which is allocated to the assets sold and the beneﬁcial interests retained based on relative fair values at the date of transfer. Beneﬁcial interests in securitizations are carried at fair value in ﬁxed maturities. Income on these beneﬁcial interests is recognized using the prospective method. The SPEs used to securitize assets are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities. Prior to the adoption of FIN 46(r), such SPEs were not consolidated because they did not meet the criteria for consolidation under previous accounting guidance. The Company purchases or receives beneﬁcial interests in SPEs, which generally acquire ﬁnancial assets, including corporate equities, debt securities and purchased options. The Company has not guaranteed the performance, liquidity or obligations of the SPEs and the Company’s exposure to loss is limited to its carrying value of the beneﬁcial interests in the SPEs. The Company uses the beneﬁcial interests as part of its risk management strategy, including asset-liability management. These SPEs are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities based on the framework provided in FIN 46(r). Prior to the adoption of FIN 46(r), such SPEs were not consolidated because they did not meet the criteria for consolidation under previous accounting guidance. These beneﬁcial interests are generally structured notes, which are included in ﬁxed maturities, and their income is recognized using the retrospective interest method or the level yield method, as appropriate. Impairments of these beneﬁcial interests are included in net investment gains (losses). The Company has sponsored four securitizations with a total of approximately $1,341 million and $1,431 million in ﬁnancial assets as of December 31, 2004 and 2003, respectively. The Company’s beneﬁcial interests in these SPEs as of December 31, 2004 and 2003 and the related investment income for the years ended December 31, 2004, 2003 and 2002 were insigniﬁcant. The Company invests in structured notes and similar type instruments, which generally provide equity-based returns on debt securities. The carrying value of such investments was approximately $666 million and $880 million at December 31, 2004 and 2003, respectively. The related net investment income recognized was $45 million, $78 million and $1 million for the years ended December 31, 2004, 2003 and 2002, respectively. Mortgage and Other Loans The Company’s mortgage and other loans are principally collateralized by commercial, agricultural and residential properties, as well as automobiles. Mortgage and other loans comprised 13.6% and 11.8% of the Company’s total cash and invested assets at December 31, 2004 and 2003, respectively. The carrying value of mortgage and other loans is stated at original cost net of repayments, amortization of premiums, accretion of discounts and valuation allowances. The following table shows the carrying value of the Company’s mortgage and other loans by type at: Commercial mortgage loans ********************************************************* $24,990 Agricultural mortgage loans ********************************************************** 5,907 Other loans *********************************************************************** 1,509 Total ********************************************************************* $32,406 77.1% $20,300 5,327 18.2 622 4.7 77.3% 20.3 2.4 100.0% $26,249 100.0% December 31, 2004 December 31, 2003 Carrying Value % of Total Carrying Value % of Total (Dollars in millions) 32 MetLife, Inc. Commercial Mortgage Loans. The Company diversiﬁes its commercial mortgage loans by both geographic region and property type. The following table presents the distribution across geographic regions and property types for commercial mortgage loans at: December 31, 2004 December 31, 2003 Carrying Value % of Total Carrying Value (Dollars in millions) % of Total Region South Atlantic ******************************************************************* $ 5,696 Paciﬁc ************************************************************************* 6,075 Middle Atlantic ****************************************************************** 4,057 East North Central *************************************************************** 2,550 New England ******************************************************************* 1,412 West South Central ************************************************************** 2,024 Mountain*********************************************************************** 778 West North Central ************************************************************** 667 International ******************************************************************** 1,364 East South Central ************************************************************** 268 Other************************************************************************** 99 Total******************************************************************* $24,990 Property Type Ofﬁce ************************************************************************* $11,500 Retail ************************************************************************** 5,698 Apartments ********************************************************************* 3,264 Industrial *********************************************************************** 2,499 Hotel ************************************************************************** 1,245 Other************************************************************************** 784 Total******************************************************************* $24,990 The following table presents the scheduled maturities for the Company’s commercial mortgage loans at: 22.8% $ 4,978 5,005 24.3 3,455 16.2 1,821 10.2 1,278 5.6 1,370 8.1 740 3.1 619 2.7 836 5.5 198 1.1 — 0.4 24.5% 24.7 17.0 9.0 6.3 6.8 3.6 3.0 4.1 1.0 — 100.0% $20,300 100.0% 46.0% $ 9,170 5,006 22.8 2,832 13.1 1,911 10.0 1,032 5.0 349 3.1 45.2% 24.7 13.9 9.4 5.1 1.7 100.0% $20,300 100.0% December 31, 2004 December 31, 2003 Carrying Value Due in one year or less ********************************************************** $ Due after one year through two years*********************************************** Due after two years through three years********************************************* Due after three years through four years********************************************* Due after four years through ﬁve years ********************************************** Due after ﬁve years ************************************************************** 939 1,800 2,372 2,943 4,578 12,358 Total******************************************************************* $24,990 % of Total Carrying Value (Dollars in millions) 3.7% $ 7.2 9.5 11.8 18.3 49.5 708 1,065 2,020 2,362 3,157 10,988 % of Total 3.5% 5.2 10.0 11.6 15.6 54.1 100.0% $20,300 100.0% Restructured, Potentially Delinquent, Delinquent or Under Foreclosure. The Company monitors its mortgage loan investments on an ongoing basis, including reviewing loans that are restructured, potentially delinquent, delinquent or under foreclosure. These loan classiﬁcations are consistent with those used in industry practice. The Company deﬁnes restructured mortgage loans as loans in which the Company, for economic or legal reasons related to the debtor’s ﬁnancial difﬁculties, grants a concession to the debtor that it would not otherwise consider. The Company deﬁnes potentially delinquent loans as loans that, in management’s opinion, have a high probability of becoming delinquent. The Company deﬁnes delinquent mortgage loans, consistent with industry practice, as loans in which two or more interest or principal payments are past due. The Company deﬁnes mortgage loans under foreclosure as loans in which foreclosure proceedings have formally commenced. The Company reviews all mortgage loans on an ongoing basis. These reviews may include an analysis of the property ﬁnancial statements and rent roll, lease rollover analysis, property inspections, market analysis and tenant creditworthiness. The Company records valuation allowances for loans that it deems impaired. The Company’s valuation allowances are established both on a loan speciﬁc basis for those loans where a property or market speciﬁc risk has been identiﬁed that could likely result in a future default, as well as for pools of loans with similar high risk characteristics where a property speciﬁc or market risk has not been identiﬁed. Such valuation allowances are established for the excess carrying value of the mortgage loan over the present value of expected future cash ﬂows discounted at the loan’s original effective interest rate, the value of the loan’s collateral or the loan’s market value if the loan is being sold. The Company records valuation allowances as investment losses. The Company records subsequent adjustments to allowances as investment gains (losses). MetLife, Inc. 33 The following table presents the amortized cost and valuation allowance for commercial mortgage loans distributed by loan classiﬁcation at: Performing ******************************************** $25,077 Restructured******************************************* 55 Potentially delinquent************************************ 7 Delinquent or under foreclosure *************************** — 99.8% $128 18 3 — Total ***************************************** $25,139 100.0% $149 0.2 — — December 31, 2004 December 31, 2003 Amortized % of Total Cost(1) Valuation Allowance % of Amortized Cost Amortized % of Total Cost(1) Valuation Allowance (Dollars in millions) 0.5% 32.7% 42.9% $20,315 77 30 — 99.5% $ 95 23 4 — 0.4 0.1 — 0.6% $20,422 100.0% $122 0.6% % of Amortized Cost 0.5% 29.9% 13.3% (1) Amortized cost is equal to carrying value before valuation allowances. The following table presents the changes in valuation allowances for commercial mortgage loans for the: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance, beginning of year ********************************************************************** Additions ************************************************************************************* Deductions *********************************************************************************** Balance, end of year *************************************************************************** $122 53 (26) $149 $119 51 (48) $122 $134 38 (53) $119 Agricultural Mortgage Loans. The Company diversiﬁes its agricultural mortgage loans by both geographic region and product type. Approximately 69% of the $5,907 million of agricultural mortgage loans outstanding at December 31, 2004 were subject to rate resets prior to maturity. A substantial portion of these loans generally is successfully renegotiated and remain outstanding to maturity. The process and policies for monitoring the agricultural mortgage loans and classifying them by performance status are generally the same as those for the commercial loans. The following table presents the amortized cost and valuation allowances for agricultural mortgage loans distributed by loan classiﬁcation at: December 31, 2004 December 31, 2003 Amortized % of Total Cost(1) Valuation Allowance % of Amortized Cost Amortized % of Total Cost(1) Valuation Allowance % of Amortized Cost Performing ******************************************** Restructured******************************************* Potentially delinquent************************************ Delinquent or under foreclosure *************************** Total ***************************************** $5,803 67 4 40 98.1% $ 4 — 1 2 1.1 0.1 0.7 $5,914 100.0% $ 7 (Dollars in millions) 0.1% 0.0% 25.0% 5.0% 0.1% $5,162 111 24 36 96.7% $ — 1 3 2 2.1 0.5 0.7 $5,333 100.0% $ 6 0.0% 0.9% 12.5% 5.6% 0.1% (1) Amortized cost is equal to carrying value before valuation allowances. The following table presents the changes in valuation allowances for agricultural mortgage loans for the: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance, beginning of year ********************************************************************** Additions ************************************************************************************* Deductions *********************************************************************************** Balance, end of year *************************************************************************** $ 6 5 (4) $ 7 $ 6 1 (1) $ 6 $ 9 3 (6) $ 6 Other Loans. Other loans consist of residential mortgages and auto loans. Real Estate and Real Estate Joint Ventures The Company’s real estate and real estate joint venture investments consist of commercial properties located primarily throughout the United States. At December 31, 2004 and 2003, the carrying value of the Company’s real estate, real estate joint ventures and real estate held-for-sale was $4,233 million and $4,677 million, respectively, or 1.8%, and 2.1% of total cash and invested assets, respectively. The carrying value of real estate is stated at depreciated cost net of impairments and valuation allowances. The carrying value of real estate joint ventures is stated at the Company’s equity 34 MetLife, Inc. 68.2% 6.7 0.1 75.0 25.0 — 25.0 3,981 94.1 3,507 1,169 1 1,170 5.9 — 5.9 100.0% $4,677 100.0% in the real estate joint ventures net of impairments and valuation allowances. The following table presents the carrying value of the Company’s real estate, real estate joint ventures, real estate held-for-sale and real estate acquired upon foreclosure at: Type December 31, 2004 December 31, 2003 Carrying Value % of Total Carrying Value % of Total Real estate held-for-investment ******************************************************* $3,592 Real estate joint ventures held-for-investment ******************************************* 386 Foreclosed real estate held-for-investment ********************************************** 3 (Dollars in millions) 84.9% $3,193 312 2 9.1 0.1 Real estate held-for-sale ************************************************************* Foreclosed real estate held-for-sale**************************************************** 251 1 252 Total real estate, real estate joint ventures and real estate held-for-sale ********************** $4,233 The Company’s carrying value of real estate held-for-sale, including real estate acquired upon foreclosure of commercial and agricultural mortgage loans, in the amounts of $252 million and $1,170 million at December 31, 2004 and 2003, respectively, are net of valuation allowances of $4 million and $12 million, respectively, and net of prior year impairments of $6 million and $151 million at December 31, 2004 and 2003, respectively. The Company records real estate acquired upon foreclosure of commercial and agricultural mortgage loans at the lower of estimated fair value or the carrying value of the mortgage loan at the date of foreclosure. Certain of the Company’s investments in real estate joint ventures meet the deﬁnition of a VIE under FIN 46(r). See ‘‘— Investments — Variable Interest Entities.’’ Other Limited Partnership Interests The carrying value of other limited partnership interests (which primarily represent ownership interests in pooled investment funds that make private equity investments in companies in the United States and overseas) was $2,907 million and $2,600 million at December 31, 2004 and 2003, respectively. The Company uses the equity method of accounting for investments in limited partnership interests in which it has more than a minor interest, has inﬂuence over the partnership’s operating and ﬁnancial policies and does not have a controlling interest. The Company uses the cost method for minor interest investments and when it has virtually no inﬂuence over the partnership’s operating and ﬁnancial policies. The Company’s investments in other limited partnerships represented 1.2% of cash and invested assets at both December 31, 2004 and 2003. Some of the Company’s investments in other limited partnership interests meet the deﬁnition of a VIE under FIN 46(r). See ‘‘— Investments — Variable Interest Entities.’’ Other Invested Assets The Company’s other invested assets consist principally of leveraged leases and funds withheld at interest of $3.9 billion at both December 31, 2004 and 2003. The leveraged leases are recorded net of non-recourse debt. The Company participates in lease transactions, which are diversiﬁed by industry, asset type and geographic area. The Company regularly reviews residual values and writes down residuals to expected values as needed. Funds withheld represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. For agreements written on a modiﬁed coinsurance basis and certain agreements written on a coinsurance basis, assets supporting the reinsured policies equal to the net statutory reserves are withheld and continue to be legally owned by the ceding company. Other invested assets also include the fair value of embedded derivatives related to funds withheld and modiﬁed coinsurance contracts. Interest accrues to these funds withheld at rates deﬁned by the treaty terms and may be contractually speciﬁed or directly related to the investment portfolio. The Company’s other invested assets represented 2.1% of cash and invested assets at both December 31, 2004 and 2003. Derivative Financial Instruments The Company uses a variety of derivatives, including swaps, forwards, future and option contracts, to manage its various risks. Additionally, the Company enters into income generation and replication derivative transactions as permitted by its insurance subsidiaries’ Derivatives Use Plans approved by the applicable state insurance departments. The table below provides a summary of the notional amount and current market or fair value of derivative ﬁnancial instruments held at: December 31, 2004 December 31, 2003 Notional Amount Current Market or Fair Value Assets Liabilities Notional Amount Current Market or Fair Value Assets Liabilities Interest rate swaps *********************************************** $12,681 Interest rate ﬂoors ************************************************ 3,325 Interest rate caps ************************************************ 7,045 Financial futures ************************************************* 611 Foreign currency swaps******************************************* 8,214 Foreign currency forwards ***************************************** 1,013 Options ******************************************************** 825 Financial forwards ************************************************ 326 Credit default swaps ********************************************* 1,897 Synthetic GICs ************************************************** 5,869 Other ********************************************************** 450 Total ********************************************************* $42,256 $284 38 12 — 150 5 37 — 11 — 1 $538 (Dollars in millions) $ 22 — — 13 1,302 57 7 — 5 — 1 $ 9,944 325 9,345 1,348 4,710 695 6,065 1,310 615 5,177 — $1,407 $39,534 $189 5 29 8 9 5 7 2 2 — — $256 $ 36 — — 30 796 32 — 3 1 — — $898 MetLife, Inc. 35 Variable Interest Entities The Company has adopted the provisions of FIN 46 and FIN 46(r). See ‘‘— Application of Recent Accounting Pronouncements.’’ The adoption of FIN 46(r) required the Company to consolidate certain VIEs for which it is the primary beneﬁciary. The following table presents the total assets of and maximum exposure to loss relating to VIEs for which the Company has concluded that (i) it is the primary beneﬁciary and which are consolidated in the Company’s consolidated ﬁnancial statements at December 31, 2004, and (ii) it holds signiﬁcant variable interests but it is not the primary beneﬁciary and which have not been consolidated: December 31, 2004 Primary Beneﬁciary Not Primary Beneﬁciary Total Assets(1) Maximum Exposure to Loss(2) Assets(1) Total Maximum Exposure to Loss(2) Asset-backed securitizations and collateralized debt obligations ****************************** $ — Real estate joint ventures(3) ************************************************************ 15 Other limited partnerships(4)************************************************************ 249 Other structured investments(5) ********************************************************* — Total ***************************************************************************** $264 (Dollars in millions) $ — $1,418 132 914 856 13 191 — $204 $3,320 $ 3 — 146 103 $252 (1) The assets of the asset-backed securitizations and collateralized debt obligations are reﬂected at fair value at December 31, 2004. The assets of the real estate joint ventures, other limited partnerships and other structured investments are reﬂected at the carrying amounts at which such assets would have been reﬂected on the Company’s balance sheet had the Company consolidated the VIE from the date of its initial investment in the entity. (2) The maximum exposure to loss of the asset-backed securitizations and collateralized debt obligations is equal to the carrying amounts of retained interests. In addition, the Company provides collateral management services for certain of these structures for which it collects a management fee. The maximum exposure to loss relating to real estate joint ventures, other limited partnerships and other structured investments is equal to the carrying amounts plus any unfunded commitments, reduced by amounts guaranteed by other partners. (3) Real estate joint ventures include partnerships and other ventures, which engage in the acquisition, development, management and disposal of real estate investments. (4) Other limited partnerships include partnerships established for the purpose of investing in real estate funds, public and private debt and equity securities, as well as limited partnerships established for the purpose of investing in low-income housing that qualiﬁes for federal tax credits. (5) Other structured investments include an offering of a collateralized fund of funds based on the securitization of a pool of private equity funds. Securities Lending The Company participates in a securities lending program whereby blocks of securities, which are included in investments, are loaned to third parties, primarily major brokerage ﬁrms. The Company requires a minimum of 102% of the fair value of the loaned securities to be separately maintained as collateral for the loans. Securities with a cost or amortized cost of $26,564 million and $25,121 million and an estimated fair value of $27,974 million and $26,387 million were on loan under the program at December 31, 2004 and 2003, respectively. The Company was liable for cash collateral under its control of $28,678 million and $27,083 million at December 31, 2004 and 2003, respectively. Security collateral on deposit from customers may not be sold or repledged and is not reﬂected in the consolidated ﬁnancial statements. Separate Accounts The Company had $86.8 billion and $75.8 billion held in its separate accounts, for which the Company generally does not bear investment risk, as of December 31, 2004 and 2003, respectively. The Company manages each separate account’s assets in accordance with the prescribed investment policy that applies to that speciﬁc separate account. The Company establishes separate accounts on a single client and multi-client commingled basis in compliance with insurance laws. Effective with the adoption of SOP 03-1, on January 1, 2004, the Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if (i) such separate accounts are legally recognized; (ii) assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities; (iii) investments are directed by the contractholder; and (iv) all investment performance, net of contract fees and assessments, is passed through to the contractholder. The Company reports separate account assets meeting such criteria at their fair value. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the consolidated statements of income. In connection with the adoption of SOP 03-1, separate account assets with a fair value of $1.7 billion were reclassiﬁed to general account investments with a corresponding transfer of separate account liabilities to future policy beneﬁts and policyholder account balances. See ‘‘— Application of Recent Accounting Pronouncements.’’ The Company’s revenues reﬂect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Separate accounts not meeting the above criteria are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. Off-Balance Sheet Arrangements Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commit- ments were approximately $1,324 million and $1,380 million at December 31, 2004 and 2003, respectively. The Company anticipates that these amounts will be invested in the partnerships over the next three to ﬁve years. Mortgage Loan Commitments The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $1,189 million and $679 million, respectively, at December 31, 2004 and 2003. Guarantees In the course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties pursuant to which it may be required to make payments now or in the future. 36 MetLife, Inc. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other speciﬁc liabilities, and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemniﬁca- tions to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $800 million, while in other cases such limitations are not speciﬁed or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In addition, the Company indemniﬁes its directors and ofﬁcers as provided in its charters and by-laws. Also, the Company indemniﬁes other of its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these indemnities in the future. During the year ended December 31, 2004, the Company recorded liabilities of $10 million with respect to indemnities provided in certain dispositions. The approximate term for these liabilities ranges from 12 to 18 months. The maximum potential amount of future payments that MetLife could be required to pay is $73 million. Due to the uncertainty in assessing changes to the liabilities over the term, the liability on the balance sheet will remain until either expiration or settlement of the guarantee unless evidence clearly indicates that the estimates should be revised. The fair value of the remaining indemnities, guarantees and commitments entered into during 2004 was insigniﬁcant and thus, no liabilities were recorded. The Company’s recorded liability at December 31, 2004 and 2003 for indemnities, guarantees and commitments, excluding amounts recorded during 2004 as described in the preceding sentences, is insigniﬁcant. Accelerated Share Repurchase On December 16, 2004, the Holding Company repurchased 7,281,553 shares of its outstanding common stock at an aggregate cost of approximately $300 million under an accelerated share repurchase agreement with a major bank. The bank borrowed the stock sold to the Holding Company from third parties and is purchasing the shares in the open market over the next few months to return to the lenders. The Holding Company will either pay or receive an amount based on the actual amount paid by the bank to purchase the shares. The ﬁnal purchase price is expected to be determined in April 2005, and will be settled in either cash or Holding Company stock at the Holding Company’s option. The Holding Company recorded the initial repurchase of shares as treasury stock and will record any amount paid or received as an adjustment to the cost of the treasury stock. Quantitative and Qualitative Disclosures About Market Risk The Company must effectively manage, measure and monitor the market risk associated with its invested assets and interest rate sensitive insurance contracts. It has developed an integrated process for managing risk, which it conducts through its Corporate Risk Management Department, Asset/Liability Management Committees (‘‘A/LM Committees’’) and additional specialists at the business segment level. The Company has established and implemented comprehensive policies and procedures at both the corporate and business segment level to minimize the effects of potential market volatility. Market Risk Exposures The Company has exposure to market risk through its insurance operations and investment activities. For purposes of this disclosure, ‘‘market risk’’ is deﬁned as the risk of loss resulting from changes in interest rates, equity prices and foreign currency exchange rates. Interest rates. The Company’s exposure to interest rate changes results from its signiﬁcant holdings of ﬁxed maturities, as well as its interest rate sensitive liabilities. The ﬁxed maturities include U.S. and foreign government bonds, securities issued by government agencies, corporate bonds and mortgage-backed securities, all of which are mainly exposed to changes in medium- and long-term treasury rates. The interest rate sensitive liabilities for purposes of this disclosure include guaranteed interest contracts and ﬁxed annuities, which have the same type of interest rate exposure (medium- and long-term treasury rates) as the ﬁxed maturities. The Company employs product design, pricing and asset/liability management strategies to reduce the adverse effects of interest rate volatility. Product design and pricing strategies include the use of surrender charges or restrictions on withdrawals in some products. Asset/liability management strategies include the use of derivatives, the purchase of securities structured to protect against prepayments, prepayment restrictions and related fees on mortgage loans and consistent monitoring of the pricing of the Company’s products in order to better match the duration of the assets and the liabilities they support. Equity prices. The Company’s investments in equity securities expose it to changes in equity prices, as do certain liabilities which involve long term guarantees on equity performance. It manages this risk on an integrated basis with other risks through its asset/liability management strategies. The Company also manages equity price risk through industry and issuer diversiﬁcation, asset allocation techniques and the use of derivatives. Foreign currency exchange rates. The Company’s exposure to ﬂuctuations in foreign currency exchange rates against the U.S. dollar results from its holdings in non-U.S. dollar denominated ﬁxed maturity securities, equity securities and liabilities, as well as through its investments in foreign subsidiaries. The principal currencies which create foreign currency exchange rate risk in the Company’s investment portfolios are the Euro, Canadian dollars and British pounds. The Company mitigates the majority of its ﬁxed maturities’ foreign currency exchange rate risk through the utilization of foreign currency swaps and forward contracts. Through its investments in foreign subsidiaries, the Company is primarily exposed to the Mexican peso, South Korean won, Chilean peso and Taiwanese dollar. The Company has matched substantially all of its foreign currency liabilities in its foreign subsidiaries with their respective foreign currency assets, thereby reducing its risk to currency exchange rate ﬂuctuation. In some countries, local surplus is held entirely or in part in U.S. dollar assets which further minimizes exposure to exchange rate ﬂuctuation risk. Selectively, the Company uses U.S. dollar assets to support certain long duration foreign currency liabilities. Risk Management Corporate risk management. MetLife has established several ﬁnancial and non-ﬁnancial senior management committees as part of its risk management process. These committees manage capital and risk positions, approve asset/liability management strategies and establish appropriate corporate business standards. MetLife, Inc. 37 MetLife also has a separate Corporate Risk Management Department, which is responsible for risk throughout MetLife and reports to MetLife’s Chief Financial Ofﬁcer. The Corporate Risk Management Department’s primary responsibilities consist of: ) implementing a board of directors-approved corporate risk framework, which outlines the Company’s approach for managing risk on an enterprise-wide basis; ) developing policies and procedures for managing, measuring and monitoring those risks identiﬁed in the corporate risk framework; ) establishing appropriate corporate risk tolerance levels; ) deploying capital on an economic capital basis; and ) reporting on a periodic basis to the Governance Committee of the Holding Company’s Board of Directors and various ﬁnancial and non-ﬁnancial senior management committees. Asset/liability management. The Company actively manages its assets using an approach that balances quality, diversiﬁcation, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize, net of income taxes, risk-adjusted investment income and risk-adjusted total return while ensuring that the assets and liabilities are managed on a cash ﬂow and duration basis. The asset/liability management process is the shared responsibility of the Portfolio Management Unit, the Business Finance Asset/Liability Management Unit, and the operating business segments under the supervision of the various product line speciﬁc A/LM Committees. The A/LM Committees’ duties include reviewing and approving target portfolios on a periodic basis, establishing investment guidelines and limits and providing oversight of the asset/liability management process. The portfolio managers and asset sector specialists, who have responsibility on a day-to-day basis for risk management of their respective investing activities, implement the goals and objectives established by the A/LM Committees. Each of MetLife’s business segments has an asset/liability ofﬁcer who works with portfolio managers in the investment department to monitor investment, product pricing, hedge strategy and liability management issues. MetLife establishes target asset portfolios for each major insurance product, which represent the investment strategies used to proﬁtably fund its liabilities within acceptable levels of risk. These strategies include objectives for effective duration, yield curve sensitivity, convexity, liquidity, asset sector concentration and credit quality. To manage interest rate risk, the Company performs periodic projections of asset and liability cash ﬂows to evaluate the potential sensitivity of its securities investments and liabilities to interest rate movements. These projections involve evaluating the potential gain or loss on most of the Company’s in-force business under various increasing and decreasing interest rate environments. New York State Department of Insurance regulations require that MetLife perform some of these analyses annually as part of MetLife’s review of the sufﬁciency of its regulatory reserves. For several of its legal entities, the Company maintains segmented operating and surplus asset portfolios for the purpose of asset/liability management and the allocation of investment income to product lines. For each segment, invested assets greater than or equal to the GAAP liabilities less the DAC asset and any non-invested assets allocated to the segment are maintained, with any excess swept to the surplus segment. The operating segments may reﬂect differences in legal entity, statutory line of business and any product market characteristic which may drive a distinct investment strategy with respect to duration, liquidity or credit quality of the invested assets. Certain smaller entities make use of unsegmented general accounts for which the investment strategy reﬂects the aggregate characteristics of liabilities in those entities. The Company measures relative sensitivities of the value of its assets and liabilities to changes in key assumptions utilizing Company models. These models reﬂect speciﬁc product characteristics and include assumptions based on current and anticipated experience regarding lapse, mortality and interest crediting rates. In addition, these models include asset cash ﬂow projections reﬂecting interest payments, sinking fund payments, principal payments, bond calls, mortgage prepayments and defaults. Common industry metrics, such as duration and convexity, are also used to measure the relative sensitivity of assets and liability values to changes in interest rates. In computing the duration of liabilities, consideration is given to all policyholder guarantees and to how the Company intends to set indeterminate policy elements such as interest credits or dividends. Each operating asset segment has a duration constraint based on the liability duration and the investment objectives of that portfolio. Where a liability cash ﬂow may exceed the maturity of available assets, as is the case with certain retirement and non-medical health products, the Company may support such liabilities with equity investments or curve mismatch strategies. Hedging activities. MetLife’s risk management strategies incorporate the use of various interest rate derivatives to adjust the overall duration and cash ﬂow proﬁle of its invested asset portfolios to better match the duration and cash ﬂow proﬁle of its liabilities to reduce interest rate risk. Such instruments include ﬁnancial futures, ﬁnancial forwards, interest rate and credit default swaps, caps, ﬂoors and options. MetLife also uses foreign currency swaps and foreign currency forwards to hedge its foreign currency denominated ﬁxed income investments. In 2004, MetLife initiated a hedging strategy for certain equity price risks within its liabilities using equity futures and options. Economic Capital. Beginning in 2003, the Company changed its methodology of allocating capital to its business segments from Risk-Based Capital (‘‘RBC’’) to Economic Capital. Prior to 2003, the Company’s business segments’ allocated equity was primarily based on RBC, an internally developed formula based on applying a multiple to the NAIC Statutory Risk-Based Capital and included certain adjustments in accordance with GAAP. Economic Capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The Economic Capital model accounts for the unique and speciﬁc nature of the risks inherent in MetLife’s businesses. This is in contrast to the standardized regulatory RBC formula, which is not as reﬁned in its risk calculations with respect to the nuances of the Company’s businesses. This change in methodology is being applied prospectively. This change has and will continue to impact the level of net investment income and net income of each of the Company’s business segments. A portion of net investment income is credited to the segments based on the level of allocated equity. This change in methodology of allocating equity does not impact the Company’s consolidated net investment income or net income. Risk Measurement; Sensitivity Analysis The Company measures market risk related to its holdings of invested assets and other ﬁnancial instruments, including certain market risk sensitive insurance contracts, based on changes in interest rates, equity prices and currency exchange rates, utilizing a sensitivity analysis. This analysis estimates the potential changes in fair value, cash ﬂows and earnings based on a hypothetical 10% change (increase or decrease) in interest rates, equity prices and currency exchange rates. The Company believes that a 10% change (increase or decrease) in these market rates and prices is reasonably possible in the near-term. In performing this analysis, the Company used market rates at December 31, 2004 to re-price its invested assets and other ﬁnancial instruments. The sensitivity analysis separately calculated each of MetLife’s market risk exposures (interest rate, equity price and foreign currency exchange rate) related to its non-trading invested assets and other ﬁnancial instruments. The Company does not maintain a trading portfolio. 38 MetLife, Inc. The sensitivity analysis performed included the market risk sensitive holdings described above. The Company modeled the impact of changes in market rates and prices on the fair values of its invested assets, earnings and cash ﬂows as follows: Fair values. The Company bases its potential change in fair values on an immediate change (increase or decrease) in: ) the net present values of its interest rate sensitive exposures resulting from a 10% change (increase or decrease) in interest rates; ) the U.S. dollar equivalent balances of the Company’s currency exposures due to a 10% change (increase or decrease) in currency exchange rates; and ) the market value of its equity positions due to a 10% change (increase or decrease) in equity prices. Earnings and cash ﬂows. MetLife calculates the potential change in earnings and cash ﬂows on the change in its earnings and cash ﬂows over a one-year period based on an immediate 10% change (increase or decrease) in market rates and equity prices. The following factors were incorporated into the earnings and cash ﬂows sensitivity analyses: ) the reinvestment of ﬁxed maturity securities; ) the reinvestment of payments and prepayments of principal related to mortgage-backed securities; ) the re-estimation of prepayment rates on mortgage-backed securities for each 10% change (increase or decrease) in the interest rates; and ) the expected turnover (sales) of ﬁxed maturities and equity securities, including the reinvestment of the resulting proceeds. The sensitivity analysis is an estimate and should not be viewed as predictive of the Company’s future ﬁnancial performance. The Company cannot assure that its actual losses in any particular year will not exceed the amounts indicated in the table below. Limitations related to this sensitivity analysis include: ) the market risk information is limited by the assumptions and parameters established in creating the related sensitivity analysis, including the impact of prepayment rates on mortgages; ) for derivatives which qualify as hedges, the impact on reported earnings may be materially different from the change in market values; ) the analysis excludes other signiﬁcant real estate holdings and liabilities pursuant to insurance contracts; and ) the model assumes that the composition of assets and liabilities remains unchanged throughout the year. Accordingly, the Company uses such models as tools and not substitutes for the experience and judgment of its corporate risk and asset/liability management personnel. Based on its analysis of the impact of a 10% change (increase or decrease) in market rates and prices, MetLife has determined that such a change could have a material adverse effect on the fair value of its interest rate sensitive invested assets. The equity and foreign currency portfolios do not expose the Company to material market risk. The table below illustrates the potential loss in fair value of the Company’s interest rate sensitive ﬁnancial instruments at December 31, 2004. In addition, the potential loss with respect to the fair value of currency exchange rates and the Company’s equity price sensitive positions at December 31, 2004 is set forth in the table below. The potential loss in fair value for each market risk exposure of the Company’s portfolio, all of which is non-trading, as of the period indicated was: Interest rate risk **************************************************************************************** Equity price risk **************************************************************************************** Foreign currency exchange rate risk *********************************************************************** $3,650 $ 167 $ 601 December 31, 2004 (Dollars in millions) MetLife, Inc. 39 The table below provides additional detail regarding the potential loss in fair value of the Company’s interest sensitive ﬁnancial instruments at December 31, 2004 by type of asset or liability. As of December 31, 2004 Notional Amount Fair Value Assuming a 10% increase in the yield curve (Dollars in millions) Assets Fixed maturities *********************************************************************** $ Mortgage loans on real estate *********************************************************** Equity securities*********************************************************************** Short-term investments***************************************************************** Cash and cash equivalents ************************************************************* Policy loans ************************************************************************** Mortgage loan commitments ************************************************************ Total assets ********************************************************************** Liabilities Policyholder account balances ********************************************************** $ Short-term debt *********************************************************************** Long-term debt *********************************************************************** Shares subject to mandatory redemption************************************************** $ Payable under securities loaned transactions*********************************************** Total liabilities ********************************************************************* — $176,763 33,902 — 2,188 — 2,663 — 4,051 — 8,899 — 4 1,189 — $ 69,688 1,445 — 7,818 — 365 — $ 28,678 — Other Derivative instruments (designated hedges or otherwise) Swaps **************************************************************************** $22,792 Futures **************************************************************************** 611 Forwards ************************************************************************** 1,339 Options**************************************************************************** 17,514 Total other *********************************************************************** Net change ************************************************************************* $ (884) (13) (52) 80 $(3,651) (534) — 6 — (290) (5) $(4,474) $ 450 — 264 1 — $ $ 715 $ 95 8 — 6 $ 109 $(3,650) In addition to the analysis discussed above, the Company also performs an analysis of the sensitivity of its insurance and interest sensitive liabilities to changes in interest rates as a part of its asset liability management program. As of December 31, 2004, a hypothetical instantaneous 10% decrease in interest rates applied to the Company’s insurance and interest sensitive liabilities and their associated operating asset portfolios would reduce the fair value of equity by $227 million. Management does not expect that this sensitivity would produce a liquidity strain on the Company. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure None. Management’s Annual Report on Internal Control Over Financial Reporting Management of MetLife, Inc. and subsidiaries is responsible for establishing and maintaining adequate internal control over ﬁnancial reporting. In fulﬁlling this responsibility, estimates and judgments by management are required to assess the expected beneﬁts and related costs of control procedures. The objectives of internal control include providing management with reasonable, but not absolute, assurance that assets are safeguarded against loss from unauthorized use or disposition, and that transactions are executed in accordance with management’s authorization and recorded properly to permit the preparation of consolidated ﬁnancial statements in conformity with accounting principles generally accepted in the United States of America. Financial management has documented and evaluated the effectiveness of the internal control of the Company as of December 31, 2004 pertaining to ﬁnancial reporting in accordance with the criteria established in ‘‘Internal Control — Integrated Framework’’ issued by the Committee of Sponsoring Organizations of the Treadway Commission. In the opinion of management, MetLife, Inc. maintained effective internal control over ﬁnancial reporting as of December 31, 2004. Deloitte & Touche LLP, an independent registered public accounting ﬁrm, has audited the consolidated ﬁnancial statements and consolidated ﬁnancial statement schedules included in the Annual Report on Form 10-K for the year ended December 31, 2004. The Report of the Independent Registered Public Accounting Firm on their audit of management’s assessment of the Company’s internal control over ﬁnancial reporting and their audit on the effectiveness of the Company’s internal control over ﬁnancial reporting is included at page F-2. The Report of the Independent Registered Public Accounting Firm on their audit of the consolidated ﬁnancial statements is included at page F-3. 40 MetLife, Inc. Financial Statements INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Reports of Independent Registered Public Accounting Firm *************************************************************** Financial Statements as of December 31, 2004 and 2003 and for the years ended December 31, 2004, 2003 and 2002: Consolidated Balance Sheets **************************************************************************************** Consolidated Statements of Income*********************************************************************************** Consolidated Statements of Stockholders’ Equity ********************************************************************** Consolidated Statements of Cash Flows ****************************************************************************** Notes to Consolidated Financial Statements *************************************************************************** Page F-2 F-4 F-5 F-6 F-7 F-9 MetLife, Inc. F-1 Report of Independent Registered Public Accounting Firm The Board of Directors and Stockholders of MetLife, Inc. New York, New York We have audited management’s assessment, included in management’s annual report on internal control over ﬁnancial reporting that MetLife, Inc. and subsidiaries (the ‘‘Company’’) maintained effective internal control over ﬁnancial reporting as of December 31, 2004, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company’s manage- ment is responsible for maintaining effective internal control over ﬁnancial reporting and for its assessment of the effectiveness of internal control over ﬁnancial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over ﬁnancial reporting based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over ﬁnancial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over ﬁnancial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions. A company’s internal control over ﬁnancial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal ﬁnancial ofﬁcers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of ﬁnancial reporting and the preparation of ﬁnancial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over ﬁnancial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reﬂect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of ﬁnancial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the ﬁnancial statements. Because of the inherent limitations of internal control over ﬁnancial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over ﬁnancial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, management’s assessment that the Company maintained effective internal control over ﬁnancial reporting as of December 31, 2004, is fairly stated, in all material respects, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Also in our opinion, the Company maintained, in all material respects, effective internal control over ﬁnancial reporting as of December 31, 2004, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated ﬁnancial statements as of and for the year ended December 31, 2004 of the Company and our report dated March 4, 2005 expressed an unqualiﬁed opinion on those ﬁnancial statements and included an explanatory paragraph regarding the Company’s change of its accounting method for certain non- traditional long duration contracts and separate accounts as required by new accounting guidance which became effective on January 1, 2004. DELOITTE & TOUCHE LLP New York, New York March 4, 2005 F-2 MetLife, Inc. Report of Independent Registered Public Accounting Firm The Board of Directors and Stockholders of MetLife, Inc. New York, New York We have audited the accompanying consolidated balance sheets of MetLife, Inc. and subsidiaries (the ‘‘Company’’) as of December 31, 2004 and 2003, and the related consolidated statements of income, stockholders’ equity, and cash ﬂows for each of the three years in the period ended December 31, 2004. These ﬁnancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these ﬁnancial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the ﬁnancial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the ﬁnancial statements. An audit also includes assessing the accounting principles used and signiﬁcant estimates made by management, as well as evaluating the overall ﬁnancial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, such consolidated ﬁnancial statements present fairly, in all material respects, the ﬁnancial position of MetLife, Inc. and subsidiaries as of December 31, 2004 and 2003, and the results of their operations and their cash ﬂows for each of the three years in the period ended December 31, 2004 in conformity with accounting principles generally accepted in the United States of America. As discussed in Note 1, the Company changed its method of accounting for certain non-traditional long duration contracts and separate accounts, and for embedded derivatives in certain insurance products as required by new accounting guidance which became effective on January 1, 2004 and October 1, 2003, respectively, and recorded the impact as cumulative effects of changes in accounting principles. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company’s internal control over ﬁnancial reporting as of December 31, 2004, based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 4, 2005 expressed an unqualiﬁed opinion on management’s assessment of the effectiveness of the Company’s internal control over ﬁnancial reporting and an unqualiﬁed opinion on the effectiveness of the Company’s internal control over ﬁnancial reporting. DELOITTE & TOUCHE LLP New York, New York March 4, 2005 MetLife, Inc. F-3 METLIFE, INC. CONSOLIDATED BALANCE SHEETS DECEMBER 31, 2004 AND 2003 (Dollars in millions, except share and per share data) 2004 2003 ASSETS Investments: Fixed maturities available-for-sale, at fair value (amortized cost: $166,996 and $158,333, respectively) *************** $176,763 Equity securities, at fair value (cost: $1,913 and $1,215, respectively) ****************************************** 2,188 Mortgage and other loans ******************************************************************************* 32,406 Policy loans ******************************************************************************************* 8,899 Real estate and real estate joint ventures held-for-investment************************************************** 3,981 Real estate held-for-sale ******************************************************************************** 252 Other limited partnership interests************************************************************************* 2,907 Short-term investments ********************************************************************************* 2,663 Other invested assets ********************************************************************************** 4,926 Total investments ******************************************************************************** Cash and cash equivalents ******************************************************************************** Accrued investment income ******************************************************************************* Premiums and other receivables **************************************************************************** Deferred policy acquisition costs *************************************************************************** Assets of subsidiaries held-for-sale ************************************************************************* Other assets ******************************************************************************************** Separate account assets ********************************************************************************** 234,985 4,051 2,338 6,696 14,336 379 7,254 86,769 Total assets ************************************************************************************* $356,808 LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities: Future policy beneﬁts *********************************************************************************** $100,159 Policyholder account balances *************************************************************************** 83,570 Other policyholder funds ******************************************************************************** 6,984 Policyholder dividends payable *************************************************************************** 1,071 Policyholder dividend obligation*************************************************************************** 2,243 Short-term debt *************************************************************************************** 1,445 Long-term debt **************************************************************************************** 7,412 Shares subject to mandatory redemption ****************************************************************** 278 Liabilities of subsidiaries held-for-sale ********************************************************************** 240 Current income taxes payable**************************************************************************** 421 Deferred income taxes payable*************************************************************************** 2,473 Payables under securities loaned transactions ************************************************************** 28,678 Other liabilities ***************************************************************************************** 12,241 Separate account liabilities******************************************************************************* 86,769 Total liabilities************************************************************************************ 333,984 $167,752 1,584 26,249 8,749 3,507 1,170 2,600 1,809 4,637 218,057 3,683 2,186 7,024 12,943 183 7,009 75,756 $326,841 $ 94,148 75,901 6,343 1,049 2,130 3,642 5,703 277 70 651 2,397 27,083 10,542 75,756 305,692 Stockholders’ Equity: Preferred stock, par value $0.01 per share; 200,000,000 shares authorized; none issued ************************* Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 786,766,664 shares issued at — — December 31, 2004 and 2003; 732,487,999 shares outstanding at December 31, 2004 and 757,186,137 shares outstanding at December 31, 2003 ********************************************************************* Additional paid-in capital ******************************************************************************** Retained earnings ************************************************************************************** Treasury stock, at cost; 54,278,665 shares at December 31, 2004 and 29,580,527 shares at December 31, 2003*** Accumulated other comprehensive income***************************************************************** Total stockholders’ equity************************************************************************** 22,824 Total liabilities and stockholders’ equity ************************************************************** $356,808 8 15,037 6,608 (1,785) 2,956 8 14,991 4,193 (835) 2,792 21,149 $326,841 See accompanying notes to consolidated ﬁnancial statements. F-4 MetLife, Inc. METLIFE, INC. CONSOLIDATED STATEMENTS OF INCOME FOR THE YEARS ENDED DECEMBER 31, 2004, 2003 AND 2002 (Dollars in millions, except per share data) REVENUES Premiums**************************************************************************************** $22,316 Universal life and investment-type product policy fees *************************************************** 2,900 Net investment income **************************************************************************** 12,418 Other revenues *********************************************************************************** 1,198 Net investment gains (losses) *********************************************************************** 182 Total revenues **************************************************************************** 39,014 $20,673 2,496 11,539 1,199 (582) $19,077 2,147 11,183 1,166 (892) 35,325 32,681 2004 2003 2002 EXPENSES Policyholder beneﬁts and claims ********************************************************************* Interest credited to policyholder account balances ****************************************************** Policyholder dividends ***************************************************************************** Other expenses ********************************************************************************** Total expenses *************************************************************************** Income from continuing operations before provision for income taxes ************************************** Provision for income taxes************************************************************************** Income from continuing operations******************************************************************* Income from discontinued operations, net of income taxes*********************************************** Income before cumulative effect of a change in accounting ********************************************** 2,844 Cumulative effect of a change in accounting, net of income taxes **************************************** (86) Net income ************************************************************************************** $ 2,758 22,662 2,998 1,814 7,761 2,708 136 3,779 1,071 35,235 20,665 3,035 1,975 7,091 32,766 2,559 660 1,899 344 2,243 (26) 19,373 2,950 1,942 6,813 31,078 1,603 490 1,113 492 1,605 — $ 2,217 $ 1,605 Income from continuing operations available to common shareholders per share Basic ***************************************************************************************** $ 3.61 $ 2.55 $ 1.58 Diluted **************************************************************************************** $ 3.59 $ 2.51 $ 1.53 Net income available to common shareholders per share Basic ***************************************************************************************** $ 3.68 $ 2.98 $ 2.28 Diluted **************************************************************************************** $ 3.65 $ 2.94 $ 2.20 Cash dividends per share ************************************************************************** $ 0.46 $ 0.23 $ 0.21 See accompanying notes to consolidated ﬁnancial statements. MetLife, Inc. F-5 METLIFE, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2004, 2003 AND 2002 (Dollars in millions) Balance at January 1, 2002 ************************* Treasury stock transactions, net ********************** Dividends on common stock************************* Comprehensive income (loss): Net income ************************************* Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************** Unrealized investment gains (losses), net of related offsets, reclassiﬁcation adjustments and income taxes ************************************** Foreign currency translation adjustments *********** Other comprehensive income (loss) *************** Comprehensive income (loss) ********************** Balance at December 31, 2002 ********************** Treasury stock transactions, net ********************** Issuance of shares — by subsidiary ******************* Dividends on common stock************************* Settlement of common stock purchase contracts ******* Premium on conversion of company-obligated mandatorily redeemable securities of a subsidiary trust *********** Comprehensive income (loss): Net income ************************************* Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************** Unrealized investment gains (losses), net of related offsets, reclassiﬁcation adjustments and income taxes ************************************** Foreign currency translation adjustments *********** Minimum pension liability adjustment ************** Other comprehensive income (loss) *************** Comprehensive income (loss) ********************** Balance at December 31, 2003 ********************** Treasury stock transactions, net ********************** Dividends on common stock************************* Comprehensive income (loss): Net income ************************************* Other comprehensive income (loss): Unrealized gains (losses) on derivative instruments, net of income taxes ************************** Unrealized investment gains (losses), net of related offsets, reclassiﬁcation adjustments and income taxes ************************************** Cumulative effect of a change in accounting, net of income taxes******************************** Foreign currency translation adjustments *********** Minimum pension liability adjustment ************** Other comprehensive income (loss) *************** Comprehensive income (loss) ********************** Balance at December 31, 2004 ********************** Common Stock Additional Paid-In Capital Retained Earnings Treasury Stock at Cost $8 $14,966 $1,349 $(1,934) (471) 2 (147) 1,605 8 14,968 20 24 2,807 (2,405) (92) (175) (656) 1,662 (21) 2,217 8 14,991 46 (835) (950) 4,193 (343) 2,758 Accumulated Other Comprehensive Income (Loss) Net Unrealized Investment Foreign Currency Translation Minimum Pension Liability Gains (Losses) Adjustment Adjustment Total $1,879 $(160) $ (46) (60) 463 (69) 2,282 (229) (46) (250) 940 177 (82) 2,972 (52) (128) (62) (6) 90 144 (2) $16,062 (469) (147) 1,605 (60) 463 (69) 334 1,939 17,385 (72) 24 (175) 1,006 (21) 2,217 (250) 940 177 (82) 785 3,002 21,149 (904) (343) 2,758 (62) (6) 90 144 (2) 164 2,922 $8 $15,037 $6,608 $(1,785) $2,994 $ 92 $(130) $22,824 See accompanying notes to consolidated ﬁnancial statements. F-6 MetLife, Inc. METLIFE, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2004, 2003 AND 2002 (Dollars in millions) 2004 2003 2002 Cash ﬂows from operating activities Net income************************************************************************************ $ 2,758 Adjustments to reconcile net income to net cash provided by operating activities: $ 2,217 $ 1,605 Depreciation and amortization expenses******************************************************** Amortization of premiums and accretion of discounts associated with investments, net***************** (Gains) losses from sales of investments and businesses, net ************************************* Interest credited to other policyholder account balances ****************************************** Universal life and investment-type product policy fees ******************************************** Change in premiums and other receivables ***************************************************** Change in deferred policy acquisition costs, net ************************************************* Change in insurance-related liabilities ********************************************************** Change in income taxes payable ************************************************************* Change in other assets********************************************************************** Change in other liabilities ******************************************************************** Other, net ********************************************************************************* Net cash provided by operating activities *********************************************************** 441 (110) (302) 2,998 (2,900) 78 (1,331) 5,330 (135) (178) 1,682 (265) 8,066 Cash ﬂows from investing activities Sales, maturities and repayments of: Fixed maturities **************************************************************************** Equity securities **************************************************************************** Mortgage and other loans ******************************************************************* Real estate and real estate joint ventures ******************************************************* Other limited partnership interests ************************************************************* 87,451 1,686 3,954 1,214 799 Purchases of: Fixed maturities **************************************************************************** Equity securities **************************************************************************** Mortgage and other loans ******************************************************************* Real estate and real estate joint ventures ******************************************************* Other limited partnership interests ************************************************************* Net change in short-term investments *********************************************************** Purchase of businesses, net of cash received of $0, $27 and $71, respectively ************************ Proceeds from sales of businesses ************************************************************* Net change in payable under securities loaned transactions ***************************************** Net change in other invested assets************************************************************* Other, net *********************************************************************************** (94,275) (2,178) (9,931) (619) (894) (740) (7) 29 1,595 (958) (141) Net cash used in investing activities *************************************************************** $(13,015) 478 (180) 152 3,035 (2,496) (334) (1,332) 4,687 241 (374) 1,131 (195) 7,030 76,200 612 3,483 866 331 (101,532) (232) (4,975) (289) (643) 98 18 5 9,221 (629) (222) 498 (519) 317 2,950 (2,147) (473) (741) 3,104 479 (1,071) 104 74 4,180 64,602 2,703 2,638 831 213 (85,155) (1,260) (3,206) (148) (516) (477) (879) — 5,201 (451) (309) $ (17,688) $(16,213) See accompanying notes to consolidated ﬁnancial statements. MetLife, Inc. F-7 METLIFE, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued) FOR THE YEARS ENDED DECEMBER 31, 2004, 2003 AND 2002 (Dollars in millions) 2004 2003 2002 Cash ﬂows from ﬁnancing activities Policyholder account balances: Deposits ********************************************************************************** $ 36,416 Withdrawals ******************************************************************************* (29,333) Net change in short-term debt****************************************************************** (2,178) Long-term debt issued ************************************************************************ 1,825 Long-term debt repaid ************************************************************************ (119) Treasury stock acquired *********************************************************************** (1,000) Settlement of common stock purchase contracts ************************************************** — Proceeds from offering of common stock by subsidiary, net ***************************************** — Dividends on common stock ******************************************************************* (343) Stock options exercised *********************************************************************** 51 Other, net *********************************************************************************** 3 Net cash provided by ﬁnancing activities *********************************************************** Change in cash and cash equivalents ************************************************************* 373 Cash and cash equivalents, beginning of year ****************************************************** 3,733 Cash and cash equivalents, end of year ******************************************************* $ 4,106 5,322 Cash and cash equivalents, subsidiaries held-for-sale, beginning of year************************************************************************************** $ Cash and cash equivalents, subsidiaries held-for-sale, end of year ***************************** $ 50 55 Cash and cash equivalents, from continuing operations, beginning of year************************************************************************************** $ 3,683 Cash and cash equivalents, from continuing operations, end of year**************************** $ 4,051 Supplemental disclosures of cash ﬂow information: Net cash paid during the year for: Interest *********************************************************************************** $ Income taxes ****************************************************************************** $ 362 977 Non-cash transactions during the year: Purchase money mortgage on real estate sale ************************************************** $ 2 $ $ $ $ $ $ $ $ MetLife Capital Trust I transactions ************************************************************ $ — $ 1,037 Real estate acquired in satisfaction of debt ***************************************************** $ Transfer from funds withheld at interest to ﬁxed maturities ***************************************** $ Contribution of equity securities to MetLife Foundation ******************************************** $ Business acquisitions: Assets acquired ************************************************************************** $ Cash paid******************************************************************************* Liabilities assumed************************************************************************ $ 7 606 50 20 (7) 13 $ $ $ $ $ $ 37,023 (28,667) 2,481 934 (763) (97) 1,006 317 (175) 1 8 12,068 1,410 2,323 $ 31,061 (25,151) 806 1,008 (211) (471) — — (147) — (12) 6,883 (5,150) 7,473 3,733 $ 2,323 54 50 $ $ 50 54 2,269 $ 7,423 3,683 $ 2,269 468 702 196 $ $ $ $ $ 14 — $ — $ 400 193 954 — 30 — — 153 (9) 144 $ 2,701 (950) $ 1,751 See accompanying notes to consolidated ﬁnancial statements. F-8 MetLife, Inc. METLIFE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. Summary of Accounting Policies Business ‘‘MetLife’’ or the ‘‘Company’’ refers to MetLife, Inc., a Delaware corporation incorporated in 1999 (the ‘‘Holding Company’’), and its subsidiaries, including Metropolitan Life Insurance Company (‘‘Metropolitan Life’’). MetLife is a leading provider of insurance and other ﬁnancial services to individual and institutional customers. The Company offers life insurance, annuities, automobile and homeowner’s insurance and retail banking services to individuals, as well as group insurance, reinsurance and retirement & savings products and services to corporations and other institutions. Basis of Presentation The accompanying consolidated ﬁnancial statements include the accounts of (i) the Holding Company and its subsidiaries; (ii) partnerships and joint ventures in which the Company has control; and (iii) variable interest entities (‘‘VIEs’’) for which the Company is deemed to be the primary beneﬁciary. Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item (see Note 6). Assets, liabilities, revenues and expenses of the general account for 2004 include amounts related to certain separate accounts previously reported in separate account assets and liabilities. See ‘‘— Application of Recent Accounting Pronouncements.’’ Intercompany accounts and transactions have been eliminated. The Company uses the equity method of accounting for investments in equity securities in which it has more than a 20% interest and for real estate joint ventures and other limited partnership interests in which it has more than a minor equity interest or more than minor inﬂuence over the partnership’s operations, but does not have a controlling interest and is not the primary beneﬁciary. The Company uses the cost method of accounting for real estate joint ventures and other limited partnership interests in which it has a minor equity investment and virtually no inﬂuence over the partnership’s operations. Minority interest related to consolidated entities included in other liabilities was $1,145 million and $950 million at December 31, 2004 and 2003, respectively. Certain amounts in the prior years’ consolidated ﬁnancial statements have been reclassiﬁed to conform with the 2004 presentation. Summary of Critical Accounting Estimates The preparation of ﬁnancial statements in conformity with accounting principles generally accepted in the United States of America (‘‘GAAP’’) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated ﬁnancial statements. The most critical estimates include those used in determining: (i) investment impairments; (ii) the fair value of investments in the absence of quoted market values; (iii) application of the consolidation rules to certain investments; (iv) the fair value of and accounting for derivatives; (v) the capitalization and amortization of deferred policy acquisition costs (‘‘DAC’’), including value of business acquired (‘‘VOBA’’); (vi) the liability for future policyholder beneﬁts; (vii) the liability for litigation and regulatory matters; and (viii) accounting for reinsurance transactions and employee beneﬁt plans. In applying these policies, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and ﬁnancial services industries; others are speciﬁc to the Company’s businesses and operations. Actual results could differ from those estimates. Investments The Company’s principal investments are in ﬁxed maturities, mortgage and other loans and real estate, all of which are exposed to three primary sources of investment risk: credit, interest rate and market valuation. The ﬁnancial statement risks are those associated with the recognition of impairments and income, as well as the determination of fair values. The assessment of whether impairments have occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used by the Company in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the market value has been below cost or amortized cost; (ii) the potential for impairments of securities when the issuer is experiencing signiﬁcant ﬁnancial difﬁculties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments of securities where the issuer, series of issuers or industry has suffered a catastrophic type of loss or has exhausted natural resources; (vi) the Company’s ability and intent to hold the security for a period of time sufﬁcient to allow for the recovery of its value to an amount equal to or greater than cost or amortized cost; (vii) unfavorable changes in forecasted cash ﬂows on asset-backed securities; and (viii) other subjective factors, including concentrations and information obtained from regulators and rating agencies. In addition, the earnings on certain investments are dependent upon market conditions, which could result in prepayments and changes in amounts to be earned due to changing interest rates or equity markets. The determination of fair values in the absence of quoted market values is based on: (i) valuation methodologies; (ii) securities the Company deems to be comparable; and (iii) assumptions deemed appropriate given the circumstances. The use of different methodologies and assumptions may have a material effect on the estimated fair value amounts. In addition, the Company enters into certain structured investment transactions, real estate joint ventures and limited partnerships for which the Company may be deemed to be the primary beneﬁciary and, therefore, may be required to consolidate such investments. The accounting rules for the determination of the primary beneﬁciary are complex and require evaluation of the contractual rights and obligations associated with each party involved in the entity, an estimate of the entity’s expected losses and expected residual returns and the allocation of such estimates to each party. Derivatives The Company enters into freestanding derivative transactions primarily to manage the risk associated with variability in cash ﬂows or changes in fair values related to the Company’s ﬁnancial assets and liabilities. The Company also uses derivative instruments to hedge its currency exposure associated with net investments in certain foreign operations. The Company also purchases investment securities, issues certain insurance policies and engages in certain reinsurance contracts that have embedded derivatives. The associated ﬁnancial statement risk is the volatility in net income which can result from (i) changes in fair value of derivatives not qualifying as accounting hedges; (ii) ineffectiveness of designated hedges; and (iii) counterparty default. In addition, there is a risk that embedded derivatives requiring bifurcation are not identiﬁed and reported at fair value in the consolidated ﬁnancial statements. Accounting for derivatives is complex, as evidenced by signiﬁcant authoritative interpretations of the primary accounting standards which continue to evolve, as well as the signiﬁcant judgments and estimates involved in determining fair value in the absence of quoted market values. These estimates are MetLife, Inc. F-9 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. based on valuation methodologies and assumptions deemed appropriate in the circumstances. Such assumptions include estimated volatility and interest rates used in the determination of fair value where quoted market values are not available. The use of different assumptions may have a material effect on the estimated fair value amounts. Deferred Policy Acquisition Costs The Company incurs signiﬁcant costs in connection with acquiring new and renewal insurance business. These costs, which vary with and are primarily related to the production of that business, are deferred. The recovery of such costs is dependent upon the future proﬁtability of the related business. The amount of future proﬁt is dependent principally on investment returns in excess of the amounts credited to policyholders, mortality, morbidity, persistency, interest crediting rates, expenses to administer the business, creditworthiness of reinsurance counterparties and certain economic variables, such as inﬂation. Of these factors, the Company anticipates that investment returns are most likely to impact the rate of amortization of such costs. The aforementioned factors enter into management’s estimates of gross margins and proﬁts, which generally are used to amortize such costs. Revisions to estimates result in changes to the amounts expensed in the reporting period in which the revisions are made and could result in the impairment of the asset and a charge to income if estimated future gross margins and proﬁts are less than amounts deferred. In addition, the Company utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC, including VOBA. This practice assumes that the expectation for long-term appreciation in equity markets is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Liability for Future Policy Beneﬁts and Unpaid Claims and Claim Expenses The Company establishes liabilities for amounts payable under insurance policies, including traditional life insurance, traditional annuities and non- medical health insurance. Generally, amounts are payable over an extended period of time and liabilities are established based on methods and underlying assumptions in accordance with GAAP and applicable actuarial standards. Principal assumptions used in the establishment of liabilities for future policy beneﬁts are mortality, morbidity, expenses, persistency, investment returns and inﬂation. The Company also establishes liabilities for unpaid claims and claim expenses for property and casualty claim insurance which represent the amount estimated for claims that have been reported but not settled and claims incurred but not reported. Liabilities for unpaid claims are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation. Differences between actual experience and the assumptions used in pricing these policies and in the establishment of liabilities result in variances in proﬁt and could result in losses. The effects of changes in such estimated reserves are included in the results of operations in the period in which the changes occur. Reinsurance The Company enters into reinsurance transactions as both a provider and a purchaser of reinsurance. Accounting for reinsurance requires extensive use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company periodically reviews actual and anticipated experience compared to the aforementioned assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance and evaluates the ﬁnancial strength of counterparties to its reinsurance agreements using criteria similar to that evaluated in the security impairment process discussed previously. Additionally, for each of its reinsurance contracts, the Company must determine if the contract provides indemniﬁcation against loss or liability relating to insurance risk, in accordance with applicable accounting standards. The Company must review all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. If the Company determines that a reinsurance contract does not expose the reinsurer to a reasonable possibility of a signiﬁcant loss from insurance risk, the Company records the contract using the deposit method of accounting. Litigation The Company is a party to a number of legal actions and regulatory investigations. Given the inherent unpredictability of these matters, it is difﬁcult to estimate the impact on the Company’s consolidated ﬁnancial position. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities related to certain lawsuits, including the Company’s asbestos-related liability, are especially difﬁcult to estimate due to the limitation of available data and uncertainty regarding numerous variables used to determine amounts recorded. The data and variables that impact the assumptions used to estimate the Company’s asbestos-related liability include the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. On a quarterly and annual basis the Company reviews relevant information with respect to liabilities for litigation, regulatory investigations and litigation-related contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. It is possible that an adverse outcome in certain of the Company’s litigation and regulatory investigations, including asbestos- related cases, or the use of different assumptions in the determination of amounts recorded could have a material effect upon the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Employee Beneﬁt Plans The Company sponsors pension and other retirement plans in various forms covering employees who meet speciﬁed eligibility requirements. The reported expense and liability associated with these plans requires an extensive use of assumptions which include the discount rate, expected return on plan assets and rate of future compensation increases as determined by the Company. Management determines these assumptions based upon currently available market and industry data, historical performance of the plan and its assets, and consultation with an independent consulting actuarial ﬁrm. These assumptions used by the Company may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of the participants. These differences may have a signiﬁcant effect on the Company’s consolidated ﬁnancial statements and liquidity. F-10 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Signiﬁcant Accounting Policies Investments The Company’s ﬁxed maturity and equity securities are classiﬁed as available-for-sale and are reported at their estimated fair value. Unrealized investment gains and losses on securities are recorded as a separate component of other comprehensive income or loss, net of policyholder related amounts and deferred income taxes. The cost of ﬁxed maturity and equity securities is adjusted for impairments in value deemed to be other-than- temporary in the period that determination is made. These adjustments are recorded as investment losses. The assessment of whether such impairment has occurred is based on management’s case-by-case evaluation of the underlying reasons for the decline in fair value. Management considers a wide range of factors, as described in ‘‘Summary of Critical Accounting Estimates-Investments,’’ about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. The Company’s review of its ﬁxed maturities and equity securities for impairments also includes an analysis of the total gross unrealized losses by three categories of securities: (i) securities where the estimated fair value had declined and remained below cost or amortized cost by less than 20%; (ii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for less than six months; and (iii) securities where the estimated fair value had declined and remained below cost or amortized cost by 20% or more for six months or greater. Investment gains and losses on sales of securities are determined on a speciﬁc identiﬁcation basis. All security transactions are recorded on a trade date basis. Amortization of premium and accretion of discount on ﬁxed maturity securities is recorded using the effective interest method. Mortgage loans on real estate are stated at amortized cost, net of valuation allowances. Valuation allowances are recorded when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the contractual terms of the loan agreement. Such valuation allowances are established for the excess carrying value of the mortgage loan over the present value of expected future cash ﬂows discounted at the loan’s original effective interest rate, the value of the loan’s collateral or the loan’s market value if the loan is being sold. The Company also establishes allowances for loan loss when a loss contingency exists for pools of loans with similar characteristics based on property types and loan to value risk factors. A loss contingency exists when the likelihood that a future event will occur is probable based on past events. Changes in valuation allowances are included in net investment gains and losses. Interest income earned on impaired loans is accrued on the principal amount of the loan based on the loan’s contractual interest rate. However, interest ceases to be accrued for loans on which interest is generally more than 60 days past due and/or where the collection of interest is not considered probable. Cash receipts on impaired loans are recorded as a reduction of the recorded investment. Real estate held-for-investment, including related improvements, is stated at cost less accumulated depreciation. Depreciation is provided on a straight-line basis over the estimated useful life of the asset (typically 20 to 55 years). Once the Company identiﬁes a property that is expected to be sold within one year and commences a ﬁrm plan for marketing the property, the Company, if applicable, classiﬁes the property as held-for-sale and reports the related net investment income and any resulting investment gains and losses as discontinued operations. Real estate held-for-sale is stated at the lower of depreciated cost or fair value less expected disposition costs. Real estate is not depreciated while it is classiﬁed as held-for-sale. Cost of real estate held-for-investment is adjusted for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Impaired real estate is written down to estimated fair value with the impairment loss being included in net investment gains and losses. Impairment losses are based upon the estimated fair value of real estate, which is generally computed using the present value of expected future cash ﬂows from the real estate discounted at a rate commensurate with the underlying risks. Real estate acquired upon foreclosure of commercial and agricultural mortgage loans is recorded at the lower of estimated fair value or the carrying value of the mortgage loan at the date of foreclosure. Policy loans are stated at unpaid principal balances. Short-term investments are stated at amortized cost, which approximates fair value. Other invested assets consist principally of leveraged leases and funds withheld at interest. The leveraged leases are recorded net of non-recourse debt. The Company participates in lease transactions which are diversiﬁed by industry, asset type and geographic area. The Company regularly reviews residual values and impairs residuals to expected values as needed. Funds withheld represent amounts contractually withheld by ceding companies in accordance with reinsurance agreements. For agreements written on a modiﬁed coinsurance basis and certain agreements written on a coinsurance basis, assets supporting the reinsured policies and equal to the net statutory reserves are withheld and continue to be legally owned by the ceding companies. Other invested assets also includes the fair value of embedded derivatives related to funds withheld and modiﬁed coinsurance contracts. The Company recognizes interest on funds withheld in accordance with the treaty terms as investment income is earned on the assets supporting the reinsured policies. The Company participates in structured investment transactions, primarily asset securitizations and structured notes. These transactions enhance the Company’s total return of the investment portfolio principally by generating management fee income on asset securitizations and by providing equity- based returns on debt securities through structured notes and similar instruments. The Company sponsors ﬁnancial asset securitizations of high yield debt securities, investment grade bonds and structured ﬁnance securities and also is the collateral manager and a beneﬁcial interest holder in such transactions. As the collateral manager, the Company earns management fees on the outstanding securitized asset balance, which are recorded in income as earned. When the Company transfers assets to a bankruptcy-remote special purpose entity (‘‘SPE’’) and surrenders control over the transferred assets, the transaction is accounted for as a sale. Gains or losses on securitizations are determined with reference to the carrying amount of the ﬁnancial assets transferred, which is allocated to the assets sold and the beneﬁcial interests retained based on relative fair values at the date of transfer. Beneﬁcial interests in securitizations are carried at fair value in ﬁxed maturities. Income on these beneﬁcial interests is recognized using the prospective method. The SPEs used to securitize assets are not consolidated by the Company because the Company has determined that it is not the primary beneﬁciary of these entities. Prior to the adoption of FIN 46(r), such SPEs were not consolidated because they did not meet the criteria for consolidation under previous accounting guidance. The Company purchases or receives beneﬁcial interests in SPEs, which generally acquire ﬁnancial assets, including corporate equities, debt securities and purchased options. The Company has not guaranteed the performance, liquidity or obligations of the SPEs and the Company’s exposure to loss is limited to its carrying value of the beneﬁcial interests in the SPEs. The Company uses the beneﬁcial interests as part of its risk management strategy, including asset-liability management. These SPEs are not consolidated by the Company because the Company has determined that it is not the MetLife, Inc. F-11 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. primary beneﬁciary of these entities based on the framework provided in FIN 46(r). Prior to the adoption of FIN 46(r), such SPEs were not consolidated because they did not meet the criteria for consolidation under previous accounting guidance. These beneﬁcial interests are generally structured notes, which are included in ﬁxed maturities, and their income is recognized using the retrospective interest method or the level yield method, as appropriate. Impairments of these beneﬁcial interests are included in net investment gains (losses). Derivative Financial Instruments Derivatives are ﬁnancial instruments whose values are derived from interest rates, foreign exchange rates, or other ﬁnancial indices. Derivatives may be exchange traded or contracted in the over-the-counter market. The Company uses a variety of derivatives, including swaps, forwards, futures and option contracts, to manage its various risks. Additionally, the Company enters into income generation and replication derivatives as permitted by its insurance subsidiaries’ Derivatives Use Plans approved by the applicable state insurance departments. Freestanding derivatives are carried on the Company’s consolidated balance sheet either as assets within Other invested assets or as liabilities within Other liabilities at fair value as determined by quoted market prices or through the use of pricing models. Values can be affected by changes in interest rates, foreign exchange rates, ﬁnancial indices, credit spreads, market volatility, and liquidity. Values can also be affected by changes in estimates and assumptions used in pricing models. If a derivative does not qualify for hedge accounting pursuant to Statement of Financial Accounting Standards (‘‘SFAS’’) No. 133, Accounting for Derivative Instruments and Hedging Activities (‘‘SFAS 133’’), as amended, changes in the fair value of the derivative are reported in Net investment gains (losses), or in Interest credited to policyholder account balances for hedges of liabilities embedded in certain variable annuity products offered by the Company. To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge as either (i) a hedge of the fair value of a recognized asset or liability or an unrecognized ﬁrm commitment (‘‘fair value hedge’’); (ii) a hedge of a forecasted transaction or of the variability of cash ﬂows to be received or paid related to a recognized asset or liability (‘‘cash ﬂow hedge’’); or (iii) a hedge of a net investment in a foreign operation. In this documentation, the Company sets forth how the hedging instrument is expected to hedge the risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method which will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and throughout the life of the hedging relationship. The ineffective portion of the changes in fair value of the hedging instrument is recorded in Net investment gains (losses). Under a fair value hedge, changes in the fair value of the derivative, along with changes in the fair value of the hedged item related to the risk being hedged, are reported in Net investment gains (losses). In a cash ﬂow hedge, changes in the fair value of the derivative are recorded in Other comprehensive income (loss), a separate component of shareholders’ equity, and the deferred gains or losses on the derivative are reclassiﬁed into the income statement when the Company’s earnings are affected by the variability in cash ﬂows of the hedged item. In a hedge of a net investment in a foreign operation, changes in the fair value of the derivative are recorded in Other comprehensive income (loss). The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the fair value or cash ﬂows of a hedged item; (ii) the derivative expires or is sold, terminated, or exercised; (iii) it is no longer probable that the forecasted transaction will occur; (iv) a hedged ﬁrm commitment no longer meets the deﬁnition of a ﬁrm commitment; or (v) the derivative is de-designated as a hedging instrument. When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the fair value or cash ﬂows of a hedged item, the derivative continues to be carried on the consolidated balance sheet at its fair value, with changes in fair value recognized currently in Net investment gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its fair value due to hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. The changes in fair value of derivatives recorded in Other comprehensive income (loss) related to discontinued cash ﬂow hedges are amortized into income over the remaining life of the hedging instruments. When hedge accounting is discontinued because it is probable that the forecasted transactions will not occur by the end of the speciﬁed time period or the hedged item no longer meets the deﬁnition of a ﬁrm commitment, the derivative continues to be carried on the consolidated balance sheet at its fair value, with changes in fair value recognized currently in Net investment gains (losses). Any asset or liability associated with a recognized ﬁrm commitment is derecognized from the consolidated balance sheet, and recorded currently in Net investment gains (losses). Deferred gains and losses of a derivative recorded in Other comprehensive income (loss) pursuant to the cash ﬂow hedge of a forecasted transaction are recognized immediately in Net investment gains (losses). In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value on the consolidated balance sheet, with changes in its fair value recognized in the current period as Net investment gains (losses). The Company is also a party to ﬁnancial instruments in which a derivative is ‘‘embedded.’’ For each ﬁnancial instrument in which a derivative is embedded, the Company assesses whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract, and determines whether a separate instrument with the same terms as the embedded instrument would meet the deﬁnition of a derivative, as deﬁned in SFAS 133. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a freestanding derivative. Such embedded derivatives are carried on the consolidated balance sheet at fair value with the host contract and changes in their fair value are reported currently in Net investment gains (losses). If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at fair value, with changes in fair value recognized in the current period in Net investment gains (losses). F-12 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Cash and Cash Equivalents The Company considers all investments purchased with an original maturity of three months or less to be cash equivalents. Property, Equipment, Leasehold Improvements and Computer Software Property, equipment and leasehold improvements, which are included in other assets, are stated at cost, less accumulated depreciation and amortization. Depreciation is determined using either the straight-line or sum-of-the-years-digits method over the estimated useful lives of the assets. The estimated life for company occupied real estate property is generally 40 years. Estimated lives generally range from ﬁve to ten years for leasehold improvements and three to ﬁve years for all other property and equipment. Accumulated depreciation and amortization of property, equipment and leasehold improvements was $566 million and $530 million at December 31, 2004 and 2003, respectively. Related depreciation and amortization expense was $112 million, $117 million and $81 million for the years ended December 31, 2004, 2003 and 2002, respectively. Computer software, which is included in other assets, is stated at cost, less accumulated amortization. Purchased software costs, as well as internal and external costs incurred to develop internal-use computer software during the application development stage, are capitalized. Such costs are amortized generally over a four-year period using the straight-line method. Accumulated amortization of capitalized software was $552 million and $434 million at December 31, 2004 and 2003, respectively. Related amortization expense was $139 million, $154 million and $154 million for the years ended December 31, 2004, 2003 and 2002, respectively. Deferred Policy Acquisition Costs The costs of acquiring new and renewal insurance business that vary with, and are primarily related to, the production of that business are deferred. Such costs, which consist principally of commissions, agency and policy issue expenses, are amortized with interest over the expected life of the contract for participating traditional life, universal life and investment-type products. Generally, DAC is amortized in proportion to the present value of estimated gross margins or proﬁts from investment, mortality, expense margins and surrender charges. Interest rates used to compute the present value of estimated gross margins and proﬁts are based on rates in effect at the inception or acquisition of the contracts. Actual gross margins or proﬁts can vary from management’s estimates resulting in increases or decreases in the rate of amortization. Management utilizes the reversion to the mean assumption, a common industry practice, in its determination of the amortization of DAC. This practice assumes that the expectation for long-term equity investment appreciation is not changed by minor short-term market ﬂuctuations, but that it does change when large interim deviations have occurred. Management periodically updates these estimates and evaluates the recoverability of DAC. When appropriate, management revises its assumptions of the estimated gross margins or proﬁts of these contracts, and the cumulative amortization is re-estimated and adjusted by a cumulative charge or credit to current operations. DAC for non-participating traditional life, non-medical health and annuity policies with life contingencies is amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are made at the date of policy issuance or acquisition and are consistently applied during the lives of the contracts. Deviations from estimated experience are included in operations when they occur. For these contracts, the amortization period is typically the estimated life of the policy. Policy acquisition costs related to internally replaced contracts are expensed at the date of replacement. DAC for property and casualty insurance contracts, which is primarily comprised of commissions and certain underwriting expenses, are deferred and amortized on a pro rata basis over the applicable contract term or reinsurance treaty. VOBA, included as part of DAC, represents the present value of estimated future proﬁts to be generated from existing insurance contracts in-force at the date of acquisition and is amortized over the expected policy or contract duration in relation to the estimated gross proﬁts or premiums from such policies and contracts. Sales Inducements The Company has two different types of sales inducements: (i) the policyholder receives a bonus whereby the policyholder’s initial account balance is increased by an amount equal to a speciﬁed percentage of the customer’s deposit and (ii) the policyholder receives a higher interest rate using a dollar cost averaging method than would have been received based on the normal general account interest rate credited. The Company defers sales inducements and amortizes them over the life of the policy using the same methodology and assumptions used to amortize DAC. Goodwill The excess of cost over the fair value of net assets acquired (‘‘goodwill’’) is included in other assets. On January 1, 2002, the Company adopted the provisions of SFAS No. 142, Goodwill and Other Intangible Assets, (‘‘SFAS 142’’). In accordance with SFAS 142, goodwill is not amortized but is tested for impairment at least annually to determine whether a writedown of the cost of the asset is required. Impairments are recognized in operating results when the carrying amount of goodwill exceeds its implied fair value. Prior to the adoption of SFAS 142, goodwill was amortized on a straight-line basis over a period ranging from 10 to 30 years and impairments were recognized in operating results when permanent diminution in value was deemed to have occurred. Changes in net goodwill were as follows: Balance, beginning of year *********************************************************************** $628 Acquisitions ************************************************************************************ 4 Impairment losses******************************************************************************* — Disposition and other **************************************************************************** 1 Balance, end of year **************************************************************************** $633 $ 750 3 — (125) $ 628 $609 166 (8) (17) $750 Years Ended December 31, 2004 2003 2002 (Dollars in millions) MetLife, Inc. F-13 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Liability for Future Policy Beneﬁts and Policyholder Account Balances Future policy beneﬁt liabilities for participating traditional life insurance policies are equal to the aggregate of (i) net level premium reserves for death and endowment policy beneﬁts (calculated based upon the non-forfeiture interest rate, ranging from 3% to 11%, and mortality rates guaranteed in calculating the cash surrender values described in such contracts), (ii) the liability for terminal dividends, and (iii) premium deﬁciency reserves, which are established when the liabilities for future policy beneﬁts plus the present value of expected future gross premiums are insufﬁcient to provide for expected future policy beneﬁts and expenses after DAC is written off. Future policy beneﬁts for non-participating traditional life insurance policies are equal to the aggregate of (i) the present value of future beneﬁt payments and related expenses less the present value of future net premiums and (ii) premium deﬁciency reserves. Assumptions as to mortality and persistency are based upon the Company’s experience when the basis of the liability is established. Interest rates for the aggregate future policy beneﬁt liabilities range from 5.0% to 6.5%. Participating business represented approximately 14% and 14% of the Company’s life insurance in-force, and 56% and 57% of the number of life insurance policies in-force, at December 31, 2004 and 2003, respectively. Participating policies represented approximately 35% and 34%, 38% and 38%, and 39% and 41% of gross and net life insurance premiums for the years ended December 31, 2004, 2003 and 2002, respectively. The percentages indicated are calculated excluding the business of the Reinsurance segment. Future policy beneﬁt liabilities for individual and group traditional ﬁxed annuities after annuitization are equal to the present value of expected future payments and premium deﬁciency reserves. Interest rates used in establishing such liabilities range from 2% to 11%. Future policy beneﬁt liabilities for non-medical health insurance are calculated using the net level premium method and assumptions as to future morbidity, withdrawals and interest, which provide a margin for adverse deviation. Interest rates used in establishing such liabilities range from 2% to 11%. Future policy beneﬁt liabilities for disabled lives are estimated using the present value of beneﬁts method and experience assumptions as to claim terminations, expenses and interest. Interest rates used in establishing such liabilities range from 3% to 11%. Liabilities for unpaid claims and claim expenses for property and casualty insurance are included in future policyholder beneﬁts and are estimated based upon the Company’s historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur. Policyholder account balances relate to investment-type contracts and universal life-type policies. Investment-type contracts principally include traditional individual ﬁxed annuities in the accumulation phase and non-variable group annuity contracts. Policyholder account balances are equal to the policy account values, which consist of an accumulation of gross premium payments plus credited interest, ranging from 1% to 13%, less expenses, mortality charges, and withdrawals. The Company issues ﬁxed and ﬂoating rate obligations under its guaranteed investment contract (‘‘GIC’’) program. During the years ended December 31, 2004, 2003 and 2002, the Company issued $3,941 million, $4,341 million and $500 million, respectively, in such obligations. There have been no repayments of any of the contracts. Accordingly, the GICs outstanding, which are included in policyholder account balances in the accompanying consolidated balance sheets, were $8,978 and $4,862, respectively, at December 31, 2004 and 2003. Interest credited on the contracts for the years ended December 31, 2004, 2003 and 2002 was $139 million, $56 million and $12 million, respectively. The Company establishes liabilities for minimum death and income beneﬁt guarantees relating to certain annuity contracts and secondary and paid up guarantees relating to certain life policies. Annuity guaranteed death beneﬁt liabilities are determined by estimating the expected value of death beneﬁts in excess of the projected account balance and recognizing the excess ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used in estimating the liabilities are consistent with those used for amortizing DAC, including the mean reversion assumption. The assumptions of investment performance and volatility are consistent with the historical experience of the Standard & Poor’s 500 Index (‘‘S&P’’). The beneﬁts used in calculating the liabilities are based on the average beneﬁts payable over a range of scenarios. Guaranteed annuitization beneﬁt liabilities are determined by estimating the expected value of the annuitization beneﬁts in excess of the projected account balance at the date of annuitization and recognizing the excess ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used for calculating such guaranteed annuitization beneﬁt liabilities are consistent with those used for calculating the guaranteed death beneﬁt liabilities. In addition, the calculation of guaranteed annuitization beneﬁt liabilities incorporates a percentage of the potential annuitizations that may be elected by the contractholder. Liabilities for universal and variable life secondary guarantees and paid-up guarantees are determined by estimating the expected value of death beneﬁts payable when the account balance is projected to be zero and recognizing those beneﬁts ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the additional liability balances, with a related charge or credit to beneﬁt expense, if actual experience or other evidence suggests that earlier assumptions should be revised. The assumptions used in estimating the secondary and paid up guarantee liabilities are consistent with those used for amortizing DAC. The assumptions of investment performance and volatility for variable products are consistent with historical S&P experience. The beneﬁts used in calculating the liabilities are based on the average beneﬁts payable over a range of scenarios. Recognition of Insurance Revenue and Related Beneﬁts Premiums related to traditional life and annuity policies with life contingencies are recognized as revenues when due. Beneﬁts and expenses are provided against such revenues to recognize proﬁts over the estimated lives of the policies. When premiums are due over a signiﬁcantly shorter period than the period over which beneﬁts are provided, any excess proﬁt is deferred and recognized into operations in a constant relationship to insurance in- force or, for annuities, the amount of expected future policy beneﬁt payments. Premiums related to non-medical health and disability contracts are recognized on a pro rata basis over the applicable contract term. Deposits related to universal life-type and investment-type products are credited to policyholder account balances. Revenues from such contracts consist of amounts assessed against policyholder account balances for mortality, policy administration and surrender charges and are recognized in the F-14 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. period in which services are provided. Amounts that are charged to operations include interest credited and beneﬁt claims incurred in excess of related policyholder account balances. Premiums related to property and casualty contracts are recognized as revenue on a pro rata basis over the applicable contract term. Unearned premiums are included in other liabilities. Other Revenues Other revenues include advisory fees, broker/dealer commissions and fees, and administrative service fees. Such fees and commissions are recognized in the period in which services are performed. Other revenues also include changes in account value relating to corporate-owned life insurance (‘‘COLI’’). Under certain COLI contracts, if the Company reports certain unlikely adverse results in its consolidated ﬁnancial statements, withdrawals would not be immediately available and would be subject to market value adjustment, which could result in a reduction of the account value. Policyholder Dividends Policyholder dividends are approved annually by the insurance subsidiaries’ boards of directors. The aggregate amount of policyholder dividends is related to actual interest, mortality, morbidity and expense experience for the year, as well as management’s judgment as to the appropriate level of statutory surplus to be retained by the insurance subsidiaries. Income Taxes The Holding Company and its includable life insurance and non-life insurance subsidiaries ﬁle a consolidated U.S. federal income tax return in accordance with the provisions of the Internal Revenue Code of 1986, as amended (the ‘‘Code’’). Non-includable subsidiaries ﬁle either separate tax returns or separate consolidated tax returns. The future tax consequences of temporary differences between ﬁnancial reporting and tax bases of assets and liabilities are measured at the balance sheet dates and are recorded as deferred income tax assets and liabilities. Valuation allowances are established when management assesses, based on available information, that it is more likely than not that deferred income tax assets will not be realized. Reinsurance The Company has reinsured certain of its life insurance and property and casualty insurance contracts with other insurance companies under various agreements. Reinsurance premiums, commissions, expense reimbursements, beneﬁts and reserves related to reinsured long-duration contracts are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. The cost of reinsurance related to short-duration contracts is accounted for over the reinsurance contract period. Amounts due from reinsurers, for both short- and long-duration arrangements, are estimated based upon assumptions consistent with those used in establishing the liabilities related to the underlying reinsured contracts. Policy and contract liabilities are reported gross of reinsurance credits. DAC is reduced by amounts recovered under reinsurance contracts. Amounts received from reinsurers for policy administration are reported in other revenues. The Company assumes and retrocedes ﬁnancial reinsurance contracts, which represent low mortality risk reinsurance treaties. These contracts are reported as deposits and are included in other assets. The amount of revenue reported on these contracts represents fees and the cost of insurance under the terms of the reinsurance agreement and is reported in other revenues. Separate Accounts Separate accounts are established in conformity with insurance laws and are generally not chargeable with liabilities that arise from any other business of the Company. Separate account assets are subject to general account claims only to the extent the value of such assets exceeds the separate account liabilities. Effective with the adoption of Statement of Position 03-1, Accounting and Reporting by Insurance Enterprises for Certain Nontraditional Long-Duration Contracts and for Separate Accounts (‘‘SOP 03-1’’), on January 1, 2004, the Company reports separately, as assets and liabilities, investments held in separate accounts and liabilities of the separate accounts if (i) such separate accounts are legally recognized; (ii) assets supporting the contract liabilities are legally insulated from the Company’s general account liabilities; (iii) investments are directed by the contractholder; and (iv) all investment performance, net of contact fees and assessments, is passed through to the contractholder. The Company reports separate account assets meeting such criteria at their fair value. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to contractholders of such separate accounts are offset within the same line in the consolidated statements of income. In connection with the adoption of SOP 03-1, separate account assets with a fair value of $1.7 billion were reclassiﬁed to general account investments with a corresponding transfer of separate account liabilities to future policy beneﬁts and policyholder account balances. See ‘‘— Application of Recent Accounting Pronouncements.’’ The Company’s revenues reﬂect fees charged to the separate accounts, including mortality charges, risk charges, policy administration fees, investment management fees and surrender charges. Separate accounts not meeting the above criteria are combined on a line-by-line basis with the Company’s general account assets, liabilities, revenues and expenses. Stock-Based Compensation Effective January 1, 2003, the Company accounts for stock-based compensation plans using the prospective fair value accounting method prescribed by SFAS No. 123, Accounting for Stock-Based Compensation (‘‘SFAS 123’’), as amended by SFAS No. 148, Accounting for Stock-Based Compensation — Transition and Disclosure (‘‘SFAS 148’’). The fair value method requires compensation cost to be measured based on the fair value of the equity instrument at the grant or award date. Stock-based compensation grants prior to January 1, 2003 are accounted for using the intrinsic value method prescribed by Accounting Principles Board Opinion (‘‘APB’’) No. 25, Accounting for Stock Issued to Employees (‘‘APB 25’’). Note 12 includes the pro forma disclosures required by SFAS No. 123, as amended. The intrinsic value method represents the quoted market price or fair value of the equity award at the measurement date less the amount, if any, the employee is required to pay. Stock-based compensation is accrued over the vesting period of the grant or award. MetLife, Inc. F-15 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Foreign Currency Balance sheet accounts of foreign operations are translated at the exchange rates in effect at each year-end and income and expense accounts are translated at the average rates of exchange prevailing during the year. The local currencies of foreign operations are the functional currencies unless the local economy is highly inﬂationary. Translation adjustments are charged or credited directly to other comprehensive income or loss. Gains and losses from foreign currency transactions are reported in earnings in the respective ﬁnancial statement lines to which they relate. Discontinued Operations The results of operations of a component of the Company that either has been disposed of or is classiﬁed as held-for-sale are reported in discontinued operations if the operations and cash ﬂows of the component have been or will be eliminated from the ongoing operations of the Company as a result of the disposal transaction and the Company will not have any signiﬁcant continuing involvement in the operations of the component after the disposal transaction. Earnings Per Share Basic earnings per share is computed based on the weighted average number of shares outstanding during the period. Diluted earnings per share includes the dilutive effect of the assumed: (i) conversion of forward purchase contracts; (ii) exercise of stock options, and (iii) issuance under deferred stock compensation using the treasury stock method. Under the treasury stock method, conversion of forward purchase contracts, exercise of the stock options and issuance under deferred stock compensation is assumed with the proceeds used to purchase common stock at the average market price for the period. The difference between the number of shares assumed issued and number of shares assumed purchased represents the dilutive shares. Application of Recent Accounting Pronouncements In December 2004, the Financial Accounting Standards Board (‘‘FASB’’) issued Staff Position Paper (‘‘FSP’’) 109-2, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004 (‘‘AJCA’’). The AJCA introduced a one-time dividend received deduction on the repatriation of certain earnings to a U.S. taxpayer. FSP 109-2 provides companies additional time beyond the ﬁnancial reporting period of enactment to evaluate the effects of the AJCA on their plans to repatriate foreign earnings for purposes of applying SFAS 109, Accounting for Income Taxes. The Company is currently evaluating the repatriation provision of the AJCA. If the repatriation provision is implemented by the Company, the impact on the Company’s income tax expense and deferred income tax assets and liabilities would be immaterial. In December 2004, the FASB issued SFAS No. 153, Exchange of Nonmonetary Assets, an amendment of APB Opinion No. 29 (‘‘SFAS 153’’). SFAS 153 amends prior guidance to eliminate the exception for nonmonetary exchanges of similar productive assets and replaces it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial substance if the future cash ﬂows of the entity are expected to change signiﬁcantly as a result of the exchange. The provisions of SFAS 153 are effective for nonmonetary asset exchanges occurring in ﬁscal periods beginning after June 15, 2005 and shall be applied prospectively. SFAS 153 is not expected to have a material impact on the Company’s consolidated ﬁnancial statements at the date of adoption. In December 2004, FASB revised SFAS 123 to Share-Based Payment (‘‘SFAS 123(r)’’). SFAS 123(r) provides additional guidance on determining whether certain ﬁnancial instruments awarded in share-based payment transactions are liabilities. SFAS 123(r) also requires that the cost of all share- based transactions be recorded in the ﬁnancial statements. The revised pronouncement must be adopted by the Company by July 1, 2005. As all stock options currently accounted for under APB 25 will vest prior to the effective date, implementation of SFAS 123(r) will not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2003, the Company adopted SFAS 148, which provides guidance on how to apply the fair value method of accounting for share-based payments. As permitted under SFAS 148, the Company elected to use the prospective method of accounting for stock options granted subsequent to December 31, 2002. Options granted prior to January 1, 2003 will continue to be accounted for under the intrinsic value method until the adoption of SFAS 123(r), and the pro forma impact of accounting for these options at fair value will continue to be disclosed in the consolidated ﬁnancial statements until the last of those options vest in 2005. See Note 12. In March 2004, the Emerging Issues Task Force (‘‘EITF’’) reached further consensus on Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments (‘‘EITF 03-1’’). EITF 03-1 provides accounting guidance regarding the determination of when an impairment of debt and marketable equity securities and investments accounted for under the cost method should be considered other-than-temporary and recognized in income. An EITF 03-1 consensus reached in November 2003 also requires certain quantitative and qualitative disclosures for debt and marketable equity securities classiﬁed as available-for-sale or held-to-maturity under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities, that are impaired at the balance sheet date but for which an other-than-temporary impairment has not been recognized. The Company has complied with the disclosure requirements of EITF 03-1, which were effective December 31, 2003. The accounting guidance of EITF 03-1 relating to the recognition of investment impairment which was to be effective in the third quarter of 2004 has been delayed pending the development of additional guidance. The Company is actively monitoring the deliberations relating to this issue at the FASB and currently is unable to determine the ultimate impact EITF 03-1 will have on its consolidated ﬁnancial statements. In March 2004, the EITF reached consensus on Issue No. 03-6, Participating Securities and the Two-Class Method under FASB Statement No. 128 (‘‘EITF 03-6’’). EITF 03-6 provides guidance in determining whether a security should be considered a participating security for purposes of computing earnings per share and how earnings should be allocated to the participating security. EITF 03-6 did not have an impact on the Company’s earnings per share calculations or amounts. In March 2004, the EITF reached consensus on Issue No. 03-16, Accounting for Investments in Limited Liability Companies (‘‘EITF 03-16’’). EITF 03-16 provides guidance regarding whether a limited liability company should be viewed as similar to a corporation or similar to a partnership for purposes of determining whether a noncontrolling investment should be accounted for using the cost method or the equity method of accounting. EITF 03-16 did not have a material impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2004, the Company adopted SOP 03-1, as interpreted by Technical Practices Aids issued by the American Institute of Certiﬁed Public Accountants. SOP 03-1 provides guidance on (i) the classiﬁcation and valuation of long-duration contract liabilities; (ii) the accounting for sales inducements; and (iii) separate account presentation and valuation. In June 2004, the FASB released FSP No. 97-1, Situations in Which Paragraphs 17(b) and 20 of FASB Statement No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for F-16 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Realized Gains and Losses from the Sale of Investments, Permit or Require Accrual of an Unearned Revenue Liability (‘‘FSP 97-1’’) which included clariﬁcation that unearned revenue liabilities should be considered in determining the necessary insurance beneﬁt liability required under SOP 03-1. Since the Company had considered unearned revenue in determining its SOP 03-1 beneﬁt liabilities, FSP 97-1 did not impact its consolidated ﬁnancial statements. As a result of the adoption of SOP 03-1, effective January 1, 2004, the Company decreased the liability for future policyholder beneﬁts for changes in the methodology relating to various guaranteed death and annuitization beneﬁts and for determining liabilities for certain universal life insurance contracts by $4 million, which has been reported as a cumulative effect of a change in accounting. This amount is net of corresponding changes in DAC, including VOBA and unearned revenue liability (‘‘offsets’’) under certain variable annuity and life contracts and income taxes. Certain other contracts sold by the Company provide for a return through periodic crediting rates, surrender adjustments or termination adjustments based on the total return of a contractually referenced pool of assets owned by the Company. To the extent that such contracts are not accounted for as derivatives under the provisions of SFAS 133 and not already credited to the contract account balance, under SOP 03-1 the change relating to the fair value of the referenced pool of assets is recorded as a liability with the change in the liability recorded as policyholder beneﬁts and claims. Prior to the adoption of SOP 03-1, the Company recorded the change in such liability as other comprehensive income. At adoption, this change decreased net income and increased other comprehensive income by $63 million, net of income taxes, which were recorded as cumulative effects of changes in accounting. Effective with the adoption of SOP 03-1, costs associated with enhanced or bonus crediting rates to contractholders must be deferred and amortized over the life of the related contract using assumptions consistent with the amortization of DAC. Since the Company followed a similar approach prior to adoption of SOP 03-1, the provisions of SOP 03-1 relating to sales inducements had no signiﬁcant impact on the Company’s consolidated ﬁnancial statements. At adoption, the Company reclassiﬁed $155 million of ownership in its own separate accounts from other assets to ﬁxed maturities, equity securities and cash and cash equivalents. This reclassiﬁcation had no signiﬁcant impact on net income or other comprehensive income at adoption. In accordance with SOP 03-1’s guidance for the reporting of certain separate accounts, at adoption, the Company also reclassiﬁed $1.7 billion of separate account assets to general account investments and $1.7 billion of separate account liabilities to future policy beneﬁts and policyholder account balances. This reclassiﬁcation decreased net income and increased other comprehensive income by $27 million, net of income taxes, which were reported as cumulative effects of changes in accounting. The application of SOP 03-1 decreased the Company’s 2004 net income by $67 million, including the cumulative effect of adoption of a decrease in net income of $86 million as described above. In December 2003, FASB revised SFAS No. 132, Employers’ Disclosures about Pensions and Other Postretirement Beneﬁts — an Amendment of FASB Statements No. 87, 88 and 106 (‘‘SFAS 132(r)’’). SFAS 132(r) retains most of the disclosure requirements of SFAS 132 and requires additional disclosure about assets, obligations, cash ﬂows and net periodic beneﬁt cost of deﬁned beneﬁt pension plans and other postretirement plans. SFAS 132(r) was primarily effective for ﬁscal years ending after December 15, 2003; however, certain disclosures about foreign plans and estimated future beneﬁt payments were effective for ﬁscal years ending after June 15, 2004. The Company’s adoption of SFAS 132(r) on December 31, 2003 did not have a signiﬁcant impact on its consolidated ﬁnancial statements since it only revised disclosure requirements. In May 2004, the FASB issued FASB Staff Position (‘‘FSP’’) No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (‘‘FSP 106-2’’), which provides accounting guidance to a sponsor of a postretirement health care plan that provides prescription drug beneﬁts. The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003 based on the Company’s determination that the prescription drug beneﬁts offered under certain postretirement plans are actuarially equivalent to the beneﬁts offered under Medicare Part D. FSP 106-2 was effective for interim periods beginning after June 15, 2004 and provides for either retroactive application to the date of enactment of the legislation or prospective application from the date of adoption of FSP 106-2. Effective July 1, 2004, the Company adopted FSP 106-2 prospectively and the postretirement beneﬁt plan assets and accumulated beneﬁt obligation were remeasured to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation and net periodic postretirement beneﬁt cost was reduced by $213 million and $17 million, for 2004, respectively. Effective October 1, 2003, the Company adopted Statement 133 Implementation Issue No. B36, Embedded Derivatives: Modiﬁed Coinsurance Arrangements and Debt Instruments That Incorporate Credit Risk Exposures That Are Unrelated or Only Partially Related to the Creditworthiness of the Obligor under Those Instruments (‘‘Issue B36’’). Issue B36 concluded that (i) a company’s funds withheld payable and/or receivable under certain reinsurance arrangements, and (ii) a debt instrument that incorporates credit risk exposures that are unrelated or only partially related to the creditworthi- ness of the obligor include an embedded derivative feature that is not clearly and closely related to the host contract. Therefore, the embedded derivative feature is measured at fair value on the balance sheet and changes in fair value are reported in income. The Company’s application of Issue B36 increased (decreased) net income by $4 million and ($12) million, net of amortization of DAC and income taxes, for 2004 and 2003, respectively. The 2003 impact includes a decrease in net income of $26 million relating to the cumulative effect of a change in accounting from the adoption of the new guidance. Effective July 1, 2003, the Company adopted SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities (‘‘SFAS 149’’). SFAS 149 amended and clariﬁed the accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Except for certain previously issued and effective guidance, SFAS 149 was effective for contracts entered into or modiﬁed after June 30, 2003. The Company’s adoption of SFAS 149 did not have a signiﬁcant impact on its consolidated ﬁnancial statements. During 2003, the Company adopted FASB Interpretation (‘‘FIN’’) No. 46, Consolidation of Variable Interest Entities — An Interpretation of ARB No. 51 (‘‘FIN 46’’), and its December 2003 revision (‘‘FIN 46(r)’’). Certain of the Company’s investments in real estate joint ventures and other limited partnership interests meet the deﬁnition of a VIE and have been consolidated, in accordance with the transition rules and effective dates, because the Company is deemed to be the primary beneﬁciary. A VIE is deﬁned as (i) any entity in which the equity investments at risk in such entity do not have the characteristics of a controlling ﬁnancial interest, or (ii) any entity that does not have sufﬁcient equity at risk to ﬁnance its activities without additional subordinated support from other parties. Effective February 1, 2003, the Company adopted FIN 46 for VIEs created or acquired on or after February 1, 2003 and, effective December 31, 2003, the Company adopted FIN 46(r) with respect to interests in entities formerly considered special purpose entities (‘‘SPEs’’), including interests in asset-backed securities and collateralized debt obligations. The adoption of FIN 46 as of February 1, 2003 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. The adoption of the provisions of FIN 46(r) at December 31, 2003 did not require the Company to consolidate any additional VIEs that were not previously consolidated. In accordance with the provisions of FIN 46(r), the Company elected to defer until MetLife, Inc. F-17 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. March 31, 2004 the consolidation of interests in VIEs for non-SPEs acquired prior to February 1, 2003 for which it is the primary beneﬁciary. As of March 31, 2004, the Company consolidated assets and liabilities relating to real estate joint ventures of $78 million and $11 million, respectively, and assets and liabilities relating to other limited partnerships of $29 million and less than $1 million, respectively, for VIEs for which the Company was deemed to be the primary beneﬁciary. There was no impact to net income from the adoption of FIN 46. Effective January 1, 2003, the Company adopted FIN No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others (‘‘FIN 45’’). FIN 45 requires entities to establish liabilities for certain types of guarantees and expands ﬁnancial statement disclosures for others. The initial recognition and initial measurement provisions of FIN 45 were applicable on a prospective basis to guarantees issued or modiﬁed after December 31, 2002. The adoption of FIN 45 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. See Note 10. Effective January 1, 2003, the Company adopted SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (‘‘SFAS 146’’). SFAS 146 requires that a liability for a cost associated with an exit or disposal activity be recorded and measured initially at fair value only when the liability is incurred rather than at the date of an entity’s commitment to an exit plan as required by EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Beneﬁts and Other Costs to Exit an Activity Including Certain Costs Incurred in a Restructuring (‘‘EITF 94-3’’). The Company’s activities subject to this guidance in 2004 and 2003 were not signiﬁcant. Effective January 1, 2003, the Company adopted SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections (‘‘SFAS 145’’). In addition to amending or rescinding other existing authoritative pronouncements to make various technical corrections, clarify meanings, or describe their applicability under changed conditions, SFAS 145 generally precludes companies from recording gains and losses from the extinguishment of debt as an extraordinary item. SFAS 145 also requires sale-leaseback treatment for certain modiﬁcations of a capital lease that result in the lease being classiﬁed as an operating lease. The adoption of SFAS 145 did not have a signiﬁcant impact on the Company’s consolidated ﬁnancial statements. Effective January 1, 2002, the Company adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (‘‘SFAS 144’’). SFAS 144 provides a single model for accounting for long-lived assets to be disposed of by superseding SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of (‘‘SFAS 121’’), and the accounting and reporting provisions of APB Opinion No. 30, Reporting the Results of Operations — Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions (‘‘APB 30’’). Under SFAS 144, discontinued operations are measured at the lower of carrying value or fair value less costs to sell, rather than on a net realizable value basis. Future operating losses relating to discontinued operations also are no longer recognized before they occur. SFAS 144: (i) broadens the deﬁnition of a discontinued operation to include a component of an entity (rather than a segment of a business); (ii) requires long-lived assets to be disposed of other than by sale to be considered held and used until disposed; and (iii) retains the basic provisions of (a) APB 30 regarding the presentation of discontinued operations in the statements of income, (b) SFAS 121 relating to recognition and measurement of impaired long-lived assets (other than goodwill), and (c) SFAS 121 relating to the measurement of long-lived assets classiﬁed as held-for-sale. Adoption of SFAS 144 did not have a material impact on the Company’s consolidated ﬁnancial statements other than the presentation as discontinued operations of net investment income and net investment gains related to operations of real estate on which the Company initiated disposition activities subsequent to January 1, 2002 and the classiﬁcation of such real estate as held-for-sale on the consolidated balance sheets. Effective January 1, 2002, the Company adopted SFAS No. 142. SFAS 142 eliminates the systematic amortization and establishes criteria for measuring the impairment of goodwill and certain other intangible assets by reporting unit. There was no impairment of identiﬁed intangibles or signiﬁcant reclassiﬁcations between goodwill and other intangible assets at January 1, 2002. Amortization of other intangible assets was not material for the years ended December 31, 2004, 2003 and 2002. F-18 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 2. Investments Fixed Maturities and Equity Securities Fixed maturities and equity securities at December 31, 2004 were as follows: Cost or Amortized Cost Gross Unrealized Gain Loss (Dollars in millions) Estimated Fair Value Fixed Maturities: Bonds: U.S. treasury/agency securities ********************************************* $ 16,534 State and political subdivision securities ************************************** 3,683 U.S. corporate securities ************************************************** 58,022 Foreign government securities ********************************************** 7,637 Foreign corporate securities ************************************************ 25,341 Residential mortgage-backed securities ************************************** 31,683 Commercial mortgage-backed securities ************************************* 12,099 Asset-backed securities *************************************************** 10,784 Other ﬁxed maturity securities ********************************************** 887 Total bonds ********************************************************* Redeemable preferred stocks ********************************************** 166,670 326 Total ﬁxed maturities ************************************************** $166,996 $ 1,314 220 3,870 974 2,582 612 440 125 131 10,268 — $ 22 4 172 26 85 65 38 33 33 478 23 $ 17,826 3,899 61,720 8,585 27,838 32,230 12,501 10,876 985 176,460 303 $10,268 $501 $176,763 Equity Securities: Common stocks *********************************************************** $ Nonredeemable preferred stocks ********************************************* Total equity securities ************************************************* $ 1,412 501 1,913 $ $ 244 39 283 $ 5 3 $ 8 $ $ 1,651 537 2,188 Fixed maturities and equity securities at December 31, 2003 were as follows: Cost or Amortized Cost Gross Unrealized Gain Loss (Dollars in millions) Estimated Fair Value Fixed Maturities: Bonds: U.S. treasury/agency securities ********************************************* $ 14,707 State and political subdivision securities ************************************** 3,155 U.S. corporate securities ************************************************** 56,757 Foreign government securities ********************************************** 7,789 Foreign corporate securities ************************************************ 21,727 Residential mortgage-backed securities ************************************** 30,836 Commercial mortgage-backed securities ************************************* 10,523 Asset-backed securities *************************************************** 11,736 Other ﬁxed maturity securities ********************************************** 492 Total bonds ********************************************************* Redeemable preferred stocks ********************************************** 157,722 611 Total ﬁxed maturities ************************************************** $158,333 $ 1,264 209 3,886 1,003 2,194 720 530 187 167 10,160 2 $ 26 15 252 28 79 102 22 60 83 667 76 $ 15,945 3,349 60,391 8,764 23,842 31,454 11,031 11,863 576 167,215 537 $10,162 $743 $167,752 Equity Securities: Common stocks *********************************************************** $ Nonredeemable preferred stocks ********************************************* 613 602 Total equity securities ************************************************* $ 1,215 $ $ 327 48 375 $ 2 4 $ 6 $ $ 938 646 1,584 The Company held foreign currency derivatives with notional amounts of $4,720 million and $3,502 million to hedge the exchange rate risk associated with foreign bonds and loans at December 31, 2004 and 2003, respectively. Excluding investments in U.S. Treasury securities and obligations of U.S. government corporations and agencies, the Company is not exposed to any signiﬁcant concentration of credit risk in its ﬁxed maturities portfolio. The Company held ﬁxed maturities at estimated fair values that were below investment grade or not rated by an independent rating agency that totaled $12,370 million and $12,825 million at December 31, 2004 and 2003, respectively. These securities had a net unrealized gain of $936 million and $888 million at December 31, 2004 and 2003, respectively. Non-income producing ﬁxed maturities were $90 million and $371 million at December 31, 2004 and 2003, respectively. MetLife, Inc. F-19 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The cost or amortized cost and estimated fair value of bonds at December 31, 2004, by contractual maturity date (excluding scheduled sinking funds), are shown below: Due in one year or less **************************************************************** Due after one year through ﬁve years ***************************************************** Due after ﬁve years through ten years***************************************************** Due after ten years ******************************************************************** Subtotal ********************************************************************* Mortgage-backed and other asset-backed securities **************************************** Subtotal ********************************************************************* Redeemable preferred stock ************************************************************ Total ﬁxed maturities *********************************************************** Cost or Amortized Cost Estimated Fair Value (Dollars in millions) $ 6,751 29,850 33,543 41,960 112,104 54,566 166,670 326 $ 6,845 31,168 36,008 46,832 120,853 55,607 176,460 303 $166,996 $176,763 Bonds not due at a single maturity date have been included in the above table in the year of ﬁnal contractual maturity. Actual maturities may differ from contractual maturities due to the exercise of prepayment options. Sales or disposals of ﬁxed maturities and equity securities classiﬁed as available-for-sale were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Proceeds ******************************************************************************** $57,604 Gross investment gains ******************************************************************** $ 844 Gross investment losses ******************************************************************* $ (516) $54,801 498 $ (500) $ $37,427 $ 1,661 (979) $ Gross investment losses above exclude writedowns recorded during 2004, 2003 and 2002 for other-than-temporarily impaired available-for-sale ﬁxed maturities and equity securities of $102 million, $355 million and $1,375 million, respectively. The Company periodically disposes of ﬁxed maturity and equity securities at a loss. Generally, such losses are insigniﬁcant in amount or in relation to the cost basis of the investment or are attributable to declines in fair value occurring in the period of disposition. The following table shows the estimated fair values and gross unrealized losses of the Company’s ﬁxed maturities (aggregated by sector) and equity securities in an unrealized loss position, aggregated by length of time that the securities have been in a continuous unrealized loss position at December 31, 2004 and 2003: Less than 12 Months U.S. treasury/agency securities************ State and political subdivision securities***** U.S. corporate securities ***************** Foreign government securities ************* Foreign corporate securities*************** Residential mortgage-backed securities ***** Commercial mortgage-backed securities **** Asset-backed securities ****************** Other ﬁxed maturity securities ************* Total bonds ******************** Redeemable preferred stocks ************* Total ﬁxed maturities ************* Estimated Fair Value $ 5,014 211 9,963 899 3,979 8,545 3,920 3,927 46 36,504 303 $36,807 Equity securities ************************ $ 136 Total number of securities in an unrealized loss position ******** 4,208 Gross Unrealized Loss $ 22 2 120 21 71 58 33 25 33 385 23 $408 $ 6 December 31, 2004 Equal to or Greater than 12 Months Estimated Fair Value Gross Unrealized Loss (Dollars in millions) $ — 2 52 5 14 7 5 8 — 93 — $ 93 $ 2 $ 4 72 1,211 117 456 375 225 209 26 2,695 — $2,695 $ 27 402 Total Gross Unrealized Loss $ 22 4 172 26 85 65 38 33 33 478 23 $501 $ 8 Estimated Fair Value $ 5,018 283 11,174 1,016 4,435 8,920 4,145 4,136 72 39,199 303 $39,502 $ 163 4,610 F-20 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Less than 12 Months U.S. treasury/agency securities************ State and political subdivision securities***** U.S. corporate securities ***************** Foreign government securities ************* Foreign corporate securities*************** Residential mortgage-backed securities ***** Commercial mortgage-backed securities **** Asset-backed securities ****************** Other ﬁxed maturity securities ************* Total bonds ******************** Redeemable preferred stocks ************* Total ﬁxed maturities ************* Estimated Fair Value $ 3,697 389 7,214 331 2,583 8,372 2,449 2,555 130 27,720 222 $27,942 Equity securities ************************ $ 53 Securities Lending Program Gross Unrealized Loss $ 26 12 152 28 65 98 20 34 73 508 62 $570 $ 6 December 31, 2003 Equal to or Greater than 12 Months Estimated Fair Value Gross Unrealized Loss (Dollars in millions) $ — 38 1,056 2 355 27 282 861 40 2,661 278 $2,939 $ 22 $ — 3 100 — 14 4 2 26 10 159 14 $173 $ — Total Gross Unrealized Loss $ 26 15 252 28 79 102 22 60 83 667 76 $743 $ 6 Estimated Fair Value $ 3,697 427 8,270 333 2,938 8,399 2,731 3,416 170 30,381 500 $30,881 $ 75 The Company participates in a securities lending program whereby blocks of securities, which are included in investments, are loaned to third parties, primarily major brokerage ﬁrms. The Company requires a minimum of 102% of the fair value of the loaned securities to be separately maintained as collateral for the loans. Securities with a cost or amortized cost of $26,564 million and $25,121 million and an estimated fair value of $27,974 million and $26,387 million were on loan under the program at December 31, 2004 and 2003, respectively. The Company was liable for cash collateral under its control of $28,678 million and $27,083 million at December 31, 2004 and 2003, respectively. Security collateral on deposit from customers may not be sold or repledged and is not reﬂected in the consolidated ﬁnancial statements. Assets on Deposit and Held in Trust The Company had investment assets on deposit with regulatory agencies with a fair market value of $1,391 million and $1,353 million at December 31, 2004 and 2003, respectively. Company securities held in trust to satisfy collateral requirements had an amortized cost of $2,473 million and $2,276 million at December 31, 2004 and 2003, respectively. Mortgage and Other Loans Mortgage and other loans were categorized as follows: December 31, 2004 2003 Amount Percent Amount Percent Commercial mortgage loans********************************************************* $25,139 Agricultural mortgage loans********************************************************** 5,914 Other loans*********************************************************************** 1,510 Total ******************************************************************** 32,563 (Dollars in millions) 77% $20,422 5,333 18 623 5 78% 20 2 100% 26,378 100% Less: Valuation allowances ********************************************************** 157 Mortgage and other loans ************************************************** $32,406 129 $26,249 Mortgage loans are collateralized by properties primarily located throughout the United States. At December 31, 2004, approximately 21%, 11% and 7% of the properties were located in California, New York and Florida, respectively. Generally, the Company (as the lender) requires that a minimum of one-fourth of the purchase price of the underlying real estate be paid by the borrower. Certain of the Company’s real estate joint ventures have mortgage loans with the Company. The carrying values of such mortgages were $641 million and $639 million at December 31, 2004 and 2003, respectively. Changes in loan valuation allowances for mortgage and other loans were as follows: Balance, beginning of year************************************************************************ $129 Additions ************************************************************************************** 57 Deductions************************************************************************************* (29) Balance, end of year***************************************************************************** $157 $126 52 (49) $129 $144 41 (59) $126 Years Ended December 31, 2004 2003 2002 (Dollars in millions) MetLife, Inc. F-21 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. A portion of the Company’s mortgage and other loans was impaired and consisted of the following: December 31, 2004 2003 (Dollars in millions) Impaired loans with valuation allowances****************************************************************** $185 Impaired loans without valuation allowances *************************************************************** 133 Total **************************************************************************************** Less: Valuation allowances on impaired loans ************************************************************* 318 41 Impaired loans ******************************************************************************* $277 $296 165 461 62 $399 The average investment in impaired loans was $404 million, $652 million and $1,088 million for the years ended December 31, 2004, 2003 and 2002, respectively. Interest income on impaired loans was $29 million, $58 million and $91 million for the years ended December 31, 2004, 2003 and 2002, respectively. The investment in restructured loans was $125 million and $191 million at December 31, 2004 and 2003, respectively. Interest income of $9 million, $19 million and $44 million was recognized on restructured loans for the years ended December 31, 2004, 2003 and 2002, respectively. Gross interest income that would have been recorded in accordance with the original terms of such loans amounted to $12 million, $24 million and $41 million for the years ended December 31, 2004, 2003 and 2002, respectively. Mortgage and other loans with scheduled payments of 60 days (90 days for agricultural mortgages) or more past due or in foreclosure had an amortized cost of $58 million and $51 million at December 31, 2004 and 2003, respectively. Real Estate and Real Estate Joint Ventures Real estate and real estate joint ventures consisted of the following: December 31, 2004 2003 (Dollars in millions) Real estate and real estate joint ventures held-for-investment **************************************** $4,105 Impairments ********************************************************************************* (124) Total *********************************************************************************** Real estate held-for-sale *********************************************************************** Impairments ********************************************************************************* Valuation allowance *************************************************************************** Total *********************************************************************************** 252 Real estate and real estate joint ventures ************************************************* $4,233 262 (6) (4) 3,981 $3,639 (132) 3,507 1,333 (151) (12) 1,170 $4,677 Accumulated depreciation on real estate was $2,005 million and $1,955 million at December 31, 2004 and 2003, respectively. Related depreciation expense was $179 million, $183 million and $227 million for the years ended December 31, 2004, 2003 and 2002, respectively. These amounts include $17 million, $39 million and $83 million of depreciation expense related to discontinued operations for the years ended December 31, 2004, 2003 and 2002, respectively. Real estate and real estate joint ventures were categorized as follows: 2004 Amount Ofﬁce *************************************************************************** $2,297 Retail**************************************************************************** 558 Apartments*********************************************************************** 918 Land **************************************************************************** 56 Agriculture *********************************************************************** 1 Other**************************************************************************** 403 Total ******************************************************************** $4,233 December 31, Percent (Dollars in millions) Amount 54% 13 22 1 — 10 $2,775 667 858 81 1 295 2003 Percent 59% 14 18 3 — 6 100% $4,677 100% The Company’s real estate holdings are primarily located throughout the United States. At December 31, 2004, approximately 31%, 21% and 19% of the Company’s real estate holdings were located in New York, California and Texas, respectively. F-22 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Changes in real estate and real estate joint ventures held-for-sale valuation allowance were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance, beginning of year************************************************************************** $ 12 Additions **************************************************************************************** 13 Deductions*************************************************************************************** (21) Balance, end of year ****************************************************************************** $ 4 $ 11 17 (16) $ 12 $ 35 21 (45) $ 11 Investment income related to impaired real estate and real estate joint ventures held-for-investment was $15 million, $34 million and $49 million for the years ended December 31, 2004, 2003 and 2002, respectively. Investment (expense) income related to impaired real estate and real estate joint ventures held-for-sale was ($1) million, $1 million, and $2 million for the years ended December 31, 2004, 2003 and 2002, respectively. The carrying value of non-income producing real estate and real estate joint ventures was $41 million and $77 million at December 31, 2004 and 2003, respectively. The Company owned real estate acquired in satisfaction of debt of $4 million and $3 million at December 31, 2004 and 2003, respectively. Leveraged Leases Leveraged leases, included in other invested assets, consisted of the following: December 31, 2004 2003 (Dollars in millions) Investment ********************************************************************************** $1,059 Estimated residual values ********************************************************************** 480 Total *********************************************************************************** Unearned income **************************************************************************** 1,539 (424) Leveraged leases ************************************************************************ $1,115 $ 974 386 1,360 (380) $ 980 The investment amounts set forth above are generally due in monthly installments. The payment periods generally range from one to 15 years, but in certain circumstances are as long as 30 years. These receivables are generally collateralized by the related property. The Company’s deferred income tax liability related to leveraged leases was $757 million and $870 million at December 31, 2004 and 2003, respectively. Funds Withheld at Interest Included in other invested assets at December 31, 2004 and 2003, were funds withheld at interest of $2,801 million and $2,939 million, respectively. Net Investment Income The components of net investment income were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Fixed maturities ******************************************************************* $ 9,431 Equity securities ****************************************************************** 80 Mortgage and other loans ********************************************************** 1,963 Real estate and real estate joint ventures ********************************************* 953 Policy loans ********************************************************************** 541 Other limited partnership interests**************************************************** 324 Cash, cash equivalents and short-term investments ************************************ 167 Other *************************************************************************** 124 Total ************************************************************************ Less: Investment expenses ********************************************************* 13,583 1,165 Net investment income **************************************************** $12,418 $ 8,817 31 1,903 866 554 80 171 142 12,564 1,025 $ 8,367 43 1,883 898 543 57 252 129 12,172 989 $11,539 $11,183 MetLife, Inc. F-23 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Net Investment Gains (Losses) Net investment gains (losses) were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Fixed maturities ************************************************************************** $ 71 Equity securities ************************************************************************* 155 Mortgage and other loans ***************************************************************** (47) Real estate and real estate joint ventures **************************************************** 23 Other limited partnership interests ********************************************************** 53 Sales of businesses ********************************************************************** 23 Derivatives ****************************************************************************** (255) Other ********************************************************************************** 159 Total net investment gains (losses) ************************************************** $ 182 $(398) 41 (56) 19 (84) — (134) 30 $(917) 224 (22) (6) (2) — (140) (29) $(582) $(892) Net Unrealized Investment Gains The components of net unrealized investment gains, included in accumulated other comprehensive income, were as follows: Fixed maturities ***************************************************************************** $ 9,602 Equity securities **************************************************************************** 287 Derivatives ********************************************************************************* (503) Other invested assets *********************************************************************** (65) Total ********************************************************************************** 9,321 $ 9,204 376 (427) (33) $ 7,360 57 (24) 16 9,120 7,409 Amounts allocated from: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Future policy beneﬁt loss recognition ********************************************************* Deferred policy acquisition costs ************************************************************ Participating contracts ********************************************************************* Policyholder dividend obligation ************************************************************* Total ********************************************************************************** Deferred income taxes*********************************************************************** Total ********************************************************************************** (1,991) (541) — (2,119) (1,482) (674) (183) (2,130) (1,269) (559) (153) (1,882) (4,651) (4,469) (3,863) (1,676) (1,679) (1,264) (6,327) Net unrealized investment gains (losses) ************************************************ $ 2,994 (6,148) (5,127) $ 2,972 $ 2,282 The changes in net unrealized investment gains were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance, beginning of year ******************************************************************** $2,972 Unrealized investment gains (losses) during the year *********************************************** 201 Unrealized investment gains (losses) relating to: Future policy beneﬁt gains (losses) recognition ************************************************** (509) Deferred policy acquisition costs ************************************************************* 133 Participating contracts ********************************************************************** 183 Policyholder dividend obligation ************************************************************** 11 Deferred income taxes************************************************************************ 3 Balance, end of year ************************************************************************* $2,994 $2,282 1,711 $ 1,879 3,565 (213) (115) (30) (248) (415) (1,239) (538) (26) (1,174) (185) $2,972 $ 2,282 Net change in unrealized investment gains (losses) ************************************************ $ 22 $ 690 $ 403 Structured Investment Transactions The Company securitizes high yield debt securities, investment grade bonds and structured ﬁnance securities. The Company has sponsored four securitizations with a total of approximately $1,341 million and $1,431 million in ﬁnancial assets as of December 31, 2004 and 2003, respectively. The Company’s beneﬁcial interests in these SPEs as of December 31, 2004 and 2003 and the related investment income for the years ended December 31, 2004, 2003 and 2002 were insigniﬁcant. The Company invests in structured notes and similar type instruments, which generally provide equity-based returns on debt securities. The carrying value of such investments was approximately $666 million and $880 million at December 31, 2004 and 2003, respectively. The related net investment income recognized was $45 million, $78 million and $1 million for the years ended December 31, 2004, 2003 and 2002, respectively. F-24 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Variable Interest Entities As discussed in Note 1, the Company has adopted the provisions of FIN 46 and FIN 46(r). The adoption of FIN 46(r) required the Company to consolidate certain VIEs for which it is the primary beneﬁciary. The following table presents the total assets of and maximum exposure to loss relating to VIEs for which the Company has concluded that (i) it is the primary beneﬁciary and which are consolidated in the Company’s consolidated ﬁnancial statements at December 31, 2004, and (ii) it holds signiﬁcant variable interests but it is not the primary beneﬁciary and which have not been consolidated: December 31, 2004 Primary Beneﬁciary Not Primary Beneﬁciary Total Assets(1) Maximum Exposure to Loss(2) Total Assets(1) Maximum Exposure to Loss(2) Asset-backed securitizations and collateralized debt obligations ************************** Real estate joint ventures(3) ******************************************************** Other limited partnerships(4)******************************************************** Other structured investments(5) ***************************************************** Total *************************************************************************** $ — 15 249 — $264 (Dollars in millions) $ — 13 191 — $204 $1,418 132 914 856 $3,320 $ 3 — 146 103 $252 (1) The assets of the asset-backed securitizations and collateralized debt obligations are reﬂected at fair value at December 31, 2004. The assets of the real estate joint ventures, other limited partnerships and other structured investments are reﬂected at the carrying amounts at which such assets would have been reﬂected on the Company’s balance sheet had the Company consolidated the VIE from the date of its initial investment in the entity. (2) The maximum exposure to loss of the asset-backed securitizations and collateralized debt obligations is equal to the carrying amounts of retained interests. In addition, the Company provides collateral management services for certain of these structures for which it collects a management fee. The maximum exposure to loss relating to real estate joint ventures, other limited partnerships and other structured investments is equal to the carrying amounts plus any unfunded commitments, reduced by amounts guaranteed by other partners. (3) Real estate joint ventures include partnerships and other ventures, which engage in the acquisition, development, management and disposal of real estate investments. (4) Other limited partnerships include partnerships established for the purpose of investing in real estate funds, public and private debt and equity securities, as well as limited partnerships established for the purpose of investing in low-income housing that qualiﬁes for federal tax credits. (5) Other structured investments include an offering of a collateralized fund of funds based on the securitization of a pool of private equity funds. 3. Derivative Financial Instruments Types of Derivative Instruments The following table provides a summary of the notional amounts and fair value of derivative ﬁnancial instruments held at: December 31, 2004 December 31, 2003 Notional Amount Current Market or Fair Value Assets Liabilities Notional Amount Current Market or Fair Value Assets Liabilities Interest rate swaps **************************************************** $12,681 $284 Interest rate ﬂoors ***************************************************** 38 Interest rate caps ***************************************************** 12 Financial futures ****************************************************** — Foreign currency swaps************************************************ 150 Foreign currency forwards ********************************************** 5 Options ************************************************************* 37 Financial forwards ***************************************************** — Credit default swaps ************************************************** 11 Synthetic GICs ******************************************************* — Other *************************************************************** 1 Total ************************************************************ $42,256 $538 3,325 7,045 611 8,214 1,013 825 326 1,897 5,869 450 (Dollars in millions) $ 22 — — 13 1,302 57 7 — 5 — 1 $ 9,944 $189 5 29 8 9 5 7 2 2 — — 325 9,345 1,348 4,710 695 6,065 1,310 615 5,177 — $1,407 $39,534 $256 $ 36 — — 30 796 32 — 3 1 — — $898 MetLife, Inc. F-25 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The following table provides a summary of the notional amounts of derivative ﬁnancial instruments by maturity at December 31, 2004: Interest rate swaps*************************************************** Interest rate ﬂoors**************************************************** Interest rate caps **************************************************** Financial futures ***************************************************** Foreign currency swaps ********************************************** Foreign currency forwards********************************************* Options ************************************************************ Financial forwards**************************************************** Credit default swaps ************************************************* Synthetic GICs ****************************************************** Other ************************************************************** Total *********************************************************** Remaining Life After One Year Through Five Years After Five Years Through Ten Years (Dollars in millions) $ 6,846 — 5,020 — 3,425 — — — 1,217 1,000 — $ 2,098 3,325 — — 3,155 — 256 — 379 3,869 — One Year or Less $1,878 — 2,025 611 277 1,013 6 326 301 1,000 450 After Ten Years Total $1,859 — — — 1,357 — 563 — — — — $12,681 3,325 7,045 611 8,214 1,013 825 326 1,897 5,869 450 $7,887 $17,508 $13,082 $3,779 $42,256 Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at speciﬁed intervals, the difference between ﬁxed rate and ﬂoating rate interest amounts as calculated by reference to an agreed notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate caps and ﬂoors are used by the Company primarily to protect its ﬂoating rate liabilities against rises in interest rates above a speciﬁed level, and to protect its minimum rate guarantee liabilities against declines in interest rates below a speciﬁed level, respectively. In exchange-traded Treasury and equity futures transactions, the Company agrees to purchase or sell a speciﬁed number of contracts, the value of which is determined by the different classes of Treasury and equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchanges. Exchange-traded Treasury futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury performance. The value of Treasury futures is substantially impacted by changes in interest rates and they can be used to modify or hedge existing interest rate risk. Exchange-traded equity futures are used primarily to hedge liabilities embedded in certain variable annuity products offered by the Company. Foreign currency derivatives, including foreign currency swaps and foreign currency forwards, are used by the Company to reduce the risk from ﬂuctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. The Company also uses foreign currency forwards to hedge the foreign currency risk associated with certain of its net investments in foreign operations. In a foreign currency forward transaction, the Company agrees with another party to deliver a speciﬁed amount of an identiﬁed currency at a speciﬁed future date. The price is agreed upon at the time of the contract and payment for such a contract is made in a different currency at the speciﬁed future date. In a foreign currency swap transaction, the Company agrees with another party to exchange, at speciﬁed intervals, the difference between one currency and another at a forward exchange rate calculated by reference to an agreed upon principal amount. The principal amount of each currency is exchanged at the inception and termination of the currency swap by each party. Swaptions are used by the Company primarily to sell, or monetize, embedded call options in its ﬁxed rate liabilities. A swaption is an option to enter into a swap with an effective date equal to the exercise date of the embedded call and a maturity date equal to the maturity date of the underlying liability. The Company receives a premium for entering into the swaption. Equity options are used by the Company primarily to hedge liabilities embedded in certain variable annuity products offered by the Company. The Company enters into ﬁnancial forwards, primarily ‘‘to-be-announced’’ (‘‘TBA’’) securities, to gain exposure to the investment risk and return of securities not yet available. The price is agreed upon at the time of the contract and payment for such a contract is made at a speciﬁed future date. Certain credit default swaps are used by the Company to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party, at speciﬁed intervals, to pay a premium to insure credit risk. If a credit event, as deﬁned by the contract, occurs, generally the contract will require the swap to be settled gross by the delivery of par quantities of the referenced investment equal to the speciﬁed swap notional in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit default swaps are also used in replication synthetic asset transactions (‘‘RSATs’’) to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. RSATs are a combination of a derivative and usually a U.S. Treasury or Agency security. RSATs that involve the use of credit default swaps are included in such classiﬁcation in the preceding table. Total rate of return swaps (‘‘TRRs’’) are swaps whereby the Company agrees with another party to exchange, at speciﬁed intervals, the difference between the economic risk and reward of an asset or a market index and LIBOR, calculated by reference to an agreed notional principal amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. TRRs can be used as hedges or RSATs and are included in the other classiﬁcation in the preceding table. F-26 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. A synthetic guaranteed investment contract (‘‘GIC’’) is a contract that simulates the performance of a traditional GIC through the use of ﬁnancial instruments. Under a synthetic GIC, the policyholder owns the underlying assets. The Company guarantees a rate return on those assets for a premium. Hedging The table below provides a summary of the notional amount and fair value of derivatives by type of hedge designation at: December 31, 2004 December 31, 2003 Notional Amount Fair Value Assets Liabilities Notional Amount Fair Value Assets Liabilities (Dollars in millions) Fair value ************************************************************ $ 4,879 $173 Cash ﬂow *********************************************************** 41 Foreign operations **************************************************** — Non qualifying ******************************************************** 324 Total ******************************************************** $42,256 $538 8,787 535 28,055 $ 234 689 47 437 $ 4,027 $ 27 59 — 170 13,173 527 21,807 $1,407 $39,534 $256 $297 449 10 142 $898 The following table provides the settlement payments recorded in income for the: Qualifying hedges: Net investment income ****************************************************************************** $(147) $(63) $ 9 Interest credited to policyholder account balances ******************************************************* 45 — — Non-qualifying hedges: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Net investment gains (losses) ************************************************************************* 32 Total**************************************************************************************** $ (51) $ 21 $41 84 51 Fair Value Hedges The Company designates and accounts for the following as fair value hedges when they have met the requirements of SFAS 133: (i) interest rate swaps to convert ﬁxed rate investments to ﬂoating rate investments; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated investments and liabilities; and (iii) treasury futures to hedge against changes in value of ﬁxed rate securities. The Company recognized Net investment gains (losses) representing the ineffective portion of all fair value hedges as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Changes in the fair value of derivatives ***************************************************************** $ 200 $(191) $(30) Changes in the fair value of the items hedged *********************************************************** 34 Net ineffectiveness of fair value hedging activities********************************************************* $ 49 $ (32) $ 4 (151) 159 All components of each derivative’s gain or loss were included in the assessment of hedge ineffectiveness. There were no instances in which the Company discontinued fair value hedge accounting due to a hedged ﬁrm commitment no longer qualifying as a fair value hedge. Cash Flow Hedges The Company designates and accounts for the following as cash ﬂow hedges, when they have met the requirements of SFAS 133: (i) interest rate swaps to convert ﬂoating rate investments to ﬁxed rate investments; (ii) interest rate swaps to convert ﬂoating rate liabilities into ﬁxed rate liabilities; (iii) foreign currency swaps to hedge the foreign currency cash ﬂow exposure of foreign currency denominated investments and liabilities; (iv) treasury futures to hedge against changes in value of securities to be acquired; (v) treasury futures to hedge against changes in interest rates on liabilities to be issued; and (vi) ﬁnancial forwards to gain exposure to the investment risk and return of securities not yet available. For the years ended December 31, 2004, 2003 and 2002, the Company recognized Net investment gains (losses) of ($19) million, ($69) million, and ($3) million, respectively, which represented the ineffective portion of all cash ﬂow hedges. All components of each derivative’s gains or loss were included in the assessment of hedge ineffectiveness. There were no instances in which the Company discontinued cash ﬂow hedge accounting because the forecasted transactions did not occur on the anticipated date or in the additional time period permitted by SFAS 133. There were no hedged forecasted transactions, other than the receipt or payment of variable interest payments. MetLife, Inc. F-27 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Presented below is a roll forward of the components of Other comprehensive income (loss), before income taxes, related to cash ﬂow hedges: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Other comprehensive income (loss) balance at the beginning of the year************************************ $(417) $ (24) $ 71 Gains (losses) deferred in other comprehensive income (loss) on the effective portion of cash ﬂow hedges ******* (142) Amounts reclassiﬁed to net investment income ********************************************************* 57 Amortization of transition adjustment ****************************************************************** (10) Other comprehensive income (losses) balance at the end of the year ************************************** $(456) $(417) $ (24) (387) 2 (8) (34) 2 (7) At December 31, 2004, approximately $34 million of the deferred net gains on derivatives accumulated in Other comprehensive income (loss) are expected to be reclassiﬁed to earnings during the year ending December 31, 2005. Hedges of Net Investments in Foreign Operations The Company uses forward exchange contracts to hedge portions of its net investment in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness based upon the change in forward rates. There was no ineffectiveness recorded in 2004, 2003 or 2002. For the years ended December 31, 2004 and 2003, the Company recorded net unrealized foreign currency losses of $47 million and $10 million, respectively, in Other comprehensive income (loss) related to hedges of its net investments in foreign operations. For the year ended December 31, 2004, the Company recorded a foreign currency translation loss of $10 million, in Other comprehensive income (loss) related to the disposal of certain hedges of net investments in foreign operations. There were no disposals of such hedges for the year ended December 31, 2003. Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging The Company enters into the following derivatives that do not qualify for hedge accounting under SFAS 133 or for purposes other than hedging: (i) interest rate swaps, purchased caps and ﬂoors, and Treasury futures to minimize its exposure to interest rate volatility; (ii) foreign currency forwards and swaps to minimize its exposure to adverse movements in exchange rates; (iii) swaptions to sell embedded call options in ﬁxed rate liabilities; (iv) credit default swaps to minimize its exposure to adverse movements in credit; (v) equity futures and equity options to economically hedge liabilities embedded in certain variable annuity products; (vi) synthetic GICs to synthetically create traditional GICs; and (vii) RSATs and TRRs to synthetically create investments. For the years ended December 31, 2004, 2003 and 2002, the Company recognized as Net investment gains (losses) changes in fair value of ($177) million, ($114) million and ($172) million, respectively, related to derivatives that do not qualify for hedge accounting. Embedded Derivatives The Company has certain embedded derivatives which are required to be separated from their host contracts and accounted for as derivatives. These host contracts include guaranteed rate of return contracts, guaranteed minimum withdrawal beneﬁt contracts and modiﬁed coinsurance contracts. The fair value of the Company’s embedded derivative assets was $46 million and $43 million at December 31, 2004 and 2003, respectively. The fair value of the Company’s embedded derivative liabilities was $26 million and $33 million at December 31, 2004 and 2003, respectively. The amounts recorded to Net investment gains (losses) during the years ended December 31, 2004 and 2003 were gains of $37 million and $19 million, respectively. There were no amounts recorded to Net investment gains (losses) during the year ended December 31, 2002 related to embedded derivatives. Credit Risk The Company may be exposed to credit related losses in the event of nonperformance by counterparties to derivative ﬁnancial instruments. Generally, the current credit exposure of the Company’s derivative contracts is limited to the fair value at the reporting date. The credit exposure of the Company’s derivative transactions is represented by the fair value of contracts with a net positive fair value at the reporting date. Because exchange traded futures and options are effected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit related losses in the event of nonperformance by counterparties to such derivative ﬁnancial instruments. The Company manages its credit risk by entering into derivative transactions with creditworthy counterparties. In addition, the Company enters into over-the-counter derivatives pursuant to master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. Likewise, the Company effects exchange traded futures and options through regulated exchanges and these positions are marked to market and margined on a daily basis. F-28 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 4. Insurance Deferred Policy Acquisition Costs Information regarding VOBA and DAC for the years ended December 31, 2002, 2003 and 2004 is as follows: Value of Business Acquired Deferred Policy Acquisition Costs (Dollars in millions) Total Balance at January 1, 2002*************************************************************** $1,678 Capitalizations ************************************************************************** — Acquisitions **************************************************************************** 369 Total ****************************************************************************** 2,047 $ 9,489 2,340 — $11,167 2,340 369 11,829 13,876 Amortization related to: Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Dispositions and other ******************************************************************* Balance at December 31, 2002 *********************************************************** Capitalizations ************************************************************************** Acquisitions **************************************************************************** Total ****************************************************************************** Amortization related to: Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Dispositions and other ******************************************************************* Balance at December 31, 2003 *********************************************************** Capitalizations ************************************************************************** Acquisitions **************************************************************************** Total ****************************************************************************** Amortization related to: 16 154 132 302 (6) 1,739 — 40 1,779 (7) (31) 162 124 2 (11) 384 1,507 1,880 39 9,988 2,792 218 12,998 (24) 146 1,656 1,778 66 5 538 1,639 2,182 33 11,727 2,792 258 14,777 (31) 115 1,818 1,902 68 1,657 11,286 12,943 — 6 3,101 — 3,101 6 1,663 14,387 16,050 Net investment gains (losses) *********************************************************** Unrealized investment gains (losses) ****************************************************** Other expenses *********************************************************************** Total amortization ******************************************************************** Dispositions and other ******************************************************************* (27) Balance at December 31, 2004 *********************************************************** $1,584 4 (92) 140 52 7 (41) 1,754 1,720 85 11 (133) 1,894 1,772 58 $12,752 $14,336 The estimated future amortization expense allocated to other expenses for VOBA is $137 million in 2005, $130 million in 2006, $124 million in 2007, $119 million in 2008 and $117 million in 2009. Amortization of VOBA and DAC is related to (i) investment gains and losses and the impact of such gains and losses on the amount of the amortization, (ii) unrealized investment gains and losses to provide information regarding the amount that would have been amortized if such gains and losses had been recognized, and (iii) other expenses to provide amounts related to the gross margins or proﬁts originating from transactions other than investment gains and losses. Sales Inducements Changes in deferred sales inducements are as follows: Balance at January 1, 2004 ****************************************************************************** Capitalization ******************************************************************************************* Amortization******************************************************************************************** Balance at December 31, 2004 *************************************************************************** $196 121 (23) $294 Sales Inducements (Dollars in millions) MetLife, Inc. F-29 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Liabilities for Unpaid Claims and Claim Expenses The following table provides an analysis of the activity in the liability for unpaid claims and claim expenses relating to property and casualty, group accident and non-medical health policies and contracts: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance at January 1 ********************************************************************** $ 5,412 (525) Reinsurance recoverables **************************************************************** Net balance at January 1 ****************************************************************** $ 4,885 (498) $ 4,597 (457) 4,887 4,387 4,140 Incurred related to: Current year *************************************************************************** Prior years ***************************************************************************** Paid related to: Current year *************************************************************************** Prior years ***************************************************************************** 4,591 (29) 4,562 (2,717) (1,394) (4,111) Net Balance at December 31 *************************************************************** Add: Reinsurance recoverables *********************************************************** 5,338 486 Balance at December 31 ****************************************************************** $ 5,824 4,483 45 4,528 (2,676) (1,352) (4,028) 4,887 525 4,219 (81) 4,138 (2,559) (1,332) (3,891) 4,387 498 $ 5,412 $ 4,885 Guarantees The Company issues annuity contracts which may include contractual guarantees to the contractholder for: (i) return of no less than total deposits made to the contract less any partial withdrawals (‘‘return of net deposits’’) and (ii) the highest contract value on a speciﬁed anniversary date minus any withdrawals following the contract anniversary, or total deposits made to the contract less any partial withdrawals plus a minimum return (‘‘anniversary contract value’’ or ‘‘minimum return’’). The Company also issues annuity contracts that apply a lower rate of funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize (‘‘two tier annuities’’). These guarantees include beneﬁts that are payable in the event of death or at annuitization. The Company also issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid up beneﬁt. The Company had the following types of guarantees relating to annuity and universal and variable life contracts at: Annuity Contracts RETURN OF NET DEPOSITS Separate account value *********************************************************************** Net amount at risk **************************************************************************** Average attained age of contractholders ********************************************************** ANNIVERSARY CONTRACT VALUE OR MINIMUM RETURN Separate account value *********************************************************************** Net amount at risk **************************************************************************** Average attained age of contractholders ********************************************************** TWO TIER ANNUITIES General account value ************************************************************************ Net amount at risk **************************************************************************** Average attained age of contractholders ********************************************************** Universal and Variable Life Contracts December 31, 2004 In the Event of Death At Annuitization (Dollars in millions) $ 6,925 $ 60 years 22(1) N/A N/A N/A $ 43,414 $ 61 years 990(1) $ 14,297 $ 58 years 51(2) N/A N/A N/A 301 $ $ 58 years 36(3) Account value (general and separate account) ******************************************************* $ 4,715 Net amount at risk ****************************************************************************** $ 94,163(1) Average attained age of policyholders ************************************************************** 45 years $ 4,570 $ 42,318(1) 52 years (1) The net amount at risk for guarantees of amounts in the event of death is deﬁned as the current guaranteed minimum death beneﬁt in excess of the current account balance at the balance sheet date. December 31, 2004 Secondary Guarantees Paid Up Guarantees (Dollars in millions) F-30 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. (2) The net amount at risk for guarantees of amounts at annuitization is deﬁned as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. (3) The net amount at risk for two tier annuities is based on the excess of the upper tier, adjusted for a proﬁt margin, less the lower tier. The net amount at risk is based on the direct amount at risk (excluding reinsurance). The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive. Liabilities for guarantees (excluding base policy liabilities) relating to annuity and universal and variable life contracts are as follows: Annuity Contracts Guaranteed Death Beneﬁts Guaranteed Annuitization Beneﬁts Universal and Variable Life Contracts Secondary Guarantees Paid Up Guarantees (Dollars in millions) Balance at January 1, 2004 *********************************** Incurred guaranteed beneﬁts *********************************** Paid guaranteed beneﬁts ************************************** Balance at December 31, 2004 ******************************** $ 9 23 (8) $24 $17 2 — $19 $ 6 4 (4) $ 6 $25 4 — $29 Account balances of contracts with insurance guarantees are invested in separate account asset classes as follows at: Total $ 57 33 (12) $ 78 December 31, 2004 (Dollars in millions) Mutual Fund Groupings Equity*********************************************************************************************** Bond *********************************************************************************************** Balanced ******************************************************************************************** Money Market**************************************************************************************** Specialty ******************************************************************************************** Total ********************************************************************************************** $31,829 3,621 1,730 383 245 $37,808 Separate Accounts Separate account assets and liabilities include two categories of account types: pass-through separate accounts totaling $71,623 million and $59,278 million at December 31, 2004 and 2003, respectively, for which the policyholder assumes all investment risk, and separate accounts with a minimum return or account value for which the Company contractually guarantees either a minimum return or account value to the policyholder which totaled $15,146 million and $16,478 million at December 31, 2004 and 2003, respectively. The latter category consisted primarily of Met Managed Guaranteed Interest Contracts and participating close-out contracts. The average interest rates credited on these contracts were 4.7% and 4.5% at December 31, 2004 and 2003, respectively. Fees charged to the separate accounts by the Company (including mortality charges, policy administration fees and surrender charges) are reﬂected in the Company’s revenues as universal life and investment-type product policy fees and totaled $843 million, $626 million and $542 million for the years ended December 31, 2004, 2003 and 2002, respectively. At December 31, 2004, ﬁxed maturities, equity securities, and cash and cash equivalents reported on the consolidated balance sheet include $47 million, $20 million and $2 million, respectively, of the Company’s proportional interest in separate accounts. For the year ended December 31, 2004, there were no investment gains (losses) on transfers of assets from the general account to the separate accounts. 5. Reinsurance The Company’s life insurance operations participate in reinsurance activities in order to limit losses, minimize exposure to large risks, and to provide additional capacity for future growth. The Company currently reinsures up to 90% of the mortality risk for all new individual life insurance policies that it writes through its various franchises. This practice was initiated by different franchises for different products starting at various points in time between 1992 and 2000. The Company retains up to $25 million on single life policies and $30 million on survivorship policies and reinsures 100% of amounts in excess of the Company’s retention limits. The Company reinsures a portion of the mortality risk on its universal life policies. The Company reinsures its business through a diversiﬁed group of reinsurers. Placement of reinsurance is done primarily on an automatic basis and also on a facultative basis for risks of speciﬁc characteristics. The Company is contingently liable with respect to ceded reinsurance should any reinsurer be unable to meet its obligations under these agreements. In addition to reinsuring mortality risk, the Company reinsures other risks and speciﬁc coverages. The Company routinely reinsures certain classes of risks in order to limit its exposure to particular travel, avocation and lifestyle hazards. The Company has exposure to catastrophes, which are an inherent risk of the property and casualty business and could contribute to signiﬁcant ﬂuctuations in the Company’s results of operations. The Company uses excess of loss and quota share reinsurance arrangements to limit its maximum loss, provide greater diversiﬁcation of risk and minimize exposure to larger risks. The Company has also protected itself through the purchase of combination risk coverage. This reinsurance coverage pools risks from several lines of business and includes individual and group life claims in excess of $2 million per policy, as well as excess property and casualty losses, among others. In the Reinsurance Segment, Reinsurance Group of America, Incorporated (‘‘RGA’’), retains a maximum of $6 million of coverage per individual life with respect to its assumed reinsurance business. See Note 10 for information regarding certain excess of loss reinsurance agreements providing coverage for risks associated primarily with sales practices claims. MetLife, Inc. F-31 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The amounts in the consolidated statements of income are presented net of reinsurance ceded. The effects of reinsurance were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Direct premiums ************************************************************************ $20,237 Reinsurance assumed ******************************************************************* 4,492 Reinsurance ceded ********************************************************************* (2,413) Net premiums ************************************************************************** $22,316 $19,396 3,706 (2,429) $18,439 2,993 (2,355) $20,673 $19,077 Reinsurance recoveries netted against policyholder beneﬁts ************************************ $ 2,046 $ 2,417 $ 2,886 Reinsurance recoverables, included in premiums and other receivables, were $3,965 million and $4,014 million at December 31, 2004 and 2003, respectively, including $1,302 million and $1,341 million, respectively, relating to reinsurance of long-term guaranteed interest contracts and structured settlement lump sum contracts accounted for as a ﬁnancing transaction. Reinsurance and ceded commissions payables, included in other liabilities, were $78 million and $106 million at December 31, 2004 and 2003, respectively. 6. Closed Block On April 7, 2000 (the ‘‘date of demutualization’’), Metropolitan Life established a closed block for the beneﬁt of holders of certain individual life insurance policies of Metropolitan Life. Assets have been allocated to the closed block in an amount that has been determined to produce cash ﬂows which, together with anticipated revenues from the policies included in the closed block, are reasonably expected to be sufﬁcient to support obligations and liabilities relating to these policies, including, but not limited to, provisions for the payment of claims and certain expenses and taxes, and to provide for the continuation of policyholder dividend scales in effect for 1999, if the experience underlying such dividend scales continues, and for appropriate adjustments in such scales if the experience changes. At least annually, the Company compares actual and projected experience against the experience assumed in the then-current dividend scales. Dividend scales are adjusted periodically to give effect to changes in experience. The closed block assets, the cash ﬂows generated by the closed block assets and the anticipated revenues from the policies in the closed block will beneﬁt only the holders of the policies in the closed block. To the extent that, over time, cash ﬂows from the assets allocated to the closed block and claims and other experience related to the closed block are, in the aggregate, more or less favorable than what was assumed when the closed block was established, total dividends paid to closed block policyholders in the future may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect for 1999 had been continued. Any cash ﬂows in excess of amounts assumed will be available for distribution over time to closed block policyholders and will not be available to stockholders. If the closed block has insufﬁcient funds to make guaranteed policy beneﬁt payments, such payments will be made from assets outside of the closed block. The closed block will continue in effect as long as any policy in the closed block remains in-force. The expected life of the closed block is over 100 years. The Company uses the same accounting principles to account for the participating policies included in the closed block as it used prior to the date of demutualization. However, the Company establishes a policyholder dividend obligation for earnings that will be paid to policyholders as additional dividends as described below. The excess of closed block liabilities over closed block assets at the effective date of the demutualization (adjusted to eliminate the impact of related amounts in accumulated other comprehensive income) represents the estimated maximum future earnings from the closed block expected to result from operations attributed to the closed block after income taxes. Earnings of the closed block are recognized in income over the period the policies and contracts in the closed block remain in-force. Management believes that over time the actual cumulative earnings of the closed block will approximately equal the expected cumulative earnings due to the effect of dividend changes. If, over the period the closed block remains in existence, the actual cumulative earnings of the closed block is greater than the expected cumulative earnings of the closed block, the Company will pay the excess of the actual cumulative earnings of the closed block over the expected cumulative earnings to closed block policyholders as additional policyholder dividends unless offset by future unfavorable experience of the closed block and, accordingly, will recognize only the expected cumulative earnings in income with the excess recorded as a policyholder dividend obligation. If over such period, the actual cumulative earnings of the closed block is less than the expected cumulative earnings of the closed block, the Company will recognize only the actual earnings in income. However, the Company may change policyholder dividend scales in the future, which would be intended to increase future actual earnings until the actual cumulative earnings equal the expected cumulative earnings. Closed block liabilities and assets designated to the closed block are as follows: December 31, 2004 2003 (Dollars in millions) CLOSED BLOCK LIABILITIES Future policy beneﬁts ************************************************************************ $42,348 Other policyholder funds ********************************************************************* 258 Policyholder dividends payable **************************************************************** 690 Policyholder dividend obligation **************************************************************** 2,243 Payables under securities loaned transactions *************************************************** 4,287 Other liabilities ****************************************************************************** 199 Total closed block liabilities *********************************************************** 50,025 $41,928 260 682 2,130 6,418 180 51,598 F-32 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. December 31, 2004 2003 (Dollars in millions) ASSETS DESIGNATED TO THE CLOSED BLOCK Investments: Fixed maturities available-for-sale, at fair value (amortized cost: $27,757 and $30,381, respectively) **** Equity securities, at fair value (cost: $898 and $217, respectively) ********************************* Mortgage loans on real estate *************************************************************** Policy loans ****************************************************************************** Short-term investments********************************************************************* Other invested assets********************************************************************** Total investments******************************************************************** Cash and cash equivalents ******************************************************************* Accrued investment income******************************************************************* Deferred income taxes *********************************************************************** Premiums and other receivables *************************************************************** Total assets designated to the closed block ********************************************* Excess of closed block liabilities over assets designated to the closed block************************** 29,766 979 8,165 4,067 101 221 43,299 325 511 1,002 103 45,240 4,785 32,348 250 7,431 4,036 123 108 44,296 531 527 1,043 164 46,561 5,037 Amounts included in accumulated other comprehensive loss: Net unrealized investment gains, net of deferred income tax of $752 and $730, respectively ********** Unrealized derivative gains (losses), net of deferred income tax beneﬁt of ($31) and ($28), respectively ** Allocated from policyholder dividend obligation, net of deferred income tax beneﬁt of ($763) and ($778), respectively **************************************************************************** 1,338 (55) 1,270 (48) (1,356) (1,352) (73) Maximum future earnings to be recognized from closed block assets and liabilities********************* $ 4,712 (130) $ 4,907 Information regarding the policyholder dividend obligation is as follows: Years Ended December 31 2004 2003 2002 (Dollars in millions) Balance at beginning of year ******************************************************************* $2,130 Impact on revenues, net of expenses and income taxes ******************************************** 124 Change in unrealized investment and derivative gains (losses) *************************************** (11) Balance at end of year ************************************************************************ $2,243 $1,882 — 248 $ 708 — 1,174 $2,130 $1,882 Closed block revenues and expenses were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) REVENUES Premiums *********************************************************************************** $3,156 Net investment income and other revenues******************************************************* 2,504 Net investment gains (losses) ****************************************************************** (19) Total revenues *********************************************************************** 5,641 $3,365 2,554 (128) $3,551 2,568 11 5,791 6,130 EXPENSES Policyholder beneﬁts and claims **************************************************************** Policyholder dividends************************************************************************* Change in policyholder dividend obligation******************************************************** Other expenses ****************************************************************************** Total expenses*********************************************************************** Revenues net of expenses before income taxes*************************************************** 304 Income taxes ******************************************************************************** 109 Revenues net of expenses and income taxes ***************************************************** $ 195 3,480 1,458 124 275 5,337 3,660 1,509 — 297 5,466 325 118 3,770 1,573 — 310 5,653 477 173 $ 207 $ 304 MetLife, Inc. F-33 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The change in maximum future earnings of the closed block is as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Balance at end of year ************************************************************************ $4,712 Less: Reallocation of assets *********************************************************************** Balance at beginning of year ***************************************************************** — 4,907 Change during year*************************************************************************** $ (195) $4,907 $5,114 — 5,114 85 5,333 $ (207) $ (304) During the year ended December 31, 2002, the allocation of assets to the closed block was revised to appropriately classify assets in accordance with the plan of demutualization. The reallocation of assets had no impact on consolidated assets or liabilities. Metropolitan Life charges the closed block with federal income taxes, state and local premium taxes, and other additive state or local taxes, as well as investment management expenses relating to the closed block as provided in the plan of demutualization. Metropolitan Life also charges the closed block for expenses of maintaining the policies included in the closed block. 7. Debt Debt consisted of the following: December 31, 2004 2003 (Dollars in millions) Senior notes, interest rates ranging from 3.91% to 7.25%, maturity dates ranging from 2005 to 2034 ****** $6,017 Surplus notes, interest rates ranging from 7.00% to 7.88%, maturity dates ranging from 2005 to 2025 ***** 946 Fixed rate notes, interest rates ranging from 2.99% to 10.50%, maturity dates ranging from 2005 to 2006 ** 110 Capital lease obligations *********************************************************************** 66 Other notes with varying interest rates *********************************************************** 273 Total long-term debt ************************************************************************** Total short-term debt ************************************************************************** 7,412 1,445 Total ******************************************************************************* $8,857 $4,256 940 110 74 323 5,703 3,642 $9,345 The Company maintains committed and unsecured credit facilities aggregating $2.8 billion ($1.1 billion expiring in 2005, $175 million expiring in 2006 and $1.5 billion expiring in 2009). If these facilities were drawn upon, they would bear interest at varying rates in accordance with the respective agreements. The facilities can be used for general corporate purposes and $2.5 billion of the facilities also serve as back-up lines of credit for the Company’s commercial paper programs. At December 31, 2004, the Company had drawn approximately $56 million under the facilities expiring in 2005 at interest rates ranging from 5.44% to 6.38% and approximately another $50 million under the facility expiring in 2006 at an interest rate of 2.99%. In April 2003, the Company replaced an expiring $1 billion ﬁve-year credit facility with a $1 billion 364-day credit facility and the Holding Company was added as a borrower. In May 2003, the Company replaced an expiring $140 million three-year credit facility with a $175 million three-year credit facility, which expires in 2006. In April 2004, the Company replaced the $2.25 billion credit facilities expiring in 2004 and 2005, with a $1.0 billion 364-day credit facility expiring in 2005 and a $1.5 billion ﬁve-year credit facility expiring in 2009. In July 2004, the Company renewed a $50 million 364-day credit facility. At December 31, 2004, the Company had $961 million in outstanding letters of credit from various banks. Payments of interest and principal on the surplus notes, subordinated to all other indebtedness, may be made only with the prior approval of the insurance department of the state of domicile. The aggregate maturities of long-term debt for the Company are $1,468 million in 2005, $662 million in 2006, $36 million in 2007, $44 million in 2008, $58 million in 2009 and $5,144 million thereafter. Short-term debt of the Company consisted of commercial paper with a weighted average interest rate of 2.3% and a weighted average maturity of 27 days at December 31, 2004. Short-term debt of the Company included commercial paper with a weighted average interest rate of 1.1% and a weighted average maturity of 31 days at December 31, 2003. The Company has no other collateralized borrowings at December 31, 2004. The Company had other collateralized borrowings with a weighted average coupon rate of 5.07% and a weighted average maturity of 30 days at December 31, 2003. Interest expense related to the Company’s indebtedness included in other expenses was $428 million, $420 million and $288 million for the years ended December 31, 2004, 2003 and 2002, respectively. 8. Shares Subject to Mandatory Redemption and Company-Obligated Mandatorily Redeemable Securities of Subsidiary Trusts MetLife Capital Trust I. In connection with MetLife, Inc.’s, initial public offering in April 2000, the Holding Company and MetLife Capital Trust I (the ‘‘Trust’’) issued equity security units (the ‘‘units’’). Each unit originally consisted of (i) a contract to purchase, for $50, shares of the Holding Company’s common stock (the ‘‘purchase contracts’’) on May 15, 2003; and (ii) a capital security of the Trust, with a stated liquidation amount of $50. In accordance with the terms of the units, the Trust was dissolved on February 5, 2003, and $1,006 million aggregate principal amount of 8.00% debentures of the Holding Company (the ‘‘MetLife debentures’’), the sole assets of the Trust, were distributed to the owners of the Trust’s capital securities in exchange for their capital securities. The MetLife debentures were remarketed on behalf of the debenture owners on February 12, 2003 and the interest rate on the MetLife debentures was reset as of February 15, 2003 to 3.911% per annum for a yield to maturity of 2.876%. As a result of the remarketing, the debenture owners received $21 million ($0.03 per diluted common share) in excess of the carrying value of the capital securities. This excess was recorded by the Company as a charge to additional paid-in capital and, for the purpose of calculating earnings per share, is subtracted from net income to arrive at net income available to common shareholders. On May 15, 2003, the purchase contracts associated with the units were settled. In exchange for $1,006 million, the Company issued 2.97 shares of MetLife, Inc. common stock per purchase contract, or 59.8 million shares of treasury stock. The excess of the Company’s cost of the treasury stock F-34 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. ($1,662 million) over the contract price of the stock issued to the purchase contract holders ($1,006 million) was $656 million, which was recorded as a direct reduction to retained earnings. Due to the dissolution of the Trust in 2003, there was no interest expense on capital securities for the year ended December 31, 2004. Interest expense on the capital securities is included in other expenses and was $10 million and $81 million for the years ended December 31, 2003 and 2002, respectively. GenAmerica Capital I. In June 1997, GenAmerica Corporation (‘‘GenAmerica’’) issued $125 million of 8.525% capital securities through a wholly- owned subsidiary trust, GenAmerica Capital I. GenAmerica has fully and unconditionally guaranteed, on a subordinated basis, the obligation of the trust under the capital securities and is obligated to mandatorily redeem the securities on June 30, 2027. GenAmerica may prepay the securities any time after June 30, 2007. Capital securities outstanding were $119 million, net of unamortized discounts of $6 million, at both December 31, 2004 and 2003. Interest expense on these instruments is included in other expenses and was $11 million for each of the years ended December 31, 2004, 2003 and 2002. RGA Capital Trust I. In December 2001, RGA, through its wholly-owned trust, RGA Capital Trust I (the ‘‘Trust’’), issued 4,500,000 Preferred Income Equity Redeemable Securities (‘‘PIERS’’) Units. Each PIERS unit consists of (i) a preferred security issued by the Trust, having a stated liquidation amount of $50 per unit, representing an undivided beneﬁcial ownership interest in the assets of the Trust, which consist solely of junior subordinated debentures issued by RGA which have a principal amount at maturity of $50 and a stated maturity of March 18, 2051, and (ii) a warrant to purchase, at any time prior to December 15, 2050, 1.2508 shares of RGA stock at an exercise price of $50. The fair market value of the warrant on the issuance date was $14.87 and is detachable from the preferred security. RGA fully and unconditionally guarantees, on a subordinated basis, the obligations of the Trust under the preferred securities. The preferred securities and subordinated debentures were issued at a discount (original issue discount) to the face or liquidation value of $14.87 per security. The securities will accrete to their $50 face/liquidation value over the life of the security on a level yield basis. The weighted average effective interest rate on the preferred securities and the subordinated debentures is 8.25% per annum. Capital securities outstanding were $159 million and $158 million for the years ended December 31, 2004 and 2003, respectively, net of unamortized discount of $67 million, at both December 31, 2004 and 2003. 9. Income Taxes The provision for income taxes for continuing operations was as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Current: Federal ************************************************************************************ $ 733 State and local ***************************************************************************** 51 Foreign ************************************************************************************ 154 Deferred: Federal ************************************************************************************ State and local ***************************************************************************** Foreign ************************************************************************************ 938 191 6 (64) 133 Provision for income taxes ********************************************************************** $1,071 $349 22 47 418 227 27 (12) 242 $ 797 (17) 31 811 (338) 16 1 (321) $660 $ 490 Reconciliations of the income tax provision at the U.S. statutory rate to the provision for income taxes as reported for continuing operations were as follows: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Tax provision at U.S. statutory rate ************************************************************* $1,323 Tax effect of: Tax exempt investment income ************************************************************** State and local income taxes *************************************************************** Prior year taxes *************************************************************************** Foreign operations net of foreign income taxes************************************************* Other, net******************************************************************************** (131) 37 (105) (36) (17) Provision for income taxes ******************************************************************** $1,071 $ 895 $561 (118) 44 (26) (81) (54) (88) 20 (7) (1) 5 $ 660 $490 The Company is under continuous examination by the Internal Revenue Service (‘‘IRS’’) and other tax authorities in jurisdictions in which the Company has signiﬁcant business operations. The income tax years under examination vary by jurisdiction. In 2004 the Company recorded an adjustment of $91 million for the settlement of all federal income tax issues relating to the IRS’s audit of the Company’s tax returns for the years 1997- 1999. Such settlement is reﬂected in the current year tax expense as an adjustment to prior year taxes. The Company also received $22 million in interest on such settlement and incurred an $8 million tax expense on such settlement for a total impact to net income of $105 million. The current IRS examination covers the years 2000-2002. The Company regularly assesses the likelihood of additional assessments in each taxing jurisdiction resulting from current and subsequent years’ examinations. Liabilities for income taxes have been established for future income tax assessments when it is probable there will be future assessments and the amount thereof can be reasonably estimated. Once established, liabilities for uncertain tax positions MetLife, Inc. F-35 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. are adjusted only when there is more information available or when an event occurs necessitating a change to the liabilities. The Company believes that the resolution of income tax matters for open years will not have a material effect on its consolidated ﬁnancial statements although the resolution of income tax matters could impact the Company’s effective tax rate for a particular future period. Deferred income taxes represent the tax effect of the differences between the book and tax bases of assets and liabilities. Net deferred income tax assets and liabilities consisted of the following: December 31, 2004 2003 (Dollars in millions) Deferred income tax assets: Policyholder liabilities and receivables **************************************************************** $ 3,982 Net operating losses ****************************************************************************** 434 Capital loss carryforwards************************************************************************** 118 Intangibles*************************************************************************************** 112 Litigation related ********************************************************************************** 85 Other******************************************************************************************* 182 Less: Valuation allowance ************************************************************************** Deferred income tax liabilities: Investments ************************************************************************************* Deferred policy acquisition costs ******************************************************************** Employee beneﬁts ******************************************************************************** Net unrealized investment gains********************************************************************* Other******************************************************************************************* 4,913 23 4,890 1,544 3,965 91 1,676 87 7,363 Net deferred income tax liability *********************************************************************** $(2,473) $ 3,725 352 106 120 86 127 4,516 32 4,484 1,343 3,595 131 1,679 133 6,881 $(2,397) Domestic net operating loss carryforwards amount to $985 million at December 31, 2004 and will expire beginning in 2014. Domestic capital loss carryforwards amount to $278 million at December 31, 2004 and will expire beginning in 2005. Foreign net operating loss carryforwards amount to $304 million at December 31, 2004 and were generated in various foreign countries with expiration periods of ﬁve years to inﬁnity. The Company has recorded a valuation allowance related to tax beneﬁts of certain foreign net operating loss carryforwards. The valuation allowance reﬂects management’s assessment, based on available information, that it is more likely than not that the deferred income tax asset for certain foreign net operating loss carryforwards will not be realized. The tax beneﬁt will be recognized when management believes that it is more likely than not that these deferred income tax assets are realizable. In 2004, the Company recorded a tax beneﬁt of $9 million for the reduction of the deferred income tax valuation allowance related to certain foreign net operating loss carryforwards. 10. Commitments, Contingencies and Guarantees Litigation The Company is a defendant in a large number of litigation matters. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the United States permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufﬁcient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrate to management that the monetary relief which may be speciﬁed in a lawsuit or claim bears little relevance to its merits or disposition value. Thus, unless stated below, the speciﬁc monetary relief sought is not noted. Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be inherently impossible to ascertain with any degree of certainty. Inherent uncertainties can include how fact ﬁnders will view individually and in their totality documentary evidence, the credibility and effectiveness of witnesses’ testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law. On a quarterly and yearly basis, the Company reviews relevant information with respect to liabilities for litigation and contingencies to be reﬂected in the Company’s consolidated ﬁnancial statements. The review includes senior legal and ﬁnancial personnel. Unless stated below, estimates of possible additional losses or ranges of loss for particular matters cannot in the ordinary course be made with a reasonable degree of certainty. Liabilities are established when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of December 31, 2004. Sales Practices Claims Over the past several years, Metropolitan Life, New England Mutual Life Insurance Company (‘‘New England Mutual’’) and General American Life Insurance Company (‘‘General American’’) have faced numerous claims, including class action lawsuits, alleging improper marketing and sales of individual life insurance policies or annuities. These lawsuits are generally referred to as ‘‘sales practices claims.’’ F-36 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. In December 1999, a federal court approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies and annuity contracts or certiﬁcates issued pursuant to individual sales in the United States by Metropolitan Life, Metropolitan Insurance and Annuity Company or Metropolitan Tower Life Insurance Company between January 1, 1982 and December 31, 1997. The class includes owners of approximately six million in-force or terminated insurance policies and approximately one million in-force or terminated annuity contracts or certiﬁcates. Similar sales practices class actions against New England Mutual, with which Metropolitan Life merged in 1996, and General American, which was acquired in 2000, have been settled. In October 2000, a federal court approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies issued by New England Mutual between January 1, 1983 through August 31, 1996. The class includes owners of approximately 600,000 in-force or terminated policies. A federal court has approved a settlement resolving sales practices claims on behalf of a class of owners of permanent life insurance policies issued by General American between January 1, 1982 through December 31, 1996. An appellate court has afﬁrmed the order approving the settlement. The class includes owners of approximately 250,000 in-force or terminated policies. Certain class members have opted out of the class action settlements noted above and have brought or continued non-class action sales practices lawsuits. In addition, other sales practices lawsuits have been brought. As of December 31, 2004, there are approximately 328 sales practices lawsuits pending against Metropolitan Life; approximately 49 sales practices lawsuits pending against New England Mutual, New England Life Insurance Company, and New England Securities Corporation (collectively, ‘‘New England’’); and approximately 54 sales practices lawsuits pending against General American. Metropolitan Life, New England and General American continue to defend themselves vigorously against these lawsuits. Some individual sales practices claims have been resolved through settlement, won by dispositive motions, or, in a few instances, have gone to trial. Most of the current cases seek substantial damages, including in some cases punitive and treble damages and attorneys’ fees. Additional litigation relating to the Company’s marketing and sales of individual life insurance may be commenced in the future. The Metropolitan Life class action settlement did not resolve two putative class actions involving sales practices claims ﬁled against Metropolitan Life in Canada, and these actions remain pending. The Company believes adequate provision has been made in its consolidated ﬁnancial statements for all probable and reasonably estimable losses for sales practices claims against Metropolitan Life, New England and General American. Regulatory authorities in a small number of states have had investigations or inquiries relating to Metropolitan Life’s, New England’s, or General American’s sales of individual life insurance policies or annuities. Over the past several years, these and a number of investigations by other regulatory authorities were resolved for monetary payments and certain other relief. The Company may continue to resolve investigations in a similar manner. Asbestos-Related Claims Metropolitan Life is also a defendant in thousands of lawsuits seeking compensatory and punitive damages for personal injuries allegedly caused by exposure to asbestos or asbestos-containing products. Metropolitan Life has never engaged in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products nor has Metropolitan Life issued liability or workers’ compensation insurance to companies in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products. Rather, these lawsuits principally have been based upon allegations relating to certain research, publication and other activities of one or more of Metropolitan Life’s employees during the period from the 1920’s through approximately the 1950’s and have alleged that Metropolitan Life learned or should have learned of certain health risks posed by asbestos and, among other things, improperly publicized or failed to disclose those health risks. Metropolitan Life believes that it should not have legal liability in such cases. Legal theories asserted against Metropolitan Life have included negligence, intentional tort claims and conspiracy claims concerning the health risks associated with asbestos. Although Metropolitan Life believes it has meritorious defenses to these claims, and has not suffered any adverse monetary judgments in respect of these claims, due to the risks and expenses of litigation, almost all past cases have been resolved by settlements. Metropolitan Life’s defenses (beyond denial of certain factual allegations) to plaintiffs’ claims include that: (i) Metropolitan Life owed no duty to the plaintiffs — it had no special relationship with the plaintiffs and did not manufacture, produce, distribute or sell the asbestos products that allegedly injured plaintiffs; (ii) plaintiffs cannot demonstrate justiﬁable detrimental reliance; and (iii) plaintiffs cannot demonstrate proximate causation. In defending asbestos cases, Metropolitan Life selects various strategies depending upon the jurisdictions in which such cases are brought and other factors which, in Metropolitan Life’s judgment, best protect Metropolitan Life’s interests. Strategies include seeking to settle or compromise claims, motions challenging the legal or factual basis for such claims or defending on the merits at trial. In 2002, 2003 or 2004, trial courts in California, Utah, Georgia, New York, Texas, and Ohio granted motions dismissing claims against Metropolitan Life on some or all of the above grounds. Other courts have denied motions brought by Metropolitan Life to dismiss cases without the necessity of trial. There can be no assurance that Metropolitan Life will receive favorable decisions on motions in the future. Metropolitan Life intends to continue to exercise its best judgment regarding settlement or defense of such cases, including when trials of these cases are appropriate. Metropolitan Life continues to study its claims experience, review external literature regarding asbestos claims experience in the United States and consider numerous variables that can affect its asbestos liability exposure, including bankruptcies of other companies involved in asbestos litigation and legislative and judicial developments, to identify trends and to assess their impact on the recorded asbestos liability. Bankruptcies of other companies involved in asbestos litigation, as well as advertising by plaintiffs’ asbestos lawyers, may be resulting in an increase in the cost of resolving claims and could result in an increase in the number of trials and possible adverse verdicts Metropolitan Life may experience. Plaintiffs are seeking additional funds from defendants, including Metropolitan Life, in light of such bankruptcies by certain other defendants. In addition, publicity regarding legislative reform efforts may result in an increase or decrease in the number of claims. MetLife, Inc. F-37 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The total number of asbestos personal injury claims pending against Metropolitan Life as of the dates indicated, the number of new claims during the years ended on those dates and the total settlement payments made to resolve asbestos personal injury claims during those years are set forth in the following table: At or for the Years Ended December 31, Asbestos personal injury claims at year end (approximate) *************************** Number of new claims during the year (approximate) ******************************* Settlement payments during the year(1) ****************************************** $ 108,000 23,500 85.5 111,700 58,650 84.2 $ 106,500 66,000 $ 95.1 2004 2003 2002 (Dollars in millions) (1) Settlement payments represent payments made by Metropolitan Life during the year in connection with settlements made in that year and in prior years. Amounts do not include Metropolitan Life’s attorneys’ fees and expenses and do not reﬂect amounts received from insurance carriers. The Company believes adequate provision has been made in its consolidated ﬁnancial statements for all probable and reasonably estimable losses for asbestos-related claims. The ability of Metropolitan Life to estimate its ultimate asbestos exposure is subject to considerable uncertainty due to numerous factors. The availability of data is limited and it is difﬁcult to predict with any certainty numerous variables that can affect liability estimates, including the number of future claims, the cost to resolve claims, the disease mix and severity of disease, the jurisdiction of claims ﬁled, tort reform efforts and the impact of any possible future adverse verdicts and their amounts. The number of asbestos cases that may be brought or the aggregate amount of any liability that Metropolitan Life may ultimately incur is uncertain. Accordingly, it is reasonably possible that the Company’s total exposure to asbestos claims may be greater than the liability recorded by the Company in its consolidated ﬁnancial statements and that future charges to income may be necessary. While the potential future charges could be material in particular quarterly or annual periods in which they are recorded, based on information currently known by management, it does not believe any such charges are likely to have a material adverse effect on the Company’s consolidated ﬁnancial position. Metropolitan Life increased its recorded liability for asbestos-related claims by $402 million from approximately $820 million to $1,225 million at December 31, 2002. This total recorded asbestos-related liability (after the self-insured retention) was within the coverage of the excess insurance policies discussed below. Metropolitan Life regularly reevaluates its exposure from asbestos litigation and has updated its liability analysis for asbestos- related claims through December 31, 2004. During 1998, Metropolitan Life paid $878 million in premiums for excess insurance policies for asbestos-related claims. The excess insurance policies for asbestos-related claims provide for recovery of losses up to $1,500 million, which is in excess of a $400 million self-insured retention. The asbestos-related policies are also subject to annual and per-claim sublimits. Amounts are recoverable under the policies annually with respect to claims paid during the prior calendar year. Although amounts paid by Metropolitan Life in any given year that may be recoverable in the next calendar year under the policies will be reﬂected as a reduction in the Company’s operating cash ﬂows for the year in which they are paid, management believes that the payments will not have a material adverse effect on the Company’s liquidity. Each asbestos-related policy contains an experience fund and a reference fund that provides for payments to Metropolitan Life at the commutation date if the reference fund is greater than zero at commutation or pro rata reductions from time to time in the loss reimbursements to Metropolitan Life if the cumulative return on the reference fund is less than the return speciﬁed in the experience fund. The return in the reference fund is tied to performance of the Standard & Poor’s 500 Index and the Lehman Brothers Aggregate Bond Index. A claim was made under the excess insurance policies in 2003 and 2004 for the amounts paid with respect to asbestos litigation in excess of the retention. As the performance of the indices impacts the return in the reference fund, it is possible that loss reimbursements to the Company and the recoverable with respect to later periods may be less than the amount of the recorded losses. Such foregone loss reimbursements may be recovered upon commutation depending upon future performance of the reference fund. If at some point in the future, the Company believes the liability for probable and reasonably estimable losses for asbestos-related claims should be increased, an expense would be recorded and the insurance recoverable would be adjusted subject to the terms, conditions and limits of the excess insurance policies. Portions of the change in the insurance recoverable would be recorded as a deferred gain and amortized into income over the estimated remaining settlement period of the insurance policies. The foregone loss reimbursements were approximately $8.3 million with respect to 2002 claims, $15.5 million with respect to 2003 claims and are estimated to be $10.2 million with respect to 2004 claims and estimated to be approximately $54 million in the aggregate including future years. Property and Casualty Actions A purported class action has been ﬁled against Metropolitan Property and Casualty Insurance Company’s subsidiary, Metropolitan Casualty Insurance Company, in Florida alleging breach of contract and unfair trade practices with respect to allowing the use of parts not made by the original manufacturer to repair damaged automobiles. Discovery is ongoing and a motion for class certiﬁcation is pending. Two purported nationwide class actions have been ﬁled against Metropolitan Property and Casualty Insurance Company in Illinois. One suit claims breach of contract and fraud due to the alleged underpayment of medical claims arising from the use of a purportedly biased provider fee pricing system. A motion for class certiﬁcation has been ﬁled and discovery is ongoing. The second suit claims breach of contract and fraud arising from the alleged use of preferred provider organizations to reduce medical provider fees covered by the medical claims portion of the insurance policy. A motion to dismiss has been ﬁled. A purported class action has been ﬁled against Metropolitan Property and Casualty Insurance Company in Montana. This suit alleges breach of contract and bad faith for not aggregating medical payment and uninsured coverages provided in connection with the several vehicles identiﬁed in insureds’ motor vehicle policies. A recent decision by the Montana Supreme Court in a suit involving another insurer determined that aggregation is required. Metropolitan Property and Casualty Insurance Company has posted adequate reserves to resolve the claims underlying this matter. The amount to be paid will not be material to Metropolitan Property and Casualty Insurance Company. Certain plaintiffs’ lawyers in another action have alleged that the use of certain automated databases to provide total loss vehicle valuation methods was improper. Metropolitan Property and Casualty Insurance Company, along with a number of other insurers, has tentatively agreed in January 2004 to resolve this issue in a class action format. The amount to be paid in resolution of this matter will not be material to Metropolitan Property and Casualty Insurance Company. F-38 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Demutualization Actions Several lawsuits were brought in 2000 challenging the fairness of Metropolitan Life’s plan of reorganization, as amended (the ‘‘plan’’) and the adequacy and accuracy of Metropolitan Life’s disclosure to policyholders regarding the plan. These actions named as defendants some or all of Metropolitan Life, MetLife, Inc. (the ‘‘Holding Company’’), the individual directors, the New York Superintendent of Insurance (the ‘‘Superintendent’’) and the underwriters for MetLife, Inc.’s initial public offering, Goldman Sachs & Company and Credit Suisse First Boston. On February 21, 2003, a trial court within the commercial part of the New York State court granted the defendants’ motions to dismiss two purported class actions. On April 27, 2004, the appellate court modiﬁed the trial court’s order by reinstating certain claims against Metropolitan Life, the Holding Company and the individual directors. Plaintiffs in these actions have ﬁled a consolidated amended complaint. Defendants’ motion to dismiss part of the consolidated amended complaint, and plaintiffs’ motion to certify a litigation class are pending. Another purported class action ﬁled in New York State court in Kings County has been consolidated with this action. The plaintiffs in the state court class actions seek compensatory relief and punitive damages. Five persons have brought a proceeding under Article 78 of New York’s Civil Practice Law and Rules challenging the Opinion and Decision of the Superintendent who approved the plan. In this proceeding, petitioners seek to vacate the Superintendent’s Opinion and Decision and enjoin him from granting ﬁnal approval of the plan. Respondents have moved to dismiss the proceeding. In a purported class action against Metropolitan Life and the Holding Company pending in the United States District Court for the Eastern District of New York, plaintiffs served a second consolidated amended complaint on April 2, 2004. In this action, plaintiffs assert violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 in connection with the plan, claiming that the Policyholder Information Booklets failed to disclose certain material facts. They seek rescission and compensatory damages. On June 22, 2004, the court denied the defendants’ motion to dismiss the claim of violation of the Securities Exchange Act of 1934. The court had previously denied defendants’ motion to dismiss the claim for violation of the Securities Act of 1933. On December 10, 2004, the court reafﬁrmed its earlier decision denying defendants’ motion for summary judgment as premature. Metropolitan Life, the Holding Company and the individual defendants believe they have meritorious defenses to the plaintiffs’ claims and are contesting vigorously all of the plaintiffs’ claims in these actions. In 2001, a lawsuit was ﬁled in the Superior Court of Justice, Ontario, Canada on behalf of a proposed class of certain former Canadian policyholders against the Holding Company, Metropolitan Life, and Metropolitan Life Insurance Company of Canada. Plaintiffs’ allegations concern the way that their policies were treated in connection with the demutualization of Metropolitan Life; they seek damages, declarations, and other non-pecuniary relief. The defendants believe they have meritorious defenses to the plaintiffs’ claims and will contest vigorously all of plaintiffs’ claims in this matter. On April 30, 2004, a lawsuit was ﬁled in New York state court in New York County against the Holding Company and Metropolitan Life on behalf of a proposed class comprised of the settlement class in the Metropolitan Life sales practices class action settlement approved in December 1999 by the United States District Court for the Western District of Pennsylvania. In July 2004, the plaintiffs served an amended complaint. The amended complaint challenges the treatment of the cost of the sales practices settlement in the demutualization of Metropolitan Life and asserts claims of breach of ﬁduciary duty, common law fraud, and unjust enrichment. Plaintiffs seek compensatory and punitive damages, as well as attorneys’ fees and costs. The Holding Company and Metropolitan Life have moved to dismiss the amended complaint. In October 2003, the United States District Court for the Western District of Pennsylvania dismissed plaintiffs’ similar complaint alleging that the demutualization breached the terms of the 1999 settlement agreement and unjustly enriched the Holding Company and Metropolitan Life. The Holding Company and Metropolitan Life intend to contest this matter vigorously. Race-Conscious Underwriting Claims Insurance departments in a number of states initiated inquiries in 2000 about possible race-conscious underwriting of life insurance. These inquiries generally have been directed to all life insurers licensed in their respective states, including Metropolitan Life and certain of its afﬁliates. The New York Insurance Department concluded its examination of Metropolitan Life concerning possible past race-conscious underwriting practices. On April 28, 2003, the United States District Court for the Southern District of New York approved a class action settlement of a consolidated action against Metropolitan Life alleging racial discrimination in the marketing, sale, and administration of life insurance policies. Metropolitan Life also entered into settlement agreements to resolve the regulatory examination. Twenty lawsuits involving approximately 140 plaintiffs were ﬁled in federal and state court in Alabama, Mississippi and Tennessee alleging federal and/or state law claims of racial discrimination in connection with the sale, formation, administration or servicing of life insurance policies. Metropolitan Life resolved the claims of some of these plaintiffs through settlement, and some additional plaintiffs have voluntarily dismissed their claims. Metropolitan Life resolved claims of some additional persons who opted out of the settlement class referenced in the preceding paragraph but who had not ﬁled suit. The actions ﬁled in Alabama and Tennessee have been dismissed; one action ﬁled in Mississippi remains pending. In the pending action, Metropolitan Life is contesting plaintiffs’ claims vigorously. The Company believes that adequate provision has been made to cover the costs associated with the resolution of these matters. Other A putative class action lawsuit is pending in the United States District Court for the District of Columbia, in which plaintiffs allege that they were denied certain ad hoc pension increases awarded to retirees under the Metropolitan Life retirement plan. The ad hoc pension increases were awarded only to retirees (i.e., individuals who were entitled to an immediate retirement beneﬁt upon their termination of employment) and not available to individuals like these plaintiffs whose employment, or whose spouses’ employment, had terminated before they became eligible for an immediate retirement beneﬁt. The plaintiffs seek to represent a class consisting of former Metropolitan Life employees, or their surviving spouses, who are receiving deferred vested annuity payments under the retirement plan and who were allegedly eligible to receive the ad hoc pension increases awarded in 1977, 1980, 1989, 1992, 1996 and 2001, as well as increases awarded in earlier years. Metropolitan Life is vigorously defending itself against these allegations. As previously reported, the SEC is conducting a formal investigation of New England Securities Corporation (‘‘NES’’), a subsidiary of New England Life Insurance Company (‘‘NELICO’’), in response to NES informing the SEC that certain systems and controls relating to one NES advisory program were not operating effectively. NES is cooperating fully with the SEC. Prior to ﬁling the Company’s June 30, 2003 Form 10-Q, MetLife announced a $31 million charge, net of income taxes, resulting from certain improperly deferred expenses at an afﬁliate, New England Financial. MetLife notiﬁed the SEC about the nature of this charge prior to its announcement. The SEC is pursuing a formal investigation of the matter and, in December 2004, NELICO received a so-called ‘‘Wells Notice’’ in connection with the SEC investigation. The Wells Notice provides notice that the SEC staff is considering recommending that the SEC bring a civil action alleging violations of the U.S. securities laws. Under the SEC’s procedures, a recipient can respond to the SEC staff before the staff makes a formal recommendation regarding MetLife, Inc. F-39 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. whether any action alleging violations of the U.S. securities laws should be considered. MetLife continues to cooperate fully with the SEC in its investigation. The American Dental Association and two individual providers have sued MetLife, Mutual of Omaha and Cigna in a purported class action lawsuit brought in a Florida federal district court. The plaintiffs purport to represent a nationwide class of in-network providers who allege that their claims are being wrongfully reduced by downcoding, bundling, and the improper use and programming of software. The complaint alleges federal racketeering and various state law theories of liability. MetLife is vigorously defending the case and a motion to dismiss has been ﬁled and argued. On November 16, 2004, a New York state court granted plaintiffs’ motion to certify a litigation class of owners of certain participating life insurance policies and a sub-class of New York owners of such policies in an action asserting that Metropolitan Life breached their policies and violated New York’s General Business Law in the manner in which it allocated investment income across lines of business during a period ending with the 2000 demutualization. Metropolitan has ﬁled a notice of appeal from the order granting this motion. In August 2003, an appellate court afﬁrmed the dismissal of fraud claims in this action. Plaintiffs seek compensatory damages. Metropolitan Life is vigorously defending the case. Regulatory bodies have contacted the Company and have requested information relating to market timing and late trading of mutual funds and variable insurance products and, generally, the marketing of products. The Company believes that many of these inquiries are similar to those made to many ﬁnancial services companies as part of industry-wide investigations by various regulatory agencies. The SEC has commenced an investigation with respect to market timing and late trading in a limited number of privately-placed variable insurance contracts that were sold through General American. As previously reported, in May 2004, General American received a so called ‘‘Wells Notice’’ stating that the SEC staff is considering recommending that the SEC bring a civil action alleging violations of the U.S. securities laws against General American. Under the SEC procedures, General American can avail itself of the opportunity to respond to the SEC staff before it makes a formal recommendation regarding whether any action alleging violations of the U.S. securities laws should be considered. General American has responded to the Wells Notice. The Company is fully cooperating with regard to these information requests and investigations. The Company at the present time is not aware of any systemic problems with respect to such matters that may have a material adverse effect on the Company’s consolidated ﬁnancial position. In October 2004, the SEC informed MetLife that it anticipates issuing a formal order of investigation related to certain sales by a former MetLife sales representative to the Sheriff’s Department of Fulton County, Georgia. The Company is fully cooperating with respect to inquiries from the SEC. The Company has received a number of subpoenas and other requests from the Ofﬁce of the Attorney General of the State of New York seeking, among other things, information regarding and relating to compensation agreements between insurance brokers and the Company, whether MetLife has provided or is aware of the provision of ‘‘ﬁctitious’’ or ‘‘inﬂated’’ quotes and information regarding tying arrangements with respect to reinsurance. Based upon an internal review, the Company advised the Attorney General for the State of New York that MetLife was not aware of any instance in which MetLife had provided a ‘‘ﬁctitious’’ or ‘‘inﬂated’’ quote. MetLife also has received a subpoena, including a set of interrogatories, from the Ofﬁce of the Attorney General of the State of Connecticut seeking information and documents concerning contingent commission payments to brokers and MetLife’s awareness of any ‘‘sham’’ bids for business. MetLife also has received a Civil Investigative Demand from the Ofﬁce of the Attorney General for the State of Massachusetts seeking information and documents concerning bids and quotes that the Company submitted to potential customers in Massachusetts, the identity of agents, brokers, and producers to whom the Company submitted such bids or quotes, and communications with a certain broker. MetLife is continuing to conduct an internal review of its commission payment practices. The Company continues to fully cooperate with these inquiries and is responding to the subpoenas and other requests. Approximately twelve broker related lawsuits have been received. Two class action lawsuits were ﬁled in the United States District Court for the Southern District of New York on behalf of proposed classes of all persons who purchased the securities of MetLife, Inc. between April 5, 2000 and October 19, 2004 against MetLife, Inc. and certain ofﬁcers of MetLife, Inc. In the context of contingent commissions, the complaints allege that defendants violated the federal securities laws by issuing materially false and misleading statements and failing to disclose material facts regarding MetLife, Inc.’s ﬁnancial performance throughout the class period that had the effect of artiﬁcially inﬂating the market price of MetLife Inc.’s securities. Three class action lawsuits were ﬁled in the United States District Court for the Southern District of New York on behalf of proposed classes of participants in and beneﬁciaries of Metropolitan Life Insurance Company’s Savings and Investment Plan against MetLife, Inc., the MetLife, Inc. Employee Beneﬁts Committee, certain ofﬁcers of Metropolitan Life Insurance Company, and members of MetLife, Inc.’s board of directors. In the context of contingent commissions, the complaints allege that defendants violated their ﬁduciary obligations under ERISA by failing to disclose to plan participants who had the option of allocating funds in the plan to the MetLife Company Stock Fund material facts regarding MetLife, Inc.’s ﬁnancial performance. The plaintiffs in these actions seek compensatory and other relief. Two cases have been brought in California state court against MetLife, Inc., other companies, and an insurance broker. One of these cases alleges that the insurers and the broker violated Section 17200 of the California Business and Professions Code by engaging in unfair trade practices concerning contingent commissions and fees paid to the broker; the other case has been brought by the California Insurance Commissioner and alleges that the defendants violated certain provisions of the California Insurance Code. Additionally, two civil RICO or antitrust related class action lawsuits have been brought against MetLife, Inc., and other companies in California federal court with respect to issues concerning contingent commissions and fees paid to one or more brokers. Three class action lawsuits have been brought in Illinois federal court against MetLife, Inc. and other companies alleging that insurers and brokers violated antitrust laws or engaged in civil RICO violations. The Company intends to vigorously defend these cases. In addition to those discussed above, regulators and others have made a number of inquiries of the insurance industry regarding industry brokerage practices and related matters and others may begin. It is reasonably possible that MetLife will receive additional subpoenas, interrogatories, requests and lawsuits. MetLife will fully cooperate with all regulatory inquiries and intends to vigorously defend all lawsuits. Metropolitan Life also has been named as a defendant in a number of silicosis, welding and mixed dust cases in various states. The Company intends to defend itself vigorously against these cases. Various litigation, claims and assessments against the Company, in addition to those discussed above and those otherwise provided for in the Company’s consolidated ﬁnancial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations. F-40 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Summary It is not feasible to predict or determine the ultimate outcome of all pending investigations and legal proceedings or provide reasonable ranges of potential losses, except as noted above in connection with speciﬁc matters. In some of the matters referred to above, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s consolidated ﬁnancial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company’s consolidated net income or cash ﬂows in particular quarterly or annual periods. Leases In accordance with industry practice, certain of the Company’s income from lease agreements with retail tenants is contingent upon the level of the tenants’ sales revenues. Additionally, the Company, as lessee, has entered into various lease and sublease agreements for ofﬁce space, data processing and other equipment. Future minimum rental and sublease income, and minimum gross rental payments relating to these lease agreements were as follows: Rental Income Sublease Income Gross Rental Payments (Dollars in millions) 2005 *************************************************************************** $ 603 2006 *************************************************************************** $ 582 2007 *************************************************************************** $ 541 2008 *************************************************************************** $ 465 2009 *************************************************************************** $ 400 Thereafter *********************************************************************** $2,332 $19 $19 $13 $10 $ 4 $12 $184 $163 $137 $103 $ 77 $420 Commitments to Fund Partnership Investments The Company makes commitments to fund partnership investments in the normal course of business. The amounts of these unfunded commit- ments were approximately $1,324 million and $1,380 million at December 31, 2004 and 2003, respectively. The Company anticipates that these amounts will be invested in the partnerships over the next three to ﬁve years. Guarantees In the course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties pursuant to which it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other speciﬁc liabilities, and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemniﬁca- tions to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $800 million, while in other cases such limitations are not speciﬁed or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount due under these guarantees in the future. In addition, the Company indemniﬁes its directors and ofﬁcers as provided in its charters and by-laws. Also, the Company indemniﬁes other of its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under these indemnities in the future. During the year ended December 31, 2004, the Company recorded liabilities of $10 million with respect to indemnities provided in certain dispositions. The approximate term for these liabilities ranges from 12 to 18 months. The maximum potential amount of future payments that MetLife could be required to pay is $73 million. Due to the uncertainty in assessing changes to the liabilities over the term, the liability on the balance sheet will remain until either expiration or settlement of the guarantee unless evidence clearly indicates that the estimates should be revised. The fair value of the remaining indemnities, guarantees and commitments entered into during 2004 was insigniﬁcant and thus, no liabilities were recorded. The Company’s recorded liability at December 31, 2004 and 2003 for indemnities, guarantees and commitments, excluding amounts recorded during 2004 as described in the preceding sentences, is insigniﬁcant. In conjunction with replication synthetic asset transactions, as described in Note 3, the Company writes credit default swap obligations requiring payment of principal due in exchange for the reference credit obligation, depending on the nature or occurrence of speciﬁed credit events for the referenced entities. In the event of a speciﬁed credit event, the Company’s maximum amount at risk, assuming the value of the referenced credits become worthless, is $1.1 billion at December 31, 2004. The credit default swaps expire at various times during the next seven years. 11. Employee Beneﬁt Plans Pension Beneﬁt and Other Beneﬁt Plans The Company is both the sponsor and administrator of deﬁned beneﬁt pension plans covering eligible employees and sales representatives of the Company. Retirement beneﬁts are based upon years of credited service and ﬁnal average or career average earnings history. MetLife, Inc. F-41 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. The Company also provides certain postemployment beneﬁts and certain postretirement health care and life insurance beneﬁts for retired employees through insurance contracts. Substantially all of the Company’s employees may, in accordance with the plans applicable to the postretirement beneﬁts, become eligible for these beneﬁts if they attain retirement age, with sufﬁcient service, while working for the Company. The Company uses a December 31 measurement date for all of its pension and postretirement beneﬁt plans. Obligations, Funded Status and Net Periodic Beneﬁt Costs December 31, Pension Beneﬁts Other Beneﬁts 2004 2003 2004 2003 (Dollars in millions) Change in projected beneﬁt obligation: Projected beneﬁt obligation at beginning of year ***************************************** $5,269 129 311 (3) 147 — — (330) Service cost ********************************************************************* Interest cost ********************************************************************* Acquisitions and divestitures ******************************************************** Actuarial losses (gains) ************************************************************ Curtailments and terminations******************************************************* Change in beneﬁts **************************************************************** Beneﬁts paid********************************************************************* Projected beneﬁt obligation at end of year ********************************************** $4,783 123 314 (1) 351 (7) (2) (292) $2,090 32 119 — (139) — 1 (128) $ 1,889 39 123 — 167 (4) (1) (123) 5,523 5,269 1,975 2,090 Change in plan assets: Fair value of plan assets at beginning of year******************************************** Actual return on plan assets ******************************************************** Acquisitions and divestitures ******************************************************** Employer contribution ************************************************************* Beneﬁts paid********************************************************************* Fair value of plan assets at end of year************************************************* Under funded ********************************************************************** (131) Unrecognized net asset at transition *************************************************** 1 Unrecognized net actuarial losses ***************************************************** 1,510 Unrecognized prior service cost ******************************************************* 67 Prepaid (accrued) beneﬁt cost ******************************************************** $1,447 4,728 416 (3) 581 (330) 5,392 4,051 635 (1) 335 (292) 4,728 (541) 1 1,451 82 1,005 93 — 92 (128) 1,062 (913) — 199 (165) 966 113 — 49 (123) 1,005 (1,085) — 362 (184) $ 993 $ (879) $ (907) Qualiﬁed plan prepaid pension cost**************************************************** $1,782 Non-qualiﬁed plan accrued pension cost *********************************************** (478) Intangible assets******************************************************************** 13 Accumulated other comprehensive loss ************************************************ 130 Prepaid beneﬁt cost ***************************************************************** $1,447 $1,325 (474) 14 128 $ 993 The aggregate projected beneﬁt obligation and aggregate contract value of plan assets for the pension plans were as follows: Qualiﬁed Plan Non-Qualiﬁed Plan Total 2004 2003 2004 2003 2004 2003 (Dollars in millions) Aggregate fair value of plan assets (principally Company contracts) ***** $5,392 Aggregate projected beneﬁt obligation ***************************** 4,999 Over (under) funded ******************************************** $ 393 $4,728 4,732 $ — 524 $ — 537 $5,392 5,523 $4,728 5,269 $ (4) $(524) $(537) $ (131) $ (541) The accumulated beneﬁt obligation for all deﬁned beneﬁt pension plans was $5,149 million and $4,899 million at December 31, 2004 and 2003, respectively. Information for pension plans with an accumulated beneﬁt obligation in excess of plan assets: Projected beneﬁt obligation ***************************************************************************** $550 Accumulated beneﬁt obligation ************************************************************************** $482 Fair value of plan assets ******************************************************************************* $ 17 $557 $469 $ 14 December 31, 2004 2003 (Dollars in millions) F-42 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Information for pension and postretirement plans with a projected beneﬁt obligation in excess of plan assets: December 31, Pension Beneﬁts Other Beneﬁts 2004 2003 2004 2003 (Dollars in millions) Projected beneﬁt obligation ********************************************************** $550 Fair value of plan assets ************************************************************ $ 17 $5,229 $4,673 $1,975 $1,062 $2,090 $1,005 As a result of additional pension contributions and favorable investment returns during the year ended December 31, 2004, a signiﬁcant plan that was included in the pension beneﬁts section of the above table as of December 31, 2003 was no longer included as of December 31, 2004. This plan had a fair value of plan assets of $5,316 with a projected beneﬁt obligation of $4,933 and a fair value of plan assets of $4,659 with a projected beneﬁt obligation of $4,673 as of December 31, 2004 and 2003, respectively. The components of net periodic beneﬁt cost were as follows: Service cost ********************************************************* $ 129 Interest cost ********************************************************* 311 Expected return on plan assets ***************************************** (428) Amortization of prior actuarial losses (gains) and prior service cost ************ 117 Curtailment cost ****************************************************** — Net periodic beneﬁt cost*********************************************** $ 129 $ 123 314 (335) 102 10 $ 214 (Dollars in millions) $ 105 308 (356) 33 11 $ 101 $ 32 119 (77) (12) — $ 62 $ 39 123 (72) (12) 3 $ 81 $ 36 123 (93) (9) 4 $ 61 Pension Beneﬁts Other Beneﬁts 2004 2003 2002 2004 2003 2002 The Company expects to receive subsidies on prescription drug beneﬁts beginning in 2006 under the Medicare Prescription Drug, Improvement and Modernization Act of 2003. The postretirement beneﬁt plan assets and accumulated beneﬁt obligation were remeasured effective July 1, 2004 in order to determine the effect of the expected subsidies on net periodic postretirement beneﬁt cost. As a result, the accumulated postretirement beneﬁt obligation was reduced $213 million which will be recognized as adjustments of future beneﬁt costs through the amortization of actuarial losses (gains) in accordance with FASB staff position 106-2 on a prospective basis and net periodic postretirement beneﬁt cost for the year ended 2004 was reduced $17 million. The reduction of net periodic beneﬁt cost is due to reductions in service cost of $3 million, interest cost of $6 million, and amortization of prior actuarial loss of $8 million. Assumptions Assumptions used in determining beneﬁt obligations were as follows: December 31, Pension Beneﬁts Other Beneﬁts 2004 2003 2004 2003 Weighted average discount rate ******************************************** Rate of compensation increase ******************************************** 5.87% 3%-8% 6.12% 3%-8% 5.88% N/A 6.12% N/A Assumptions used in determining net periodic beneﬁt cost were as follows: December 31, Pension Beneﬁts Other Beneﬁts 2004 2003 2002 2004 2003 2002 Weighted average discount rate *************************************** 7.23% Weighted average expected rate of return on plan assets ****************** 9.00% Rate of compensation increase **************************************** 3%-8% 3%-8% 2%-8% 6.10% 8.50% 6.74% 8.51% 6.20% 6.82% 7.40% 7.91% 7.79% 8.16% N/A N/A N/A The discount rate is based on the yield of a hypothetical portfolio of high-quality debt instruments available on the valuation date, which would provide the necessary future cash ﬂows to pay the aggregate projected beneﬁt obligation when due. The expected rate of return on plan assets is based on anticipated performance of the various asset sectors in which the plan invests, weighted by target allocation percentages. Anticipated future performance is based on long-term historical returns of the plan assets by sector, adjusted for the Company’s long-term expectations on the performance of the markets. While the precise expected return derived using this approach will ﬂuctuate from year to year, the Company’s policy is to hold this long-term assumption constant as long as it remains within reasonable tolerance from the derived rate. The weighted expected return on plan assets for use in that plan’s valuation in 2005 is currently anticipated to be 8.50% for pension beneﬁts and other postretirement medical beneﬁts and 6.25% for postretirement life beneﬁts. The assumed health care cost trend rates used in measuring the accumulated postretirement beneﬁt obligation were as follows: Pre-Medicare eligible claims ******************************************* 8% down to 5% in 2010 Medicare eligible claims *********************************************** 10% down to 5% in 2014 8.5% down to 5% in 2010 10.5% down to 5% in 2014 December 31, 2004 2003 MetLife, Inc. F-43 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Assumed health care cost trend rates may have a signiﬁcant effect on the amounts reported for health care plans. A one-percentage point change in assumed health care cost trend rates would have the following effects: Effect on total of service and interest cost components ************************************************ Effect of accumulated postretirement beneﬁt obligation ************************************************* $ 10 $104 $ (9) $(100) Plan Assets The weighted average allocation of pension plan and other beneﬁt plan assets is as follows: One Percent Increase One Percent Decrease (Dollars in millions) December 31, Pension Beneﬁts Other Beneﬁts 2004 2003 2004 2003 Asset Category Equity securities************************************************************************** Fixed maturities ************************************************************************** Other (Real Estate and Alternative Investments) ************************************************ 50% 36% 14% Total ********************************************************************************* 100% 48% 39% 13% 41% 57% 2% 38% 61% 1% 100% 100% 100% The weighted average target allocation of pension plan and other beneﬁt plan assets for 2005 is as follows: Pension Beneﬁts Other Beneﬁts Asset Category Equity securities ********************************************************************************** 30%-65% 25%-45% Fixed maturities *********************************************************************************** 20%-70% 45%-70% Other (Real Estate and Alternative Investments)********************************************************* 0%-10% 0%-25% Target allocations of assets are determined with the objective of maximizing returns and minimizing volatility of net assets through adequate asset diversiﬁcation. Adjustments are made to target allocations based on an assessment of the impact of economic factors and market conditions. Cash Flows The Company expects to contribute $32 million to its pension plans and $93 million to its other beneﬁt plans during 2005. Gross beneﬁt payments for the next ten years, which reﬂect expected future service as appropriate, are expected to be as follows: 2005 ********************************************************************************************** $ 302 2006 ********************************************************************************************** $ 314 2007 ********************************************************************************************** $ 321 2008 ********************************************************************************************** $ 334 2009 ********************************************************************************************** $ 344 2010-2014 ***************************************************************************************** $1,900 Gross subsidy payments expected to be received for the next ten years under the Medicare Prescription Drug, Improvement and Modernization Act $122 $126 $131 $135 $139 $748 of 2003 are as follows: Pension Beneﬁts Other Beneﬁts (Dollars in millions) Other Beneﬁts (Dollars in millions) 2005***************************************************************************************************** 2006***************************************************************************************************** 2007***************************************************************************************************** 2008***************************************************************************************************** 2009***************************************************************************************************** 2010-2014 *********************************************************************************************** $ — $10 $10 $11 $11 $69 Savings and Investment Plans The Company sponsors savings and investment plans for substantially all employees under which the Company matches a portion of employee contributions. The Company contributed $64 million, $59 million and $58 million for the years ended December 31, 2004, 2003 and 2002, respectively. 12. Equity Preferred Stock On September 29, 1999, the Holding Company adopted a stockholder rights plan (the ‘‘rights plan’’) under which each outstanding share of common stock issued between April 4, 2000 and the distribution date (as deﬁned in the rights plan) will be coupled with a stockholder right. Each right will entitle the holder to purchase one one-hundredth of a share of Series A Junior Participating Preferred Stock. Each one one-hundredth of a share of F-44 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Series A Junior Participating Preferred Stock will have economic and voting terms equivalent to one share of common stock. Until it is exercised, the right itself will not entitle the holder thereof to any rights as a stockholder, including the right to receive dividends or to vote at stockholder meetings. Stockholder rights are not exercisable until the distribution date, and will expire at the close of business on April 4, 2010, unless earlier redeemed or exchanged by the Holding Company. The rights plan is designed to protect stockholders in the event of unsolicited offers to acquire the Holding Company and other coercive takeover tactics. Common Stock On October 26, 2004, the Holding Company’s Board of Directors authorized a $1 billion common stock repurchase program. This program began after the completion of the February 19, 2002 and March 28, 2001 repurchase programs, each of which authorized the repurchase of $1 billion of common stock. Under these authorizations, the Holding Company may purchase common stock from the MetLife Policyholder Trust, in the open market and in privately negotiated transactions. As of January 31, 2005, the Holding Company has suspended its share repurchases during 2005 and repurchases after 2005 will be dependent upon several factors, including the Company’s capital position, its ﬁnancial strength and credit ratings, general market conditions and the price of the Company’s common stock. On December 16, 2004, the Holding Company repurchased 7,281,553 shares of its outstanding common stock at an aggregate cost of approximately $300 million under an accelerated share repurchase agreement with a major bank. The Holding Company will either pay or receive an amount based on the actual amount paid by the bank to purchase the shares. The ﬁnal purchase price will be settled in either cash or Holding Company stock at the Holding Company’s option. The Holding Company recorded the initial repurchase of shares as treasury stock and will record any amount paid or received as an adjustment to the cost of the treasury stock. The Company acquired 26,373,952, 2,997,200 and 15,244,492 shares of the Holding Company’s common stock for $1,000 million, $97 million and $471 million during the years ended December 31, 2004, 2003 and 2002, respectively. During the year ended 2004, 1,675,814 shares of common stock were issued from treasury stock for $50 million. During the year ended 2003, 59,904,925 shares of treasury common stock with a cost of $1,667 million were issued of which 59,771,221 shares were issued in connection with the settlement of common stock purchase contracts (see Note 8) for $1,006 million cash and 133,704 shares were issued in connection with activities such as share-based compensation for $5 million in cash. During the year ended 2002, 16,379 shares of common stock were issued from treasury stock for $438 thousand. At December 31, 2004, the Company had $710 million remaining on its existing share repurchase authorization. Dividend Restrictions Under New York State Insurance Law, Metropolitan Life is permitted, without prior insurance regulatory clearance, to pay a dividend to the Holding Company as long as the aggregate amount of all such dividends in any calendar year does not exceed the lesser of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year, and (ii) its statutory net gain from operations for the immediately preceding calendar year (excluding realized capital gains). Metropolitan Life will be permitted to pay a dividend to the Holding Company in excess of the lesser of such two amounts only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the New York Superintendent of Insurance ( the ‘‘Superintendent’’) and the Superintendent does not disapprove the distribution. Under New York State Insurance Law, the Superintendent has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its stockholders. The New York State Department of Insurance has established informal guidelines for such determinations. The guidelines, among other things, focus on the insurer’s overall ﬁnancial condition and proﬁtability under statutory accounting practices. For the years ended December 31, 2004, 2003 and 2002, Metropolitan Life paid to MetLife, Inc. $797 million, $698 million and $535 million, respectively, in dividends for which prior insurance regulatory clearance was not required and $0 million, $750 million and $369 million, respectively, in special dividends, as approved by the Superintendent. At December 31, 2004, the maximum amount of the dividend which may be paid to the Holding Company from Metropolitan Life in 2005, without prior regulatory approval is $880 million. Under Delaware Insurance Law, Metropolitan Tower Life Insurance Company (‘‘MTL’’) is permitted, without prior insurance regulatory clearance, to pay a dividend to the Holding Company as long as the aggregate amount of all such dividends in any calendar year does not exceed the greater of (i) 10% of its surplus to policyholders as of the next preceding calendar year, and (ii) its statutory net gain from operations for the next preceding calendar year (excluding realized capital gains). MTL will be permitted to pay a cash dividend to the Holding Company in excess of the greater of such two amounts only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the Delaware Commissioner of Insurance (the ‘‘Delaware Commissioner’’) and the Delaware Commissioner does not disapprove the distribution. Under Delaware Insurance Law, the Delaware Commissioner has broad discretion in determining whether the ﬁnancial condition of a stock life insurance company would support the payment of such dividends to its stockholders. The Delaware Insurance Department has established informal guidelines for such determinations. The guidelines, among other things, focus on the insurer’s overall ﬁnancial condition and proﬁtability under statutory accounting practices. On October 8, 2004, Metropolitan Insurance and Annuity Company (‘‘MIAC’’) was merged into MTL. Prior to the merger, MIAC paid to MetLife, Inc. $65 million in dividends for which prior insurance regulatory clearance was not required and no special dividends for the year ended December 31, 2004. For the year ended December 31, 2003, MIAC paid to MetLife, Inc, $104 million in dividends for which prior insurance regulatory clearance was not required and $94 million in special dividends. For the year ended December 31, 2002, MIAC paid to MetLife, Inc. $25 million in dividends for which prior insurance regulatory clearance was not required and paid no special dividends. MTL, exclusive of MIAC, paid no dividends during the years ended December 31, 2004, 2003 and 2002, respectively. As of December 31, 2004, the maximum amount of the dividend which may be paid to the Holding Company from MTL in 2005, without prior regulatory approval, is $119 million. Under Rhode Island Insurance Law, Metropolitan Property and Casualty Insurance Company is permitted without prior insurance regulatory clearance to pay a dividend to the Holding Company as long as the aggregate amount of all such dividends in any calendar year does not exceed the lesser of (i) 10% of its surplus to policyholders as of the immediately preceding calendar year, and (ii) the next preceding two year earnings reduced by capital gains and dividends paid to stockholders. Metropolitan Property and Casualty Insurance Company will be permitted to pay a stockholder dividend to the Holding Company in excess of the lesser of such two amounts (an ‘‘extraordinary dividend’’) only if it ﬁles notice of its intention to declare such a dividend and the amount thereof with the Rhode Island Commissioner of Insurance (‘‘Rhode Island Commissioner’’) and the Rhode Island Commissioner does not disapprove the distribution. Under Rhode Island Insurance Law, the Rhode Island Commissioner has broad discretion in determining whether the ﬁnancial condition of stock property and casualty insurance company would support the payment of such dividends to its stockholders. For the year ended December 31, 2004, Metropolitan Property and Casualty Insurance Company paid to MetLife, Inc. $300 million in extraordinary dividends. MetLife, Inc. F-45 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Insurance regulatory approval of the extraordinary dividend was received on October 15, 2004 and the extraordinary dividend was paid on October 25, 2004. For the year ended December 31, 2003, Metropolitan Property and Casualty Insurance Company paid to MetLife, Inc. $75 million in dividends for which prior insurance regulatory clearance was not required. As of December 31, 2004, the maximum amount of the dividend which may be paid to the Holding Company from Metropolitan Property and Casualty Insurance Company in 2005, without prior regulatory approval, is $187 million for dividends with a scheduled date of payment subsequent to November 16, 2005. Any dividend payment prior to November 16, 2005 will be considered extraordinary requiring prior insurance regulatory clearance. Stock Compensation Plans Under the MetLife, Inc. 2000 Stock Incentive Plan, as amended, (the ‘‘Stock Incentive Plan’’), awards granted may be in the form of non-qualiﬁed or incentive stock options qualifying under Section 422A of the Internal Revenue Code. Under the MetLife, Inc. 2000 Directors Stock Plan, as amended (the ‘‘Directors Stock Plan’’), awards granted may be in the form of stock awards, non-qualiﬁed stock options, or a combination of the foregoing to outside Directors of the Company. The aggregate number of options to purchase shares of stock that may be awarded under the Stock Incentive Plan and the Directors Stock Plan is subject to a maximum limit of 37,823,333, of which no more than 378,233 may be awarded under the Directors Stock Plan. The Directors Stock Plan has a maximum limit of 500,000 stock awards. All options granted have an exercise price equal to the fair market value price of the Company’s common stock on the date of grant, and an option’s maximum term is ten years. Certain options under the Stock Incentive Plan become exercisable over a three year period commencing with the date of grant, while other options become exercisable three years after the date of grant. Options issued under the Directors Stock Plan are exercisable immediately. The fair value of each option grant is estimated on the date of the grant using the Black-Scholes options-pricing model with the following weighted average assumptions used for grants for the: Years Ended December 31, 2004 2003 2002 Dividend yield ******************************************************************************* 0.68% Risk-free rate of return ************************************************************************ 5.71% Volatility ************************************************************************************ 34.85% 37.39% 31.62% Expected duration**************************************************************************** 6 years 6 years A summary of the status of options included in the Company’s Stock Incentive Plan and Directors Stock Plan is presented below: 0.68% 5.07% 0.70% 3.69% 6 years Options Weighted Average Exercise Price Options Exercisable Weighted Average Exercise Price Outstanding at January 1, 2002 *************************************** 11,116,684 Granted *********************************************************** 7,275,855 Exercised ********************************************************** (11,401) Canceled/Expired *************************************************** (2,121,508) Outstanding at December 31, 2002 *********************************** 16,259,630 Granted *********************************************************** 5,634,439 Exercised ********************************************************** (20,054) Canceled/Expired *************************************************** (1,578,987) Outstanding at December 31, 2003 *********************************** 20,295,028 Granted *********************************************************** 5,074,206 Exercised ********************************************************** (1,464,865) Canceled/Expired *************************************************** (642,268) Outstanding at December 31, 2004 *********************************** 23,262,101 $29.93 $30.35 $29.95 $30.07 $30.10 $26.13 $30.02 $29.45 $29.05 $35.28 $29.70 $30.27 $30.33 — — — — 1,357,034 — — — 4,566,265 — — — 12,736,500 $ — $ — $ — $ — $30.01 $ — $ — $ — $30.15 $ — $ — $ — $29.57 Years Ended December 31, 2004 2003 2002 Weighted average fair value of options granted **************************************************** $13.25 $10.41 $10.48 The following table summarizes information about stock options outstanding at December 31, 2004: Range of Exercise Prices $23.75 – $27.55 $27.55 – $31.35 $31.35 – $35.15 $35.15 – $38.95 $38.95 – $40.38 Number Outstanding at December 31, 2004 Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price 5,116,385 13,061,369 287,844 4,788,503 8,000 23,262,101 7.95 6.31 6.69 8.92 9.92 7.22 $26.02 $30.13 $33.31 $35.28 $40.16 $30.34 Number Exercisable at December 31, 2004 1,697,554 10,956,828 62,840 19,278 — 12,736,500 Weighted Average Exercise Price $26.05 $30.09 $32.94 $35.26 $ — $29.57 Effective January 1, 2003, the Company elected to prospectively apply the fair value method of accounting for stock options granted by the Holding Company subsequent to December 31, 2002. As permitted under SFAS 148, options granted prior to January 1, 2003 will continue to be accounted for F-46 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. under APB 25. Had compensation expense for grants awarded prior to January 1, 2003 been determined based on fair value at the date of grant in accordance with SFAS 123, the Company’s earnings and earnings per share amounts would have been reduced to the following pro forma amounts: Years Ended December 31, 2004 2003 2002 (Dollars in millions, except per share data) Net income ********************************************************************************* $2,758 Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust(1) ***** — Net income available to common shareholders **************************************************** $2,758 $2,217 (21) $1,605 — $2,196 $1,605 Add: Stock option-based employee compensation expense included in reported net income, net of income taxes ************************************************************************************* $ 26 Deduct: Total stock option-based employee compensation determined under fair value based method for all awards, net of income taxes ***************************************************************** $ (44) Pro forma net income available to common shareholders(2) ***************************************** $2,740 $ $ 11 (40) $ $ 1 (33) $2,167 $1,573 Basic earnings per share As reported ********************************************************************************* $ 3.68 $ 2.98 $ 2.28 Pro forma(2) ********************************************************************************* $ 3.65 $ 2.94 $ 2.23 Diluted earnings per share As reported ********************************************************************************* $ 3.65 $ 2.94 $ 2.20 Pro forma(2) ********************************************************************************* $ 3.63 $ 2.90 $ 2.15 (1) See Note 8 for a discussion of this charge included in the calculation of net income available to common shareholders. (2) The pro forma earnings disclosures are not necessarily representative of the effects on net income and earnings per share in future years. The Company also awards stock-based compensation to certain levels of management under the Company’s Long Term Performance Compensa- tion Plan (‘‘LTPCP’’). LTPCP awards vest in their entirety at the end of the three year performance period. Each participant is assigned a target compensation amount at the inception of the performance period with the ﬁnal compensation amount determined by the performance of the Holding Company’s stock over the three-year vesting period, subject to management’s discretion. Final awards may be paid in whole or in part with shares of the Holding Company’s stock. Compensation expense related to the LTPCP was $49 million, $45 million, and $23 million for the years ended December 31, 2004, 2003 and 2002, respectively. For the years ended December 31, 2004, 2003 and 2002, stock-based compensation expense related to the Company’s Stock Incentive Plan, Directors Stock Plan and LTPCP was $89 million, $63 million and $25 million, respectively, including stock-based compensation for non-employees of $468 thousand, $550 thousand and $2 million, respectively. Statutory Equity and Income The National Association of Insurance Commissioners (‘‘NAIC’’) adopted the Codiﬁcation of Statutory Accounting Principles (‘‘Codiﬁcation’’) in 2001. Codiﬁcation was intended to standardize regulatory accounting and reporting to state insurance departments. However, statutory accounting principles continue to be established by individual state laws and permitted practices. The New York State Department of Insurance has adopted Codiﬁcation with certain modiﬁcations for the preparation of statutory ﬁnancial statements of insurance companies domiciled in New York. Modiﬁcations by the various state insurance departments may impact the effect of Codiﬁcation on the statutory capital and surplus of Metropolitan Life and the Holding Company’s other insurance subsidiaries. Statutory accounting practices differ from GAAP primarily by charging policy acquisition costs to expense as incurred, establishing future policy beneﬁt liabilities using different actuarial assumptions, reporting surplus notes as surplus instead of debt and valuing securities on a different basis. Statutory net income of Metropolitan Life, a New York domiciled insurer, was $2,648 million, $2,169 million and $1,455 million for the years ended December 31, 2004 2003 and 2002, respectively. Statutory capital and surplus, as ﬁled with the New York State Department of Insurance, was $8,804 million and $7,967 million at December 31, 2004 and 2003, respectively. MIAC was merged into another Delaware incorporated entity, MTL, on October 8, 2004. Statutory net income of MTL (including MIAC), as ﬁled with the Delaware Insurance Department, was $144 million for the year ended December 31, 2004. Statutory net income of MIAC, as ﬁled with the Delaware Insurance Department, was $341 million and $34 million for the years ended December 31, 2003 and 2002, respectively. Statutory capital and surplus of MTL, as ﬁled, was $1,195 million as of December 31, 2004. Statutory capital and surplus of MIAC, as ﬁled, was $1,051 million at December 31, 2003. Statutory net income of Metropolitan Property and Casualty Insurance Company, which is domiciled in Rhode Island, as ﬁled with the Insurance Department of Rhode Island, was $356 million, $214 million and $173 million for the years ended December 31, 2004, 2003 and 2002, respectively. Statutory capital and surplus, as ﬁled, was $1,875 million and $1,996 million at December 31, 2004 and 2003, respectively. MetLife, Inc. F-47 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. Other Comprehensive Income The following table sets forth the reclassiﬁcation adjustments required for the years ended December 31, 2004, 2003 and 2002 in other comprehensive income (loss) that are included as part of net income for the current year that have been reported as a part of other comprehensive income (loss) in the current or prior year: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Holding gains on investments arising during the year************************************************** $ 513 $1,497 $ 3,387 Income tax effect of holding gains ***************************************************************** (1,064) Reclassiﬁcation adjustments: (562) 74 Recognized holding (gains) losses included in current year income ************************************ Amortization of premiums and accretion of discounts associated with investments *********************** Income tax effect ***************************************************************************** Allocation of holding losses on investments relating to other policyholder amounts ************************* Income tax effect of allocation of holding losses to other policyholder amounts **************************** Net unrealized investment gains (losses) ************************************************************ Foreign currency translation adjustment ************************************************************* (69) Minimum pension liability adjustment *************************************************************** — Other comprehensive income (losses) ************************************************************** $ 164 $ 785 $ 334 704 (526) (56) (2,977) 935 382 (168) (81) (606) 228 (218) (94) (45) (182) (26) 144 (2) 177 (82) 690 403 22 13. Other Expenses Other expenses were comprised of the following: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Compensation******************************************************************************** $ 2,874 $ 2,707 $ 2,499 Commissions ******************************************************************************** 2,000 Interest and debt issue costs ******************************************************************* 403 Amortization of policy acquisition costs *********************************************************** 1,644 Capitalization of policy acquisition costs ********************************************************** (2,340) Rent, net of sublease income ******************************************************************* 295 Minority interest******************************************************************************* 73 Other *************************************************************************************** 2,239 Total other expenses ************************************************************************ $ 7,761 $ 7,091 $ 6,813 2,876 408 1,905 (3,101) 264 152 2,383 2,474 478 1,787 (2,792) 254 110 2,073 F-48 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 14. Earnings Per Share The following presents the weighted average shares used in calculating basic earnings per share and those used in calculating diluted earnings per share for each income category presented below: Weighted average common stock outstanding for basic earnings per share *********** Incremental shares from assumed: Conversion of forward purchase contracts ************************************* Exercise of stock options**************************************************** Issuance under deferred stock compensation*********************************** Weighted average common stock outstanding for diluted earnings per share ********** For the Years Ended December 31, 2004 2003 2002 (Dollars in millions, except share and per share data) 749,695,661 737,903,107 704,599,115 — 4,053,813 1,083,970 8,293,269 68,111 579,810 24,596,950 5,233 — 754,833,444 746,844,297 729,201,298 Income from continuing operations ***************************************** $ Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust(1) ***************************************** Income from continuing operations available to common shareholders per share******************************************************************** $ Basic ******************************************************************** $ Diluted ******************************************************************* $ Income from discontinued operations, net of income taxes, available to common shareholders per share ***************************************** $ Basic ******************************************************************** $ Diluted ******************************************************************* $ Cumulative effect of change in accounting, net of income taxes, per share *** $ Basic ******************************************************************** $ Diluted ******************************************************************* $ Net Income**************************************************************** $ Charge for conversion of company-obligated mandatorily redeemable securities of a subsidiary trust(1) ***************************************** Net income available to common shareholders per share ******************** $ Basic ******************************************************************** $ Diluted ******************************************************************* $ 2,708 $ 1,899 $ 1,113 — (21) — 2,708 $ 1,878 $ 1,113 3.61 $ 3.59 $ 136 $ 0.18 $ 0.18 $ (86) $ (0.11) $ (0.11) $ 2.55 $ 2.51 $ 344 $ 0.47 $ 0.46 $ (26) $ (0.04) $ (0.03) $ 1.58 1.53 492 0.70 0.67 — — — 2,758 $ 2,217 $ 1,605 — (21) 2,758 $ 2,196 $ 3.68 $ 3.65 $ 2.98 $ 2.94 $ — 1,605 2.28 2.20 (1) See Note 8 for a discussion of this charge included in the calculation of net income available to common shareholders. MetLife, Inc. F-49 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. 15. Quarterly Results of Operations (Unaudited) The unaudited quarterly results of operations for the years ended December 31, 2004 and 2003 are summarized in the table below: Three Months Ended March 31, June 30, September 30, December 31, (Dollars in millions, except per share data) 2004 Total revenues******************************************************* Total expenses ****************************************************** Income from continuing operations************************************** Income from discontinued operations, net of income taxes ***************** Income before cumulative effect of a change in accounting ***************** Net income ********************************************************* Basic earnings per share: Income from continuing operations available to common shareholders ****** Income from discontinued operations, net of income taxes *************** Income before cumulative effect of a change in accounting available to common shareholders ******************************************** Net income available to common shareholders ************************* Diluted earnings per share: Income from continuing operations available to common shareholders ****** Income from discontinued operations, net of income taxes *************** Income before cumulative effect of a change in accounting available to common shareholders ******************************************** Net income available to common shareholders ************************* 2003 Total revenues******************************************************* Total expenses ****************************************************** Income from continuing operations************************************** Income from discontinued operations, net of income taxes ***************** Income before cumulative effect of a change in accounting ***************** Net income ********************************************************* Basic earnings per share: Income from continuing operations available to common shareholders ****** Income from discontinued operations, net of income taxes *************** Income before cumulative effect of a change in accounting available to common shareholders ******************************************** Net income available to common shareholders ************************* Diluted earnings per share: Income from continuing operations available to common shareholders ****** Income from discontinued operations, net of income taxes *************** Income before cumulative effect of a change in accounting available to common shareholders ******************************************** Net income available to common shareholders ************************* $9,426 $8,471 $ 655 $ 29 $ 684 $ 598 $ 0.87 $ 0.04 $ 0.90 $ 0.79 $ 0.86 $ 0.04 $ 0.90 $ 0.79 $8,269 $7,872 $ 287 $ 75 $ 362 $ 362 $ 0.38 $ 0.11 $ 0.49 $ 0.49 $ 0.37 $ 0.10 $ 0.47 $ 0.47 $9,479 $8,389 $ 843 $ 111 $ 954 $ 954 $ 1.12 $ 0.15 $ 1.27 $ 1.27 $ 1.11 $ 0.15 $ 1.26 $ 1.26 $8,809 $8,036 $ 564 $ 16 $ 580 $ 580 $ 0.77 $ 0.02 $ 0.79 $ 0.79 $ 0.77 $ 0.02 $ 0.79 $ 0.79 $10,047 $ 9,048 698 $ (3) $ 695 $ 695 $ $ $ $ $ $ $ $ $ 0.93 — 0.93 0.93 0.93 — 0.92 0.92 $ 8,718 $ 8,027 549 $ 25 $ 574 $ 574 $ $ $ $ $ $ $ $ $ 0.72 0.03 0.75 0.75 0.72 0.03 0.75 0.75 $10,062 $ 9,327 512 $ (1) $ 511 $ 511 $ $ $ $ $ $ $ $ $ 0.69 — 0.69 0.69 0.68 — 0.68 0.68 $ 9,529 $ 8,831 499 $ 228 $ 727 $ 701 $ $ $ $ $ $ $ $ $ 0.66 0.30 0.96 0.92 0.66 0.30 0.95 0.92 16. Business Segment Information The Company provides insurance and ﬁnancial services to customers in the United States, Canada, Central America, South America, Asia and various other international markets. The Company’s business is divided into ﬁve operating segments: Institutional, Individual, Auto & Home, International and Reinsurance, as well as Corporate & Other. These segments are managed separately because they either provide different products and services, require different strategies or have different technology requirements. Institutional offers a broad range of group insurance and retirement & savings products and services, including group life insurance, non-medical health insurance, such as short and long-term disability, long-term care, and dental insurance, and other insurance products and services. Individual offers a wide variety of protection and asset accumulation products, including life insurance, annuities and mutual funds. Auto & Home provides personal lines property and casualty insurance, including private passenger automobile, homeowner’s and personal excess liability insurance. International provides life insurance, accident and health insurance, annuities and retirement & savings products to both individuals and groups. Reinsurance provides primarily reinsurance of life and annuity policies in North America and various international markets. Additionally, reinsurance of critical illness policies is provided in select international markets. Corporate & Other contains the excess capital not allocated to the business segments, various start-up entities, including MetLife Bank, N.A. (‘‘MetLife Bank’’), a national bank, and run-off entities, as well as interest expense related to the majority of the Company’s outstanding debt and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of all intersegment amounts, which generally relate to intersegment loans, which bear interest rates commensurate with related borrowings, as well as intersegment transactions. Additionally, the Company’s asset management business, including amounts reported as discontinued operations, is included in the results of operations for Corporate & Other. See Note 18 for disclosures regarding discontinued operations, including real estate. Set forth in the tables below is certain ﬁnancial information with respect to the Company’s operating segments for the years ended December 31, 2004, 2003 and 2002. The accounting policies of the segments are the same as those of the Company, except for the method of capital allocation and F-50 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. the accounting for gains (losses) from intercompany sales, which are eliminated in consolidation. The Company allocates capital to each segment based upon an internal capital allocation system that allows the Company to more effectively manage its capital. The Company evaluates the performance of each operating segment based upon net income excluding certain net investment gains (losses), net of income taxes, and the impact from the cumulative effect of changes in accounting, net of income taxes. Scheduled periodic settlement payments on derivative instruments not qualifying for hedge accounting are included in net investment gains (losses). The Company allocates certain non-recurring items, such as expenses associated with certain legal proceedings, to Corporate & Other. As of or for the Year Ended December 31, 2004 Institutional Individual Auto & Home International Reinsurance (Dollars in millions) Corporate & Other Total Premiums*********************************************** $ 10,103 $ Universal life and investment-type product policy fees ********** Net investment income************************************ Other revenues ****************************************** Net investment gains (losses) ****************************** Policyholder beneﬁts and claims **************************** Interest credited to policyholder account balances ************* Policyholder dividends ************************************ Other expenses****************************************** Income (loss) from continuing operations before provision 717 4,472 632 186 11,134 960 107 1,907 4,172 $2,948 — 1,831 171 6,130 35 444 (9) 74 2,079 5,102 — 1,674 2 1,638 795 2,939 $ 1,735 350 585 23 23 1,614 152 47 624 (beneﬁt) for income taxes ******************************** Income from discontinued operations, net of income taxes****** Cumulative effect of a change in accounting, net of income taxes Net income ********************************************* Total assets ********************************************* Deferred policy acquisition costs**************************** Goodwill, net ******************************************** Separate account assets ********************************** Policyholder liabilities************************************** Separate account liabilities********************************* 2,002 10 (60) 1,271 126,058 965 61 36,913 70,083 36,913 1,298 3 — 870 176,384 9,279 203 48,933 103,091 48,933 As of or for the Year Ended December 31, 2003 Institutional Individual 269 — — 208 5,233 185 157 — 3,180 — Auto & Home 279 — (30) 163 11,293 1,287 92 923 8,025 923 $ 3,367 — 588 57 60 2,725 212 20 964 151 — 5 105 14,503 2,620 99 14 10,973 14 International Reinsurance (Dollars in millions) Premiums*********************************************** $ Universal life and investment-type product policy fees ********** Net investment income************************************ Other revenues ****************************************** Net investment gains (losses) ****************************** Policyholder beneﬁts and claims **************************** Interest credited to policyholder account balances ************* Policyholder dividends ************************************ Other expenses****************************************** Income (loss) from continuing operations before provision (beneﬁt) for income taxes ******************************** Income from discontinued operations, net of income taxes****** Cumulative effect of a change in accounting, net of income taxes Net income ********************************************* Total assets ********************************************* Deferred policy acquisition costs**************************** Goodwill, net ******************************************** Separate account assets ********************************** Policyholder liabilities************************************** Separate account liabilities********************************* 9,093 $ 635 4,028 592 (293) 9,843 915 198 1,784 4,344 $2,908 — 1,589 158 6,194 32 407 (15) (307) 2,139 5,039 — 1,793 1 1,700 756 2,847 $ 1,678 272 502 80 8 1,457 143 55 660 1,315 37 (26) 849 113,743 739 59 35,632 61,599 35,632 848 34 — 601 165,774 8,817 206 39,619 100,278 39,619 187 — — 157 4,698 180 157 — 2,943 — 225 — — 208 9,935 1,046 85 504 7,179 504 $ 2,668 — 473 49 31 2,136 184 21 740 140 — — 92 12,833 2,160 100 13 9,783 13 $ (9) $ 22,316 2,900 2 12,418 472 1,198 7 182 (152) 22,662 8 2,998 — 1,814 — 7,761 532 (220) 123 (1) 141 23,337 — 21 (14) (1,325) (14) 3,779 136 (86) 2,758 356,808 14,336 633 86,769 194,027 86,769 Corporate & Other Total $ (18) $ 20,673 2,496 — 11,539 184 1,199 39 (582) (6) 20,665 51 3,035 — 1,975 — 7,091 304 (156) 273 — 310 19,858 1 21 (12) (2,211) (12) 2,559 344 (26) 2,217 326,841 12,943 628 75,756 179,571 75,756 MetLife, Inc. F-51 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. For the Year Ended December 31, 2002 Institutional Individual Auto & Home International Reinsurance (Dollars in millions) Corporate & Other Total Premiums*********************************************** $ Universal life and investment-type product policy fees ********** Net investment income************************************ Other revenues ****************************************** Net investment gains (losses) ****************************** Policyholder beneﬁts and claims **************************** Interest credited to policyholder account balances ************* Policyholder dividends ************************************ Other expenses****************************************** Income (loss) from continuing operations before provision $ 8,245 $ 624 3,909 609 (488) 9,345 932 115 1,531 4,507 $2,828 — 1,379 177 6,237 26 418 (46) (290) 2,019 5,064 — 1,793 — 1,770 793 2,639 $ 1,511 144 461 14 (9) 1,388 79 35 507 $ 2,005 — 421 43 (3) 1,554 146 22 617 (19) $ 19,077 2,147 — 11,183 (22) 1,166 56 (56) (892) 19,373 3 2,950 — 1,942 — 6,813 726 (beneﬁt) for income taxes ******************************** Income from discontinued operations, net of income taxes****** Net income (loss) **************************************** 1,603 976 492 127 1,605 759 Net investment income and net investment gains (losses) are based upon the actual results of each segment’s speciﬁcally identiﬁable asset portfolio adjusted for allocated capital. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing. Beginning in 2003, the Company changed its methodology of allocating capital to its business segments from Risk-Based Capital (‘‘RBC’’) to Economic Capital. Prior to 2003, the Company’s business segments’ allocated equity was primarily based on RBC, an internally developed formula based on applying a multiple to the NAIC Statutory Risk-Based Capital and included certain adjustments in accordance with GAAP. Economic Capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The Economic Capital model accounts for the unique and speciﬁc nature of the risks inherent in MetLife’s businesses. This is in contrast to the standardized regulatory RBC formula, which is not as reﬁned in its risk calculations with respect to the nuances of the Company’s businesses. (770) 161 (280) 127 — 84 112 — 84 985 204 826 173 — 132 The change in methodology is being applied prospectively. This change has and will continue to impact the level of net investment income and net income of each of the Company’s business segments. A portion of net investment income is credited to the segments based on the level of allocated equity. This change in methodology of allocating equity does not impact the Company’s consolidated net investment income or net income. The following table presents actual and pro forma net investment income with respect to the Company’s segments for the year ended Decem- ber 31, 2002. The amounts shown as pro forma reﬂect net investment income that would have been reported in 2002 had the Company allocated capital based on Economic Capital rather than on the basis of RBC. Net Investment Income For the Year Ended December 31, 2002 Actual Pro forma (Dollars in millions) Institutional **************************************************************************************** $ 3,909 Individual****************************************************************************************** 6,237 Auto & Home************************************************************************************** 177 International *************************************************************************************** 461 Reinsurance *************************************************************************************** 421 Corporate & Other********************************************************************************** (22) Total ************************************************************************************* $11,183 $ 3,971 6,148 160 424 382 98 $11,183 Revenues derived from any customer did not exceed 10% of consolidated revenues. Revenues from U.S. operations were $35,058 million, $31,844 million and $29,878 million for the years ended December 31, 2004, 2003 and 2002, respectively, which represented 90%, 90% and 91%, respectively, of consolidated revenues. 17. Acquisitions and Dispositions On January 31, 2005, the Holding Company completed the sale of SSRM Holdings, Inc. (‘‘SSRM’’) to a third party for $328 million of cash and stock. As a result of the sale of SSRM, the Company recognized income from discontinued operations of approximately $150 million, net of income taxes, comprised of a realized gain of $166 million, net of income taxes, and an operating expense related to a lease abandonment of $16 million, net of income taxes. Under the terms of the agreement, MetLife will have an opportunity to receive, prior to the end of 2006, additional payments aggregating up to approximately 25% of the base purchase price, based on, among other things, certain revenue retention and growth measures. The purchase price is also subject to reduction over ﬁve years, depending on retention of certain MetLife-related business. The Company has reclassiﬁed the assets, liabilities and operations of SSRM into discontinued operations for all periods presented in the consolidated ﬁnancial statements. Additionally, the sale of SSRM resulted in the elimination of the Company’s Asset Management segment. The remaining asset management business, which is insigniﬁcant, has been reclassiﬁed into Corporate & Other. The Company’s discontinued operations for the year ended December 31, 2004 also includes expenses of approximately $20 million, net of income taxes, related to the sale of SSRM. See also Note 18. In 2003, RGA entered into a coinsurance agreement under which it assumed the traditional U.S. life reinsurance business of Allianz Life Insurance Company of North America. The transaction added approximately $278 billion of life reinsurance in-force, $246 million of premium and $11 million of income before income tax expense, excluding minority interest expense, in 2003. The effects of such transaction are included within the Reinsurance segment. F-52 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. In 2002, the Company acquired Aseguradora Hidalgo S.A. (‘‘Hidalgo’’), an insurance company based in Mexico with approximately $2.5 billion in assets as of the date of acquisition (June 20, 2002). During the second quarter of 2003, as a part of its acquisition and integration strategy, the International segment completed the legal merger of Hidalgo into its original Mexican subsidiary, Seguro Genesis, S.A., forming MetLife Mexico, S.A. As a result of the merger of these companies, the Company recorded $62 million of earnings, net of income taxes, from the merger and a reduction in policyholder liabilities resulting from a change in reserve methodology. Such beneﬁt was recorded in the second quarter of 2003 in the International segment. See also Note 20 for Subsequent Events. 18. Discontinued Operations Real Estate The Company actively manages its real estate portfolio with the objective to maximize earnings through selective acquisitions and dispositions. Income related to real estate classiﬁed as held-for-sale or sold is presented as discontinued operations. These assets are carried at the lower of depreciated cost or fair value less expected disposition costs. The following table presents the components of income from discontinued real estate operations: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Investment income ******************************************************************************* $136 Investment expense ****************************************************************************** (82) Net investment gains****************************************************************************** 139 Total revenues ********************************************************************************* Interest expense ********************************************************************************* Provision for income taxes ************************************************************************* 193 13 63 Income from discontinued operations, net of income taxes ******************************************** $117 $ 231 (138) 420 $ 530 (351) 582 513 4 186 761 1 276 $ 323 $ 484 The carrying value of real estate related to discontinued operations was $252 million and $1,170 million at December 31, 2004 and 2003, respectively. The following table shows the real estate discontinued operations by segment: Year Ended December 31, 2004 2003 2002 (Dollars in millions) Net investment income Institutional *********************************************************************************** $ 6 Individual************************************************************************************* 7 Corporate & Other***************************************************************************** 41 Total net investment income*************************************************************** $ 54 Net investment gains (losses) Institutional *********************************************************************************** $ 9 Individual************************************************************************************* (3) Corporate & Other***************************************************************************** 133 Total net investment gains (losses) ********************************************************* $139 Interest Expense Individual************************************************************************************* $ — Corporate & Other***************************************************************************** 13 Total interest expense ******************************************************************** $ 13 $ 12 12 69 $ 93 $ 45 43 332 $420 $ 1 3 $ 4 $ 42 57 80 $179 $156 262 164 $582 $ 1 — $ 1 In April of 2004, MetLife sold one of its real estate investments, Sears Tower. The sale resulted in a gain of $85 million, net of income taxes. Operations During the third quarter of 2004, the Company entered into an agreement to sell its wholly-owned subsidiary, SSRM, to a third party, which was sold on January 31, 2005. Accordingly, the assets, liabilities and operations of SSRM have been reclassiﬁed into discontinued operations for all periods presented. The operations of SSRM include afﬁliated revenues of $59 million, $54 million and $56 million, for the years ended December 31, 2004, 2003 and 2002, respectively, related to asset management services provided by SSRM to the Company that have not been eliminated from discontinued MetLife, Inc. F-53 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. operations as these transactions will continue after the sale of SSRM. The following tables present the amounts related to operations of SSRM that have been combined with the discontinued real estate operations in the consolidated income statements: Years Ended December 31, 2004 2003 2002 (Dollars in millions) Revenues from discontinued operations ************************************************************* $328 Income from discontinued operations before provision for income taxes ********************************** $ 32 Provision for income taxes ************************************************************************ 13 Income from discontinued operations, net of income taxes ************************************* $ 19 $231 $ 34 13 $ 21 $239 $ 14 6 $ 8 December 31, 2004 2003 (Dollars in millions) Equity securities ************************************************************************************* $ 49 Real estate and real estate joint ventures **************************************************************** 96 Short term investments ******************************************************************************* 33 Other invested assets ******************************************************************************** 20 Cash and cash equivalents**************************************************************************** 55 Premiums and other receivables************************************************************************ 38 Other assets **************************************************************************************** 88 Total assets held-for-sale********************************************************************** $379 Short-term debt ************************************************************************************* $ 19 Current income taxes payable ************************************************************************* 1 Deferred income taxes payable ************************************************************************ 1 Other liabilities*************************************************************************************** 219 Total liabilities held-for-sale ******************************************************************** $240 $ 14 3 17 8 50 23 68 $183 $ — 1 2 67 $ 70 See Note 17 for further discussion of the disposition of SSRM. 19. Fair Value Information The estimated fair values of ﬁnancial instruments have been determined by using available market information and the valuation methodologies described below. Considerable judgment is often required in interpreting market data to develop estimates of fair value. Accordingly, the estimates presented herein may not necessarily be indicative of amounts that could be realized in a current market exchange. The use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts. Amounts related to the Company’s ﬁnancial instruments were as follows: December 31, 2004 Assets: Notional Amount Carrying Value Estimated Fair Value (Dollars in millions) Fixed maturities ********************************************************************** Equity securities ********************************************************************* Mortgage and other loans ************************************************************* Policy loans ************************************************************************* Short-term investments *************************************************************** Cash and cash equivalents ************************************************************ Mortgage loan commitments*********************************************************** $1,189 Commitments to fund partnership investments ******************************************** $1,324 Liabilities: Policyholder account balances ********************************************************* Short-term debt ********************************************************************* Long-term debt********************************************************************** Shares subject to mandatory redemption ************************************************ Payable under securities loaned transactions ********************************************* $176,763 $ 2,188 $ 32,406 8,899 $ 2,663 $ 4,051 $ — $ — $ $ 70,777 1,445 $ 7,412 $ 278 $ $ 28,678 $176,763 $ 2,188 $ 33,902 8,899 $ 2,663 $ 4,051 $ 4 $ — $ $ 69,688 1,445 $ 7,818 $ 365 $ $ 28,678 F-54 MetLife, Inc. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) METLIFE, INC. December 31, 2003 Assets: Notional Amount Carrying Value Estimated Fair Value (Dollars in millions) Fixed maturities ********************************************************************** Equity securities ********************************************************************* Mortgage and other loans ************************************************************* Policy loans ************************************************************************* Short-term investments *************************************************************** Cash and cash equivalents ************************************************************ Mortgage loan commitments*********************************************************** $ 679 Commitments to fund partnership investments ******************************************** $1,380 Liabilities: Policyholder account balances ********************************************************* Short-term debt ********************************************************************* Long-term debt********************************************************************** Shares subject to mandatory redemption ************************************************ Payable under securities loaned transactions ********************************************* $167,752 $ 1,584 $ 26,249 8,749 $ 1,809 $ 3,683 $ — $ — $ $ 63,957 3,642 $ 5,703 $ $ 277 $ 27,083 $167,752 $ 1,584 $ 28,259 8,749 $ 1,809 $ 3,683 $ (4) $ — $ $ 64,837 3,642 $ 6,041 $ $ 336 $ 27,083 The methods and assumptions used to estimate the fair values of ﬁnancial instruments are summarized as follows: Fixed Maturities and Equity Securities The fair value of ﬁxed maturities and equity securities are based upon quotations published by applicable stock exchanges or received from other reliable sources. For securities for which the market values were not readily available, fair values were estimated using quoted market prices of comparable investments. Mortgage and Other Loans, Mortgage Loan Commitments and Commitments to Fund Partnership Investments Fair values for mortgage and other loans are estimated by discounting expected future cash ﬂows, using current interest rates for similar loans with similar credit risk. For mortgage loan commitments, the estimated fair value is the net premium or discount of the commitments. Commitments to fund partnership investments have no stated interest rate and are assumed to have a fair value of zero. Policy Loans The carrying values for policy loans approximate fair value. Cash and Cash Equivalents and Short-term Investments The carrying values for cash and cash equivalents and short-term investments approximated fair values due to the short-term maturities of these instruments. Policyholder Account Balances The fair value of policyholder account balances is estimated by discounting expected future cash ﬂows based upon interest rates currently being offered for similar contracts with maturities consistent with those remaining for the agreements being valued. Short-term and Long-term Debt, Payables Under Securities Loaned Transactions and Shares Subject to Mandatory Redemption The fair values of short-term and long-term debt, payables under securities loaned transactions and shares subject to mandatory redemption are determined by discounting expected future cash ﬂows using risk rates currently available for debt with similar terms and remaining maturities. Derivative Financial Instruments The fair value of derivative instruments, including ﬁnancial futures, ﬁnancial forwards, interest rate, credit default and foreign currency swaps, foreign currency forwards, caps, ﬂoors, and options are based upon quotations obtained from dealers or other reliable sources. See Note 3 for derivative fair value disclosures. 20. Subsequent Events On January 31, 2005, the Holding Company entered into an agreement to acquire all of the outstanding shares of capital stock of certain indirect subsidiaries of Citigroup Inc., including the majority of The Travelers Insurance Company (‘‘Travelers’’), and substantially all of Citigroup Inc.’s international insurance businesses for a purchase price of $11.5 billion, subject to adjustment as described in the acquisition agreement. As a condition to closing, Citigroup Inc. and the Holding Company will enter into ten-year agreements under which the Company will expand its distribution by making products available through certain Citigroup distribution channels, subject to appropriate suitability and other standards. The transaction is expected to close in the summer of 2005. Approximately $1 billion to $3 billion of the purchase price will be paid in MetLife stock with the remainder paid in cash which will be ﬁnanced through a combination of cash on hand, debt, mandatorily convertible securities and selected asset sales depending on market conditions, timing, valuation considerations and the relative attractiveness of funding alternatives. The Company has entered into brokerage agreements relating to the possible sale of two of its real estate investments, 200 Park Avenue and One Madison Avenue in New York City. The Company is also contemplating other asset sales, including selling some or all of its beneﬁcially owned shares in RGA. The Company’s reinsurance segment consists primarily of the operations of RGA. See also Note 17 for subsequent event related to the disposition of SSRM. MetLife, Inc. F-55 BOARD OF DIRECTORS EXECUTIVE OFFICERS ROBERT H. BENMOSCHE Chairman of the Board and Chief Executive Ofﬁcer C. ROBERT HENRIKSON President and Chief Operating Ofﬁcer LELAND C. LAUNER, JR. President, Institutional Business* JAMES L. LIPSCOMB Executive Vice President and General Counsel CATHERINE A. REIN Senior Executive Vice President and Chief Administrative Ofﬁcer WILLIAM J. TOPPETA President, International LISA M. WEBER President, Individual Business WILLIAM J. WHEELER Executive Vice President and Chief Financial Ofﬁcer ROBERT H. BENMOSCHE Chairman of the Board and Chief Executive Ofﬁcer, MetLife, Inc. Chair, Executive Committee CURTIS H. BARNETTE Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP Chair, Investment Committee of Chairman of the Board, Metropolitan Life Insurance Company Member, Public Responsibility Committee JAMES M. KILTS JOHN M. KEANE General, United States Army (Retired) Member, Audit Committee, Governance Committee and Sales Practices Compliance Committee HUGH B. PRICE Senior Advisor, DLA Piper Rudnick Gray Cary US LLP Chair, Public Responsibility Committee Member, Audit Committee and Sales Practices Compliance Committee President and Chief Executive Ofﬁcer, The Gillette Company Member, Compensation Committee, Governance Committee and Sales Practices Compensation Committee and Compliance Committee KENTON J. SICCHITANO Retired Global Managing Partner, PricewaterhouseCoopers LLP Member, Audit Committee, Sales Practices Compliance Committee CHARLES M. LEIGHTON Executive Director, U.S. Sailing WILLIAM C. STEERE, JR. Chair, Sales Practices Compliance Committee Member, Compensation Committee and Executive Committee Retired Chairman of the Board and Chief Executive Ofﬁcer, Pﬁzer Inc. Chair, Compensation Committee Member, Audit Committee, Governance Committee and Sales Practices Compliance Committee SYLVIA M. MATHEWS Chief Operating Ofﬁcer and Executive Director, The Bill and Melinda Gates Foundation Member, Governance Committee and Public Responsibility Committee BURTON A. DOLE, JR. Former Partner and Chief Executive Ofﬁcer, MedSouth Therapies, LLC Chair, Audit Committee Member, Public Responsibility Committee CHERYL W. GRIS ´E President, Utility Group for Northeast Utilities, and Chief Executive Ofﬁcer of its principal operating subsidiaries Member, Compensation Committee, Governance Committee and Sales Practices Compliance Committee JAMES R. HOUGHTON Chairman and Chief Executive Ofﬁcer, Corning Incorporated Member, Executive Committee HARRY P. KAMEN Retired Chairman of the Board and Chief Executive Ofﬁcer, Metropolitan Life Insurance Company Member, Governance Committee and Executive Committee HELENE L. KAPLAN Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP Chair, Governance Committee Member, Public Responsibility Committee and Executive Committee * Mr. Launer is also presently the Chief Investment Ofﬁcer. MetLife, Inc. recently announced that Steven A. Kandarian will succeed Mr. Launer as Chief Investment Ofﬁcer. CORPORATE INFORMATION Corporate Proﬁle MetLife, Inc., through its subsidiaries and afﬁliates, is a leading provider of insurance and other ﬁnancial services to individual and institutional customers. The MetLife companies serve individuals in approximately 13 million households in the U.S. and provide beneﬁts to 37 million employees and family members through their plan sponsors. Outside the U.S., the MetLife companies serve approximately 9 million customers through direct insurance operations in Argentina, Brazil, Chile, China, Hong Kong, India, Indonesia, Mexico, South Korea, Taiwan and Uruguay. Investor Information http://ir.metlife.com Governance Information http://www.metlife.com/corporategovernance MetLife News http://metnews.metlife.com Corporate Headquarters MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 212-578-2211 Internet Address http://www.metlife.com Form 10-K and Other Information MetLife, Inc. will provide to shareholders without charge, upon written or oral request, a copy of MetLife, Inc.’s annual report on Form 10-K (including ﬁnancial statements and ﬁnancial statement schedules, but without exhibits) for the ﬁscal year ended December 31, 2004. MetLife, Inc. will furnish to requesting shareholders any exhibit to the Form 10-K upon the payment of reasonable expenses incurred by MetLife, Inc. in furnishing such exhibit. Requests should be directed to MetLife Investor Relations, MetLife, Inc., One MetLife Plaza, 27-01 Queens Plaza North, Long Island City, New York 11101-4007, via the Internet, by going to http://ir.metlife.com and selecting ‘‘Information Requests,’’ or by calling 1-800-649-3593. The annual report on Form 10-K also may be accessed at http://ir.metlife.com and at the website of the Securities and Exchange Commission at http://www.sec.gov. Transfer Agent/Shareholder Records For information or assistance regarding shareholder accounts or dividend checks, please contact MetLife’s transfer agent: Mellon Investor Services, LLC P.O. Box 4412 South Hackensack, NJ 07606-2012 1-800-649-3593 TDD for Hearing Impaired: 201-373-5040 www.melloninvestor.com Trustee, MetLife Policyholder Trust Wilmington Trust Company Rodney Square North 1100 North Market Street Wilmington, DE 19890 302-651-1000 www.wilmingtontrust.com Printed on recycled paper with environmentally friendly inks in the USA. PEANUTS © United Feature Syndicate, Inc. www.snoopy.com Common Stock and Dividend Information MetLife Inc.’s common stock is traded on the New York Stock Exchange (NYSE) under the trading symbol ‘‘MET.’’ The following table presents the high and low closing prices for the common stock of MetLife, Inc. on the NYSE for the periods indicated. MetLife, Inc. declared an annual dividend of $0.46 per share on September 28, 2004 and $0.23 per share on October 21, 2003. Future dividend decisions will be determined by MetLife, Inc.’s Board of Directors after taking into consideration factors such as MetLife, Inc.’s current earnings, expected medium- and long-term earnings, ﬁnancial condition, regulatory capital position, and applicable governmental regulations and policies. See ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources’’ and Note 12 of Notes to Consolidated Financial Statements. 2004 First quarter Second quarter Third quarter Fourth quarter 2003 First quarter Second quarter Third quarter Fourth quarter Common Stock Price High $35.87 $36.66 $38.73 $41.18 Low $32.63 $33.21 $33.97 $33.98 Common Stock Price High $29.34 $29.20 $29.58 $33.92 Low $24.01 $26.61 $27.35 $28.96 As of March 1, 2005, there were approximately 6.1 million beneﬁcial shareholders of MetLife, Inc. CEO and CFO Certiﬁcations The CEO Certiﬁcation required by Section 303A.12(a) of the New York Stock Exchange Listed Company Manual was submitted to the NYSE in 2004. MetLife, Inc. has ﬁled the CEO and CFO Certiﬁcations required by Section 302 of the Sarbanes-Oxley Act of 2002 as exhibits to its Annual Report on Form 10-K for the year ended December 31, 2004. © 2005 METLIFE, INC. PEANUTS © United Feature Syndicate, Inc. MetLife, Inc. 200 Park Avenue New York, NY 10166-0188 www.metlife.com

Continue reading text version or see original annual report in PDF format above